{"id": 41929194, "time": "2024-11-13 00:06:39", "headline": "Nvidia And SoftBank To Build Japan's Top AI Supercomputer On Blackwell Platform \u2014 Jensen Huang Says Tokyo Is 'Leaping Into The AI Industrial Revolution'", "summary": "The collaboration unveiled at the Nvidia AI Summit Japan, centers on SoftBank&#39;s implementation of Nvidia&#39;s advanced Blackwell platform and plans to utilize the Nvidia Grace Blackwell platform for future supercomputing initiatives.", "symbols": ["NVDA", "SFTBF", "SFTBY"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/global/24/11/41929194/nvidia-and-softbank-to-build-japans-top-ai-supercomputer-on-blackwell-platform-jensen-huang-says-tokyo-is-leaping-into-the-ai-industrial-revolution", "tags": []}
{"id": 41929407, "time": "2024-11-13 00:25:09", "headline": "Silk Road Creator Ross Ulbricht Awaits Trump's Promised Pardon For Bitcoin-Aided Crimes: 'See The Light Of Freedom At The End Of The Tunnel'", "summary": "Ross Ulbricht, the creator of the online illegal drug marketplace Silk Road, thanked those who voted for Donald Trump for his cause, hoping that the President-elect would commute his sentence", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41929407/silk-road-creator-ross-ulbricht-awaits-trumps-promised-pardon-for-bitcoin-aided-crimes-see-the-light-of-freedom-at-the-end-of-the-tunnel", "tags": []}
{"id": 41929420, "time": "2024-11-13 00:26:08", "headline": "Reported Earlier, Australia Wage Price Index (QoQ) For Q3 0.8% Vs. 0.9% Est.; 0.8% Prior", "summary": "", "symbols": ["EWA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41929420/reported-earlier-australia-wage-price-index-qoq-for-q3-0-8-vs-0-9-est-0-8-prior", "tags": []}
{"id": 41929545, "time": "2024-11-13 00:32:19", "headline": "Lunchables Meals Discontinued By Kraft Heinz Amid Low Sales And Health Concerns", "summary": "Kraft Heinz announced Tuesday that it is discontinuing the Lunchables meals it created for U.S. schools, introduced for the 2023-2024 academic year. ", "symbols": ["KHC"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/markets/equities/24/11/41929545/lunchables-meals-discontinued-by-kraft-heinz-amid-low-sales-and-health-concerns", "tags": []}
{"id": 41929565, "time": "2024-11-13 00:37:52", "headline": "Kyndryl Expands AI Cloud Services In Japan, Leveraging Dell AI Factory And NVIDIA Enterprise Software For Generative AI Advancements", "summary": "", "symbols": ["DELL", "KD", "NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41929565/kyndryl-expands-ai-cloud-services-in-japan-leveraging-dell-ai-factory-and-nvidia-enterprise-software", "tags": []}
{"id": 41929602, "time": "2024-11-13 00:50:30", "headline": "Halliburton Expands Operations In Namibia With New Facilities, Creating Jobs And Boosting Energy Sector Growth", "summary": "", "symbols": ["HAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41929602/halliburton-expands-operations-in-namibia-with-new-facilities-creating-jobs-and-boosting-energy-sect", "tags": []}
{"id": 41929629, "time": "2024-11-13 00:57:03", "headline": "CyberArk Software, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday", "summary": " ", "symbols": ["BZH", "CSCO", "CYBR", "MARA", "RUM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41929629/cyberark-software-cisco-systems-and-3-stocks-to-watch-heading-into-wednesday", "tags": []}
{"id": 41929722, "time": "2024-11-13 01:01:49", "headline": "Top Wall Street Forecasters Revamp Tower Semiconductor Price Expectations Ahead Of Q3 Earnings", "summary": " ", "symbols": ["TSEM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41929722/top-wall-street-forecasters-revamp-tower-semiconductor-price-expectations-ahead-of-q3-earnings", "tags": ["earnings"]}
{"id": 41929739, "time": "2024-11-13 01:02:12", "headline": "Tesla Makes 1000 Powerwalls At Giga Nevada In A Day As Energy Storage Segment Booms", "summary": "Tesla&#39;s Giga Nevada facility built 1000 Powerwall energy storage devices in a single day marking a new milestone.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41929739/tesla-makes-1000-powerwalls-at-giga-nevada-in-a-day-as-energy-storage-segment-booms", "tags": []}
{"id": 41929909, "time": "2024-11-13 01:09:21", "headline": "Dow, S&P Decline Ahead Of Key Inflation Data, Tesla, Trump Media Slides: Fear Index Remains In 'Greed' Zone", "summary": " ", "symbols": ["BZH", "CSCO", "CYBR", "DJT", "HD", "TSLA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41929909/dow-sp-decline-ahead-of-key-inflation-data-tesla-trump-media-slides-fear-index-remains-in-greed-zone", "tags": []}
{"id": 41930070, "time": "2024-11-13 01:20:46", "headline": "Innate Pharma's Revenue For The Nine Months \u20ac10.2M, Down From \u20ac36.5M YoY; Cash \u20ac96.4M", "summary": "", "symbols": ["IPHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41930070/innate-pharmas-revenue-for-the-nine-months-10-2m-down-from-36-5m-yoy-cash-96-4m", "tags": ["earnings"]}
{"id": 41930126, "time": "2024-11-13 01:24:53", "headline": "HIVE Digital Technologies Q2 EPS $(0.06) Beats $(0.09) Estimate, Sales $22.65M Miss $25.69M Estimate", "summary": "", "symbols": ["HIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41930126/hive-digital-technologies-q2-eps-0-06-beats-0-09-estimate-sales-22-65m-miss-25-69m-estimate", "tags": ["earnings"]}
{"id": 41930134, "time": "2024-11-13 01:27:38", "headline": "Amazon Unveils Black Friday And Cyber Monday Events Packed With Deals Across 35+ Categories, From November 21 To December 2", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41930134/amazon-unveils-black-friday-and-cyber-monday-events-packed-with-deals-across-35-categories-from-nove", "tags": []}
{"id": 41930391, "time": "2024-11-13 01:59:46", "headline": "Investcorp Credit Q1 EPS $0.16 Beats $0.10 Estimate, Sales $6.85M Beat $5.16M Estimate", "summary": "", "symbols": ["ICMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41930391/investcorp-credit-q1-eps-0-16-beats-0-10-estimate-sales-6-85m-beat-5-16m-estimate", "tags": ["earnings"]}
{"id": 41930430, "time": "2024-11-13 02:07:53", "headline": "Kolibri Global Energy Q3 2024 GAAP EPS $0.14 Beats $0.09 Estimate, Sales $16.485M Beat $13.600M Estimate", "summary": "", "symbols": ["KGEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41930430/kolibri-global-energy-q3-2024-gaap-eps-0-14-beats-0-09-estimate-sales-16-485m-beat-13-600m-estimate", "tags": ["earnings"]}
{"id": 41930661, "time": "2024-11-13 02:17:08", "headline": "Better Home & Finance Q3 Revenue $28.99M Up From $4.91M YoY, Adj. Net Loss $48.756M Up From $76.987M YoY", "summary": "", "symbols": ["BETR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41930661/better-home-finance-q3-revenue-28-99m-up-from-4-91m-yoy-adj-net-loss-48-756m-up-from-76-987m-yoy", "tags": ["earnings"]}
{"id": 41930698, "time": "2024-11-13 02:21:14", "headline": "TWFG Q3 2024 Adj. EPS $0.15 Misses $0.16 Estimate, Sales $54.640M Beat $53.140M Estimate", "summary": "", "symbols": ["TWFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41930698/twfg-q3-2024-adj-eps-0-15-misses-0-16-estimate-sales-54-640m-beat-53-140m-estimate", "tags": ["earnings"]}
{"id": 41930700, "time": "2024-11-13 02:21:55", "headline": "Boeing Is Up Against Airbus And China's COMAC As Vietnam Airlines Seeks Bids For 50 Planes In 2025", "summary": "The national carrier previously signed a provisional agreement with Boeing Co for 50 737 MAX jets, but a final decision has yet to be reached as other manufacturers, including Airbus and China&#39;s COMAC, remain in contention", "symbols": ["BA", "EADSF", "EADSY"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/11/41930700/boeing-airbus-and-chinas-comac-compete-as-vietnam-airlines-seeks-bids-for-50-narrowbody-jets-in-2025", "tags": ["contract"]}
{"id": 41930720, "time": "2024-11-13 02:23:02", "headline": "Ellington Credit Q3 2024 Adj. EPS $0.28, Inline, Sales $4.752M Miss $5.241M Estimate", "summary": "", "symbols": ["EARN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41930720/ellington-credit-q3-2024-adj-eps-0-28-inline-sales-4-752m-miss-5-241m-estimate", "tags": ["earnings"]}
{"id": 41930899, "time": "2024-11-13 02:26:10", "headline": "i-80 Gold Q3 2024 Adj. EPS $(0.07) Misses $(0.02) Estimate, Sales $11.509M Down From $13.215M YoY", "summary": "", "symbols": ["IAUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41930899/i-80-gold-q3-2024-adj-eps-0-07-misses-0-02-estimate-sales-11-509m-down-from-13-215m-yoy", "tags": ["earnings"]}
{"id": 41930900, "time": "2024-11-13 02:26:11", "headline": "Marques 'MKBHD' Brownlee Apologizes For Overspeeding In Recent Video, Cuts Off Snippet Of Driving A Lamborghini At 96 MPH In 35 MPH Zone", "summary": "Popular tech YouTuber Marques Brownlee apologized for overspeeding in his recent video on Tuesday, following severe backlash from viewers.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/11/41930900/marques-brownlee-apologises-for-overspeeding-in-recent-dji-sponsored-video-cuts-off-snippet-of-driving-a-lamborghini-at-96-mph-in-35-mph-zone", "tags": []}
{"id": 41930918, "time": "2024-11-13 02:30:11", "headline": "Trump's High-Inflation Regime Will Weaken The Dollar And Push Bitcoin To $1M, Says Arthur Hayes: 'Get Long And Stay Long'", "summary": "Arthur Hayes, co-founder of cryptocurrency exchange BitMEX, believed President-elect Donald Trump&#39;s policies would weaken the dollar, driving up the value of scarcer assets like Bitcoin (CRYPTO: BTC) significantly.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41930918/trumps-high-inflation-regime-will-weaken-the-dollar-and-push-bitcoin-to-1m-says-arthur-hayes-get-long-and-stay-long", "tags": []}
{"id": 41931172, "time": "2024-11-13 02:36:36", "headline": "Reported Earlier, Spirit Airlines Files Form 12b-25, Citing Ongoing Debt Restructuring Talks And Delays In Q3 Report", "summary": "", "symbols": ["SAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41931172/reported-earlier-spirit-airlines-files-form-12b-25-citing-ongoing-debt-restructuring-talks-and-delay", "tags": []}
{"id": 41931222, "time": "2024-11-13 02:41:30", "headline": "Reported Earlier, Spirit Airlines Expects Q3 Margins To Drop 12 Points Following $61M Revenue Decline And $52M Expense Surge", "summary": "", "symbols": ["SAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41931222/reported-earlier-spirit-airlines-expects-q3-margins-to-drop-12-points-following-61m-revenue-decline", "tags": ["earnings"]}
{"id": 41931338, "time": "2024-11-13 02:47:34", "headline": "Tesla's Chinese Battery Supplier CATL 'Open Minded' About US Expansion If Trump Welcomes Chinese Investments", "summary": "Chinese battery and electric vehicle companies have faced significant barriers in entering the U.S. market due to protectionist trade policies initiated during Donald Trump&#39;s first term.", "symbols": ["F", "TSLA"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/tech/24/11/41931338/teslas-chinese-battery-supplier-catl-open-minded-about-us-expansion-if-trump-welcomes-chinese-investments", "tags": []}
{"id": 41931342, "time": "2024-11-13 02:47:55", "headline": "Reported Earlier, Where Food Comes From Q3 EPS $0.09 Down From $0.13 YoY, Sales $7.11M Up From $7.01M YoY", "summary": "", "symbols": ["WFCF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41931342/reported-earlier-where-food-comes-from-q3-eps-0-09-down-from-0-13-yoy-sales-7-11m-up-from-7-01m-yoy", "tags": ["earnings"]}
{"id": 41931360, "time": "2024-11-13 02:51:32", "headline": "Apple's AirTag Users Can Now Share Location With Airlines For Faster Recovery Of Lost Luggage", "summary": "Apple has announced a new feature for its Find My app that allows users to share the location of lost items with third parties, including airlines.", "symbols": ["AAPL", "DAL", "UAL"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/tech/24/11/41931360/apples-airtag-users-can-now-share-location-with-airlines-for-faster-recovery-of-lost-luggage", "tags": []}
{"id": 41931449, "time": "2024-11-13 02:56:32", "headline": "Davis Commodities H1 EPS $0.05 Down From $0.08 YoY, Sales $66.88M Down From $97.76M YoY", "summary": "", "symbols": ["DTCK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41931449/davis-commodities-h1-eps-0-05-down-from-0-08-yoy-sales-66-88m-down-from-97-76m-yoy", "tags": ["earnings"]}
{"id": 41931456, "time": "2024-11-13 02:57:37", "headline": "Reported Earlier, 89bio Prices Upsized $125M Public Offering Of 11,455,882 Common Stock At $8.50/Share And Pre-Funded Warrants", "summary": "", "symbols": ["ETNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41931456/reported-earlier-89bio-prices-upsized-125m-public-offering-of-11-455-882-common-stock-at-8-50share-a", "tags": ["offering"]}
{"id": 41931502, "time": "2024-11-13 03:03:49", "headline": "Reported Earlier, V2X Prices Secondary Offering At $61/Share, No Proceeds To Company", "summary": "", "symbols": ["VVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41931502/reported-earlier-v2x-prices-secondary-offering-at-61share-no-proceeds-to-company", "tags": ["offering"]}
{"id": 41931522, "time": "2024-11-13 03:06:55", "headline": "Reported Earlier, Grid Dynamics Prices $93.4M Public Offering Of 5.75M Common Shares At $17.25/Share", "summary": "", "symbols": ["GDYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41931522/reported-earlier-grid-dynamics-prices-93-4m-public-offering-of-5-75m-common-shares-at-17-25share", "tags": ["offering"]}
{"id": 41931541, "time": "2024-11-13 03:11:14", "headline": "Reported Earlier, Sidus Space Prices $7M Public Offering Of 5.6M Common Shares At $1.25 Each", "summary": "", "symbols": ["SIDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41931541/reported-earlier-sidus-space-prices-7m-public-offering-of-5-6m-common-shares-at-1-25-each", "tags": ["offering"]}
{"id": 41931689, "time": "2024-11-13 03:27:10", "headline": "Reported Earlier, Cisco And LTIMindtree Expand Collaboration To Launch AI-Driven Secure Access For Global Clients", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41931689/reported-earlier-cisco-and-ltimindtree-expand-collaboration-to-launch-ai-driven-secure-access-for-gl", "tags": []}
{"id": 41931757, "time": "2024-11-13 03:32:22", "headline": "Earnings Scheduled For November 13, 2024", "summary": " ", "symbols": ["ACXP", "ADAP", "AEMD", "AFCG", "AFYA", "AGRO", "AIRJ", "ALUR", "ALVO", "AMS", "ARCO", "ATEX", "AYTU", "BCDA", "BETR", "BFRI", "BITF", "BKKT", "BNGO", "BOXL", "BRFS", "BTM", "BV", "BWEN", "BZH", "CAAS", "CAPR", "CIG", "CREX", "CRNT", "CSAN", "CSCO", "CSLR", "CSTE", "CVV", "CYBR", "DADA", "DGII", "DLO", "DMAC", "DOLE", "DRRX", "DTCK", "EC", "ECOR", "EDBL", "ENLT", "EZPW", "FORA", "FPAY", "FULC", "FVR", "GFF", "GILT", "GLAD", "GOEV", "GRYP", "GWH", "HBM", "HI", "HIVE", "HP", "HROW", "HUT", "HYZN", "IBTA", "ICAD", "ICCC", "IDN", "INLX", "INVZ", "JAGX", "JJSF", "KBDC", "KLIC", "KMDA", "KRMD", "KULR", "L", "LMFA", "LOAR", "LQDA", "LUCD", "LVLU", "MCRB", "MFI", "MPTI", "MRSN", "NN", "NTWK", "NU", "NXGL", "OMER", "OPRX", "OTRK", "OWLT", "OXBR", "PAVM", "PBL", "PCYO", "PESI", "PET", "PRPH", "PSFE", "PYPD", "QMCO", "RDCM", "RSKD", "SARO", "SB", "SCPH", "SCWO", "SDIG", "SDST", "SLRN", "SMSI", "SNAL", "SNAX", "SNDA", "SONO", "SOWG", "SPMC", "SPRU", "SPRY", "SSKN", "SSYS", "STRR", "TARS", "TLPH", "TNON", "TOI", "TSEM", "TSHA", "TTEK", "VERO", "VHI", "VXRT", "WKSP", "WYY", "XFOR", "XOS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41931757/earnings-scheduled-for-november-13-2024", "tags": ["earnings"]}
{"id": 41931782, "time": "2024-11-13 03:35:00", "headline": "Reported Earlier, Walker & Dunlop Secures $113M Financing For Bay Area's Franklin 299 Multifamily Acquisition", "summary": "", "symbols": ["WD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41931782/reported-earlier-walker-dunlop-secures-113m-financing-for-bay-areas-franklin-299-multifamily-acquisi", "tags": []}
{"id": 41931788, "time": "2024-11-13 03:39:32", "headline": "Nvidia Set For Major Surge To $204? Analyst Predicts Post-Q3 Boost Driven By Blackwell GPU Demand, Strong Margins", "summary": "Nvidia&#39;s upcoming earnings report on Nov. 20 is a crucial factor in maintaining its growth momentum.", "symbols": ["NVDA", "SMCI"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41931788/nvidia-set-for-major-surge-to-204-analyst-predicts-post-q3-boost-driven-by-blackwell-gpu-demand-strong-margins", "tags": ["earnings"]}
{"id": 41931864, "time": "2024-11-13 03:49:05", "headline": "Alphabet's Waymo Opens Robotaxi Rides For All In Los Angeles After San Francisco, Says 'More Cities On The Way'", "summary": "Alphabet Inc&#39;s Waymo said on Tuesday that it has opened autonomous rides to everyone in Los Angeles.", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41931864/alphabets-waymo-opens-robotaxi-rides-for-all-in-los-angeles-after-san-francisco-says-more-cities-on-the-way", "tags": []}
{"id": 41931993, "time": "2024-11-13 04:02:22", "headline": "Dogecoin Tumbles Despite Elon Musk, Vivek Ramaswamy's 'DOGE' Appointment: This Is What Indicators Tell About Its Next Moves", "summary": "Following weeks of relentless promotion, the Department of Government Efficiency (DOGE) is set to become a reality, potentially sending the price of Dogecoin (CRYPTO: ", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41931993/dogecoin-tumbles-despite-elon-musk-vivek-ramaswamys-doge-appointment-this-is-what-indicators-tell-about-its-next-moves", "tags": []}
{"id": 41932137, "time": "2024-11-13 04:17:50", "headline": "Piper Sandler Maintains Neutral on Shopify, Raises Price Target to $94", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932137/piper-sandler-maintains-neutral-on-shopify-raises-price-target-to-94", "tags": ["analyst_other", "price_target_up"]}
{"id": 41932147, "time": "2024-11-13 04:20:17", "headline": "Piper Sandler Maintains Neutral on ZoomInfo Technologies, Raises Price Target to $11", "summary": "", "symbols": ["ZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932147/piper-sandler-maintains-neutral-on-zoominfo-technologies-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41932171, "time": "2024-11-13 04:23:24", "headline": "A Jacobs And Mott Macdonald Consortium Has Been Appointed As The Design Development Partner By The West Yorkshire Combined Authority (the Ca) In The Next Phase Of The West Yorkshire Mass Transit Programme", "summary": "", "symbols": ["J"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932171/a-jacobs-and-mott-macdonald-consortium-has-been-appointed-as-the-design-development-partner-by-the-w", "tags": []}
{"id": 41932208, "time": "2024-11-13 04:23:49", "headline": "Piper Sandler Maintains Neutral on EverCommerce, Raises Price Target to $11", "summary": "", "symbols": ["EVCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932208/piper-sandler-maintains-neutral-on-evercommerce-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41932249, "time": "2024-11-13 04:31:51", "headline": "Needham Reiterates Buy on Alcon, Maintains $107 Price Target", "summary": "", "symbols": ["ALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932249/needham-reiterates-buy-on-alcon-maintains-107-price-target", "tags": ["analyst_other"]}
{"id": 41932257, "time": "2024-11-13 04:34:17", "headline": "Needham Reiterates Buy on Innovid, Maintains $3 Price Target", "summary": "", "symbols": ["CTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932257/needham-reiterates-buy-on-innovid-maintains-3-price-target", "tags": ["analyst_other"]}
{"id": 41932275, "time": "2024-11-13 04:36:52", "headline": "Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target", "summary": "", "symbols": ["AVDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932275/needham-reiterates-buy-on-avadel-pharmaceuticals-maintains-22-price-target", "tags": ["analyst_other"]}
{"id": 41932278, "time": "2024-11-13 04:39:20", "headline": "Needham Reiterates Buy on Camtek, Maintains $95 Price Target", "summary": "", "symbols": ["CAMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932278/needham-reiterates-buy-on-camtek-maintains-95-price-target", "tags": ["analyst_other"]}
{"id": 41932289, "time": "2024-11-13 04:40:51", "headline": "AI Capabilities Plateauing, Say Andreessen Horowitz Founders, Echoing Concerns Of OpenAI Co-Founder Ilya Sutskever", "summary": "The founders of prominent venture capital firm Andreessen Horowitz are observing a plateau in artificial intelligence capabilities, citing data shortages and computational limitations as key barriers to continued rapid advancement.", "symbols": [], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/tech/24/11/41932289/ai-capabilities-plateauing-say-andreessen-horowitz-founders-echoing-concerns-of-openai-co-founder-ilya-sutskever", "tags": []}
{"id": 41932306, "time": "2024-11-13 04:43:18", "headline": "Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $4", "summary": "", "symbols": ["HRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932306/needham-maintains-buy-on-heron-therapeutics-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 41932330, "time": "2024-11-13 04:45:37", "headline": "Evercore ISI Group Initiates Coverage On Axalta Coating Sys with Outperform Rating, Announces Price Target of $47", "summary": "", "symbols": ["AXTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932330/evercore-isi-group-initiates-coverage-on-axalta-coating-sys-with-outperform-rating-announces-price-t", "tags": ["analyst_init"]}
{"id": 41932146, "time": "2024-11-13 04:19:57", "headline": "Spirit Airlines Nears Bankruptcy, Creditors May Approve Equity 'Cancellation:' Here's What It Means For Investors As Shares Fall With A Thud", "summary": "Shares of Spirit Airlines Inc. (NYSE: SAVE) plunged by 62.73% in after-hours and closed nearly 5.29% lower at $3.22 apiece on Tuesday after the company failed to file its earnings for the quarter ended September 2024. The discount airline in a filing late Tuesday, said that it is in talks with its creditors to carve out a restructuring plan which could lead to the cancellation of its equity shares.", "symbols": ["JBLU", "SAVE", "ULCC"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/news/earnings/24/11/41932146/spirit-airlines-nears-bankruptcy-creditors-may-approve-equity-cancellation-heres-what-it-means-for-investors-as-shares-fall-with-a-thud", "tags": ["earnings"]}
{"id": 41932367, "time": "2024-11-13 04:47:28", "headline": "HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $32 Price Target", "summary": "", "symbols": ["KURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932367/hc-wainwright-co-reiterates-buy-on-kura-oncology-maintains-32-price-target", "tags": ["analyst_other"]}
{"id": 41932371, "time": "2024-11-13 04:48:18", "headline": "Goldman Sachs Maintains Buy on On Holding, Raises Price Target to $57", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932371/goldman-sachs-maintains-buy-on-on-holding-raises-price-target-to-57", "tags": ["analyst_other", "price_target_up"]}
{"id": 41932376, "time": "2024-11-13 04:50:56", "headline": "Goldman Sachs Maintains Buy on Live Nation Entertainment, Raises Price Target to $148", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932376/goldman-sachs-maintains-buy-on-live-nation-entertainment-raises-price-target-to-148", "tags": ["analyst_other", "price_target_up"]}
{"id": 41932444, "time": "2024-11-13 04:55:27", "headline": "HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target", "summary": "", "symbols": ["GEVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932444/hc-wainwright-co-reiterates-buy-on-gevo-maintains-14-price-target", "tags": ["analyst_other"]}
{"id": 41932462, "time": "2024-11-13 04:57:28", "headline": "Needham Reiterates Buy on Avidity Biosciences, Maintains $60 Price Target", "summary": "", "symbols": ["RNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932462/needham-reiterates-buy-on-avidity-biosciences-maintains-60-price-target", "tags": ["analyst_other"]}
{"id": 41932469, "time": "2024-11-13 04:58:56", "headline": "Stephens & Co. Reiterates Overweight on First Watch Restaurant Gr, Maintains $25 Price Target", "summary": "", "symbols": ["FWRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932469/stephens-co-reiterates-overweight-on-first-watch-restaurant-gr-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 41932481, "time": "2024-11-13 05:00:38", "headline": "GM Unveils 2026 Cadillac Vistiq Electric SUV With Starting Price Below Tesla Model X, Lucid Gravity", "summary": "General Motors on Tuesday debuted its new electric vehicle under its luxury brand Cadillac- a luxury three-row SUV set to rival Tesla Inc&#39;s Model X and Lucid Motors&#39; Gravity SUV.", "symbols": ["GM", "LCID", "TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41932481/gm-unveils-2026-cadillac-vistiq-electric-suv-with-starting-price-below-tesla-model-x-lucid-gravity", "tags": []}
{"id": 41932523, "time": "2024-11-13 05:02:36", "headline": "Piper Sandler Maintains Overweight on Shift4 Payments, Raises Price Target to $120", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932523/piper-sandler-maintains-overweight-on-shift4-payments-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 41932536, "time": "2024-11-13 05:06:10", "headline": "AI Coming For Translator Jobs? This CEO Says Humans Won't Be Needed For Translation 'Except...Most Difficult Use Cases' In 3 Years", "summary": "The bold prediction comes amid ongoing debates about the impact of AI on employment. ", "symbols": [], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/tech/24/11/41932536/ai-coming-for-translator-jobs-this-ceo-says-humans-wont-be-needed-for-translation-except-most-difficult-use-cases-in-3-years", "tags": ["management"]}
{"id": 41932537, "time": "2024-11-13 05:06:20", "headline": "Arelion Announced It Has Expanded Its Partnership With NETSCOUT Cybersecurity And DDoS Attack Protection Solutions, To Strengthen The Internet Carrier's DDoS Attack Mitigation Capabilities", "summary": "", "symbols": ["NTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932537/arelion-announced-it-has-expanded-its-partnership-with-netscout-cybersecurity-and-ddos-attack-protec", "tags": ["contract"]}
{"id": 41932540, "time": "2024-11-13 05:06:27", "headline": "Needham Reiterates Buy on Viridian Therapeutics, Maintains $38 Price Target", "summary": "", "symbols": ["VRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932540/needham-reiterates-buy-on-viridian-therapeutics-maintains-38-price-target", "tags": ["analyst_other"]}
{"id": 41932631, "time": "2024-11-13 05:10:16", "headline": "Lucid Diagnostics Q3 2024 GAAP EPS $(0.25) Misses $(0.22) Estimate, Sales $1.17M Beat $1.14M Estimate", "summary": "", "symbols": ["LUCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41932631/lucid-diagnostics-q3-2024-gaap-eps-0-25-misses-0-22-estimate-sales-1-17m-beat-1-14m-estimate", "tags": ["earnings"]}
{"id": 41932639, "time": "2024-11-13 05:11:10", "headline": "Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target", "summary": "", "symbols": ["NMRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932639/needham-reiterates-buy-on-neumora-therapeutics-maintains-23-price-target", "tags": ["analyst_other"]}
{"id": 41932661, "time": "2024-11-13 05:13:39", "headline": "Needham Reiterates Hold on Fate Therapeutics", "summary": "", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932661/needham-reiterates-hold-on-fate-therapeutics", "tags": ["analyst_other"]}
{"id": 41932662, "time": "2024-11-13 05:14:05", "headline": "Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["CYCC", "DAVE", "EFSH", "GRPN", "HNRG", "IAUX", "KAPA", "MAPS", "MULN", "MVST", "NA", "NMHI", "NXTT", "PAY", "RKLB", "SAVE", "SIDU", "SYRS", "VRM", "ZI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41932662/why-rocket-lab-shares-are-trading-higher-by-around-29-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 41932768, "time": "2024-11-13 05:17:36", "headline": "Needham Reiterates Hold on Chegg", "summary": "", "symbols": ["CHGG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932768/needham-reiterates-hold-on-chegg", "tags": ["analyst_other"]}
{"id": 41932777, "time": "2024-11-13 05:19:39", "headline": "Needham Reiterates Buy on Axsome Therapeutics, Maintains $130 Price Target", "summary": "", "symbols": ["AXSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932777/needham-reiterates-buy-on-axsome-therapeutics-maintains-130-price-target", "tags": ["analyst_other"]}
{"id": 41932778, "time": "2024-11-13 05:20:07", "headline": "Amgen Issued The Statement On MariTide (Maridebart Cafraglutide, Formerly AMG 133) Phase 1 Data, Saying Amgen Does Not See An Association Between The Administration Of MariTide And Bone Mineral Density Changes", "summary": "", "symbols": ["AMGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41932778/amgen-issued-the-statement-on-maritide-maridebart-cafraglutide-formerly-amg-133-phase-1-data-sayi", "tags": ["fda"]}
{"id": 41932780, "time": "2024-11-13 05:21:50", "headline": "Needham Reiterates Hold on Lexicon Pharmaceuticals", "summary": "", "symbols": ["LXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932780/needham-reiterates-hold-on-lexicon-pharmaceuticals", "tags": ["analyst_other"]}
{"id": 41932895, "time": "2024-11-13 05:25:06", "headline": "Tencent Holdings Q3 2024 Adj. EPS RMB6.34, Inline, Sales RMB167.200B Miss RMB167.855B Estimate", "summary": "", "symbols": ["TCEHY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41932895/tencent-holdings-q3-2024-adj-eps-rmb6-34-inline-sales-rmb167-200b-miss-rmb167-855b-estimate", "tags": ["earnings"]}
{"id": 41932951, "time": "2024-11-13 05:31:27", "headline": "Mega Matrix Announced That It Released 'Spoiled By My CEO Husband' On November 13, Showcasing A Heartfelt Romance That Bravely Fights Against Societal Prejudices In The World Of The Elite", "summary": "", "symbols": ["MPU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932951/mega-matrix-announced-that-it-released-spoiled-by-my-ceo-husband-on-november-13-showcasing-a-heartfe", "tags": ["management"]}
{"id": 41932952, "time": "2024-11-13 05:31:34", "headline": "Tencent Holdings Q3 Adj EPS $0.89 Beats $0.88 Estimate, Sales $23.90B Beat $23.38B Estimate", "summary": "", "symbols": ["TCEHY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41932952/tencent-holdings-q3-eps-0-89-beats-0-88-estimate-sales-23-90b-beat-23-38b-estimate", "tags": ["earnings"]}
{"id": 41932957, "time": "2024-11-13 05:32:54", "headline": "Needham Maintains Buy on Paragon 28, Raises Price Target to $13", "summary": "", "symbols": ["FNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932957/needham-maintains-buy-on-paragon-28-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 41932969, "time": "2024-11-13 05:34:09", "headline": "Needham Reiterates Hold on ICU Medical", "summary": "", "symbols": ["ICUI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932969/needham-reiterates-hold-on-icu-medical", "tags": ["analyst_other"]}
{"id": 41932972, "time": "2024-11-13 05:35:57", "headline": "Needham Maintains Buy on Cogent Biosciences, Lowers Price Target to $15", "summary": "", "symbols": ["COGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932972/needham-maintains-buy-on-cogent-biosciences-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 41932977, "time": "2024-11-13 05:37:50", "headline": "Needham Maintains Buy on Alight, Raises Price Target to $11", "summary": "", "symbols": ["ALIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41932977/needham-maintains-buy-on-alight-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41932978, "time": "2024-11-13 05:38:34", "headline": "Cisco And LTIMindtree Join Forces To Fortify Hybrid Work Security with Cutting-Edge Solutions", "summary": "LTIMindtree adopts Cisco Secure Access as its Security Service Edge solution for global employees and customers. Cisco offers AI-powered security solutions.", "symbols": ["CIBR", "CSCO", "IYZ"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/24/11/41932978/cisco-and-ltimindtree-join-forces-to-fortify-hybrid-work-security-with-cutting-edge-solutions", "tags": []}
{"id": 41933015, "time": "2024-11-13 05:41:38", "headline": "Oppenheimer Initiates Coverage On NetApp with Perform Rating", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933015/oppenheimer-initiates-coverage-on-netapp-with-perform-rating", "tags": ["analyst_init"]}
{"id": 41933018, "time": "2024-11-13 05:42:00", "headline": "Brookline Capital Downgrades Syros Pharmaceuticals to Hold", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933018/brookline-capital-downgrades-syros-pharmaceuticals-to-hold", "tags": ["analyst_down"]}
{"id": 41933023, "time": "2024-11-13 05:43:50", "headline": "BTIG Upgrades On Holding to Buy, Announces $64 Price Target", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933023/btig-upgrades-on-holding-to-buy-announces-64-price-target", "tags": ["analyst_up"]}
{"id": 41933024, "time": "2024-11-13 05:43:53", "headline": "Oppenheimer Initiates Coverage On Nutanix with Outperform Rating, Announces Price Target of $80", "summary": "", "symbols": ["NTNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933024/oppenheimer-initiates-coverage-on-nutanix-with-outperform-rating-announces-price-target-of-80", "tags": ["analyst_init"]}
{"id": 41931503, "time": "2024-11-13 03:03:54", "headline": "Trump Forms DOGE With Elon Musk And Vivek Ramaswamy At The Helm: Will It Impact Tesla CEO's Role At The EV Giant And SpaceX?", "summary": "President-elect Donald Trump, on Tuesday, greenlit the formation of the Department of Government Efficiency or DOGE, the acronym which almost sounds like a parody of the cryptocur", "symbols": ["DOGEUSD", "TSLA"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/government/regulations/24/11/41931503/trump-forms-doge-with-elon-musk-and-vivek-ramaswamy-at-the-helm-will-it-impact-tesla-ceos-role-at-the-ev-giant-and-spacex", "tags": ["management"]}
{"id": 41933060, "time": "2024-11-13 05:45:17", "headline": "Jack Dorsey's Block Shares Rally As Piper Sandler Initiates Coverage With 'Overweight' Rating: Here's What Other Analysts Are Saying", "summary": " ", "symbols": ["SQ"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41933060/jack-dorseys-block-shares-rally-as-piper-sandler-initiates-coverage-with-overweight-rating-heres-what-other-analysts-are-saying", "tags": ["analyst_init"]}
{"id": 41933062, "time": "2024-11-13 05:45:20", "headline": "Oppenheimer Initiates Coverage On Rubrik with Perform Rating", "summary": "", "symbols": ["RBRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933062/oppenheimer-initiates-coverage-on-rubrik-with-perform-rating", "tags": ["analyst_init"]}
{"id": 41933174, "time": "2024-11-13 05:47:07", "headline": "Oppenheimer Initiates Coverage On Pure Storage with Outperform Rating, Announces Price Target of $70", "summary": "", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933174/oppenheimer-initiates-coverage-on-pure-storage-with-outperform-rating-announces-price-target-of-70", "tags": ["analyst_init"]}
{"id": 41933182, "time": "2024-11-13 05:48:17", "headline": "Oppenheimer Initiates Coverage On CommVault Systems with Outperform Rating, Announces Price Target of $200", "summary": "", "symbols": ["CVLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933182/oppenheimer-initiates-coverage-on-commvault-systems-with-outperform-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 41933202, "time": "2024-11-13 05:50:30", "headline": "Oppenheimer Maintains Outperform on Shopify, Raises Price Target to $130", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933202/oppenheimer-maintains-outperform-on-shopify-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 41933206, "time": "2024-11-13 05:52:40", "headline": "TD Cowen Downgrades Coty to Hold, Announces $8.5 Price Target", "summary": "", "symbols": ["COTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933206/td-cowen-downgrades-coty-to-hold-announces-8-5-price-target", "tags": ["analyst_down"]}
{"id": 41933312, "time": "2024-11-13 05:54:39", "headline": "Stifel Downgrades Camden Prop Trust to Hold, Raises Price Target to $121", "summary": "", "symbols": ["CPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933312/stifel-downgrades-camden-prop-trust-to-hold-raises-price-target-to-121", "tags": ["analyst_down", "price_target_up"]}
{"id": 41933313, "time": "2024-11-13 05:54:45", "headline": "JMP Securities Downgrades Syros Pharmaceuticals to Market Perform", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933313/jmp-securities-downgrades-syros-pharmaceuticals-to-market-perform", "tags": ["analyst_down"]}
{"id": 41933348, "time": "2024-11-13 05:59:09", "headline": "Palantir Technologies Renewed Its Multi-year Enterprise Agreement With The Rio Tinto Group For An Additional 4 Years And Secures Rio Tinto's Ongoing Access To The Palantir Artificial Intelligence Platform", "summary": "", "symbols": ["PLTR", "RIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933348/palantir-technologies-renewed-its-multi-year-enterprise-agreement-with-the-rio-tinto-group-for-an-ad", "tags": ["contract"]}
{"id": 41933349, "time": "2024-11-13 05:59:23", "headline": "Phillip Securities Downgrades Spotify Technology to Accumulate, Raises Price Target to $485", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933349/phillip-securities-downgrades-spotify-technology-to-accumulate-raises-price-target-to-485", "tags": ["analyst_down", "price_target_up"]}
{"id": 41933350, "time": "2024-11-13 05:59:34", "headline": "ZoomInfo Surprises With Q3 Earnings Beat, But Stock Slides As Revenue Growth Lags", "summary": "ZoomInfo shares down after reporting Q3 results with revenue of $303.6M, beating estimates, and a net revenue retention of 37%.", "symbols": ["WCLD", "ZI"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/24/11/41933350/zoominfo-surprises-with-q3-earnings-beat-but-stock-slides-as-revenue-growth-lags", "tags": ["earnings"]}
{"id": 41933451, "time": "2024-11-13 06:01:34", "headline": "RBC Capital Initiates Coverage On Jumia Technologies with Sector Perform Rating, Announces Price Target of $5", "summary": "", "symbols": ["JMIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933451/rbc-capital-initiates-coverage-on-jumia-technologies-with-sector-perform-rating-announces-price-targ", "tags": ["analyst_init"]}
{"id": 41933469, "time": "2024-11-13 06:02:20", "headline": "Dole Q3 2024 Adj. EPS $0.19 Misses $0.20 Estimate, Sales $2.062B Beat $1.998B Estimate", "summary": "", "symbols": ["DOLE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41933469/dole-q3-2024-adj-eps-0-19-misses-0-20-estimate-sales-2-062b-beat-1-998b-estimate", "tags": ["earnings"]}
{"id": 41933470, "time": "2024-11-13 06:02:30", "headline": "China Automotive Systems Q3 EPS $0.18 Down From $0.31 YoY, Sales $164.2M Up From $137.5M YoY", "summary": "", "symbols": ["CAAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41933470/china-automotive-systems-q3-eps-0-18-down-from-0-31-yoy-sales-164-2m-up-from-137-5m-yoy", "tags": ["earnings"]}
{"id": 41933471, "time": "2024-11-13 06:02:32", "headline": "Hudbay Minerals Q3 2024 Adj. EPS $0.13 Beats $0.04 Estimate, Sales $485.773M Beat $455.400M Estimate", "summary": "", "symbols": ["HBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41933471/hudbay-minerals-q3-2024-adj-eps-0-13-beats-0-04-estimate-sales-485-773m-beat-455-400m-estimate", "tags": ["earnings"]}
{"id": 41933479, "time": "2024-11-13 06:03:18", "headline": "Enlight Renewable Energy Q3 2024 GAAP EPS $0.12 Beats $0.03 Estimate, Sales $109.495M Beat $84.575M Estimate", "summary": "", "symbols": ["ENLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41933479/enlight-renewable-energy-q3-2024-gaap-eps-0-12-beats-0-03-estimate-sales-109-495m-beat-84-575m-esti", "tags": ["earnings"]}
{"id": 41933496, "time": "2024-11-13 06:03:44", "headline": "Hudbay Minerals Reported Q3 Consolidated Copper Production Of 31,354 Tonnes And Consolidated Gold Production Of 89,073 Ounces", "summary": "", "symbols": ["HBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41933496/hudbay-minerals-reported-q3-consolidated-copper-production-of-31-354-tonnes-and-consolidated-gold-p", "tags": []}
{"id": 41933502, "time": "2024-11-13 06:03:57", "headline": "X4 Pharmaceuticals Announced New Clinical Data From Its Phase 2 Trial Of Mavorixafor For Chronic Neutropenia, Final Data Analysis From The Six-month Study Showed That Once-Daily Oral Mavorixafor Durably And Meaningfully Increased Mean Absolute Neutrophil Counts", "summary": "", "symbols": ["XFOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41933502/x4-pharmaceuticals-announced-new-clinical-data-from-its-phase-2-trial-of-mavorixafor-for-chronic-", "tags": ["fda"]}
{"id": 41933521, "time": "2024-11-13 06:04:13", "headline": "Gilat Satellite Networks Q3 2024 Adj EPS $0.14 Beats $0.05 Estimate, Sales $74.60M Miss $76.95M Estimate", "summary": "", "symbols": ["GILT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41933521/gilat-satellite-networks-q3-2024-adj-eps-0-14-beats-0-05-estimate-sales-74-60m-miss-76-95m-estimate", "tags": ["earnings"]}
{"id": 41933531, "time": "2024-11-13 06:04:32", "headline": "Redburn Atlantic Downgrades Starbucks to Sell, Lowers Price Target to $77", "summary": "", "symbols": ["SBUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933531/redburn-atlantic-downgrades-starbucks-to-sell-lowers-price-target-to-77", "tags": ["analyst_down", "price_target_down"]}
{"id": 41933534, "time": "2024-11-13 06:04:41", "headline": "Hudbay Minerals Reaffirms FY24 Copper Production Of 137,000 - 176,000 Tonnes And Gold Production Of 263,000 - 319,000 Ounces", "summary": "", "symbols": ["HBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933534/hudbay-minerals-reaffirms-fy24-copper-production-of-137-000-176-000-tonnes-and-gold-production-of-26", "tags": []}
{"id": 41933536, "time": "2024-11-13 06:05:01", "headline": "Dole Raised FY24  Adjusted EBITDA Target By $10.0M To At Least $380.0M, Sees Capital Expenditure Between $130.0M-$140.0M", "summary": "", "symbols": ["DOLE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933536/dole-raised-fy24-adjusted-ebitda-target-by-10-0m-to-at-least-380-0m-sees-capital-expenditure-between", "tags": []}
{"id": 41933584, "time": "2024-11-13 06:06:13", "headline": "B. Riley Securities Downgrades Adams Resources & Energy to Neutral, Lowers Price Target to $38", "summary": "", "symbols": ["AE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933584/b-riley-securities-downgrades-adams-resources-energy-to-neutral-lowers-price-target-to-38", "tags": ["analyst_down", "price_target_down"]}
{"id": 41933585, "time": "2024-11-13 06:06:16", "headline": "Dole Declares Cash Dividend Of $0.08 Per Share, Payable On January 3, 2025", "summary": "", "symbols": ["DOLE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933585/dole-declares-cash-dividend-of-0-08-per-share-payable-on-january-3-2025", "tags": ["dividend"]}
{"id": 41933596, "time": "2024-11-13 06:07:39", "headline": "Gyre Therapeutics Q3 2024 GAAP EPS Of $0.01 Vs. $0.05 YoY, With Adjusted Net Income Of $4.39M Vs. $11.19M YoY", "summary": "", "symbols": ["GYRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41933596/gyre-therapeutics-q3-2024-gaap-eps-of-0-01-vs-0-05-yoy-with-adjusted-net-income-of-4-39m-vs-11-19", "tags": ["earnings"]}
{"id": 41933604, "time": "2024-11-13 06:08:28", "headline": "AgEagle Aerial Systems Regained Compliance with NYSE American Continued Listing Standards", "summary": "", "symbols": ["UAVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933604/ageagle-aerial-systems-regained-compliance-with-nyse-american-continued-listing-standards", "tags": []}
{"id": 41933610, "time": "2024-11-13 06:09:01", "headline": "Needham Reiterates Buy on SI-BONE, Maintains $19 Price Target", "summary": "", "symbols": ["SIBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933610/needham-reiterates-buy-on-si-bone-maintains-19-price-target", "tags": ["analyst_other"]}
{"id": 41933611, "time": "2024-11-13 06:09:25", "headline": "Hudbay Minerals Revised 2024 Annual Consolidated Cash Cost Guidance Range To $0.65-$0.85 Per Pound From $0.90-$1.10 Per Pound", "summary": "", "symbols": ["HBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933611/hudbay-minerals-revised-2024-annual-consolidated-cash-cost-guidance-range-to-0-65-0-85-per-pound-fro", "tags": ["guidance"]}
{"id": 41933617, "time": "2024-11-13 06:10:03", "headline": "X4 Pharmaceuticals Q3 2024 GAAP EPS $(0.18) Misses $(0.17) Estimate, Sales $560.00K Miss $1.69M Estimate", "summary": "", "symbols": ["XFOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41933617/x4-pharmaceuticals-q3-2024-gaap-eps-0-18-misses-0-17-estimate-sales-560-00k-miss-1-69m-estimate", "tags": ["earnings"]}
{"id": 41933683, "time": "2024-11-13 06:10:59", "headline": "Bellevue Capital Partners, One Of The Largest Shareholders Of Global Net Lease, Inc., Announced The Acquisition Of An Additional 100,000 Shares Of GNL", "summary": "", "symbols": ["GNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933683/bellevue-capital-partners-one-of-the-largest-shareholders-of-global-net-lease-inc-announced-the-acqu", "tags": []}
{"id": 41933684, "time": "2024-11-13 06:11:12", "headline": "China Automotive Systems Raises FY24 Revenue Guidance From $605M To $630M", "summary": "", "symbols": ["CAAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933684/china-automotive-systems-raises-fy24-revenue-guidance-from-605m-to-630m", "tags": ["earnings", "guidance"]}
{"id": 41933685, "time": "2024-11-13 06:11:45", "headline": "Super Micro Computer Said Unable To File Its Quarterly Report On Form 10-Q For The Period Ended September 30, 2024 In A Timely Manner Without Unreasonable Effort Or Expense", "summary": "", "symbols": ["SMCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41933685/super-micro-computer-said-unable-to-file-its-quarterly-report-on-form-10-q-for-the-period-ended-sep", "tags": []}
{"id": 41933702, "time": "2024-11-13 06:13:14", "headline": "Asia Markets Down, Europe Up, Dollar Makes 5-Month High - Global Markets Today While US Slept", "summary": "US markets fell as investors took profits after a post-election rally and concerns over inflation, while Asian markets declined and oil prices rose.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/11/41933702/asia-markets-mostly-lower-europe-in-green-oil-up-on-tight-supply-global-markets-today-while-us-slept", "tags": []}
{"id": 41933763, "time": "2024-11-13 06:14:07", "headline": "Centene Plans To Reaffirm 2024 Adjusted EPS Guidance Of Greater Than $6.80 (Est $6.69); Also Plans To Reiterate That It Expects To Grow Adjusted EPS In 2025 And Beyond - Filing", "summary": "", "symbols": ["CNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933763/centene-plans-to-reaffirm-2024-adjusted-eps-guidance-of-greater-than-6-80-est-6-69-also-plans-to-rei", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 41933778, "time": "2024-11-13 06:14:18", "headline": "HC Wainwright & Co. Maintains Buy on MAG Silver, Raises Price Target to $20", "summary": "", "symbols": ["MAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933778/hc-wainwright-co-maintains-buy-on-mag-silver-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 41933909, "time": "2024-11-13 06:15:58", "headline": "Needham Maintains Buy on Urgently, Lowers Price Target to $1.5", "summary": "", "symbols": ["ULY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933909/needham-maintains-buy-on-urgently-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41933945, "time": "2024-11-13 06:17:17", "headline": "Needham Reiterates Buy on Artiva Biotherapeutics, Maintains $23 Price Target", "summary": "", "symbols": ["ARTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933945/needham-reiterates-buy-on-artiva-biotherapeutics-maintains-23-price-target", "tags": ["analyst_other"]}
{"id": 41933958, "time": "2024-11-13 06:20:53", "headline": "Enlight Renewable Energy Raises FY2024 Sales Guidance from $345.00M-360.00M to $355.00M-$370.00M  VS Est. $354.57M", "summary": "", "symbols": ["ENLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933958/enlight-renewable-energy-raises-fy2024-sales-guidance-from-345-00m-360-00m-to-355-00m-370-00m-vs-est", "tags": ["guidance"]}
{"id": 41934150, "time": "2024-11-13 06:29:02", "headline": "Rivian Shares Rise 13% In Pre-Market: What's Going On?", "summary": "Rivian shares are up 13% in premarket trading after Volkswagen increased their planned investment to $5.8 billion.", "symbols": ["RIVN", "VWAGY"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/11/41934150/rivian-shares-rise-13-in-pre-market-after-volkswagen-increases-planned-investment-to-58b", "tags": ["why_moving"]}
{"id": 41934193, "time": "2024-11-13 06:31:06", "headline": "Hut 8 Mining Q3 Sales $43.735M Beat $38.068M Estimate", "summary": "", "symbols": ["HUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934193/hut-8-mining-q3-sales-43-735m-beat-38-068m-estimate", "tags": []}
{"id": 41934194, "time": "2024-11-13 06:31:17", "headline": "S&P 500, Dow Futures Dip As Investors Brace For Key Inflation Data: Expert Says 'Strong Productivity' Will Cap Inflation Despite Fed's Rate Cuts", "summary": "U.S. stocks could open on a negative note on Wednesday after the averages scaled record highs last week.", "symbols": ["BTC", "BTCUSD", "BZH", "CSCO", "CYBR", "HOOD", "MSTR", "QQQ", "RIVN", "SAVE", "SPY", "TSLA", "VWAGY"], "source": "benzinga", "author": "Rounak Jain", "url": "https://www.benzinga.com/news/earnings/24/11/41934194/sp-500-dow-futures-dip-as-investors-brace-for-key-inflation-data-expert-says-strong-productivity-will-cap-inflation-despite-feds-rate-cuts", "tags": []}
{"id": 41934195, "time": "2024-11-13 06:31:22", "headline": "Liquidia Q3 2024 GAAP EPS $(0.30) Beats $(0.37) Estimate, Sales $4.45M Beat $4.19M Estimate", "summary": "", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934195/liquidia-q3-2024-gaap-eps-0-30-beats-0-37-estimate-sales-4-45m-beat-4-19m-estimate", "tags": ["earnings"]}
{"id": 41934196, "time": "2024-11-13 06:31:25", "headline": "Stratasys Q3 2024 Adj EPS $0.01 Beats $(0.04) Estimate, Sales $140.01M Beat $139.49M Estimate", "summary": "", "symbols": ["SSYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934196/stratasys-q3-2024-adj-eps-0-01-beats-0-04-estimate-sales-140-01m-beat-139-49m-estimate", "tags": ["earnings"]}
{"id": 41934218, "time": "2024-11-13 06:32:13", "headline": "Immunic Announced That The Data From Its Phase 1/1b Clinical Trial Of IMU-856, An Orally Available And Systemically Acting Small Molecule Modulator That Targets Sirt6 Has Been Published In The Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology", "summary": "", "symbols": ["IMUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934218/immunic-announced-that-the-data-from-its-phase-11b-clinical-trial-of-imu-856-an-orally-available-and", "tags": ["fda"]}
{"id": 41934221, "time": "2024-11-13 06:32:39", "headline": "ARS Pharmaceuticals Q3 2024 GAAP EPS $(0.20) Misses $(0.14) Estimate, Sales $2.068M Beat $565.000K Estimate. Cash and Equivalents Of $349.6M", "summary": "", "symbols": ["SPRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934221/ars-pharmaceuticals-q3-2024-gaap-eps-0-20-misses-0-14-estimate-sales-2-068m-beat-565-000k-estimate-", "tags": ["earnings"]}
{"id": 41934239, "time": "2024-11-13 06:33:23", "headline": "Zedge Announced A Significant Enhancement To Zedge Marketplace's Website That Allows Users To Purchase Premium Wallpapers Directly On The Website, Providing Purchasers With Improved Value By Avoiding Third-party App Store Fees", "summary": "", "symbols": ["ZDGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934239/zedge-announced-a-significant-enhancement-to-zedge-marketplaces-website-that-allows-users-to-purchas", "tags": []}
{"id": 41934248, "time": "2024-11-13 06:33:32", "headline": "Hut 8 Mining Q3 2024 GAAP EPS $0.01 Beats $(0.28) Estimate", "summary": "", "symbols": ["HUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934248/hut-8-mining-q3-2024-gaap-eps-0-01-beats-0-28-estimate", "tags": ["earnings"]}
{"id": 41934249, "time": "2024-11-13 06:34:17", "headline": "Parsons Announced That The Tennessee Department Of Transportation Has Selected The Company To Serve As Lead Designer For The Proposed America's River Crossing Project", "summary": "", "symbols": ["PSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934249/parsons-announced-that-the-tennessee-department-of-transportation-has-selected-the-company-to-serve", "tags": []}
{"id": 41934266, "time": "2024-11-13 06:35:09", "headline": "Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $60 Price Target", "summary": "", "symbols": ["XENE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934266/needham-reiterates-buy-on-xenon-pharmaceuticals-maintains-60-price-target", "tags": ["analyst_other"]}
{"id": 41934267, "time": "2024-11-13 06:35:19", "headline": "Hyperscale Data, Previously Announced On November 6, 2024 That It Plans To Issue A Special One-time Dividend Of A Newly Designated 10% Series E Cumulative Redeemable Perpetual Preferred Stock To All Common Stockholders And Holders Of The Series C Convertible Preferred On An As-converted Basis", "summary": "", "symbols": ["GPUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934267/hyperscale-data-previously-announced-on-november-6-2024-that-it-plans-to-issue-a-special-one-time-di", "tags": ["dividend"]}
{"id": 41934304, "time": "2024-11-13 06:40:25", "headline": "Needham Reiterates Buy on Rigetti Computing, Maintains $2 Price Target", "summary": "", "symbols": ["RGTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934304/needham-reiterates-buy-on-rigetti-computing-maintains-2-price-target", "tags": ["analyst_other"]}
{"id": 41934320, "time": "2024-11-13 06:42:13", "headline": "Needham Maintains Buy on Dayforce, Raises Price Target to $95", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934320/needham-maintains-buy-on-dayforce-raises-price-target-to-95", "tags": ["analyst_other", "price_target_up"]}
{"id": 41934335, "time": "2024-11-13 06:42:23", "headline": "B of A Securities Downgrades Teekay Tankers to Underperform, Lowers Price Target to $46", "summary": "", "symbols": ["TNK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934335/b-of-a-securities-downgrades-teekay-tankers-to-underperform-lowers-price-target-to-46", "tags": ["analyst_down", "price_target_down"]}
{"id": 41934350, "time": "2024-11-13 06:43:38", "headline": "HC Wainwright & Co. Reiterates Buy on MARA Holdings, Maintains $28 Price Target", "summary": "", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934350/hc-wainwright-co-reiterates-buy-on-mara-holdings-maintains-28-price-target", "tags": ["analyst_other"]}
{"id": 41934352, "time": "2024-11-13 06:44:00", "headline": "Stratasys Maintains FY24 Revenue Outlook Of $570M - $580M (Est $571.893M), Raises Adj EPS Outlook From $0.01 - $0.05 To $0.03 - $0.07, Est $0.01", "summary": "", "symbols": ["SSYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934352/stratasys-maintains-fy24-revenue-outlook-of-570m-580m-est-571-893m-raises-adj-eps-outlook-from-0-01", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 41934353, "time": "2024-11-13 06:44:45", "headline": "Needham Reiterates Hold on EVgo", "summary": "", "symbols": ["EVGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934353/needham-reiterates-hold-on-evgo", "tags": ["analyst_other"]}
{"id": 41934361, "time": "2024-11-13 06:45:53", "headline": "Evercore ISI Group Downgrades Caterpillar to Underperform, Raises Price Target to $365", "summary": "", "symbols": ["CAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934361/evercore-isi-group-downgrades-caterpillar-to-underperform-raises-price-target-to-365", "tags": ["analyst_down", "price_target_up"]}
{"id": 41934462, "time": "2024-11-13 06:46:09", "headline": "Spire Global Announced An Agreement To A Sell Its Maritime Business To Kpler For Approximately $241M", "summary": "", "symbols": ["SPIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934462/spire-global-announced-an-agreement-to-a-sell-its-maritime-business-to-kpler-for-approximately-241m", "tags": ["contract"]}
{"id": 41934464, "time": "2024-11-13 06:46:42", "headline": "Needham Reiterates Buy on Clearside Biomedical, Maintains $6 Price Target", "summary": "", "symbols": ["CLSD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934464/needham-reiterates-buy-on-clearside-biomedical-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 41934465, "time": "2024-11-13 06:46:58", "headline": "BioNTech Has Agreed To Acquire Biotheus For $800M And Up To $150M In Potential Milestone Payments", "summary": "", "symbols": ["BNTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41934465/biontech-has-agreed-to-acquire-biotheus-for-800m-and-up-to-150m-in-potential-milestone-payments", "tags": ["merger"]}
{"id": 41934489, "time": "2024-11-13 06:48:12", "headline": "Evercore ISI Group Downgrades Eaton Corp to In-Line, Raises Price Target to $389", "summary": "", "symbols": ["ETN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934489/evercore-isi-group-downgrades-eaton-corp-to-in-line-raises-price-target-to-389", "tags": ["analyst_down", "price_target_up"]}
{"id": 41934491, "time": "2024-11-13 06:48:21", "headline": "Stantec Along With Design-build Partners General Contractor Hensel Phelps, And Architect Jones Studio, Have Been Awarded A $274.7M Contract By The US General Services Administration For A New Commercial Inspection Port Along The Mexico Border In Douglas, Arizona", "summary": "", "symbols": ["STN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934491/stantec-along-with-design-build-partners-general-contractor-hensel-phelps-and-architect-jones-studio", "tags": ["contract"]}
{"id": 41934492, "time": "2024-11-13 06:49:04", "headline": "Gilead Sciences Presented The First In-depth Look At Full Results From Its Pivotal Phase 3 PURPOSE 2 Trial Of Twice-yearly Lenacapavir For HIV Prevention", "summary": "", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41934492/gilead-sciences-presented-the-first-in-depth-look-at-full-results-from-its-pivotal-phase-3-purpos", "tags": ["fda"]}
{"id": 41934503, "time": "2024-11-13 06:50:58", "headline": "Needham Reiterates Buy on Silvaco Group, Maintains $19 Price Target", "summary": "", "symbols": ["SVCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934503/needham-reiterates-buy-on-silvaco-group-maintains-19-price-target", "tags": ["analyst_other"]}
{"id": 41934504, "time": "2024-11-13 06:51:27", "headline": "Riskified Q3 2024 Adj EPS $0.03 Beats $0.02 Estimate, Sales $78.85M Beat $75.03M Estimate", "summary": "", "symbols": ["RSKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934504/riskified-q3-2024-adj-eps-0-03-beats-0-02-estimate-sales-78-85m-beat-75-03m-estimate", "tags": ["earnings"]}
{"id": 41934505, "time": "2024-11-13 06:51:32", "headline": "Evercore ISI Group Downgrades Illinois Tool Works to Underperform, Raises Price Target to $255", "summary": "", "symbols": ["ITW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934505/evercore-isi-group-downgrades-illinois-tool-works-to-underperform-raises-price-target-to-255", "tags": ["analyst_down", "price_target_up"]}
{"id": 41934521, "time": "2024-11-13 06:52:58", "headline": "Riskified Board Authorizes Additional $75M Share Repurchase Program", "summary": "", "symbols": ["RSKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934521/riskified-board-authorizes-additional-75m-share-repurchase-program", "tags": ["buyback"]}
{"id": 41934525, "time": "2024-11-13 06:53:13", "headline": "Evercore ISI Group Upgrades Timken to Outperform, Raises Price Target to $91", "summary": "", "symbols": ["TKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934525/evercore-isi-group-upgrades-timken-to-outperform-raises-price-target-to-91", "tags": ["analyst_up", "price_target_up"]}
{"id": 41934640, "time": "2024-11-13 06:54:32", "headline": "HC Wainwright & Co. Downgrades Syros Pharmaceuticals to Neutral, Lowers Price Target to $1", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934640/hc-wainwright-co-downgrades-syros-pharmaceuticals-to-neutral-lowers-price-target-to-1", "tags": ["analyst_down", "price_target_down"]}
{"id": 41934641, "time": "2024-11-13 06:54:33", "headline": "Evercore ISI Group Upgrades PACCAR to Outperform, Raises Price Target to $129", "summary": "", "symbols": ["PCAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934641/evercore-isi-group-upgrades-paccar-to-outperform-raises-price-target-to-129", "tags": ["analyst_up", "price_target_up"]}
{"id": 41934642, "time": "2024-11-13 06:54:57", "headline": "Riskified Raises FY24 Revenue Outlook From $320M - $325M To $322M -$327M, Est $321.819M", "summary": "", "symbols": ["RSKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934642/riskified-raises-fy24-revenue-outlook-from-320m-325m-to-322m-327m-est-321-819m", "tags": ["earnings", "guidance"]}
{"id": 41934646, "time": "2024-11-13 06:55:03", "headline": "Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["POAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41934646/trading-halt-halted-at-6-55-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41934651, "time": "2024-11-13 06:56:00", "headline": "Tencent Q3 Earnings: Gaming And AI Fuel Profit Growth, Pony Ma Eyes E-Commerce Expansion", "summary": "Tencent Holding Ltd reported 2024 Q3 results with 8% revenue growth to $23.9 billion, beating analyst estimate. MAU grew 3% &amp; mobile QQ MAU grew 0.7%.", "symbols": ["TCEHY"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/24/11/41934651/tencent-q3-earnings-gaming-and-ai-fuel-profit-growth-pony-ma-eyes-e-commerce-expansion", "tags": ["earnings"]}
{"id": 41934652, "time": "2024-11-13 06:56:07", "headline": "Evercore ISI Group Downgrades ESAB to Underperform, Raises Price Target to $122", "summary": "", "symbols": ["ESAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934652/evercore-isi-group-downgrades-esab-to-underperform-raises-price-target-to-122", "tags": ["analyst_down", "price_target_up"]}
{"id": 41934659, "time": "2024-11-13 06:56:24", "headline": "Paysafe Q3 2024 Adj. EPS $0.51 Beats $0.02 Estimate, Sales $427.100M Beat $423.096M Estimate", "summary": "", "symbols": ["PSFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934659/paysafe-q3-2024-adj-eps-0-51-beats-0-02-estimate-sales-427-100m-beat-423-096m-estimate", "tags": ["earnings"]}
{"id": 41934665, "time": "2024-11-13 06:57:02", "headline": "Paysafe Q3 Total Payment Volume $37.5B, +7% YoY", "summary": "", "symbols": ["PSFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934665/paysafe-q3-total-payment-volume-37-5b-7-yoy", "tags": []}
{"id": 41934667, "time": "2024-11-13 06:57:07", "headline": "TreeHouse Foods Announced That Its Board Of Directors Has Approved A $400M Share Repurchase Authorization And Renewal Maintains The Existing Annual Cap Of $150M", "summary": "", "symbols": ["THS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934667/treehouse-foods-announced-that-its-board-of-directors-has-approved-a-400m-share-repurchase-authoriza", "tags": ["analyst_other", "buyback"]}
{"id": 41934669, "time": "2024-11-13 06:57:50", "headline": "Evercore ISI Group Upgrades Cummins to Outperform, Raises Price Target to $408", "summary": "", "symbols": ["CMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934669/evercore-isi-group-upgrades-cummins-to-outperform-raises-price-target-to-408", "tags": ["analyst_up", "price_target_up"]}
{"id": 41934704, "time": "2024-11-13 06:58:44", "headline": "Paysafe Raises FY24 Sales Guidance From $1.69B-$1.71B to $1.71B-$1.73B Vs. $1.72B Estimate, Sees Adj. EBITDA Of $471M-$484M", "summary": "", "symbols": ["PSFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934704/paysafe-raises-fy24-sales-guidance-from-1-69b-1-71b-to-1-71b-1-73b-vs-1-72b-estimate-sees-adj-ebitda", "tags": ["guidance"]}
{"id": 41934705, "time": "2024-11-13 06:59:01", "headline": "Needham Reiterates Buy on OncoCyte, Maintains $4.25 Price Target", "summary": "", "symbols": ["OCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934705/needham-reiterates-buy-on-oncocyte-maintains-4-25-price-target", "tags": ["analyst_other"]}
{"id": 41934707, "time": "2024-11-13 06:59:20", "headline": "Flutter Entertainment Announces That It Has Entered Into Non-discretionary Arrangements With Goldman Sachs & Co To Repurchase Ordinary Shares On Flutter's Behalf For An Aggregate Maximum Consideration Of Up To $350M On The New York Stock Exchange", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934707/flutter-entertainment-announces-that-it-has-entered-into-non-discretionary-arrangements-with-goldman", "tags": ["buyback"]}
{"id": 41934708, "time": "2024-11-13 06:59:48", "headline": "Tesla Recalls Over 2400 Cybertrucks In US", "summary": "Tesla is recalling 2,431 Cybertrucks in the U.S. citing concerns there maybe a loss of drive power to the wheels, \u00a0the NHTSA\u00a0said on Wednesday.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41934708/tesla-recalls-over-2400-cybertrucks-in-us", "tags": []}
{"id": 41934710, "time": "2024-11-13 07:00:01", "headline": "Evercore ISI Group Downgrades Savara to In-Line, Lowers Price Target to $5", "summary": "", "symbols": ["SVRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934710/evercore-isi-group-downgrades-savara-to-in-line-lowers-price-target-to-5", "tags": ["analyst_down", "price_target_down"]}
{"id": 41934740, "time": "2024-11-13 07:00:05", "headline": "Triple Flag Precious Metals Announced That The Toronto Stock Exchange Has Accepted The Notice Filed By Triple Flag To Renew Its Normal Course Issuer Bid", "summary": "", "symbols": ["TFPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934740/triple-flag-precious-metals-announced-that-the-toronto-stock-exchange-has-accepted-the-notice-filed", "tags": []}
{"id": 41934785, "time": "2024-11-13 07:00:14", "headline": "Where Dayforce Stands With Analysts", "summary": " ", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41934785/where-dayforce-stands-with-analysts", "tags": []}
{"id": 41934809, "time": "2024-11-13 07:00:21", "headline": "Decoding 9 Analyst Evaluations For PACCAR", "summary": " ", "symbols": ["PCAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41934809/decoding-9-analyst-evaluations-for-paccar", "tags": []}
{"id": 41934823, "time": "2024-11-13 07:00:28", "headline": "Assessing Silvaco Group: Insights From 7 Financial Analysts", "summary": " ", "symbols": ["SVCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41934823/assessing-silvaco-group-insights-from-7-financial-analysts", "tags": []}
{"id": 41934826, "time": "2024-11-13 07:00:35", "headline": "8 Analysts Assess NetApp: What You Need To Know", "summary": " ", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41934826/8-analysts-assess-netapp-what-you-need-to-know", "tags": []}
{"id": 41934828, "time": "2024-11-13 07:00:39", "headline": "Needham Maintains Buy on Pixelworks, Lowers Price Target to $1.5", "summary": "", "symbols": ["PXLW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934828/needham-maintains-buy-on-pixelworks-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41934830, "time": "2024-11-13 07:00:42", "headline": "The Analyst Verdict: Pure Storage In The Eyes Of 15 Experts", "summary": " ", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41934830/the-analyst-verdict-pure-storage-in-the-eyes-of-15-experts", "tags": []}
{"id": 41934846, "time": "2024-11-13 07:00:58", "headline": "Demystifying Lexicon Pharmaceuticals: Insights From 10 Analyst Reviews", "summary": " ", "symbols": ["LXRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41934846/demystifying-lexicon-pharmaceuticals-insights-from-10-analyst-reviews", "tags": []}
{"id": 41934856, "time": "2024-11-13 07:01:30", "headline": "Ceragon Networks Q3 2024 Adj. EPS $0.16 Beats $0.09 Estimate, Sales $102.672M Beat $101.507M Estimate", "summary": "", "symbols": ["CRNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934856/ceragon-networks-q3-2024-adj-eps-0-16-beats-0-09-estimate-sales-102-672m-beat-101-507m-estimate", "tags": ["earnings"]}
{"id": 41934858, "time": "2024-11-13 07:01:30", "headline": "CyberArk Software Q3 2024 Adj. EPS $0.94 Beats $0.46 Estimate, Sales $240.102M Beat $234.042M Estimate", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934858/cyberark-software-q3-2024-adj-eps-0-94-beats-0-46-estimate-sales-240-102m-beat-234-042m-estimate", "tags": ["earnings"]}
{"id": 41934864, "time": "2024-11-13 07:02:00", "headline": "Tower Semiconductor Q3 2024 Adj EPS $0.57 Beats $0.53 Estimate, Sales $370.51M Beat $370.32M Estimate", "summary": "", "symbols": ["TSEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934864/tower-semiconductor-q3-2024-adj-eps-0-57-beats-0-53-estimate-sales-370-51m-beat-370-32m-estimate", "tags": ["earnings"]}
{"id": 41934868, "time": "2024-11-13 07:02:04", "headline": "Bitfarms Q3 2024 Adj EPS $(0.08) Beats $(0.10) Estimate, Sales $45.00M Miss $48.84M Estimate", "summary": "", "symbols": ["BITF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934868/bitfarms-q3-2024-adj-eps-0-08-beats-0-10-estimate-sales-45-00m-miss-48-84m-estimate", "tags": ["earnings"]}
{"id": 41934873, "time": "2024-11-13 07:02:11", "headline": "BioRestorative Therapies Reports Preliminary Phase 2 BRTX-100 Clinical Data Showing A Material Decrease In Pain And Increase In Function", "summary": "", "symbols": ["BRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41934873/biorestorative-therapies-reports-preliminary-phase-2-brtx-100-clinical-data-showing-a-material-de", "tags": ["fda"]}
{"id": 41934875, "time": "2024-11-13 07:02:11", "headline": "Morgan Stanley Upgrades CCC Intelligent Solutions to Overweight, Raises Price Target to $15", "summary": "", "symbols": ["CCCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934875/morgan-stanley-upgrades-ccc-intelligent-solutions-to-overweight-raises-price-target-to-15", "tags": ["analyst_up", "price_target_up"]}
{"id": 41934885, "time": "2024-11-13 07:02:45", "headline": "CyberArk Software Q3 Total ARR $926M, +31% YoY, Subscription Portion of ARR $735M, +46% YoY", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934885/cyberark-software-q3-total-arr-926m-31-yoy-subscription-portion-of-arr-735m-46-yoy", "tags": []}
{"id": 41934889, "time": "2024-11-13 07:02:55", "headline": "Fulcrum Therapeutics Q3 2024 GAAP EPS $(0.35) Beats $(0.41) Estimate, Ended The Third Quarter Of 2024 With $257.2M In Cash, Cash Equivalents, And Marketable Securities; Cash Runway Into At Least 2027", "summary": "", "symbols": ["FULC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934889/fulcrum-therapeutics-q3-2024-gaap-eps-0-35-beats-0-41-estimate-ended-the-third-quarter-of-2024-with", "tags": ["earnings"]}
{"id": 41934890, "time": "2024-11-13 07:02:56", "headline": "Wag Group Q3 2024 GAAP EPS $(0.13) Misses $(0.04) Estimate, Sales $13.20M Miss $20.90M Estimate", "summary": "", "symbols": ["PET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934890/wag-group-q3-2024-gaap-eps-0-13-misses-0-04-estimate-sales-13-20m-miss-20-90m-estimate", "tags": ["earnings"]}
{"id": 41934914, "time": "2024-11-13 07:03:21", "headline": "Caesarstone Q3 2024 Adj. EPS $(0.24) Misses $(0.17) Estimate, Sales $107.634M Miss $119.600M Estimate", "summary": "", "symbols": ["CSTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934914/caesarstone-q3-2024-adj-eps-0-24-misses-0-17-estimate-sales-107-634m-miss-119-600m-estimate", "tags": ["earnings"]}
{"id": 41934924, "time": "2024-11-13 07:03:24", "headline": "Innoviz Technologies Q3 2024 GAAP EPS $(0.15) Misses $(0.14) Estimate, Sales $4.520M Beat $4.460M Estimate", "summary": "", "symbols": ["INVZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934924/innoviz-technologies-q3-2024-gaap-eps-0-15-misses-0-14-estimate-sales-4-520m-beat-4-460m-estimate", "tags": ["earnings"]}
{"id": 41934940, "time": "2024-11-13 07:03:32", "headline": "Kamada Q3 2024 GAAP EPS $0.18 Beats $0.07 Estimate, Sales $41.740M Beat $40.923M Estimate", "summary": "", "symbols": ["KMDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934940/kamada-q3-2024-gaap-eps-0-18-beats-0-07-estimate-sales-41-740m-beat-40-923m-estimate", "tags": ["earnings"]}
{"id": 41934949, "time": "2024-11-13 07:03:39", "headline": "American Shared Hospital Q3 EPS $(0.03) Misses $0.08 Estimate, Sales $7.00M Miss $7.53M Estimate", "summary": "", "symbols": ["AMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934949/american-shared-hospital-q3-eps-0-03-misses-0-08-estimate-sales-7-00m-miss-7-53m-estimate", "tags": ["earnings"]}
{"id": 41934956, "time": "2024-11-13 07:03:49", "headline": "Broadwind Q3 Sales $35.503M Miss $36.802M Estimate", "summary": "", "symbols": ["BWEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934956/broadwind-q3-sales-35-503m-miss-36-802m-estimate", "tags": []}
{"id": 41934960, "time": "2024-11-13 07:04:00", "headline": "HC Wainwright & Co. Reiterates Buy on CG Oncology, Maintains $75 Price Target", "summary": "", "symbols": ["CGON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934960/hc-wainwright-co-reiterates-buy-on-cg-oncology-maintains-75-price-target", "tags": ["analyst_other"]}
{"id": 41934968, "time": "2024-11-13 07:04:25", "headline": "Truist Securities Downgrades Progyny to Hold, Lowers Price Target to $19", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934968/truist-securities-downgrades-progyny-to-hold-lowers-price-target-to-19", "tags": ["analyst_down", "price_target_down"]}
{"id": 41934969, "time": "2024-11-13 07:04:26", "headline": "CyberArk Software Q4 Outlook: Adj EPS $0.65-$0.75 vs $0.55 Est; Sees Sales $297.000M-$303.000M vs $259.61M Est", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934969/cyberark-software-q4-outlook-adj-eps-0-65-0-75-vs-0-55-est-sees-sales-297-000m-303-000m-vs-259-61m-e", "tags": ["earnings", "guidance"]}
{"id": 41934970, "time": "2024-11-13 07:04:31", "headline": "Coterra Energy Enters Definitive Agreements To Acquire Certain Assets Of Franklin Mountain Energy And Avant Natural Resources And Its Affiliates For Aggregate Consideration Of $3.95B, Consisting Of $2.95B Of Cash And $1.0B Of Coterra Common Stock", "summary": "", "symbols": ["CTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41934970/coterra-energy-enters-definitive-agreements-to-acquire-certain-assets-of-franklin-mountain-energy-an", "tags": ["merger"]}
{"id": 41934971, "time": "2024-11-13 07:04:31", "headline": "Tower Semiconductor Guides Q4 Revenue To Be $387M, With An Upward Or Downward Range Of 5%; Est $379.225M", "summary": "", "symbols": ["TSEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41934971/tower-semiconductor-guides-q4-revenue-to-be-387m-with-an-upward-or-downward-range-of-5-est-379-225m", "tags": ["earnings"]}
{"id": 41934984, "time": "2024-11-13 07:04:53", "headline": "Acurx Pharmaceuticals Q3 2024 GAAP EPS $(0.17) Beats $(0.18) Estimate", "summary": "", "symbols": ["ACXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934984/acurx-pharmaceuticals-q3-2024-gaap-eps-0-17-beats-0-18-estimate", "tags": ["earnings"]}
{"id": 41934998, "time": "2024-11-13 07:05:26", "headline": "Venus Concept Q3 2024 GAAP EPS $(1.28) Misses $(1.13) Estimate, Sales $15.007M Miss $17.278M Estimate", "summary": "", "symbols": ["VERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41934998/venus-concept-q3-2024-gaap-eps-1-28-misses-1-13-estimate-sales-15-007m-miss-17-278m-estimate", "tags": ["earnings"]}
{"id": 41935000, "time": "2024-11-13 07:05:39", "headline": "HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $5 Price Target", "summary": "", "symbols": ["ARTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935000/hc-wainwright-co-reiterates-buy-on-artelo-biosciences-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 41935001, "time": "2024-11-13 07:05:45", "headline": "Seres Therapeutics Q3 2024 GAAP EPS $(0.33) Misses $(0.25) Estimate, Seres Had $66.8M In Cash And Cash Equivalents, That Is Expected To Fund Operations Into The Fourth Quarter Of 2025", "summary": "", "symbols": ["MCRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935001/seres-therapeutics-q3-2024-gaap-eps-0-33-misses-0-25-estimate-seres-had-66-8m-in-cash-and-cash-equi", "tags": ["earnings"]}
{"id": 41935002, "time": "2024-11-13 07:05:46", "headline": "Broadwind Expects Q4 Total Revenue Of $31M-$33M Vs. Consensus Of $36.80M, And Adjusted EBITDA Of $1.0M-$1.5M", "summary": "", "symbols": ["BWEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935002/broadwind-expects-q4-total-revenue-of-31m-33m-vs-consensus-of-36-80m-and-adjusted-ebitda-of-1-0m-1-5", "tags": ["earnings"]}
{"id": 41935004, "time": "2024-11-13 07:05:50", "headline": "RADCOM Named Benny Eppstein As New CEO, Effective December 1, Taking Over From Interim Chief Hilik Itman Who Will Continue As COO", "summary": "", "symbols": ["RDCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935004/radcom-named-benny-eppstein-as-new-ceo-effective-december-1-taking-over-from-interim-chief-hilik-itm", "tags": ["management"]}
{"id": 41935005, "time": "2024-11-13 07:05:51", "headline": "CyberArk Software Raises FY24 Outlook: Adj EPS From $2.17-$2.36 to $2.85-$2.96 vs $2.31 Est; Sales From $932.00M-$942.00M to $983.00M-$989.00M vs $941.48M Est", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935005/cyberark-software-raises-fy24-outlook-adj-eps-from-2-17-2-36-to-2-85-2-96-vs-2-31-est-sales-from-932", "tags": ["earnings", "guidance"]}
{"id": 41935007, "time": "2024-11-13 07:06:03", "headline": "Edible Garden AG Q3 2024 GAAP EPS $(0.65) Misses $(0.43) Estimate, Sales $2.584M Miss $3.712M Estimate", "summary": "", "symbols": ["EDBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935007/edible-garden-ag-q3-2024-gaap-eps-0-65-misses-0-43-estimate-sales-2-584m-miss-3-712m-estimate", "tags": ["earnings"]}
{"id": 41935014, "time": "2024-11-13 07:06:30", "headline": "Mizuho Maintains Outperform on Home Depot, Raises Price Target to $440", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935014/mizuho-maintains-outperform-on-home-depot-raises-price-target-to-440", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935018, "time": "2024-11-13 07:06:52", "headline": "Entero Therapeutics Announces Proposed Reverse Merger With Journey Therapeutics; To To Receive At Least $5M Of Equity Financing", "summary": "", "symbols": ["ENTO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41935018/entero-therapeutics-announces-proposed-reverse-merger-with-journey-therapeutics-to-to-receive-at-lea", "tags": ["merger"]}
{"id": 41935021, "time": "2024-11-13 07:07:04", "headline": "Aileron Therapeutics Announces Topline Data From Cohort 2 Of Phase 1b Clinical Trial Of LTI-03 In IPF; Says High-Dose LTI-03 Reduced Expression Of Multiple Profibrotic Proteins In Both Pathological Basal-like Cells And Fibroblasts And Decreased The Expression Of A Biomarker Indicative Of Epithelial Health And Lung Function Decline", "summary": "", "symbols": ["ALRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41935021/aileron-therapeutics-announces-topline-data-from-cohort-2-of-phase-1b-clinical-trial-of-lti-03-in", "tags": ["fda"]}
{"id": 41935022, "time": "2024-11-13 07:07:07", "headline": "Radcom Q3 2024 Adj. EPS $0.23 Beats $0.19 Estimate, Sales $15.821M Beat $14.955M Estimate", "summary": "", "symbols": ["RDCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935022/radcom-q3-2024-adj-eps-0-23-beats-0-19-estimate-sales-15-821m-beat-14-955m-estimate", "tags": ["earnings"]}
{"id": 41935023, "time": "2024-11-13 07:07:12", "headline": "Needham Maintains Buy on TeraWulf, Raises Price Target to $9.5", "summary": "", "symbols": ["WULF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935023/needham-maintains-buy-on-terawulf-raises-price-target-to-9-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935024, "time": "2024-11-13 07:07:26", "headline": "PolyPid Q3 2024 GAAP EPS $(1.22) Misses $(0.96) Estimate; Cash On Hand $9.5M", "summary": "", "symbols": ["PYPD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935024/polypid-q3-2024-gaap-eps-1-22-misses-0-96-estimate-cash-on-hand-9-5m", "tags": ["earnings"]}
{"id": 41935028, "time": "2024-11-13 07:07:41", "headline": "Caesarstone Reaffirms 2024 Outlook: Expects Positive Operating Cash Flow And Adjusted EBITDA Loss In The Range Of $10M-$11M", "summary": "", "symbols": ["CSTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935028/caesarstone-reaffirms-2024-outlook-expects-positive-operating-cash-flow-and-adjusted-ebitda-loss-in", "tags": ["guidance"]}
{"id": 41935033, "time": "2024-11-13 07:08:17", "headline": "Creative Realities Q3 2024 GAAP EPS $0.01 Beats $(0.02) Estimate, Sales $14.442M Beat $13.899M Estimate", "summary": "", "symbols": ["CREX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935033/creative-realities-q3-2024-gaap-eps-0-01-beats-0-02-estimate-sales-14-442m-beat-13-899m-estimate", "tags": ["earnings"]}
{"id": 41935034, "time": "2024-11-13 07:08:20", "headline": "Kaixin Holdings Announces Receipt Of Nasdaq Letter Indicating It Has Regained Compliance With Minimum Bid Price Requirement", "summary": "", "symbols": ["KXIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935034/kaixin-holdings-announces-receipt-of-nasdaq-letter-indicating-it-has-regained-compliance-with-minimu", "tags": []}
{"id": 41935079, "time": "2024-11-13 07:08:35", "headline": "HC Wainwright & Co. Reiterates Buy on Humacyte, Maintains $12 Price Target", "summary": "", "symbols": ["HUMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935079/hc-wainwright-co-reiterates-buy-on-humacyte-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41935092, "time": "2024-11-13 07:08:44", "headline": "Wag Sees Q4 Revenue Of $15M - $18M; Cuts FY24 Revenue Outlook From $92M - $102M To $70M - $73M (Est $90.655M)", "summary": "", "symbols": ["PET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935092/wag-sees-q4-revenue-of-15m-18m-cuts-fy24-revenue-outlook-from-92m-102m-to-70m-73m-est-90-655m", "tags": ["earnings", "guidance"]}
{"id": 41935094, "time": "2024-11-13 07:08:54", "headline": "Mersana Therapeutics Q3 2024 GAAP EPS $(0.09) Beats $(0.18) Estimate, Sales $12.598M Beat $7.530M Estimate. Cash And Equivalents Of $155.2M", "summary": "", "symbols": ["MRSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935094/mersana-therapeutics-q3-2024-gaap-eps-0-09-beats-0-18-estimate-sales-12-598m-beat-7-530m-estimate-c", "tags": ["earnings"]}
{"id": 41935095, "time": "2024-11-13 07:08:57", "headline": "Tenax Therapeutics Q3 2024 GAAP EPS $(0.19) Beats $(1.39) Estimate, Cash, Cash Equivalents And Investments Of $98.3M, Expected To Provide A Cash Runway Through The End Of 2027", "summary": "", "symbols": ["TENX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935095/tenax-therapeutics-q3-2024-gaap-eps-0-19-beats-1-39-estimate-cash-cash-equivalents-and-investments-", "tags": ["earnings"]}
{"id": 41935097, "time": "2024-11-13 07:09:10", "headline": "Wag Expects Returning To Growth And Profitability In 2025", "summary": "", "symbols": ["PET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935097/wag-expects-returning-to-growth-and-profitability-in-2025", "tags": []}
{"id": 41935110, "time": "2024-11-13 07:09:52", "headline": "Ceragon Networks Expects FY24 Revenue Of $390M-$400M (Prior $385M-$405M) Vs $392.45M Est", "summary": "", "symbols": ["CRNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935110/ceragon-networks-expects-fy24-revenue-of-390m-400m-prior-385m-405m-vs-392-45m-est", "tags": ["earnings"]}
{"id": 41935132, "time": "2024-11-13 07:10:44", "headline": "CyberArk Announced That Chief Financial Officer (CFO) Josh Siegel Will Step Down On January 1, 2025 And Transition Into An Advisory Role And Erica Smith Will Become New CFO", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935132/cyberark-announced-that-chief-financial-officer-cfo-josh-siegel-will-step-down-on-january-1-2025-and", "tags": ["management"]}
{"id": 41935134, "time": "2024-11-13 07:10:58", "headline": "Passage Bio Q3 2024 GAAP EPS $(0.31) Misses $(0.28) Estimate, Cash, Cash Equivalents And Marketable Securities Were $84.8M Expected To Provide Cash Runway To The End Of Q2 2026", "summary": "", "symbols": ["PASG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935134/passage-bio-q3-2024-gaap-eps-0-31-misses-0-28-estimate-cash-cash-equivalents-and-marketable-securit", "tags": ["earnings"]}
{"id": 41935142, "time": "2024-11-13 07:11:55", "headline": "Siyata Mobile Discussed The Deployment Of Its SD7 Handsets And VK7 Vehicle Kits By The National St John Ambulance Service", "summary": "", "symbols": ["SYTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935142/siyata-mobile-discussed-the-deployment-of-its-sd7-handsets-and-vk7-vehicle-kits-by-the-national-st-j", "tags": []}
{"id": 41935161, "time": "2024-11-13 07:12:23", "headline": "HC Wainwright & Co. Reiterates Buy on Novavax, Maintains $19 Price Target", "summary": "", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935161/hc-wainwright-co-reiterates-buy-on-novavax-maintains-19-price-target", "tags": ["analyst_other"]}
{"id": 41935162, "time": "2024-11-13 07:12:37", "headline": "Innoviz Technologies Reiterates FY24 Revenue Of $23.5M-$25M Vs $28M Est", "summary": "", "symbols": ["INVZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935162/innoviz-technologies-reiterates-fy24-revenue-of-23-5m-25m-vs-28m-est", "tags": ["analyst_other", "earnings"]}
{"id": 41935164, "time": "2024-11-13 07:12:42", "headline": "Leap Therapeutics Q2 2024 GAAP EPS $(0.52) Misses $(0.43) Estimate", "summary": "", "symbols": ["LPTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935164/leap-therapeutics-q2-2024-gaap-eps-0-52-misses-0-43-estimate", "tags": ["earnings"]}
{"id": 41935172, "time": "2024-11-13 07:12:47", "headline": "Mural Oncology Q3 2024 GAAP EPS $(1.87) Beats $(1.98) Estimate, Cash, Cash Equivalents, And Marketable Securities Of $175.5M Are Expected To Fund Its Operations Into The Fourth Quarter Of 2025", "summary": "", "symbols": ["MURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935172/mural-oncology-q3-2024-gaap-eps-1-87-beats-1-98-estimate-cash-cash-equivalents-and-marketable-secur", "tags": ["earnings"]}
{"id": 41935183, "time": "2024-11-13 07:13:27", "headline": "Harrow Announced An Innovative Initiative To Expand Access And Affordability For Its Ophthalmic Pharmaceutical Products, Including A Program Of Targeted Price Reductions For Several Harrow Products And A Strategic Partnership With GoodRx", "summary": "", "symbols": ["GDRX", "HROW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935183/harrow-announced-an-innovative-initiative-to-expand-access-and-affordability-for-its-ophthalmic-phar", "tags": ["contract"]}
{"id": 41935212, "time": "2024-11-13 07:13:44", "headline": "HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $6 Price Target", "summary": "", "symbols": ["ERAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935212/hc-wainwright-co-reiterates-buy-on-erasca-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 41935311, "time": "2024-11-13 07:14:18", "headline": "Acrivon Therapeutics Q3 2024 GAAP EPS $(0.59) Misses $(0.57) Estimate, Cash, Cash Equivalents And Marketable Securities Of $202.8M Expected To Fund Operations Into The Second Half Of 2026", "summary": "", "symbols": ["ACRV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935311/acrivon-therapeutics-q3-2024-gaap-eps-0-59-misses-0-57-estimate-cash-cash-equivalents-and-marketabl", "tags": ["earnings"]}
{"id": 41935312, "time": "2024-11-13 07:14:33", "headline": "This Stock Surges Over 20% In Pre-Market Following 66% Gains In Previous Session After Embracing Bitcoin As Treasury Asset", "summary": "Genius Group Limited (NYSE:GNS) experienced a significant boost in its stock value, climbing 20% in pre-market trading on Wednesday, as per Benzinga Pro.", "symbols": ["BTCUSD", "GNS", "MSTR"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41935312/this-stock-surges-over-20-in-pre-market-following-66-gains-in-previous-session-after-embracing-bitcoin-as-treasury-asset", "tags": []}
{"id": 41935314, "time": "2024-11-13 07:14:37", "headline": "Radcom Expects FY24 Revenue Of $59M-$62M (Prior $58M-$61M) Vs $59.28M Est", "summary": "", "symbols": ["RDCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935314/radcom-expects-fy24-revenue-of-59m-62m-prior-58m-61m-vs-59-28m-est", "tags": ["earnings"]}
{"id": 41935323, "time": "2024-11-13 07:14:56", "headline": "Dragonfly Energy Announced The Entry Into A Partnership With Keystone Automotive Operations", "summary": "", "symbols": ["DFLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935323/dragonfly-energy-announced-the-entry-into-a-partnership-with-keystone-automotive-operations", "tags": ["contract"]}
{"id": 41935326, "time": "2024-11-13 07:15:13", "headline": "Venus Concept Expects Q4 2024 Revenue Of At Least $17M Vs. $18.44M Est., Down 6% YoY", "summary": "", "symbols": ["VERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935326/venus-concept-expects-q4-2024-revenue-of-at-least-17m-vs-18-44m-est-down-6-yoy", "tags": ["earnings"]}
{"id": 41935329, "time": "2024-11-13 07:15:54", "headline": "Ecovyst Announced The Launch Of Its AlphaCat Advanced Silica Products Focused On Enabling The Advancement Of Biocatalysis", "summary": "", "symbols": ["ECVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935329/ecovyst-announced-the-launch-of-its-alphacat-advanced-silica-products-focused-on-enabling-the-advanc", "tags": []}
{"id": 41935391, "time": "2024-11-13 07:16:13", "headline": "Baird Maintains Outperform on On Holding, Raises Price Target to $63", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935391/baird-maintains-outperform-on-on-holding-raises-price-target-to-63", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935435, "time": "2024-11-13 07:16:23", "headline": "CalciMedica Q3 2024 GAAP EPS $(0.50), Inline, Proforma Cash, Cash Equivalents And Short-term Investments Of Approximately $23.7M, Which Is Expected To Fund Current Operations Into The First Half Of 2026", "summary": "", "symbols": ["CALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935435/calcimedica-q3-2024-gaap-eps-0-50-inline-proforma-cash-cash-equivalents-and-short-term-investments-", "tags": ["earnings"]}
{"id": 41935436, "time": "2024-11-13 07:16:25", "headline": "Benchmark Initiates Coverage On Airship AI Holdings with Buy Rating, Announces Price Target of $6", "summary": "", "symbols": ["AISP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935436/benchmark-initiates-coverage-on-airship-ai-holdings-with-buy-rating-announces-price-target-of-6", "tags": ["analyst_init"]}
{"id": 41935437, "time": "2024-11-13 07:16:33", "headline": "Bitfarms Q3 2024 GAAP EPS $(0.08) Beats $(0.09) Estimate, Sales $44.853M Miss $48.842M Estimate", "summary": "", "symbols": ["BITF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935437/bitfarms-q3-2024-gaap-eps-0-08-beats-0-09-estimate-sales-44-853m-miss-48-842m-estimate", "tags": ["earnings"]}
{"id": 41935448, "time": "2024-11-13 07:16:34", "headline": "Altair Signed A Collaboration Agreement With Aerospace Startup Moya Aero As Part Of Altair's Aerospace Startup Acceleration Program", "summary": "", "symbols": ["ALTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935448/altair-signed-a-collaboration-agreement-with-aerospace-startup-moya-aero-as-part-of-altairs-aerospac", "tags": ["contract"]}
{"id": 41935455, "time": "2024-11-13 07:17:29", "headline": "Baird Maintains Outperform on Astrana Health, Raises Price Target to $86", "summary": "", "symbols": ["ASTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935455/baird-maintains-outperform-on-astrana-health-raises-price-target-to-86", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935458, "time": "2024-11-13 07:17:42", "headline": "Instil Bio Q2 2024 GAAP EPS $(2.29) Beats $(2.85) Estimate", "summary": "", "symbols": ["TIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935458/instil-bio-q2-2024-gaap-eps-2-29-beats-2-85-estimate", "tags": ["earnings"]}
{"id": 41935461, "time": "2024-11-13 07:17:54", "headline": "Mobilicom Enters Partnership With DT Research To Jointly Promote And Market Ground Control Station Products", "summary": "", "symbols": ["MOB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935461/mobilicom-enters-partnership-with-dt-research-to-jointly-promote-and-market-ground-control-station-p", "tags": ["contract"]}
{"id": 41935474, "time": "2024-11-13 07:18:23", "headline": "Patterson Dental Supply, A Subsidiary Of Patterson Companies, Announced An Agreement In Principle Between Patterson And PDS Health To Extend Their Strategic Relationship Through The End Of 2027", "summary": "", "symbols": ["PDCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935474/patterson-dental-supply-a-subsidiary-of-patterson-companies-announced-an-agreement-in-principle-betw", "tags": ["contract"]}
{"id": 41935477, "time": "2024-11-13 07:18:51", "headline": "Baird Maintains Outperform on Axsome Therapeutics, Raises Price Target to $116", "summary": "", "symbols": ["AXSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935477/baird-maintains-outperform-on-axsome-therapeutics-raises-price-target-to-116", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935478, "time": "2024-11-13 07:18:52", "headline": "TD Cowen Downgrades Syros Pharmaceuticals to Hold", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935478/td-cowen-downgrades-syros-pharmaceuticals-to-hold", "tags": ["analyst_down"]}
{"id": 41935517, "time": "2024-11-13 07:20:04", "headline": "Kamada Raises FY24 Adjusted EBITDA Guidance To $32M-$35M, A 12% Increase Of The Midpoint From The Previous Guidance, And Reiterates Revenue Guidance Of $158M-$162M Vs. $160.47M Estimate", "summary": "", "symbols": ["KMDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935517/kamada-raises-fy24-adjusted-ebitda-guidance-to-32m-35m-a-12-increase-of-the-midpoint-from-the-previo", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 41935528, "time": "2024-11-13 07:20:44", "headline": "Top 4 Tech Stocks That May Keep You Up At Night This Quarter", "summary": " ", "symbols": ["BASE", "BILL", "OLO", "ZS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/short-ideas/24/11/41935528/top-4-tech-stocks-that-may-keep-you-up-at-night-this-quarter", "tags": []}
{"id": 41935547, "time": "2024-11-13 07:21:27", "headline": "Baird Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $50", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935547/baird-maintains-outperform-on-mirum-pharmaceuticals-raises-price-target-to-50", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935571, "time": "2024-11-13 07:23:05", "headline": "Baird Maintains Outperform on Natera, Raises Price Target to $160", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935571/baird-maintains-outperform-on-natera-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935577, "time": "2024-11-13 07:24:03", "headline": "Baird Maintains Outperform on Spyre Therapeutics, Raises Price Target to $65", "summary": "", "symbols": ["SYRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935577/baird-maintains-outperform-on-spyre-therapeutics-raises-price-target-to-65", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935578, "time": "2024-11-13 07:24:05", "headline": "Sound Point Meridian Capital, Inc. Common Stock Q3 EPS $0.86 Beats $0.57 Estimate, Sales $17.46M Beat $16.51M Estimate", "summary": "", "symbols": ["SPMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935578/sound-point-meridian-capital-inc-common-stock-q3-eps-0-86-beats-0-57-estimate-sales-17-46m-beat-16-", "tags": ["earnings"]}
{"id": 41935646, "time": "2024-11-13 07:24:17", "headline": "Plug Power Hosts 2024 Plug Symposium, Targets ~30% CAGR For Energy And Applications Businesses From 2025 To 2030; Appoints Sanjay Shrestha As New President", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935646/plug-power-hosts-2024-plug-symposium-targets-30-cagr-for-energy-and-applications-businesses-from-202", "tags": ["management"]}
{"id": 41935694, "time": "2024-11-13 07:24:25", "headline": "HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $6 Price Target", "summary": "", "symbols": ["LXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935694/hc-wainwright-co-reiterates-buy-on-lexicon-pharmaceuticals-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 41935717, "time": "2024-11-13 07:25:05", "headline": "Baird Maintains Outperform on Maplebear, Raises Price Target to $51", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935717/baird-maintains-outperform-on-maplebear-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935720, "time": "2024-11-13 07:25:33", "headline": "Market-Moving News for November 13th", "summary": "", "symbols": ["CAVA", "NTRA", "RIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41935720/market-moving-news-for-november-13th", "tags": []}
{"id": 41935724, "time": "2024-11-13 07:25:53", "headline": "HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target", "summary": "", "symbols": ["TPST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935724/hc-wainwright-co-reiterates-buy-on-tempest-therapeutics-maintains-47-price-target", "tags": ["analyst_other"]}
{"id": 41935725, "time": "2024-11-13 07:26:03", "headline": "Viracta Therapeutics Q3 2024 GAAP EPS $(0.27) Misses $(0.24) Estimate, Cash, Cash Equivalents, And Short-term Investments Of Approximately $21.1M Is Expected To Fund Operations Late Into The First Quarter Of 2025", "summary": "", "symbols": ["VIRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935725/viracta-therapeutics-q3-2024-gaap-eps-0-27-misses-0-24-estimate-cash-cash-equivalents-and-short-ter", "tags": ["earnings"]}
{"id": 41935757, "time": "2024-11-13 07:27:12", "headline": "Baird Maintains Outperform on Fortinet, Raises Price Target to $95", "summary": "", "symbols": ["FTNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935757/baird-maintains-outperform-on-fortinet-raises-price-target-to-95", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935768, "time": "2024-11-13 07:28:28", "headline": "Baird Maintains Outperform on Paymentus Holdings, Raises Price Target to $36", "summary": "", "symbols": ["PAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935768/baird-maintains-outperform-on-paymentus-holdings-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935784, "time": "2024-11-13 07:28:45", "headline": "Predictive Oncology Q3 2024 GAAP EPS $(0.36) Misses $(0.26) Estimate, Sales $345.69K Miss $350.00K Estimate", "summary": "", "symbols": ["POAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41935784/predictive-oncology-q3-2024-gaap-eps-0-36-misses-0-26-estimate-sales-345-69k-miss-350-00k-estimate", "tags": ["earnings"]}
{"id": 41935798, "time": "2024-11-13 07:29:30", "headline": "Baird Maintains Outperform on Shopify, Raises Price Target to $126", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935798/baird-maintains-outperform-on-shopify-raises-price-target-to-126", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935880, "time": "2024-11-13 07:30:25", "headline": "HC Wainwright & Co. Reiterates Buy on OptiNose, Maintains $5 Price Target", "summary": "", "symbols": ["OPTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935880/hc-wainwright-co-reiterates-buy-on-optinose-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 41935891, "time": "2024-11-13 07:30:50", "headline": "Plug Power Provides 2025 Financial Outlook, With Revenue Of ~$850M - $950M (Est $1.185B); Sets 2030 Target Revenue Of ~$3.75B", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935891/plug-power-provides-2025-financial-outlook-with-revenue-of-850m-950m-est-1-185b-sets-2030-target-rev", "tags": ["earnings", "guidance"]}
{"id": 41935898, "time": "2024-11-13 07:31:00", "headline": "Predictive Oncology Announced That The Company Is Working With A Strategic Advisor, Has Initiated A Process To Evaluate A Broad Range Of Strategic Alternatives", "summary": "", "symbols": ["POAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41935898/predictive-oncology-announced-that-the-company-is-working-with-a-strategic-advisor-has-initiated-", "tags": []}
{"id": 41935986, "time": "2024-11-13 07:31:11", "headline": "Morgan Stanley Maintains Equal-Weight on Zeta Global Holdings, Raises Price Target to $41", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41935986/morgan-stanley-maintains-equal-weight-on-zeta-global-holdings-raises-price-target-to-41", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935994, "time": "2024-11-13 07:31:41", "headline": "Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression", "summary": "Cybin starts Phase 3 trials for its depression treatment, CYB003, backed by strong Phase 2 data and a solid cash position.", "symbols": ["CYBN"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/markets/cannabis/24/11/41935994/cybin-inc-begins-phase-3-trials-betting-big-on-cyb003-to-treat-depression", "tags": ["fda"]}
{"id": 41936009, "time": "2024-11-13 07:32:04", "headline": "Kratos Defense & Security Announced That It Has Been Awarded A Contract Valued At A Maximum Of $116.7M Over Five Years To Create And Operate An Advanced Fire Control Ground Infrastructure For The U.S. Space Development Agency's Advanced Fire Control Program", "summary": "", "symbols": ["KTOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936009/kratos-defense-security-announced-that-it-has-been-awarded-a-contract-valued-at-a-maximum-of-116-7m", "tags": ["contract"]}
{"id": 41936046, "time": "2024-11-13 07:33:04", "headline": "HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target", "summary": "", "symbols": ["EYEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936046/hc-wainwright-co-reiterates-buy-on-eyenovia-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41933602, "time": "2024-11-13 06:08:21", "headline": "Gilat Satellite Networks Narrows 2024 Revenue Guidance From $305M - $325M To $305M - $315M, Est $330.887M", "summary": "", "symbols": ["GILT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41933602/gilat-satellite-networks-narrows-2024-revenue-guidance-from-305m-325m-to-305m-315m-est-330-887m", "tags": ["earnings", "guidance"]}
{"id": 41936052, "time": "2024-11-13 07:33:12", "headline": "The Board Of Directors Of Griffon Corporation Authorized The Repurchase Of An Additional $400M Worth Of Shares Of Griffon Common Stock", "summary": "", "symbols": ["GFF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936052/the-board-of-directors-of-griffon-corporation-authorized-the-repurchase-of-an-additional-400m-worth", "tags": ["buyback"]}
{"id": 41936055, "time": "2024-11-13 07:33:29", "headline": "Morgan Stanley Maintains Equal-Weight on Skyworks Solutions, Lowers Price Target to $87", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936055/morgan-stanley-maintains-equal-weight-on-skyworks-solutions-lowers-price-target-to-87", "tags": ["analyst_other", "price_target_down"]}
{"id": 41936071, "time": "2024-11-13 07:34:28", "headline": "HC Wainwright & Co. Reiterates Buy on FibroBiologics, Maintains $12 Price Target", "summary": "", "symbols": ["FBLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936071/hc-wainwright-co-reiterates-buy-on-fibrobiologics-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41936183, "time": "2024-11-13 07:35:03", "headline": "Griffon Q4 2024 Adj EPS $1.29 Beats $1.18 Estimate, Sales $641.40M Beat $641.24M Estimate", "summary": "", "symbols": ["GFF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41936183/griffon-q4-2024-adj-eps-1-29-beats-1-18-estimate-sales-641-40m-beat-641-24m-estimate", "tags": ["earnings"]}
{"id": 41936188, "time": "2024-11-13 07:35:17", "headline": "Morgan Stanley Maintains Overweight on Vertex, Raises Price Target to $62", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936188/morgan-stanley-maintains-overweight-on-vertex-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936193, "time": "2024-11-13 07:35:38", "headline": "Canaccord Genuity Downgrades Doximity to Hold, Raises Price Target to $60", "summary": "", "symbols": ["DOCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936193/canaccord-genuity-downgrades-doximity-to-hold-raises-price-target-to-60", "tags": ["analyst_down", "price_target_up"]}
{"id": 41936211, "time": "2024-11-13 07:36:05", "headline": "CyberArk Announced A High-impact Partnership With Leading Cloud Security Provider Wiz", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936211/cyberark-announced-a-high-impact-partnership-with-leading-cloud-security-provider-wiz", "tags": ["contract"]}
{"id": 41936221, "time": "2024-11-13 07:36:21", "headline": "Morgan Stanley Maintains Overweight on Spotify Technology, Raises Price Target to $460", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936221/morgan-stanley-maintains-overweight-on-spotify-technology-raises-price-target-to-460", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936224, "time": "2024-11-13 07:36:57", "headline": "Arcos Dorados Holdings Q3 2024 GAAP EPS $0.17 Beats $0.16 Estimate, Sales $1.133B Beat $1.120B Estimate", "summary": "", "symbols": ["ARCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41936224/arcos-dorados-holdings-q3-2024-gaap-eps-0-17-beats-0-16-estimate-sales-1-133b-beat-1-120b-estimate", "tags": ["earnings"]}
{"id": 41936228, "time": "2024-11-13 07:37:23", "headline": "Canaccord Genuity Upgrades Viant Technology to Buy, Raises Price Target to $18", "summary": "", "symbols": ["DSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936228/canaccord-genuity-upgrades-viant-technology-to-buy-raises-price-target-to-18", "tags": ["analyst_up", "price_target_up"]}
{"id": 41936241, "time": "2024-11-13 07:37:40", "headline": "HC Wainwright & Co. Reiterates Neutral on Intrusion, Maintains $1 Price Target", "summary": "", "symbols": ["INTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936241/hc-wainwright-co-reiterates-neutral-on-intrusion-maintains-1-price-target", "tags": ["analyst_other"]}
{"id": 41936248, "time": "2024-11-13 07:38:10", "headline": "Susquehanna Maintains Positive on BKV, Raises Price Target to $25", "summary": "", "symbols": ["BKV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936248/susquehanna-maintains-positive-on-bkv-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936262, "time": "2024-11-13 07:38:52", "headline": "Chipotle Rival CAVA Surges Over 17% As Q3 Earnings Beat Expectations And Full-Year Outlook Improves", "summary": "The fast-casual chain, known for its Mediterranean-inspired cuisine, reported earnings of 15 cents per share, surpassing the analyst consensus of 11 cents.", "symbols": ["CAVA", "CMG"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/markets/equities/24/11/41936262/chipotle-rival-cava-surges-over-17-as-q3-earnings-beat-expectations-and-full-year-outlook-improves", "tags": ["earnings", "guidance"]}
{"id": 41936272, "time": "2024-11-13 07:39:21", "headline": "Wedbush Maintains Outperform on Cava Group, Raises Price Target to $190", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936272/wedbush-maintains-outperform-on-cava-group-raises-price-target-to-190", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936327, "time": "2024-11-13 07:40:51", "headline": "Susquehanna Maintains Positive on Flutter Entertainment, Raises Price Target to $286", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936327/susquehanna-maintains-positive-on-flutter-entertainment-raises-price-target-to-286", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936329, "time": "2024-11-13 07:41:10", "headline": "Hyzon Motors Q3 2024 GAAP EPS $(7.74) Misses $(7.00) Estimate, Sales $134.000K", "summary": "", "symbols": ["HYZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41936329/hyzon-motors-q3-2024-gaap-eps-7-74-misses-7-00-estimate-sales-134-000k", "tags": ["earnings"]}
{"id": 41936334, "time": "2024-11-13 07:41:34", "headline": "Leerink Partners Downgrades 908 Devices to Market Perform, Announces $4 Price Target", "summary": "", "symbols": ["MASS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936334/leerink-partners-downgrades-908-devices-to-market-perform-announces-4-price-target", "tags": ["analyst_down"]}
{"id": 41936362, "time": "2024-11-13 07:42:14", "headline": "Susquehanna Maintains Positive on Shift4 Payments, Raises Price Target to $120", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936362/susquehanna-maintains-positive-on-shift4-payments-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936384, "time": "2024-11-13 07:43:14", "headline": "Susquehanna Maintains Positive on StoneCo, Lowers Price Target to $19", "summary": "", "symbols": ["STNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936384/susquehanna-maintains-positive-on-stoneco-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 41936387, "time": "2024-11-13 07:44:18", "headline": "Susquehanna Maintains Neutral on Skyworks Solutions, Lowers Price Target to $100", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936387/susquehanna-maintains-neutral-on-skyworks-solutions-lowers-price-target-to-100", "tags": ["analyst_other", "price_target_down"]}
{"id": 41936392, "time": "2024-11-13 07:44:42", "headline": "What's Going On With Palantir Stock After Renewing Collaboration With Rio Tinto?", "summary": "Palantir renewed a multi-year agreement with Rio Tinto, extending access to its AI platform to enhance operational efficiency, while both companies expect continued innovation and improvements in performance.", "symbols": ["AIPI", "GABF", "HAP", "PLTR", "RIO", "SHLD", "SLX"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/11/41936392/whats-going-on-with-palantir-stock-after-renewing-collaboration-with-rio-tinto", "tags": ["why_moving", "contract"]}
{"id": 41936456, "time": "2024-11-13 07:45:44", "headline": "Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday", "summary": " ", "symbols": ["CAT", "DAY", "FOUR", "HRTX", "LYV", "MAG", "NTRA", "SBUX", "SHOP", "SPOT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41936456/starbucks-to-77-here-are-10-top-analyst-forecasts-for-wednesday", "tags": []}
{"id": 41936590, "time": "2024-11-13 07:46:44", "headline": "Customer Retention Drives GrowGeneration's Q3 Results: Sales Up, Revenue Down", "summary": "The drop was driven by the closure of 25 retail locations as part of the company&#39;s ongoing restructuring plan.", "symbols": ["GRWG"], "source": "benzinga", "author": "Nicol\u00e1s Jose Rodriguez", "url": "https://www.benzinga.com/24/11/41936590/customer-retention-powers-growgenerations-q3-results-gardening-sales-thrive-despite-revenue-drop", "tags": ["earnings"]}
{"id": 41936609, "time": "2024-11-13 07:47:38", "headline": "HC Wainwright & Co. Reiterates Buy on FTC Solar, Maintains $1.5 Price Target", "summary": "", "symbols": ["FTCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936609/hc-wainwright-co-reiterates-buy-on-ftc-solar-maintains-1-5-price-target", "tags": ["analyst_other"]}
{"id": 41936610, "time": "2024-11-13 07:47:52", "headline": "Rivian Recalls Over 5000 R1 Vehicles After Halloween Software Update Interrupted Exterior Lights", "summary": "EV startup Rivian Automotive recalled 5,128 units of its R1T trucks and R1S SUVs together owing to concerns about a recent software update disabling certain exterior lights, the National Highway Traffic Safety Administration (NHTSA)\u00a0said on Wednesday.", "symbols": ["RIVN"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/markets/equities/24/11/41936610/rivian-recalls-over-5000-r1-vehicles-after-halloween-software-update-interrupted-exterior-lights", "tags": []}
{"id": 41936611, "time": "2024-11-13 07:48:01", "headline": "Northland Capital Markets Maintains Market Perform on Chegg, Lowers Price Target to $3", "summary": "", "symbols": ["CHGG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936611/northland-capital-markets-maintains-market-perform-on-chegg-lowers-price-target-to-3", "tags": ["analyst_other", "price_target_down"]}
{"id": 41936635, "time": "2024-11-13 07:48:16", "headline": "Ladenburg Thalmann Downgrades SoundHound AI to Neutral, Maintains Price Target to $7", "summary": "", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936635/ladenburg-thalmann-downgrades-soundhound-ai-to-neutral-maintains-price-target-to-7", "tags": ["analyst_down", "analyst_other"]}
{"id": 41936647, "time": "2024-11-13 07:49:40", "headline": "Northland Capital Markets Maintains Outperform on Groupon, Lowers Price Target to $17", "summary": "", "symbols": ["GRPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936647/northland-capital-markets-maintains-outperform-on-groupon-lowers-price-target-to-17", "tags": ["analyst_other", "price_target_down"]}
{"id": 41936690, "time": "2024-11-13 07:50:58", "headline": "Citigroup Downgrades Angi to Neutral, Lowers Price Target to $2", "summary": "", "symbols": ["ANGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936690/citigroup-downgrades-angi-to-neutral-lowers-price-target-to-2", "tags": ["analyst_down", "price_target_down"]}
{"id": 41936691, "time": "2024-11-13 07:50:59", "headline": "Wall Street's Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields", "summary": " ", "symbols": ["AVA", "AY", "CWEN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41936691/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-3", "tags": ["dividend"]}
{"id": 41936692, "time": "2024-11-13 07:51:20", "headline": "Kroger Announces Extension of Exchange Offers, Consent Solicitations For Albertsons Companies", "summary": "", "symbols": ["ACI", "KR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41936692/kroger-announces-extension-of-exchange-offers-consent-solicitations-for-albertsons-companies", "tags": []}
{"id": 41936694, "time": "2024-11-13 07:51:27", "headline": "Northland Capital Markets Reiterates Outperform on Airgain, Raises Price Target to $11.5", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936694/northland-capital-markets-reiterates-outperform-on-airgain-raises-price-target-to-11-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936706, "time": "2024-11-13 07:52:28", "headline": "AFC Gamma Q3 2024 Adj. EPS $0.35, Inline, Sales $8.882M Miss $12.008M Estimate", "summary": "", "symbols": ["AFCG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41936706/afc-gamma-q3-2024-adj-eps-0-35-inline-sales-8-882m-miss-12-008m-estimate", "tags": ["earnings"]}
{"id": 41936707, "time": "2024-11-13 07:52:34", "headline": "HC Wainwright & Co. Reiterates Buy on Plug Power, Maintains $18 Price Target", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936707/hc-wainwright-co-reiterates-buy-on-plug-power-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 41936736, "time": "2024-11-13 07:54:20", "headline": "FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'", "summary": "FDA Chief Robert Califf reflects on potential changes as Trump&#39;s re-election looms, expressing disappointment and highlighting uncertainty within the agency.", "symbols": ["FXH", "IHE", "IYH", "PJP", "PTH", "SPY", "VHT"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/government/regulations/24/11/41936736/fda-commissioner-califf-candid-on-trumps-impact-we-just-dont-know-whats-going-to-happen", "tags": ["fda"]}
{"id": 41936763, "time": "2024-11-13 07:54:22", "headline": "Northland Capital Markets Maintains Market Perform on Target Hospitality, Raises Price Target to $11", "summary": "", "symbols": ["TH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936763/northland-capital-markets-maintains-market-perform-on-target-hospitality-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936855, "time": "2024-11-13 07:55:42", "headline": "HC Wainwright & Co. Reiterates Buy on Kopin, Maintains $3 Price Target", "summary": "", "symbols": ["KOPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936855/hc-wainwright-co-reiterates-buy-on-kopin-maintains-3-price-target", "tags": ["analyst_other"]}
{"id": 41936856, "time": "2024-11-13 07:55:43", "headline": "Northland Capital Markets Downgrades Alta Equipment Group to Market Perform, Lowers Price Target to $20", "summary": "", "symbols": ["ALTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936856/northland-capital-markets-downgrades-alta-equipment-group-to-market-perform-lowers-price-target-to-2", "tags": ["analyst_down", "price_target_down"]}
{"id": 41936897, "time": "2024-11-13 07:57:00", "headline": "Northland Capital Markets Maintains Outperform on Camtek, Raises Price Target to $102", "summary": "", "symbols": ["CAMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936897/northland-capital-markets-maintains-outperform-on-camtek-raises-price-target-to-102", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936905, "time": "2024-11-13 07:57:19", "headline": "This Cummins Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday", "summary": " ", "symbols": ["CCCS", "CMI", "DSP", "ONON", "PCAR"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41936905/this-cummins-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday", "tags": ["analyst_up"]}
{"id": 41936916, "time": "2024-11-13 07:57:58", "headline": "Top 4 Consumer Stocks That May Explode In November", "summary": " ", "symbols": ["AEO", "CROX", "HAS", "LEVI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/11/41936916/top-4-consumer-stocks-that-may-explode-in-november", "tags": []}
{"id": 41936928, "time": "2024-11-13 07:58:46", "headline": "Paymentus Powers Up: Q3 Revenue Soars 51.9%, Fueling High Hopes For FY24", "summary": "Paymentus Holdings reports strong Q3 results, with 51.9% revenue increase and 58.2% adjusted EBITDA growth. ", "symbols": ["PAY"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/24/11/41936928/paymentus-powers-up-q3-revenue-soars-51-9-fueling-high-hopes-for-fy24", "tags": ["earnings"]}
{"id": 41936929, "time": "2024-11-13 07:58:50", "headline": "Northland Capital Markets Maintains Outperform on Honest Co, Raises Price Target to $7.5", "summary": "", "symbols": ["HNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936929/northland-capital-markets-maintains-outperform-on-honest-co-raises-price-target-to-7-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41936938, "time": "2024-11-13 07:59:20", "headline": "Wells Fargo Upgrades BankUnited to Overweight, Raises Price Target to $48", "summary": "", "symbols": ["BKU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41936938/wells-fargo-upgrades-bankunited-to-overweight-raises-price-target-to-48", "tags": ["analyst_up", "price_target_up"]}
{"id": 41937043, "time": "2024-11-13 08:00:15", "headline": "HC Wainwright & Co. Reiterates Buy on Prime Medicine, Maintains $10 Price Target", "summary": "", "symbols": ["PRME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937043/hc-wainwright-co-reiterates-buy-on-prime-medicine-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41937136, "time": "2024-11-13 08:00:31", "headline": "Analyst Ratings For Gevo", "summary": " ", "symbols": ["GEVO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41937136/analyst-ratings-for-gevo", "tags": []}
{"id": 41937138, "time": "2024-11-13 08:00:35", "headline": "Northland Capital Markets Maintains Outperform on TeraWulf, Raises Price Target to $10", "summary": "", "symbols": ["WULF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937138/northland-capital-markets-maintains-outperform-on-terawulf-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937140, "time": "2024-11-13 08:00:47", "headline": "Cracking The Code: Understanding Analyst Reviews For Alight", "summary": " ", "symbols": ["ALIT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41937140/cracking-the-code-understanding-analyst-reviews-for-alight", "tags": []}
{"id": 41937144, "time": "2024-11-13 08:01:01", "headline": "Where ESAB Stands With Analysts", "summary": " ", "symbols": ["ESAB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41937144/where-esab-stands-with-analysts", "tags": []}
{"id": 41937159, "time": "2024-11-13 08:01:12", "headline": "Assessing Avidity Biosciences: Insights From 10 Financial Analysts", "summary": " ", "symbols": ["RNA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41937159/assessing-avidity-biosciences-insights-from-10-financial-analysts", "tags": []}
{"id": 41937160, "time": "2024-11-13 08:01:11", "headline": "Allurion Technologies Q3 2024 GAAP EPS $(0.14) Beats $(0.17) Estimate, Sales $5.367M Miss $8.550M Estimate", "summary": "", "symbols": ["ALUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937160/allurion-technologies-q3-2024-gaap-eps-0-14-beats-0-17-estimate-sales-5-367m-miss-8-550m-estimate", "tags": ["earnings"]}
{"id": 41937175, "time": "2024-11-13 08:01:25", "headline": "ProPhase Labs Q3 2024 GAAP EPS $(0.35) Misses $0.04 Estimate, Sales $3.146M Miss $23.850M Estimate", "summary": "", "symbols": ["PRPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937175/prophase-labs-q3-2024-gaap-eps-0-35-misses-0-04-estimate-sales-3-146m-miss-23-850m-estimate", "tags": ["earnings"]}
{"id": 41937182, "time": "2024-11-13 08:01:35", "headline": "What 7 Analyst Ratings Have To Say About Skyworks Solutions", "summary": " ", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41937182/what-7-analyst-ratings-have-to-say-about-skyworks-solutions", "tags": []}
{"id": 41937196, "time": "2024-11-13 08:01:52", "headline": "Expert Outlook: MARA Holdings Through The Eyes Of 5 Analysts", "summary": " ", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41937196/expert-outlook-mara-holdings-through-the-eyes-of-5-analysts", "tags": ["guidance"]}
{"id": 41937211, "time": "2024-11-13 08:02:17", "headline": "ProPhase Labs Anticipates 'Significant 'Sequential Improvement In Revenues And EBITDA In Q4 2024, And Beyond", "summary": "", "symbols": ["PRPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937211/prophase-labs-anticipates-significant-sequential-improvement-in-revenues-and-ebitda-in-q4-2024-and-b", "tags": []}
{"id": 41937216, "time": "2024-11-13 08:02:25", "headline": "HC Wainwright & Co. Downgrades BioAtla to Neutral", "summary": "", "symbols": ["BCAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937216/hc-wainwright-co-downgrades-bioatla-to-neutral", "tags": ["analyst_down"]}
{"id": 41937218, "time": "2024-11-13 08:02:28", "headline": "Stronghold Digital Mining Q3 Sales $11.168M Miss $16.150M Estimate", "summary": "", "symbols": ["SDIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937218/stronghold-digital-mining-q3-sales-11-168m-miss-16-150m-estimate", "tags": []}
{"id": 41937220, "time": "2024-11-13 08:02:44", "headline": "Perma-Fix Envirn Servs Q3 2024 GAAP EPS $(0.57) Misses $(0.10) Estimate, Sales $16.812M Miss $17.200M Estimate", "summary": "", "symbols": ["PESI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937220/perma-fix-envirn-servs-q3-2024-gaap-eps-0-57-misses-0-10-estimate-sales-16-812m-miss-17-200m-estima", "tags": ["earnings"]}
{"id": 41937235, "time": "2024-11-13 08:03:04", "headline": "Jaguar Health Q3 2024 GAAP EPS $(1.05) Beats $(2.37) Estimate, Sales $3.11M Miss $3.94M Estimate", "summary": "", "symbols": ["JAGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937235/jaguar-health-q3-2024-gaap-eps-1-05-beats-2-37-estimate-sales-3-11m-miss-3-94m-estimate", "tags": ["earnings"]}
{"id": 41937245, "time": "2024-11-13 08:03:12", "headline": "CORRECTION: Surmodics reported Q4 financial results on Nov. 6", "summary": "", "symbols": ["SRDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/24/11/41937245/correction-surmodics-reported-q4-financial-results-on-nov-6", "tags": []}
{"id": 41937247, "time": "2024-11-13 08:03:15", "headline": "Stronghold Digital Mining Q3 2024 GAAP EPS $(1.34) Misses $(0.54) Estimate", "summary": "", "symbols": ["SDIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937247/stronghold-digital-mining-q3-2024-gaap-eps-1-34-misses-0-54-estimate", "tags": ["earnings"]}
{"id": 41937256, "time": "2024-11-13 08:03:37", "headline": "BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $134", "summary": "", "symbols": ["NUVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937256/bmo-capital-maintains-outperform-on-nuvalent-raises-price-target-to-134", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937266, "time": "2024-11-13 08:03:59", "headline": "Cannabis Co. iAnthus Q3 Revenue Drops 6.1% YoY, Needs Capital 'To Continue As A Going Concern'", "summary": " ", "symbols": ["CSE:IAN", "ITHUF"], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/markets/cannabis/24/11/41937266/cannabis-co-ianthus-q3-revenue-drops-6-1-yoy-needs-capital-to-continue-as-a-going-concern", "tags": ["earnings"]}
{"id": 41937302, "time": "2024-11-13 08:04:37", "headline": "BMO Capital Maintains Outperform on Dayforce, Raises Price Target to $90", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937302/bmo-capital-maintains-outperform-on-dayforce-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937314, "time": "2024-11-13 08:04:49", "headline": "MoonLake Immunotherapeutics Screens First Patients In Phase 3 IZAR Program", "summary": "", "symbols": ["MLTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41937314/moonlake-immunotherapeutics-screens-first-patients-in-phase-3-izar-program", "tags": ["fda"]}
{"id": 41937316, "time": "2024-11-13 08:04:55", "headline": "Innovative Eyewear Q3 2024 GAAP EPS $(0.99) Beats $(2.00) Estimate, Sales $253.60K Miss $1.20M Estimate", "summary": "", "symbols": ["LUCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937316/innovative-eyewear-q3-2024-gaap-eps-0-99-beats-2-00-estimate-sales-253-60k-miss-1-20m-estimate", "tags": ["earnings"]}
{"id": 41937341, "time": "2024-11-13 08:05:22", "headline": "Catheter Precision, Inc. Common Stock Q3 Sales $96.00K", "summary": "", "symbols": ["VTAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937341/catheter-precision-inc-common-stock-q3-sales-96-00k", "tags": []}
{"id": 41937343, "time": "2024-11-13 08:05:31", "headline": "Allurion Technologies Expects FY24 Revenue Of $30M-$35M (Prior $40M-$45M) Vs $39.93M Est", "summary": "", "symbols": ["ALUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937343/allurion-technologies-expects-fy24-revenue-of-30m-35m-prior-40m-45m-vs-39-93m-est", "tags": ["earnings"]}
{"id": 41937349, "time": "2024-11-13 08:06:03", "headline": "Loar Holdings Q3 2024 GAAP EPS $0.09, Sales $103.519M Beat $97.531M Estimate", "summary": "", "symbols": ["LOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937349/loar-holdings-q3-2024-gaap-eps-0-09-sales-103-519m-beat-97-531m-estimate", "tags": ["earnings"]}
{"id": 41937350, "time": "2024-11-13 08:06:05", "headline": "BMO Capital Maintains Market Perform on Maplebear, Raises Price Target to $48", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937350/bmo-capital-maintains-market-perform-on-maplebear-raises-price-target-to-48", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937358, "time": "2024-11-13 08:06:22", "headline": "Tharimmune Granted European Patent Covering Biodegradable Polymeric Nanoparticles Created For Carrying Therapeutic And Targeting Agents", "summary": "", "symbols": ["THAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41937358/tharimmune-granted-european-patent-covering-biodegradable-polymeric-nanoparticles-created-for-car", "tags": []}
{"id": 41937377, "time": "2024-11-13 08:06:32", "headline": "TD Cowen Maintains Buy on Cava Group, Raises Price Target to $150", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937377/td-cowen-maintains-buy-on-cava-group-raises-price-target-to-150", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937405, "time": "2024-11-13 08:06:36", "headline": "Bitcoin Depot Q3 Sales $135.30M Miss $135.81M Estimate", "summary": "", "symbols": ["BTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937405/bitcoin-depot-q3-sales-135-30m-miss-135-81m-estimate", "tags": []}
{"id": 41937415, "time": "2024-11-13 08:06:37", "headline": "Universe Pharmaceuticals Announces 15-for-1 Share Consolidation, Converting 15 Pre-Consolidation Shares Into One New Share With Par Value Of $0.28125", "summary": "", "symbols": ["UPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937415/universe-pharmaceuticals-announces-15-for-1-share-consolidation-converting-15-pre-consolidation-shar", "tags": []}
{"id": 41937483, "time": "2024-11-13 08:07:11", "headline": "Mobix Labs Announces Strategic Partnership With Talking Heads Wireless To Develop AI-Powered Solutions For Reducing Power Consumption In Base Stations", "summary": "", "symbols": ["MOBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41937483/mobix-labs-announces-strategic-partnership-with-talking-heads-wireless-to-develop-ai-powered-solu", "tags": ["contract"]}
{"id": 41937487, "time": "2024-11-13 08:07:50", "headline": "Cocrystal Pharma Q3 2024 GAAP EPS $(0.49) Beats $(0.52) Estimate", "summary": "", "symbols": ["COCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937487/cocrystal-pharma-q3-2024-gaap-eps-0-49-beats-0-52-estimate", "tags": ["earnings"]}
{"id": 41937488, "time": "2024-11-13 08:07:50", "headline": "Williams Trading Upgrades On Holding to Buy, Raises Price Target to $60", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937488/williams-trading-upgrades-on-holding-to-buy-raises-price-target-to-60", "tags": ["analyst_up", "price_target_up"]}
{"id": 41937503, "time": "2024-11-13 08:08:13", "headline": "ATAI Life Sciences Q3 EPS $(0.16), Inline, Sales $40.00K Down From $87.00K YoY", "summary": "", "symbols": ["ATAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937503/atai-life-sciences-q3-eps-0-16-inline-sales-40-00k-down-from-87-00k-yoy", "tags": ["earnings"]}
{"id": 41937507, "time": "2024-11-13 08:08:56", "headline": "Tokyo Lifestyle Co. Launches New Online Platform For Reiwatakiya Brand In The UK", "summary": "", "symbols": ["TKLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937507/tokyo-lifestyle-co-launches-new-online-platform-for-reiwatakiya-brand-in-the-uk", "tags": []}
{"id": 41937513, "time": "2024-11-13 08:09:46", "headline": "GE HealthCare Receives FDA Clearance For SIGNA MAGNUS 3.0T Head-Only MRI System, Advancing Neuroimaging And Biomarker Research With Innovative Design And Enhanced Gradient Performance", "summary": "", "symbols": ["GEHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937513/ge-healthcare-receives-fda-clearance-for-signa-magnus-3-0t-head-only-mri-system-advancing-neuroimagi", "tags": ["fda"]}
{"id": 41937514, "time": "2024-11-13 08:09:51", "headline": "Pitney Bowes Announces That It Has Reached An Agreement In Principle With DRF Logistics To Resolve Ongoing Disputes With The Official Committee Of Unsecured Creditors", "summary": "", "symbols": ["PBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937514/pitney-bowes-announces-that-it-has-reached-an-agreement-in-principle-with-drf-logistics-to-resolve-o", "tags": ["contract"]}
{"id": 41937517, "time": "2024-11-13 08:09:58", "headline": "Yeti Holdings Enters Into An Accelerated Share Repurchase Agreement With Goldman Sachs To Repurchase $100M Of The Company's Common Stock", "summary": "", "symbols": ["YETI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937517/yeti-holdings-enters-into-an-accelerated-share-repurchase-agreement-with-goldman-sachs-to-repurchase", "tags": ["contract", "buyback"]}
{"id": 41937519, "time": "2024-11-13 08:10:06", "headline": "Leading And Lagging Sectors For November 13, 2024", "summary": " ", "symbols": ["XLE", "XLF", "XLI", "XLK", "XLP", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/24/11/41937519/leading-and-lagging-sectors-for-november-13-2024", "tags": []}
{"id": 41937546, "time": "2024-11-13 08:11:29", "headline": "Comcast Signs Agreements With State Of Indiana, Joint $55M Investment To Bring Fast Internet To 10,000+ Rural Homes, Businesses, Kicking Off The Latest Collaborative Effort Between OCRA, The IBO, And Comcast Under Indiana's Next Level Connections Broadband Grant Program", "summary": "", "symbols": ["CMCSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937546/comcast-signs-agreements-with-state-of-indiana-joint-55m-investment-to-bring-fast-internet-to-10-000", "tags": []}
{"id": 41937547, "time": "2024-11-13 08:11:36", "headline": "Pineapple Financial Announces $1.0 Million Registered Direct Offering, Expected To Close On November 15, 2024", "summary": "", "symbols": ["PAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937547/pineapple-financial-announces-1-0-million-registered-direct-offering-expected-to-close-on-november-1", "tags": ["offering"]}
{"id": 41937548, "time": "2024-11-13 08:11:52", "headline": "OSS Announces Order With An AI Infrastructure Company; Initial Order Valued At $2M", "summary": "", "symbols": ["OSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937548/oss-announces-order-with-an-ai-infrastructure-company-initial-order-valued-at-2m", "tags": []}
{"id": 41937633, "time": "2024-11-13 08:12:23", "headline": "Ituran And Nissan Sign A Contract For Vehicle Tracking And Recovery Services In Chile", "summary": "", "symbols": ["ITRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937633/ituran-and-nissan-sign-a-contract-for-vehicle-tracking-and-recovery-services-in-chile", "tags": ["contract"]}
{"id": 41937637, "time": "2024-11-13 08:12:55", "headline": "B of A Securities Maintains Underperform on Huntington Ingalls Indus, Lowers Price Target to $195", "summary": "", "symbols": ["HII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937637/b-of-a-securities-maintains-underperform-on-huntington-ingalls-indus-lowers-price-target-to-195", "tags": ["analyst_other", "price_target_down"]}
{"id": 41937638, "time": "2024-11-13 08:12:57", "headline": "Immunology Data Shows INOVIO's INO-3107 Induced Expansion Of New Clonal T Cells That Infiltrate Airway Tissue And Correspond With Reduction Of Surgeries For RRP Patients Observed In Phase 1/2 Trial", "summary": "", "symbols": ["INO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41937638/immunology-data-shows-inovios-ino-3107-induced-expansion-of-new-clonal-t-cells-that-infiltrate-ai", "tags": ["fda"]}
{"id": 41937639, "time": "2024-11-13 08:12:59", "headline": "Benchmark Reiterates Hold on Skyworks Solutions", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937639/benchmark-reiterates-hold-on-skyworks-solutions", "tags": ["analyst_other"]}
{"id": 41937652, "time": "2024-11-13 08:13:50", "headline": "Demopolis Equity Partners Announces Strategic Partnership With TPG; TPG Will Invest In Demopolis Through TPG NEXT, Its Strategy Focused On Seeding And Scaling The Next Generation Of Investment Firms By Providing Growth Capital And Operational And Investment Support", "summary": "", "symbols": ["TPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937652/demopolis-equity-partners-announces-strategic-partnership-with-tpg-tpg-will-invest-in-demopolis-thro", "tags": ["contract"]}
{"id": 41937653, "time": "2024-11-13 08:13:56", "headline": "MeiraGTx Hldgs Q3 2024 GAAP EPS $(0.55) Misses $(0.53) Estimate, Sales $10.90M Beat $1.63M Estimate", "summary": "", "symbols": ["MGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937653/meiragtx-hldgs-q3-2024-gaap-eps-0-55-misses-0-53-estimate-sales-10-90m-beat-1-63m-estimate", "tags": ["earnings"]}
{"id": 41937663, "time": "2024-11-13 08:14:38", "headline": "B of A Securities Maintains Buy on Howmet Aerospace, Raises Price Target to $135", "summary": "", "symbols": ["HWM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937663/b-of-a-securities-maintains-buy-on-howmet-aerospace-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937665, "time": "2024-11-13 08:14:49", "headline": "Twin Vee PowerCats Co. and Forza X1, Inc. Shareholders Vote to Approve Merger Between Companies; Merged Company Will Operate Under The Twin Vee PowerCats Co. Name, And The Company's Common Stock Is Expected To Continue To Trade On Nasdaq Under Its Current Ticker Symbol, \"VEEE\"", "summary": "", "symbols": ["FRZA", "VEEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41937665/twin-vee-powercats-co-and-forza-x1-inc-shareholders-vote-to-approve-merger-between-companies-merged", "tags": ["merger"]}
{"id": 41937682, "time": "2024-11-13 08:15:39", "headline": "Volato Group Announces Vaunt Has Launched Its Third-Party Operator Program", "summary": "", "symbols": ["SOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937682/volato-group-announces-vaunt-has-launched-its-third-party-operator-program", "tags": []}
{"id": 41937683, "time": "2024-11-13 08:15:41", "headline": "Needham Reiterates Hold on MARA Holdings", "summary": "", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937683/needham-reiterates-hold-on-mara-holdings", "tags": ["analyst_other"]}
{"id": 41937820, "time": "2024-11-13 08:17:10", "headline": "Dar\u00e9 Bioscience Announces It Entered Into A Grant Agreement With The Bill & Melinda Gates Foundation For A Grant Of Up To ~$10.7M To Fund Activities Related To The Identification And Development Of A Novel Non-Hormonal Intravaginal Contraceptive Product Candidate And To Add Additional Clinical Sites To Accelerate The Ongoing Ovaprene Pivotal Study", "summary": "", "symbols": ["DARE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41937820/dar-bioscience-announces-it-entered-into-a-grant-agreement-with-the-bill-melinda-gates-foundation", "tags": ["fda", "contract"]}
{"id": 41937836, "time": "2024-11-13 08:17:11", "headline": "B of A Securities Maintains Buy on Home Depot, Raises Price Target to $450", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937836/b-of-a-securities-maintains-buy-on-home-depot-raises-price-target-to-450", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937948, "time": "2024-11-13 08:17:56", "headline": "AYR Wellness Q3 Revenue Flat, Net Loss Soars 160% Amid Consumer Wallet Pressure", "summary": " ", "symbols": ["AYRWF"], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/news/earnings/24/11/41937948/ayr-wellness-q3-revenue-flat-net-loss-soars-160-amid-consumer-wallet-pressure", "tags": ["earnings"]}
{"id": 41937968, "time": "2024-11-13 08:18:16", "headline": "Jacksonville Jaguars Partner With Shift4, To Power Payments For The NFL Team's Ticket Sales At EverBank Stadium.", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937968/jacksonville-jaguars-partner-with-shift4-to-power-payments-for-the-nfl-teams-ticket-sales-at-everban", "tags": []}
{"id": 41937978, "time": "2024-11-13 08:18:31", "headline": "B of A Securities Maintains Neutral on Maplebear, Raises Price Target to $51", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937978/b-of-a-securities-maintains-neutral-on-maplebear-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937989, "time": "2024-11-13 08:18:48", "headline": "Needham Reiterates Hold on Maplebear", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937989/needham-reiterates-hold-on-maplebear", "tags": ["analyst_other"]}
{"id": 41937990, "time": "2024-11-13 08:19:04", "headline": "Giftify Q3 2024 Revenue $23.2M; EPS $(0.16) Vs $(0.04) YoY", "summary": "", "symbols": ["GIFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41937990/giftify-q3-2024-revenue-23-2m-eps-0-16-vs-0-04-yoy", "tags": ["earnings"]}
{"id": 41937996, "time": "2024-11-13 08:19:08", "headline": "Genius Group Said in 6K, US District Court For Southern District Of New York Issued Temporary Restraining Order On Vstock Transfer", "summary": "", "symbols": ["GNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937996/genius-group-said-in-6k-us-district-court-for-southern-district-of-new-york-issued-temporary-restrai", "tags": ["legal"]}
{"id": 41937999, "time": "2024-11-13 08:20:07", "headline": "Zentalis Pharmaceuticals Announces Julie Eastland Appointed Chief Executive Officer, President And Director; Scott Myers Appointed To The Board Of Directors As Chairperson", "summary": "", "symbols": ["ZNTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41937999/zentalis-pharmaceuticals-announces-julie-eastland-appointed-chief-executive-officer-president-and-di", "tags": []}
{"id": 41938001, "time": "2024-11-13 08:20:19", "headline": "Why Is Instacart Parent Maplebear Stock Sliding Today?", "summary": "Maplebear reported Q3 financial results with revenue of $852 million and EPS of $0.42, exceeding expectations. Buyback program expanded.", "symbols": ["CART"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/24/11/41938001/why-is-instacart-parent-maplebear-stock-sliding-today", "tags": ["earnings", "why_moving", "buyback"]}
{"id": 41938018, "time": "2024-11-13 08:20:46", "headline": "Stellantis Recalling Jeep And Dodge SUVs In The US To Fix Computer Problem That Can Disable Anti-Lock Brakes And Electronic Stability Control Safety Features", "summary": "", "symbols": ["STLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938018/stellantis-recalling-jeep-and-dodge-suvs-in-the-us-to-fix-computer-problem-that-can-disable-anti-loc", "tags": []}
{"id": 41938022, "time": "2024-11-13 08:21:05", "headline": "Clene Q3 EPS $(1.22) Beats $(1.32) Estimate, Sales $87.00K Miss $90.00K Estimate", "summary": "", "symbols": ["CLNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938022/clene-q3-eps-1-22-beats-1-32-estimate-sales-87-00k-miss-90-00k-estimate", "tags": ["earnings"]}
{"id": 41938024, "time": "2024-11-13 08:21:08", "headline": "HC Wainwright & Co. Maintains Buy on Avadel Pharmaceuticals, Lowers Price Target to $25", "summary": "", "symbols": ["AVDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938024/hc-wainwright-co-maintains-buy-on-avadel-pharmaceuticals-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 41938025, "time": "2024-11-13 08:21:17", "headline": "Mizuho Maintains Outperform on Grab Holdings, Raises Price Target to $6", "summary": "", "symbols": ["GRAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938025/mizuho-maintains-outperform-on-grab-holdings-raises-price-target-to-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938038, "time": "2024-11-13 08:21:59", "headline": "Evaxion Receives And Appeals Delisting Determination From Nasdaq, Remains Committed To Nasdaq Listing", "summary": "", "symbols": ["EVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938038/evaxion-receives-and-appeals-delisting-determination-from-nasdaq-remains-committed-to-nasdaq-listing", "tags": []}
{"id": 41938083, "time": "2024-11-13 08:22:57", "headline": "Canaccord Genuity Maintains Buy on Natera, Raises Price Target to $165", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938083/canaccord-genuity-maintains-buy-on-natera-raises-price-target-to-165", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938096, "time": "2024-11-13 08:23:47", "headline": "Grace Therapeutics Q2 2025 GAAP EPS $(0.30) Beats $(0.44) Estimate", "summary": "", "symbols": ["GRCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938096/grace-therapeutics-q2-2025-gaap-eps-0-30-beats-0-44-estimate", "tags": ["earnings"]}
{"id": 41938104, "time": "2024-11-13 08:23:58", "headline": "Mizuho Maintains Outperform on Alkermes, Raises Price Target to $40", "summary": "", "symbols": ["ALKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938104/mizuho-maintains-outperform-on-alkermes-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938105, "time": "2024-11-13 08:24:06", "headline": "Bitcoin Proxy MicroStrategy Director Sells 40K Company Shares Worth $12M As Stock Hits All-Time High", "summary": "MicroStrategy Inc. (NASDAQ:MSTR) director Leslie J. Rechan has executed a significant sale of company shares, amounting to approximately $12 million, as per a recent SEC filing.", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/markets/equities/24/11/41938105/bitcoin-proxy-microstrategy-director-sells-40k-company-shares-worth-12m-as-stock-hits-all-time-high", "tags": []}
{"id": 41938106, "time": "2024-11-13 08:24:11", "headline": "Orgenesis Q3 EPS $(1.93) Down From $(0.12) YoY, Sales $347.00K Up From $110.00K YoY", "summary": "", "symbols": ["ORGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938106/orgenesis-q3-eps-1-93-down-from-0-12-yoy-sales-347-00k-up-from-110-00k-yoy", "tags": ["earnings"]}
{"id": 41938214, "time": "2024-11-13 08:24:49", "headline": "Sonida Senior Living Q3 EPS $(0.98) Up From $(1.94) YoY, Sales $74.75M Up From $64.67M YoY", "summary": "", "symbols": ["SNDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938214/sonida-senior-living-q3-eps-0-98-up-from-1-94-yoy-sales-74-75m-up-from-64-67m-yoy", "tags": ["earnings"]}
{"id": 41938215, "time": "2024-11-13 08:24:52", "headline": "Mizuho Maintains Neutral on Mosaic, Raises Price Target to $29", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938215/mizuho-maintains-neutral-on-mosaic-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938220, "time": "2024-11-13 08:25:03", "headline": "Trading Halt: Halted at 8:25:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["LBRDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41938220/trading-halt-halted-at-8-25-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41938221, "time": "2024-11-13 08:25:04", "headline": "Trading Halt: Halted at 8:25:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["LBRDK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41938221/trading-halt-halted-at-8-25-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41938222, "time": "2024-11-13 08:25:04", "headline": "Trading Halt: Halted at 8:25:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["LBRDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41938222/trading-halt-halted-at-8-25-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41938223, "time": "2024-11-13 08:25:04", "headline": "Canaccord Genuity Maintains Buy on Alight, Raises Price Target to $12", "summary": "", "symbols": ["ALIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938223/canaccord-genuity-maintains-buy-on-alight-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938224, "time": "2024-11-13 08:25:12", "headline": "AgriFORCE Provides Updated On LOI To Purchase Bitcoin Mining Facility; Highlights Integration Of Bitcoin Mining Solutions And The Ancillary Environmental And Power-generation Benefits, Says Intends To Utilize 10-20% Of Our Future Capital Raised To Purchase And Hold Bitcoin", "summary": "", "symbols": ["AGRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938224/agriforce-provides-updated-on-loi-to-purchase-bitcoin-mining-facility-highlights-integration-of-bitc", "tags": []}
{"id": 41938225, "time": "2024-11-13 08:25:28", "headline": "Healthy Choice Wellness Q3 Sales $18.00M", "summary": "", "symbols": ["HCWC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938225/healthy-choice-wellness-q3-sales-18-00m", "tags": []}
{"id": 41938226, "time": "2024-11-13 08:25:48", "headline": "Oklo Secures Partnerships for Up to 750 MW of Low-Carbon Power for U.S. Data Centers, Expanding Its Clean Energy Pipeline to 2,100 MW", "summary": "", "symbols": ["OKLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938226/oklo-secures-partnerships-for-up-to-750-mw-of-low-carbon-power-for-u-s-data-centers-expanding-its-cl", "tags": []}
{"id": 41938230, "time": "2024-11-13 08:26:00", "headline": "Enphase Energy Announces Safe Harbor Agreement With IGS Solar To Expand Deployments Of IQ8 Microinverters Produced In The U.S.", "summary": "", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938230/enphase-energy-announces-safe-harbor-agreement-with-igs-solar-to-expand-deployments-of-iq8-microinve", "tags": ["contract"]}
{"id": 41938238, "time": "2024-11-13 08:26:19", "headline": "Mizuho Maintains Neutral on Shopify, Raises Price Target to $105", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938238/mizuho-maintains-neutral-on-shopify-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938240, "time": "2024-11-13 08:26:40", "headline": "Canaccord Genuity Maintains Buy on Atara Biotherapeutics, Raises Price Target to $21", "summary": "", "symbols": ["ATRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938240/canaccord-genuity-maintains-buy-on-atara-biotherapeutics-raises-price-target-to-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938241, "time": "2024-11-13 08:26:42", "headline": "HC Wainwright & Co. Reiterates Neutral on Bolt Biotherapeutics", "summary": "", "symbols": ["BOLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938241/hc-wainwright-co-reiterates-neutral-on-bolt-biotherapeutics", "tags": ["analyst_other"]}
{"id": 41938259, "time": "2024-11-13 08:27:31", "headline": "NRx Pharmaceuticals Reschedules Conference Call To Discuss Q3 And Year To Date 2024 Financial Results To November 18, 2024", "summary": "", "symbols": ["NRXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938259/nrx-pharmaceuticals-reschedules-conference-call-to-discuss-q3-and-year-to-date-2024-financial-resul", "tags": []}
{"id": 41938289, "time": "2024-11-13 08:27:56", "headline": "Mizuho Maintains Outperform on Skyworks Solutions, Lowers Price Target to $105", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938289/mizuho-maintains-outperform-on-skyworks-solutions-lowers-price-target-to-105", "tags": ["analyst_other", "price_target_down"]}
{"id": 41938317, "time": "2024-11-13 08:28:52", "headline": "Organovo To Present Clinical Data Of FXR314 In Phase 2 MASH In An Oral Presentation At The Liver Meeting Sponsored By The American Association For The Study Of Liver Diseases", "summary": "", "symbols": ["ONVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41938317/organovo-to-present-clinical-data-of-fxr314-in-phase-2-mash-in-an-oral-presentation-at-the-liver-", "tags": ["fda"]}
{"id": 41938328, "time": "2024-11-13 08:29:15", "headline": "Canaccord Genuity Reiterates Buy on Repay Holdings, Maintains $13 Price Target", "summary": "", "symbols": ["RPAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938328/canaccord-genuity-reiterates-buy-on-repay-holdings-maintains-13-price-target", "tags": ["analyst_other"]}
{"id": 41938341, "time": "2024-11-13 08:29:47", "headline": "Mizuho Maintains Outperform on EPAM Sys, Raises Price Target to $282", "summary": "", "symbols": ["EPAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938341/mizuho-maintains-outperform-on-epam-sys-raises-price-target-to-282", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938386, "time": "2024-11-13 08:30:09", "headline": "USA Core CPI (MoM) For Oct. 0.3% Vs  0.3% Est.; 0.3% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41938386/usa-core-cpi-mom-for-oct-0-3-vs-0-3-est-0-3-prior", "tags": []}
{"id": 41938412, "time": "2024-11-13 08:30:13", "headline": "USA CPI (MoM) For October 0.2% Vs 0.2% Est.; 0.2% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41938412/usa-cpi-mom-for-october-0-2-vs-0-2-est-0-2-prior", "tags": []}
{"id": 41938414, "time": "2024-11-13 08:30:16", "headline": "Core CPI (YoY) For Oct. 2.6% Vs 2.6% Est, 2.4% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41938414/core-cpi-yoy-for-oct-2-6-vs-2-6-est-2-4-prior", "tags": []}
{"id": 41938387, "time": "2024-11-13 08:30:09", "headline": "US CPI (YoY) (Oct) +2.6% vs +2.6% Est.; Prior 2.4%", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41938387/us-cpi-yoy-oct-2-6-vs-2-6-est", "tags": []}
{"id": 41938425, "time": "2024-11-13 08:30:28", "headline": "Canaccord Genuity Maintains Buy on Bridger Aerospace Gr, Raises Price Target to $5.75", "summary": "", "symbols": ["BAER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938425/canaccord-genuity-maintains-buy-on-bridger-aerospace-gr-raises-price-target-to-5-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938429, "time": "2024-11-13 08:30:51", "headline": "Metropolitan Transportation Authority Awards Clear Channel Outdoor A 15-Year Deal To Reimagine And Grow Revenue For More Than 250 Roadside Displays On MTA Property In The NY/NJ/CT Metro Area", "summary": "", "symbols": ["CCO", "COO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938429/metropolitan-transportation-authority-awards-clear-channel-outdoor-a-15-year-deal-to-reimagine-and-g", "tags": ["earnings", "contract"]}
{"id": 41938453, "time": "2024-11-13 08:31:12", "headline": "Mizuho Maintains Outperform on Dayforce, Raises Price Target to $95", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938453/mizuho-maintains-outperform-on-dayforce-raises-price-target-to-95", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938481, "time": "2024-11-13 08:31:38", "headline": "NETSOL Technologies Q1 EPS $0.01 Up From $(0.00) YoY, Sales $14.60M Up From $14.24M YoY", "summary": "", "symbols": ["NTWK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938481/netsol-technologies-q1-eps-0-01-up-from-0-00-yoy-sales-14-60m-up-from-14-24m-yoy", "tags": ["earnings"]}
{"id": 41938485, "time": "2024-11-13 08:31:43", "headline": "Stratus Properties Q3 EPS $(0.05) Up From $(0.36) YoY, Sales $8.89M Up From $3.67M YoY", "summary": "", "symbols": ["STRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938485/stratus-properties-q3-eps-0-05-up-from-0-36-yoy-sales-8-89m-up-from-3-67m-yoy", "tags": ["earnings"]}
{"id": 41938498, "time": "2024-11-13 08:32:24", "headline": "Reborn Coffee Forms Major Distribution Partnership With Leading Korean Coffee Chain, Expanding Preservative-Free Bakery Offerings to 8,000 Stores Across South Korea", "summary": "", "symbols": ["REBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938498/reborn-coffee-forms-major-distribution-partnership-with-leading-korean-coffee-chain-expanding-preser", "tags": ["contract"]}
{"id": 41938499, "time": "2024-11-13 08:32:33", "headline": "Mizuho Maintains Neutral on ZoomInfo Technologies, Raises Price Target to $11", "summary": "", "symbols": ["ZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938499/mizuho-maintains-neutral-on-zoominfo-technologies-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938510, "time": "2024-11-13 08:33:04", "headline": "Charter To Acquire Liberty Broadband Corporation In All-Stock Transaction", "summary": "", "symbols": ["CHTR", "LBRDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41938510/charter-to-acquire-liberty-broadband-corporation-in-all-stock-transaction", "tags": ["merger"]}
{"id": 41938521, "time": "2024-11-13 08:33:13", "headline": "Canaccord Genuity Maintains Buy on Bioceres Crop Solutions, Lowers Price Target to $9.5", "summary": "", "symbols": ["BIOX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938521/canaccord-genuity-maintains-buy-on-bioceres-crop-solutions-lowers-price-target-to-9-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41938533, "time": "2024-11-13 08:33:41", "headline": "This Nutanix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday", "summary": " ", "symbols": ["AISP", "AXTA", "JMIA", "NTAP", "NTNX"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41938533/this-nutanix-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday", "tags": ["analyst_init"]}
{"id": 41938540, "time": "2024-11-13 08:34:02", "headline": "Stagwell Expands Partnership With VII The Seventh Estate; Terms Not Disclosed", "summary": "", "symbols": ["STGW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938540/stagwell-expands-partnership-with-vii-the-seventh-estate-terms-not-disclosed", "tags": ["contract"]}
{"id": 41938542, "time": "2024-11-13 08:34:04", "headline": "ZK International To Accept Cryptocurrency Payments, Including Bitcoin, To Enhance Global Transactions With Suppliers, Vendors, And Customers", "summary": "", "symbols": ["ZKIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41938542/zk-international-to-accept-cryptocurrency-payments-including-bitcoin-to-enhance-global-tra", "tags": []}
{"id": 41938544, "time": "2024-11-13 08:34:08", "headline": "Intelligent Bio Solutions Reports Results Of PK Study Required For FDA Submission", "summary": "", "symbols": ["INBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41938544/intelligent-bio-solutions-reports-results-of-pk-study-required-for-fda-submission", "tags": ["fda"]}
{"id": 41938545, "time": "2024-11-13 08:34:17", "headline": "Xenetic Biosciences Q3 EPS $(0.28) Misses $(0.20) Estimate, Sales $614.24K Beat $230.00K Estimate", "summary": "", "symbols": ["XBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938545/xenetic-biosciences-q3-eps-0-28-misses-0-20-estimate-sales-614-24k-beat-230-00k-estimate", "tags": ["earnings"]}
{"id": 41938578, "time": "2024-11-13 08:35:06", "headline": "Quantum Computing Secures First Order For TFLN Photonic Chip Foundry From Leading Asian Research Institute, Marking Milestone In Telecom And Quantum Markets", "summary": "", "symbols": ["QUBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938578/quantum-computing-secures-first-order-for-tfln-photonic-chip-foundry-from-leading-asian-research-ins", "tags": []}
{"id": 41938587, "time": "2024-11-13 08:35:22", "headline": "Artelo Biosciences Reports Data On Novel Non-Opioid Treatment Approach For Osteoarthritis Pain At 13th Annual Musculoskeletal Repair And Regeneration Symposium", "summary": "", "symbols": ["ARTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41938587/artelo-biosciences-reports-data-on-novel-non-opioid-treatment-approach-for-osteoarthritis-pain-at", "tags": []}
{"id": 41938588, "time": "2024-11-13 08:35:24", "headline": "Why Is Super Micro Computer Stock Trading Lower On Wednesday?", "summary": "Super Micro Computer (NASDAQ: SMCI) unable to file 2024 Q1 10-Q &amp; 2024 10-K due to audit &amp; internal control issues. Delisting risk &amp; analyst downgrades.", "symbols": ["SMCI"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41938588/why-is-super-micro-computer-stock-trading-lower-on-wednesday", "tags": ["analyst_down", "why_moving"]}
{"id": 41938589, "time": "2024-11-13 08:35:34", "headline": "Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $31", "summary": "", "symbols": ["CBLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938589/canaccord-genuity-maintains-buy-on-ceribell-raises-price-target-to-31", "tags": ["analyst_other", "price_target_up"]}
{"id": 41938590, "time": "2024-11-13 08:35:43", "headline": "Under Terms Of Agreement, Each Holder Of Liberty Broadband Common Stock Will Receive 0.236 Shares Of Charter Common Stock In Lieu Of Liberty Broadband Stock; As A Result Of Transaction, Charter Expects To Retire The ~45.6M Charter Shares Currently Owner By Liberty Broadband And Issue ~34M Shares To Holders Of Liberty Broadband Common Stock At Closing", "summary": "", "symbols": ["CHTR", "LBRDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41938590/under-terms-of-agreement-each-holder-of-liberty-broadband-common-stock-will-receive-0-236-shares-of", "tags": ["contract"]}
{"id": 41938602, "time": "2024-11-13 08:36:09", "headline": "HC Wainwright & Co. Reiterates Buy on Quantum-Si, Maintains $4 Price Target", "summary": "", "symbols": ["QSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938602/hc-wainwright-co-reiterates-buy-on-quantum-si-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 41938603, "time": "2024-11-13 08:36:14", "headline": "LEEF Brands Cannabis Co. Reports Revenue Growth, Higher Operating Expenses In Q3", "summary": " ", "symbols": ["CSE:LEEF", "LEEEF"], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/news/earnings/24/11/41938603/leef-brands-cannabis-co-reports-revenue-growth-higher-operating-expenses-in-q3", "tags": ["earnings"]}
{"id": 41938605, "time": "2024-11-13 08:36:23", "headline": "LM Funding America Q3 EPS $(2.41) Misses $(1.25) Estimate, Sales $1.25M Miss $1.80M Estimate", "summary": "", "symbols": ["LMFA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938605/lm-funding-america-q3-eps-2-41-misses-1-25-estimate-sales-1-25m-miss-1-80m-estimate", "tags": ["earnings"]}
{"id": 41938606, "time": "2024-11-13 08:36:24", "headline": "Simulations Plus And University Of Connecticut Receive FDA Grant To Expand Mechanistic Modeling Approaches For Long-Acting Injectables Using PBPK Models To Improve Bioequivalence Predictions", "summary": "", "symbols": ["SLP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938606/simulations-plus-and-university-of-connecticut-receive-fda-grant-to-expand-mechanistic-modeling-appr", "tags": ["fda"]}
{"id": 41938611, "time": "2024-11-13 08:36:37", "headline": "Canaccord Genuity Maintains Buy on Paragon 28, Lowers Price Target to $15", "summary": "", "symbols": ["FNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938611/canaccord-genuity-maintains-buy-on-paragon-28-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 41938616, "time": "2024-11-13 08:36:55", "headline": "Locafy Announces Up To $6.5M Contract With A Media Company", "summary": "", "symbols": ["LCFY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938616/locafy-announces-up-to-6-5m-contract-with-a-media-company", "tags": ["contract"]}
{"id": 41938626, "time": "2024-11-13 08:37:48", "headline": "Needham Maintains Buy on Azenta, Lowers Price Target to $55", "summary": "", "symbols": ["AZTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938626/needham-maintains-buy-on-azenta-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 41938639, "time": "2024-11-13 08:38:12", "headline": "Nuvei Receives All Regulatory Approvals For Going Private Transaction, Expecting Completion On November 15, 2024", "summary": "", "symbols": ["NVEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938639/nuvei-receives-all-regulatory-approvals-for-going-private-transaction-expecting-completion-on-novemb", "tags": []}
{"id": 41938683, "time": "2024-11-13 08:38:31", "headline": "Liberty Media President And CEO  Greg Maffei To Resign At End Of 2024; John Malone To Assume Role As Interim CEO", "summary": "", "symbols": ["FWONA", "FWONK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938683/liberty-media-president-and-ceo-greg-maffei-to-resign-at-end-of-2024-john-malone-to-assume-role-as-i", "tags": ["management"]}
{"id": 41938712, "time": "2024-11-13 08:39:44", "headline": "Liberty Media To Split Off Liberty Live Group", "summary": "", "symbols": ["FWONA", "FWONK", "LLYVA", "LLYVK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938712/liberty-media-to-split-off-liberty-live-group", "tags": []}
{"id": 41938722, "time": "2024-11-13 08:39:58", "headline": "Benchmark Maintains Speculative Buy on Peraso, Lowers Price Target to $3", "summary": "", "symbols": ["PRSO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938722/benchmark-maintains-speculative-buy-on-peraso-lowers-price-target-to-3", "tags": ["analyst_other", "price_target_down"]}
{"id": 41938737, "time": "2024-11-13 08:40:40", "headline": "SaverOne Regains Nasdaq Compliance", "summary": "", "symbols": ["SVRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938737/saverone-regains-nasdaq-compliance", "tags": []}
{"id": 41938741, "time": "2024-11-13 08:41:08", "headline": "Lightwave Logic Reports Strong Q3 2024 Progress, Wins ECOC Industry Innovation Award, Expands Board, Advances Licensing Talks, and Targets 2025 Global Agreements With $27M Funding Through 2026", "summary": "", "symbols": ["LWLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938741/lightwave-logic-reports-strong-q3-2024-progress-wins-ecoc-industry-innovation-award-expands-board-ad", "tags": []}
{"id": 41938753, "time": "2024-11-13 08:42:11", "headline": "CyberArk Q3 Earnings: Subscription Growth Soars, ARR Up, New CFO Announced And More", "summary": "CyberArk Software Ltd reported Q3 2024 revenue growth of 26%, beating analyst consensus. EPS also beat estimates. CFO to step down in 2025. Company expects strong Q4 and 2024 revenue and EPS.", "symbols": ["CYBR"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/24/11/41938753/cyberark-q3-earnings-subscription-growth-soars-arr-up-new-cfo-announced-and-more", "tags": ["earnings", "management"]}
{"id": 41938754, "time": "2024-11-13 08:42:16", "headline": "Vroom, Inc. Files for Voluntary Chapter 11 Bankruptcy With Prepackaged Restructuring Plan, Secures Support From Major Creditors And Shareholder To Restructure Debt Obligations", "summary": "", "symbols": ["VRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938754/vroom-inc-files-for-voluntary-chapter-11-bankruptcy-with-prepackaged-restructuring-plan-secures-supp", "tags": []}
{"id": 41938766, "time": "2024-11-13 08:42:44", "headline": "This Caterpillar Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday", "summary": " ", "symbols": ["CAT", "DOCS", "SBUX", "SOUN", "SPOT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41938766/this-caterpillar-analyst-turns-bearish-here-are-top-5-downgrades-for-wednesday", "tags": ["analyst_down"]}
{"id": 41938796, "time": "2024-11-13 08:43:11", "headline": "Spirit Airlines, Groupon, ZoomInfo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["CART", "GDEN", "GRPN", "IAUX", "JOUT", "PGNY", "PSFE", "RKT", "RUM", "SAVE", "ZI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41938796/spirit-airlines-groupon-zoominfo-technologies-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41938825, "time": "2024-11-13 08:43:39", "headline": "SAIHEAT Limited Reports Total Revenues Of $3.2M For The Six Months Ended Ju. 30, Up 6% YoY; EPS $(0.0792) vs $(0.1578)  YoY", "summary": "", "symbols": ["SAIH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938825/saiheat-limited-reports-total-revenues-of-3-2m-for-the-six-months-ended-ju-30-up-6-yoy-eps-0-0792-v", "tags": ["earnings"]}
{"id": 41938834, "time": "2024-11-13 08:43:53", "headline": "Fed's Kashkari Says CPI Headline Confirms Path We Are On; Still There Are 6 Weeks Before Fed's Next Meeting, With More Data To Come; Inflation Heading In The Right Direction", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938834/feds-kashkari-says-cpi-headline-confirms-path-we-are-on-still-there-are-6-weeks-before-feds-next-mee", "tags": []}
{"id": 41938837, "time": "2024-11-13 08:44:25", "headline": "Vivani Medical Q3 2024 GAAP EPS $(0.11), Inline", "summary": "", "symbols": ["VANI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938837/vivani-medical-q3-2024-gaap-eps-0-11-inline", "tags": ["earnings"]}
{"id": 41938863, "time": "2024-11-13 08:45:29", "headline": "Skyworks Beats Q4 EPS Estimates, Projects AI-Driven Smartphone Surge Despite Modest Q1 Outlook", "summary": "Skyworks Solutions reported Q4 results, beating EPS estimates &amp; paying 70 cent dividend. ", "symbols": ["FTXL", "SNSR", "SWKS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/24/11/41938863/skyworks-beats-q4-eps-estimates-projects-ai-driven-smartphone-surge-despite-modest-q1-outlook", "tags": ["earnings", "guidance", "dividend"]}
{"id": 41938888, "time": "2024-11-13 08:46:21", "headline": "Fed's Kashkari Says Not Ready To Say Inflation Is Stuck Above 2%; Labor Market Is Softening; We Are In A Good Place In Labor Market, Want To Keep It There; Have Two-Way Risks", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41938888/feds-kashkari-says-not-ready-to-say-inflation-is-stuck-above-2-labor-market-is-softening-we-are-in-a", "tags": []}
{"id": 41938911, "time": "2024-11-13 08:46:34", "headline": "QT Imaging Q3 EPS $(0.17) Down From $(0.14) YoY; Revenue $956K Up From $25K YoY", "summary": "", "symbols": ["QTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41938911/qt-imaging-q3-eps-0-17-down-from-0-14-yoy-revenue-956k-up-from-25k-yoy", "tags": ["earnings"]}
{"id": 41938972, "time": "2024-11-13 08:46:39", "headline": "Donald Trump To Establish A National Bitcoin Reserve? A 30% Chance, Polymarket Traders Speculate", "summary": "Persistent speculation about President-elect Donald Trump establishing a national Bitcoin (CRYPTO: BTC) reserve has increased on the possible appointment of a ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41938972/donald-trump-to-establish-a-national-bitcoin-reserve-a-30-chance-polymarket-traders-speculate", "tags": []}
{"id": 41939001, "time": "2024-11-13 08:46:45", "headline": "Microsoft, Salesforce, Target  And More On CNBC's 'Final Trades'", "summary": "On CNBC&#39;s &#34;Halftime Report Final Trades,&#34; Bill Baruch picked Microsoft, expecting it to outperform the Nasda qby the end of the year.", "symbols": ["CRM", "MSFT", "RSP", "TGT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/11/41939001/microsoft-salesforce-target-and-more-on-cnbcs-final-trades", "tags": []}
{"id": 41939018, "time": "2024-11-13 08:47:22", "headline": "Japan Increases Semiconductor Funding As US Trade Policies Pressure Taiwan Semiconductor", "summary": "Japan&#39;s PM commits $64.9 billion to boost semiconductor and AI industries, aiming to maintain competitive edge in advanced tech.", "symbols": ["TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/government/regulations/24/11/41939018/japan-increases-semiconductor-funding-as-us-trade-policies-pressure-taiwan-semiconductor", "tags": []}
{"id": 41939022, "time": "2024-11-13 08:47:29", "headline": "Fed's Kashkari Says Not Yet Seeing A Lot Of Upside Inflation Risks; Bigger Risk Is Getting Stuck; Risks Existed Before The Election, Need To Watch The Data", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939022/feds-kashkari-says-not-yet-seeing-a-lot-of-upside-inflation-risks-bigger-risk-is-getting-stuck-risks", "tags": []}
{"id": 41939024, "time": "2024-11-13 08:47:45", "headline": "HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $11 Price Target", "summary": "", "symbols": ["ETON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939024/hc-wainwright-co-reiterates-buy-on-eton-pharmaceuticals-maintains-11-price-target", "tags": ["analyst_other"]}
{"id": 41939045, "time": "2024-11-13 08:48:14", "headline": "Adial Pharmaceuticals Q3 Net Loss $2.2M", "summary": "", "symbols": ["ADIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41939045/adial-pharmaceuticals-q3-net-loss-2-2m", "tags": []}
{"id": 41939125, "time": "2024-11-13 08:49:20", "headline": "Canaccord Genuity Maintains Hold on Progyny, Lowers Price Target to $17", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939125/canaccord-genuity-maintains-hold-on-progyny-lowers-price-target-to-17", "tags": ["analyst_other", "price_target_down"]}
{"id": 41933025, "time": "2024-11-13 08:49:55", "headline": "Tesla Shares Rise In Pre-Market Wednesday After Cooling Down In Previous Session: What's Going On? (CORRECTED)", "summary": "Trump has appointed Musk and former presidential candidate Vivek Ramaswamy to lead the newly formed Department of Government Efficiency (DOGE). ", "symbols": ["TSLA"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/equities/24/11/41933025/tesla-shares-rise-in-pre-market-tuesday-after-cooling-down-in-previous-session-whats-going-on", "tags": ["why_moving"]}
{"id": 41939139, "time": "2024-11-13 08:50:26", "headline": "QT Imaging Holdings Announces Insiders PIPE Invesmtnet Of $1M", "summary": "", "symbols": ["QTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939139/qt-imaging-holdings-announces-insiders-pipe-invesmtnet-of-1m", "tags": []}
{"id": 41939146, "time": "2024-11-13 08:51:49", "headline": "Montana Technologies Changes Name To AirJoule Technologies", "summary": "", "symbols": ["AIRJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939146/montana-technologies-changes-name-to-airjoule-technologies", "tags": []}
{"id": 41939161, "time": "2024-11-13 08:52:46", "headline": "How To Earn $500 A Month From Helmerich & Payne Stock Ahead Of Q4 Earnings", "summary": "Helmerich &amp; Payne offers an annual dividend yield of 2.77%. That&#39;s a quarterly dividend amount of 25 cents per share ($1.00 a year).", "symbols": ["HP"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41939161/how-to-earn-500-a-month-from-helmerich-payne-stock-ahead-of-q4-earnings", "tags": ["earnings", "dividend"]}
{"id": 41939162, "time": "2024-11-13 08:52:47", "headline": "Mohamed El-Erian Says Rising Bond Yields Driven By Pro-Tariff Administration Picks And Expected Bond Issuance Surge", "summary": "The U.S. Treasury yields have priced in the expectations of higher Consumer Price Inflation as the two-year bonds declined, with the yields rising to 4.34%, on Tuesday. These yields have risen the most since July 2024, as per Bloomberg. The ten-year yields followed and rose to 4.40% as well.", "symbols": [], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/24/11/41939162/us-treasuries-edge-up-as-trumps-proposed-policies-possible-rate-cut-may-rekindle-inflation-fears-all-eyes-on-federal-reserves-next-steps", "tags": []}
{"id": 41939188, "time": "2024-11-13 08:53:19", "headline": "Canaccord Genuity Maintains Buy on Pagaya Techs, Lowers Price Target to $25", "summary": "", "symbols": ["PGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939188/canaccord-genuity-maintains-buy-on-pagaya-techs-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 41939196, "time": "2024-11-13 08:53:46", "headline": "CORRECTION: USA Core CPI (YoY) For October 3.3% Vs 3.3% Est.; 3.3% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41939196/correction-usa-core-cpi-yoy-for-october-3-3-vs-3-3-est-3-3-prior", "tags": []}
{"id": 41939200, "time": "2024-11-13 08:54:04", "headline": "Cisco Earnings On Deck As AI, Cybersecurity Drive Growth Potential", "summary": "Cisco (CSCO) stock is on a rally with 16.23% YTD. JPMorgan sees further growth potential due to strong demand and new partnerships. Technicals indicate a bullish trend.", "symbols": ["CSCO"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41939200/cisco-earnings-on-deck-as-ai-cybersecurity-drive-growth-potential", "tags": ["earnings"]}
{"id": 41939220, "time": "2024-11-13 08:54:29", "headline": "HC Wainwright & Co. Maintains Buy on IN8bio, Lowers Price Target to $8", "summary": "", "symbols": ["INAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939220/hc-wainwright-co-maintains-buy-on-in8bio-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41938838, "time": "2024-11-13 08:44:22", "headline": "Rivian's Deal With Volkswagen Will Help EV Giant 'Navigate The Ship In Stormy Waters': Analyst", "summary": "Rivian has faced significant financial challenges, including a steep loss of approximately $40,000 per EV in the third quarter.", "symbols": ["RIVN", "VWAGY"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41938838/rivians-deal-with-volkswagen-will-help-ev-giant-navigate-the-ship-in-stormy-waters-says-top-analyst-maintains-outperform-rating-with-20-target", "tags": ["contract"]}
{"id": 41939329, "time": "2024-11-13 08:55:03", "headline": "Trading Halt: Halted at 8:55:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["PULM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41939329/trading-halt-halted-at-8-55-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41939330, "time": "2024-11-13 08:55:04", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["LBRDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41939330/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41939339, "time": "2024-11-13 08:56:14", "headline": "HC Wainwright & Co. Reiterates Buy on Lifeward, Maintains $13 Price Target", "summary": "", "symbols": ["LFWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939339/hc-wainwright-co-reiterates-buy-on-lifeward-maintains-13-price-target", "tags": ["analyst_other"]}
{"id": 41939380, "time": "2024-11-13 08:59:11", "headline": "Robinhood Crypto Expands Offering With Solana (SOL), Pepe (PEPE), Cardano (ADA) & XRP (XRP) For U.S. Customers", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41939380/robinhood-crypto-expands-offering-with-solana-sol-pepe-pepe-cardano-ada-xrp-xrp-for-u-s-cu", "tags": ["offering"]}
{"id": 41939381, "time": "2024-11-13 08:59:27", "headline": "Coinbase CEO Brian Armstrong Says Using Crypto Sometimes Means 'Pushing Back On Bad Government'", "summary": "Coinbase&#39;s CEO Armstrong believes in economic freedom and standing up against bad government. They see the recent US election as pro-crypto.", "symbols": ["COIN"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41939381/coinbase-ceo-brian-armstrong-says-using-crypto-sometimes-means-pushing-back-on-bad-government", "tags": ["management"]}
{"id": 41939491, "time": "2024-11-13 09:00:07", "headline": "Trading Halt: Halt status updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["LBRDK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41939491/trading-halt-halt-status-updated-at-9-00-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41939536, "time": "2024-11-13 09:00:13", "headline": "A Closer Look at 11 Analyst Recommendations For Progyny", "summary": " ", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41939536/a-closer-look-at-11-analyst-recommendations-for-progyny", "tags": []}
{"id": 41939618, "time": "2024-11-13 09:00:28", "headline": "Deep Dive Into EVgo Stock: Analyst Perspectives (10 Ratings)", "summary": " ", "symbols": ["EVGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41939618/deep-dive-into-evgo-stock-analyst-perspectives-10-ratings", "tags": []}
{"id": 41939672, "time": "2024-11-13 09:00:39", "headline": "Where TeraWulf Stands With Analysts", "summary": " ", "symbols": ["WULF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41939672/where-terawulf-stands-with-analysts", "tags": []}
{"id": 41939684, "time": "2024-11-13 09:00:44", "headline": "Oppenheimer Maintains Outperform on EverCommerce, Raises Price Target to $13", "summary": "", "symbols": ["EVCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939684/oppenheimer-maintains-outperform-on-evercommerce-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 41939688, "time": "2024-11-13 09:00:46", "headline": "The Analyst Landscape: 15 Takes On Camden Prop Trust", "summary": " ", "symbols": ["CPT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41939688/the-analyst-landscape-15-takes-on-camden-prop-trust", "tags": []}
{"id": 41939704, "time": "2024-11-13 09:00:55", "headline": "Insights into KeyCorp's Upcoming Earnings", "summary": " ", "symbols": ["KEY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939704/insights-into-keycorps-upcoming-earnings", "tags": ["earnings"]}
{"id": 41939706, "time": "2024-11-13 09:00:56", "headline": "Analyst Expectations For Eton Pharmaceuticals's Future", "summary": " ", "symbols": ["ETON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41939706/analyst-expectations-for-eton-pharmaceuticalss-future", "tags": []}
{"id": 41939709, "time": "2024-11-13 09:00:58", "headline": "Jim Cramer Says Intuitive Surgical Is A 'Fantastic, Expensive Company'", "summary": "Intuitive Surgical reported third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion.", "symbols": ["CEG", "ET", "IBM", "ISRG", "SNOW", "TMUS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/11/41939709/jim-cramer-says-intuitive-surgical-is-a-fantastic-expensive-company", "tags": ["earnings"]}
{"id": 41939716, "time": "2024-11-13 09:01:04", "headline": "Expert Ratings For Home Depot", "summary": " ", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41939716/expert-ratings-for-home-depot", "tags": []}
{"id": 41939718, "time": "2024-11-13 09:01:05", "headline": "Insights into Celcuity's Upcoming Earnings", "summary": " ", "symbols": ["CELC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939718/insights-into-celcuitys-upcoming-earnings", "tags": ["earnings"]}
{"id": 41939724, "time": "2024-11-13 09:01:09", "headline": "CORRECTION: Paysafe Reaffirms FY24 Sales Guidance Of $1.71B-$1.73B Vs. $1.72B Estimate, Sees Adj. EBITDA Of $471M-$484M", "summary": "", "symbols": ["PSFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939724/correction-paysafe-reaffirms-fy24-sales-guidance-of-1-71b-1-73b-vs-1-72b-estimate-sees-adj-ebitda-of", "tags": ["guidance"]}
{"id": 41939728, "time": "2024-11-13 09:01:13", "headline": "A Glimpse of Ascendis Pharma's Earnings Potential", "summary": " ", "symbols": ["ASND"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939728/a-glimpse-of-ascendis-pharmas-earnings-potential", "tags": ["earnings"]}
{"id": 41939729, "time": "2024-11-13 09:01:17", "headline": "INmune Bio Completed Randomization Of Patients For Its Phase 2 Trial", "summary": "", "symbols": ["INMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41939729/inmune-bio-completed-randomization-of-patients-for-its-phase-2-trial", "tags": ["fda"]}
{"id": 41939730, "time": "2024-11-13 09:01:22", "headline": "Earnings Preview: Globant", "summary": " ", "symbols": ["GLOB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939730/earnings-preview-globant", "tags": ["earnings"]}
{"id": 41939731, "time": "2024-11-13 09:01:28", "headline": "Earnings Outlook For Eagle Point Credit Co", "summary": " ", "symbols": ["ECC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939731/earnings-outlook-for-eagle-point-credit-co", "tags": ["earnings", "guidance"]}
{"id": 41939740, "time": "2024-11-13 09:01:37", "headline": "A Look at Youdao's Upcoming Earnings Report", "summary": " ", "symbols": ["DAO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939740/a-look-at-youdaos-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 41939745, "time": "2024-11-13 09:01:46", "headline": "Oppenheimer Maintains Outperform on Pentair, Raises Price Target to $115", "summary": "", "symbols": ["PNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939745/oppenheimer-maintains-outperform-on-pentair-raises-price-target-to-115", "tags": ["analyst_other", "price_target_up"]}
{"id": 41939746, "time": "2024-11-13 09:01:49", "headline": "Earnings Outlook For NetEase", "summary": " ", "symbols": ["NTES"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939746/earnings-outlook-for-netease", "tags": ["earnings", "guidance"]}
{"id": 41939748, "time": "2024-11-13 09:01:56", "headline": "La Rosa Holdings Corp. Acquires Remaining 49% Interest Of La Rosa Realty Premier", "summary": "", "symbols": ["LRHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41939748/la-rosa-holdings-corp-acquires-remaining-49-interest-of-la-rosa-realty-premier", "tags": ["merger"]}
{"id": 41939749, "time": "2024-11-13 09:02:00", "headline": "CI&T's Earnings: A Preview", "summary": " ", "symbols": ["CINT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939749/ci-ts-earnings-a-preview", "tags": ["earnings"]}
{"id": 41939763, "time": "2024-11-13 09:02:12", "headline": "A Glimpse of Vuzix's Earnings Potential", "summary": " ", "symbols": ["VUZI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939763/a-glimpse-of-vuzixs-earnings-potential", "tags": ["earnings"]}
{"id": 41939767, "time": "2024-11-13 09:02:19", "headline": "An Overview of Consolidated Water Co's Earnings", "summary": " ", "symbols": ["CWCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939767/an-overview-of-consolidated-water-cos-earnings", "tags": ["earnings"]}
{"id": 41939770, "time": "2024-11-13 09:02:25", "headline": "LiqTech Receives Order From Leading Technology Company For Lithium Brine Production In The U.S.; Financial Terms Not Disclosed", "summary": "", "symbols": ["LIQT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939770/liqtech-receives-order-from-leading-technology-company-for-lithium-brine-production-in-the-u-s-finan", "tags": []}
{"id": 41939772, "time": "2024-11-13 09:02:35", "headline": "Trinseo To Sell Polycarbonate Technology License And Stade, Germany Polycarbonate Assets To Deepak Chem Tech; Total value $52.5M", "summary": "", "symbols": ["TSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939772/trinseo-to-sell-polycarbonate-technology-license-and-stade-germany-polycarbonate-assets-to-deepak-ch", "tags": []}
{"id": 41939773, "time": "2024-11-13 09:02:37", "headline": "Earnings Outlook For European Wax Center", "summary": " ", "symbols": ["EWCZ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939773/earnings-outlook-for-european-wax-center", "tags": ["earnings", "guidance"]}
{"id": 41939774, "time": "2024-11-13 09:02:44", "headline": "A Look Ahead: Affimed's Earnings Forecast", "summary": " ", "symbols": ["AFMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41939774/a-look-ahead-affimeds-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41939839, "time": "2024-11-13 09:03:58", "headline": "IBM Announces Quantum Hardware And Software Advancements", "summary": "", "symbols": ["IBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/tech/24/11/41939839/ibm-announces-quantum-hardware-and-software-advancements", "tags": []}
{"id": 41939850, "time": "2024-11-13 09:04:15", "headline": "Canaccord Genuity Maintains Hold on Plug Power, Lowers Price Target to $2.25", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939850/canaccord-genuity-maintains-hold-on-plug-power-lowers-price-target-to-2-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 41938762, "time": "2024-11-13 09:04:14", "headline": "October Inflation Rate Rises To 2.6% As Expected: December Interest Rate Cut Remains Uncertain (UPDATED)", "summary": "Inflation rate rises to 2.6% in October, casting doubt on hopes for continued disinflation. Fed president warns of potential pause in rate cut if data is higher. Odds of December cut at 58%.", "symbols": ["SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41938762/october-inflation-rate-rises-to-2-6-as-expected-december-interest-rate-cut-remains-uncertain", "tags": []}
{"id": 41939872, "time": "2024-11-13 09:04:49", "headline": "Pulmatrix And Cullgen Announce Proposed Merger; Pre-Merger Pulmatrix Stockholers To Own ~3.6% Of Combined Company; Pre-Merger Cullgen Stockholders To Own ~96.4% Of Combined Company Under Name Cullgen", "summary": "", "symbols": ["PULM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41939872/pulmatrix-and-cullgen-announce-proposed-merger-pre-merger-pulmatrix-stockholers-to-own-3-6-of-combin", "tags": ["merger"]}
{"id": 41939947, "time": "2024-11-13 09:06:08", "headline": "Rockwell Medical Files For Stock Offering Of Up To $25M", "summary": "", "symbols": ["RMTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41939947/rockwell-medical-files-for-stock-offering-of-up-to-25m", "tags": ["offering"]}
{"id": 41939965, "time": "2024-11-13 09:06:38", "headline": "BTC Digital Announces Agreement With Recte Technologies And Asia Investment Fund To Host 1,100 Bitcoin Mining Machines In U.S., Expanding Its Presence In Cryptocurrency Mining Industry", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41939965/btc-digital-announces-agreement-with-recte-technologies-and-asia-investment-fund-to-host-1", "tags": ["contract"]}
{"id": 41939983, "time": "2024-11-13 09:07:17", "headline": "Microsoft President Warns Beijing's Tech Progress Is Catching Up With The West: 'People Who Don't Go To China Too Often Assume They're Behind'", "summary": "Chinese and American Companies are navigating the tricky waters as political and economic tensions between the two nations increase. ", "symbols": ["MSFT"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/global/24/11/41939983/microsoft-president-warns-beijings-tech-progress-is-catching-up-with-the-west-people-who-dont-go-to-china-too-often-assume-theyre-behind", "tags": []}
{"id": 41939984, "time": "2024-11-13 09:07:18", "headline": "Tonix Pharmaceuticals Publishes Peer-Reviewed Publication In mSphere Journal Highlighting Tolerability Of its Single-Dose Mpox And Smallpox Vaccine Candidate TNX-801, In Immune-Compromised Animals", "summary": "", "symbols": ["TNXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41939984/tonix-pharmaceuticals-publishes-peer-reviewed-publication-in-msphere-journal-highlighting-tolerab", "tags": []}
{"id": 41939998, "time": "2024-11-13 09:07:54", "headline": "Nokia Rapid's Technology Assets And R&D Unit, Terms Not Disclosed", "summary": "", "symbols": ["NOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41939998/nokia-rapids-technology-assets-and-r-d-unit-terms-not-disclosed", "tags": []}
{"id": 41940006, "time": "2024-11-13 09:08:04", "headline": "Paysafe Stock Falls Despite Q3 Earnings Beat, Outlook Remains Unchanged", "summary": "Paysafe shares drop despite beating Q3 earnings and revenue estimates, with its FY24 outlook remaining unchanged.", "symbols": ["PSFE"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/news/earnings/24/11/41940006/paysafe-stock-falls-despite-q3-earnings-beat-outlook-remains-unchanged", "tags": ["earnings", "guidance"]}
{"id": 41940017, "time": "2024-11-13 09:08:14", "headline": "Canaccord Genuity Maintains Hold on Quantum-Si, Lowers Price Target to $1", "summary": "", "symbols": ["QSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940017/canaccord-genuity-maintains-hold-on-quantum-si-lowers-price-target-to-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 41940027, "time": "2024-11-13 09:08:25", "headline": "ServiceNow And Five9 Expand Partnership To Launch AI-Powered Solution For Unified Employee And Customer Experiences, Aiming To Streamline Self-Service, Enhance Agent Efficiency, And Boost Customer Satisfaction", "summary": "", "symbols": ["FIVN", "NOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940027/servicenow-and-five9-expand-partnership-to-launch-ai-powered-solution-for-unified-employee-and-custo", "tags": ["contract"]}
{"id": 41940046, "time": "2024-11-13 09:09:00", "headline": "Needham Reiterates Buy on ZoomInfo Technologies, Maintains $15 Price Target", "summary": "", "symbols": ["ZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940046/needham-reiterates-buy-on-zoominfo-technologies-maintains-15-price-target", "tags": ["analyst_other"]}
{"id": 41940048, "time": "2024-11-13 09:09:08", "headline": "Invizyne Technologies To Begin Trading On NASDAQ At 12:00 pm EST Under Ticker \"IZTC\"", "summary": "", "symbols": ["IZTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940048/invizyne-technologies-to-begin-trading-on-nasdaq-at-12-00-pm-est-under-ticker-iztc", "tags": []}
{"id": 41940050, "time": "2024-11-13 09:09:07", "headline": "Carvana Expands Same-Day Vehicle Delivery Service To Las Vegas, Enabling Local Customers To Receive Online Purchases Within Hours", "summary": "", "symbols": ["CVNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940050/carvana-expands-same-day-vehicle-delivery-service-to-las-vegas-enabling-local-customers-to-receive-o", "tags": []}
{"id": 41940062, "time": "2024-11-13 09:10:01", "headline": "Tower Semiconductor Q3 Earnings: Revenue And Profit Beat, Plans $350 Million Expansion", "summary": "Tower Semiconductor (TSEM) reported 3.4% revenue growth and $0.57 EPS, beating analyst estimates. It plans to invest $350 million to expand capacity and enhance SiPho and SiGe capabilities.", "symbols": ["INTC", "TSEM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/24/11/41940062/tower-semiconductor-q3-earnings-revenue-and-profit-beat-plans-350-million-expansion", "tags": ["earnings"]}
{"id": 41940140, "time": "2024-11-13 09:10:13", "headline": "Adaptimmune To Present Data From Primary Analysis Of Phase 2 IGNYTE-ESO Trial; Says Results Include Six Complete Responses And Twenty One Partial Responses", "summary": "", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41940140/adaptimmune-to-present-data-from-primary-analysis-of-phase-2-ignyte-eso-trial-says-results-includ", "tags": ["fda"]}
{"id": 41940240, "time": "2024-11-13 09:10:35", "headline": "HPE Launches Advanced Liquid-Cooled Supercomputing Solutions With Two New AI Systems For Service Providers And Enterprises, Featuring AMD, Intel, And NVIDIA Accelerators To Enhance AI Training And Supercomputing Capabilities", "summary": "", "symbols": ["AMD", "HPE", "INTC", "NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940240/hpe-launches-advanced-liquid-cooled-supercomputing-solutions-with-two-new-ai-systems-for-service-pro", "tags": []}
{"id": 41940251, "time": "2024-11-13 09:10:54", "headline": "HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $73 Price Target", "summary": "", "symbols": ["LEGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940251/hc-wainwright-co-reiterates-buy-on-legend-biotech-maintains-73-price-target", "tags": ["analyst_other"]}
{"id": 41940263, "time": "2024-11-13 09:11:47", "headline": "Recursion And Exscientia Receive Shareholder Approve For Proposed Combination", "summary": "", "symbols": ["EXAI", "RXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41940263/recursion-and-exscientia-receive-shareholder-approve-for-proposed-combination", "tags": []}
{"id": 41940270, "time": "2024-11-13 09:12:34", "headline": "Glucotrack Announces $10M Public Offering, Pricing 7.2M Shares With Attached Warrants At $1.39 Per Share; Closing Expected On November 14", "summary": "", "symbols": ["GCTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940270/glucotrack-announces-10m-public-offering-pricing-7-2m-shares-with-attached-warrants-at-1-39-per-shar", "tags": ["offering"]}
{"id": 41940283, "time": "2024-11-13 09:13:18", "headline": "Canaccord Genuity Maintains Buy on Shopify, Raises Price Target to $125", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940283/canaccord-genuity-maintains-buy-on-shopify-raises-price-target-to-125", "tags": ["analyst_other", "price_target_up"]}
{"id": 41940288, "time": "2024-11-13 09:14:11", "headline": "Canaccord Genuity Maintains Hold on Beauty Health, Raises Price Target to $1.75", "summary": "", "symbols": ["SKIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940288/canaccord-genuity-maintains-hold-on-beauty-health-raises-price-target-to-1-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41940302, "time": "2024-11-13 09:14:54", "headline": "Color Star Technology To Implement 100-For-1 Reverse Share Split For Class A And Class B Shares, Effective November 15", "summary": "", "symbols": ["ADD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940302/color-star-technology-to-implement-100-for-1-reverse-share-split-for-class-a-and-class-b-shares-effe", "tags": []}
{"id": 41940317, "time": "2024-11-13 09:15:10", "headline": "Creative Medical Technology Holdings Says Data Safety Monitoring Board  Concluded ADAPT Trial Of CELZ-201 May Proceed As Planned", "summary": "", "symbols": ["CELZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41940317/creative-medical-technology-holdings-says-data-safety-monitoring-board-concluded-adapt-trial-of-c", "tags": ["fda"]}
{"id": 41940320, "time": "2024-11-13 09:15:14", "headline": "Looking Into Blue Owl Cap's Recent Short Interest", "summary": " ", "symbols": ["OWL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41940320/looking-into-blue-owl-caps-recent-short-interest", "tags": []}
{"id": 41940323, "time": "2024-11-13 09:15:20", "headline": "How Is The Market Feeling About Parsons?", "summary": " ", "symbols": ["PSN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41940323/how-is-the-market-feeling-about-parsons", "tags": []}
{"id": 41940358, "time": "2024-11-13 09:15:25", "headline": "Peering Into Vistra's Recent Short Interest", "summary": " ", "symbols": ["VST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41940358/peering-into-vistras-recent-short-interest", "tags": []}
{"id": 41940401, "time": "2024-11-13 09:16:09", "headline": "Pineapple Financial Prices $1M Registered Direct Offering At $0.60 Per Share, With Closing Anticipated On November 15", "summary": "", "symbols": ["PAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940401/pineapple-financial-prices-1m-registered-direct-offering-at-0-60-per-share-with-closing-anticipated", "tags": ["offering"]}
{"id": 41940402, "time": "2024-11-13 09:16:15", "headline": "Virpax Pharmaceuticals Prices $5.0M Public Offering Of Common Stock And Pre-Funded Warrants", "summary": "", "symbols": ["VRPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940402/virpax-pharmaceuticals-prices-5-0m-public-offering-of-common-stock-and-pre-funded-warrants", "tags": ["offering"]}
{"id": 41940527, "time": "2024-11-13 09:18:14", "headline": "Top 10 Trending Stocks On WallStreetBets As Of November 13, 2024 (Via Swaggy Stocks)", "summary": "", "symbols": ["ASTS", "BTCUSD", "COIN", "LOT", "LUNR", "MARA", "NVDA", "OKLO", "RKLB", "TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41940527/top-10-trending-stocks-on-wallstreetbets-as-of-november-13-2024-via-swaggy-stocks", "tags": []}
{"id": 41940528, "time": "2024-11-13 09:18:26", "headline": "RWE Q3 EPS $0.42 Beats $0.15 Estimate, Sales $5.21B Down From $6.61B YoY", "summary": "", "symbols": ["RWEOY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41940528/rwe-q3-eps-0-42-beats-0-15-estimate-sales-5-21b-down-from-6-61b-yoy", "tags": ["earnings"]}
{"id": 41940531, "time": "2024-11-13 09:18:43", "headline": "Rakuten Group Q3 EPS $(0.23) Down From $(0.21) YoY, Sales $3.81B Up From $3.59B YoY", "summary": "", "symbols": ["RKUNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41940531/rakuten-group-q3-eps-0-23-down-from-0-21-yoy-sales-3-81b-up-from-3-59b-yoy", "tags": ["earnings"]}
{"id": 41940543, "time": "2024-11-13 09:19:09", "headline": "'TSMC Opening Ceremony For Arizona Site Puts On Hold, Sources Say' - DigiTimes", "summary": "", "symbols": ["TSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940543/tsmc-opening-ceremony-for-arizona-site-puts-on-hold-sources-say-digitimes", "tags": []}
{"id": 41940665, "time": "2024-11-13 09:21:00", "headline": "What Dip? Dogecoin Roars Back To 40 Cents With 11% Gain", "summary": "Dogecoin (CRYPTO: DOGE) is back at 40 cents, recovering from a shallow dip to 36 cents and leaving cryptocurrency traders calling for more upside.", "symbols": ["BNBUSD", "DOGEUSD", "SOLUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41940665/what-dip-dogecoin-roars-back-to-40-cents-with-11-gain", "tags": []}
{"id": 41940707, "time": "2024-11-13 09:23:29", "headline": "Shopify Analysts Boost Their Forecasts Following Q3 Earnings Results", "summary": " ", "symbols": ["SHOP"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41940707/shopify-analysts-boost-their-forecasts-following-q3-earnings-results", "tags": ["earnings"]}
{"id": 41940886, "time": "2024-11-13 09:24:46", "headline": "Piper Sandler Reiterates Overweight on Dayforce, Raises Price Target to $94", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41940886/piper-sandler-reiterates-overweight-on-dayforce-raises-price-target-to-94", "tags": ["analyst_other", "price_target_up"]}
{"id": 41940958, "time": "2024-11-13 09:24:58", "headline": "Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price", "summary": "MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access. Novo Nordisk&#39;s production shift raises concerns as diabetes cases rise, particularly in low-income regions.", "symbols": ["LLY", "NVO", "SNY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41940958/humanitarian-organization-criticizes-eli-lilly-novo-nordisk-and-sanofi-of-having-double-standards-for-high-insulin-price", "tags": []}
{"id": 41940960, "time": "2024-11-13 09:25:11", "headline": "Lexaria Bioscience Receives Human Research Ethics Committee Approval That Was Required Before Dosing Can Begin In GLP-1-H24-4 Study", "summary": "", "symbols": ["LEXX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41940960/lexaria-bioscience-receives-human-research-ethics-committee-approval-that-was-required-before-dos", "tags": []}
{"id": 41940984, "time": "2024-11-13 09:25:55", "headline": "Disney Bulls Await Earnings For Streaming Growth, Bob Iger Successor Clues", "summary": "Disney (NYSE:DIS) will report Q4 earnings, with expected EPS of $1.10 and $22.35B in revenue. Analysts watch streaming progress and CEO successor.", "symbols": ["DIS", "NFLX", "PARA", "WBD"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/general/entertainment/24/11/41940984/disney-bulls-await-earnings-for-streaming-growth-bob-iger-successor-clues", "tags": ["earnings", "management"]}
{"id": 41941064, "time": "2024-11-13 09:28:25", "headline": "Wingstop To Complete Securitized Financing Transaction; To Issue $500M Of New Securitized Notes; Expects Upzized Capacity Of Current Variable Funding Note Facility Of $200M-$300M", "summary": "", "symbols": ["WING"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941064/wingstop-to-complete-securitized-financing-transaction-to-issue-500m-of-new-securitized-notes-expect", "tags": []}
{"id": 41941068, "time": "2024-11-13 09:29:45", "headline": "Rocket Lab Stock Is Blasting Off Wednesday: What's Going On?", "summary": "Rocket Lab USA Inc (NASDAQ:RKLB) shares are trading higher Wednesday after the company reported better-than-expected financial results for the third quarter. The company also announced a multi-launch agreement with a confidential customer and was awarded a defense contract worth up to $8 million.", "symbols": ["RKLB"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/contracts/24/11/41941068/rocket-lab-stock-is-blasting-off-wednesday-whats-going-on", "tags": ["why_moving", "contract"]}
{"id": 41941113, "time": "2024-11-13 09:30:23", "headline": "These Analysts Increase Their Forecasts On Spotify Following Q3 Earnings", "summary": " ", "symbols": ["SPOT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41941113/these-analysts-increase-their-forecasts-on-spotify-following-q3-earnings", "tags": ["earnings"]}
{"id": 41941227, "time": "2024-11-13 09:33:18", "headline": "Datasea Q1 2025 Revenue $21.1M Vs $6.9M YoY; EPS $(0.49) Vs $(0.01) YoY", "summary": "", "symbols": ["DTSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41941227/datasea-q1-2025-revenue-21-1m-vs-6-9m-yoy-eps-0-49-vs-0-01-yoy", "tags": ["earnings"]}
{"id": 41941228, "time": "2024-11-13 09:33:19", "headline": "AT&T Data Breach Exposes 50 Billion Records: Hackers Identified, Ransom Paid", "summary": "Prosecutors identified two hackers behind a massive AT&amp;T data breach. Several other Snowflake customers experienced similar breaches.", "symbols": ["SNOW", "T"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/media/24/11/41941228/att-data-breach-exposes-50-billion-records-hackers-identified-ransom-paid", "tags": []}
{"id": 41941242, "time": "2024-11-13 09:33:52", "headline": "BTC Digital Shares Halted On Circuit Breaker To The Upside, Stock Now Up 130.5%", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41941242/btc-digital-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-130-5", "tags": ["halt"]}
{"id": 41941266, "time": "2024-11-13 09:35:31", "headline": "HC Wainwright & Co. Reiterates Buy on Dyne Therapeutics, Maintains $55 Price Target", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941266/hc-wainwright-co-reiterates-buy-on-dyne-therapeutics-maintains-55-price-target", "tags": ["analyst_other"]}
{"id": 41941285, "time": "2024-11-13 09:37:01", "headline": "HC Wainwright & Co. Reiterates Buy on Acumen Pharmaceuticals, Maintains $15 Price Target", "summary": "", "symbols": ["ABOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941285/hc-wainwright-co-reiterates-buy-on-acumen-pharmaceuticals-maintains-15-price-target", "tags": ["analyst_other"]}
{"id": 41941294, "time": "2024-11-13 09:37:35", "headline": "ZoomInfo Analysts Raise Their Forecasts After Q3 Results", "summary": " ", "symbols": ["ZI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41941294/zoominfo-analysts-raise-their-forecasts-after-q3-results", "tags": ["earnings"]}
{"id": 41941304, "time": "2024-11-13 09:37:39", "headline": "'Amazon Launches Temu Competitor Called 'Haul'' - The Information", "summary": "", "symbols": ["AMZN", "PDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941304/amazon-launches-temu-competitor-called-haul-the-information", "tags": []}
{"id": 41941305, "time": "2024-11-13 09:37:40", "headline": "Jefferies Downgrades Arch Resources to Hold, Raises Price Target to $165", "summary": "", "symbols": ["ARCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941305/jefferies-downgrades-arch-resources-to-hold-raises-price-target-to-165", "tags": ["analyst_down", "price_target_up"]}
{"id": 41941346, "time": "2024-11-13 09:38:54", "headline": "HC Wainwright & Co. Reiterates Buy on WAVE Life Sciences, Maintains $22 Price Target", "summary": "", "symbols": ["WVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941346/hc-wainwright-co-reiterates-buy-on-wave-life-sciences-maintains-22-price-target", "tags": ["analyst_other"]}
{"id": 41941348, "time": "2024-11-13 09:39:17", "headline": "'Boeing Delivers Advanced O3b mPOWER Satellites To Operator SES'  - Boeing", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941348/boeing-delivers-advanced-o3b-mpower-satellites-to-operator-ses-boeing", "tags": []}
{"id": 41941358, "time": "2024-11-13 09:39:49", "headline": "Oklo Stock Is Surging Wednesday: What's Going On?", "summary": "Oklo Inc (NYSE:OKLO) shares are trading higher Wednesday after the company announced it secured a partnership to supply up to 750 megawatts (MW) of power to U.S. data centers.", "symbols": ["OKLO"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/contracts/24/11/41941358/oklo-stock-is-surging-wednesday-whats-going-on", "tags": ["why_moving", "contract"]}
{"id": 41941382, "time": "2024-11-13 09:40:49", "headline": "Jefferies Maintains Hold on AMN Healthcare Services, Lowers Price Target to $27", "summary": "", "symbols": ["AMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941382/jefferies-maintains-hold-on-amn-healthcare-services-lowers-price-target-to-27", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941391, "time": "2024-11-13 09:41:05", "headline": "Johnson & Johnson Challenges Government Drug Pricing Dispute Over Two Drugs", "summary": "Johnson &amp; Johnson sues the U.S. government agency over a 340B Drug Pricing Program dispute, arguing the program&#39;s misuse.", "symbols": ["JNJ"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41941391/johnson-johnson-challenges-government-drug-pricing-dispute-over-two-drugs", "tags": []}
{"id": 41941386, "time": "2024-11-13 09:41:05", "headline": "HC Wainwright & Co. Reiterates Buy on Prothena Corp, Maintains $84 Price Target", "summary": "", "symbols": ["PRTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941386/hc-wainwright-co-reiterates-buy-on-prothena-corp-maintains-84-price-target", "tags": ["analyst_other"]}
{"id": 41941407, "time": "2024-11-13 09:41:33", "headline": "Oppenheimer Maintains Outperform on Corvus Pharma, Raises Price Target to $14", "summary": "", "symbols": ["CRVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941407/oppenheimer-maintains-outperform-on-corvus-pharma-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 41941424, "time": "2024-11-13 09:42:11", "headline": "What's Going On With Plug Power Stock Today?", "summary": "Plug Power provided a mixed 2025 financial outlook, and announced a leadership change.", "symbols": ["HYDR", "PLUG"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/11/41941424/whats-going-on-with-plug-power-stock-today", "tags": ["guidance", "why_moving"]}
{"id": 41941446, "time": "2024-11-13 09:43:12", "headline": "Oppenheimer Maintains Outperform on Flutter Entertainment, Raises Price Target to $305", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941446/oppenheimer-maintains-outperform-on-flutter-entertainment-raises-price-target-to-305", "tags": ["analyst_other", "price_target_up"]}
{"id": 41941454, "time": "2024-11-13 09:43:21", "headline": "HC Wainwright & Co. Maintains Buy on Savara, Lowers Price Target to $6", "summary": "", "symbols": ["SVRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941454/hc-wainwright-co-maintains-buy-on-savara-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941519, "time": "2024-11-13 09:44:05", "headline": "Oppenheimer Maintains Outperform on Genius Sports, Raises Price Target to $12", "summary": "", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941519/oppenheimer-maintains-outperform-on-genius-sports-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41941522, "time": "2024-11-13 09:44:20", "headline": "JD Analysts Raise Price Target, Eye 35% Upside Ahead Of Earnings", "summary": "JD to report Q3 earnings before market hours on Thursday. Analysts predict $1.06 EPS and $37B in revenue. Stock up 40.19% in past year, 32.72% YTD.", "symbols": ["JD"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/24/11/41941522/jd-ta-preview", "tags": ["earnings"]}
{"id": 41941541, "time": "2024-11-13 09:45:04", "headline": "Trading Halt: Halt status updated at 9:45:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["PULM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41941541/trading-halt-halt-status-updated-at-9-45-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41941557, "time": "2024-11-13 09:45:16", "headline": "Peering Into Apple's Recent Short Interest", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41941557/peering-into-apples-recent-short-interest", "tags": []}
{"id": 41941558, "time": "2024-11-13 09:45:21", "headline": "How Is The Market Feeling About Roper Techs?", "summary": " ", "symbols": ["ROP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41941558/how-is-the-market-feeling-about-roper-techs", "tags": []}
{"id": 41941560, "time": "2024-11-13 09:45:26", "headline": "Peering Into Humacyte's Recent Short Interest", "summary": " ", "symbols": ["HUMA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41941560/peering-into-humacytes-recent-short-interest", "tags": []}
{"id": 41941571, "time": "2024-11-13 09:45:41", "headline": "These Analysts Slash Their Forecasts On Progyny Following Q3 Results", "summary": " ", "symbols": ["PGNY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41941571/these-analysts-slash-their-forecasts-on-progyny-following-q3-results", "tags": ["earnings"]}
{"id": 41941574, "time": "2024-11-13 09:45:44", "headline": "Jet.AI Board Approves $2M Share Repurchase Program Through 2025 And Withdraws S-1 Registration, Citing Shift In Strategic Focus; Expects NASDAQ Compliance Without Offering", "summary": "", "symbols": ["JTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941574/jet-ai-board-approves-2m-share-repurchase-program-through-2025-and-withdraws-s-1-registration-citing", "tags": ["offering", "buyback"]}
{"id": 41941591, "time": "2024-11-13 09:46:10", "headline": "'Meta Wins Limits To FTC Antitrust Suit Over Instagram, WhatsApp; Company Wins Dismissal Of Some Claims From FTC Antitrust Case; Judge To Schedule Trial Date At Hearing Later This Month' - Bloomberg News", "summary": "", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941591/meta-wins-limits-to-ftc-antitrust-suit-over-instagram-whatsapp-company-wins-dismissal-of-some-claims", "tags": ["fda"]}
{"id": 41941602, "time": "2024-11-13 09:46:34", "headline": "JP Morgan Maintains Neutral on Skyworks Solutions, Lowers Price Target to $100", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941602/jp-morgan-maintains-neutral-on-skyworks-solutions-lowers-price-target-to-100", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941700, "time": "2024-11-13 09:47:08", "headline": "RBC Capital Maintains Outperform on Americold Realty Trust, Lowers Price Target to $30", "summary": "", "symbols": ["COLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941700/rbc-capital-maintains-outperform-on-americold-realty-trust-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941704, "time": "2024-11-13 09:47:08", "headline": "Jet.AI Shares Halted On Circuit Breaker To The Upside, Stock Now Up 7.23%", "summary": "", "symbols": ["JTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41941704/jet-ai-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-7-23", "tags": ["halt"]}
{"id": 41941711, "time": "2024-11-13 09:47:33", "headline": "Spirit Airlines Shares Halted To The Downside; Stock Now Down -60.87%", "summary": "", "symbols": ["SAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41941711/spirit-airlines-shares-halted-to-the-downside-stock-now-down-60-87", "tags": ["halt"]}
{"id": 41941712, "time": "2024-11-13 09:47:41", "headline": "JP Morgan Maintains Neutral on APA, Lowers Price Target to $25", "summary": "", "symbols": ["APA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941712/jp-morgan-maintains-neutral-on-apa-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941714, "time": "2024-11-13 09:47:48", "headline": "BTC Digital Shares Resumed Trade Then Again Halted On Circuit Breaker, This Time To The Downside, Stock Now Up 83.4%", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41941714/btc-digital-shares-resumed-trade-then-again-halted-on-circuit-breaker-this-time-to-the-downside-sto", "tags": ["halt"]}
{"id": 41941715, "time": "2024-11-13 09:47:54", "headline": "Oppenheimer Maintains Outperform on Maplebear, Raises Price Target to $60", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941715/oppenheimer-maintains-outperform-on-maplebear-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 41941740, "time": "2024-11-13 09:49:19", "headline": "Oppenheimer Maintains Outperform on Integral Ad Science, Lowers Price Target to $18", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941740/oppenheimer-maintains-outperform-on-integral-ad-science-lowers-price-target-to-18", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941751, "time": "2024-11-13 09:49:53", "headline": "JP Morgan Maintains Neutral on Topgolf Callaway Brands, Lowers Price Target to $11", "summary": "", "symbols": ["MODG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941751/jp-morgan-maintains-neutral-on-topgolf-callaway-brands-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941755, "time": "2024-11-13 09:50:28", "headline": "Fed's Logan Says U.S. Central Bank 'Most Likely' Will Need More Interest Rate Cuts, But Should 'proceed Cautiously,'; Models Show That Fed Funds Rate Could Be 'very Close' To Neutral Rate; If Fed Cuts Too Far, Past Neutral Level, Inflation Could Reaccelerate; Difficult To Know How Many Fed Rate Cuts May Be Needed, And How Soon They May Need To Happen; Fed Has Made 'great Deal Of Progress' Bringing Down Inflation, Restoring Balance To Economy; Fed Is Not Quite Back To Price Stability Yet", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41941755/feds-logan-says-u-s-central-bank-most-likely-will-need-more-interest-rate-cuts-bu", "tags": ["contract"]}
{"id": 41941757, "time": "2024-11-13 09:50:57", "headline": "Oppenheimer Maintains Outperform on Amdocs, Raises Price Target to $105", "summary": "", "symbols": ["DOX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941757/oppenheimer-maintains-outperform-on-amdocs-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 41941759, "time": "2024-11-13 09:51:12", "headline": "Fed's Logan Says U.S. Economic Activity Is 'Resilient'; Labor Market 'cooling Gradually' But Not Weakening Materially; Logan Sees Upside Risk To Inflation, Downside Risk To Employment, Says Financial Conditions Pose Biggest Potential Challenges For Monetary Policy; Says Rise In Bond Yields In Part Reflects Rise In Term Premiums; If Rise Continues, Fed May Need Less Restrictive Policy", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41941759/feds-logan-says-u-s-economic-activity-is-resilient-labor-market-cooling-gradually", "tags": []}
{"id": 41941761, "time": "2024-11-13 09:51:39", "headline": "RBC Capital Maintains Outperform on Biohaven, Lowers Price Target to $66", "summary": "", "symbols": ["BHVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941761/rbc-capital-maintains-outperform-on-biohaven-lowers-price-target-to-66", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941772, "time": "2024-11-13 09:52:05", "headline": "'Verizon's Takeover Of Frontier Set To Clear Shareholder Vote; Investors Set To Approve $9.6B Deal That Some Shareholders Had Opposed As Too Low' - WSJ", "summary": "", "symbols": ["FYBR", "VZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41941772/verizons-takeover-of-frontier-set-to-clear-shareholder-vote-investors-set-to-approve-9-6b-deal-that", "tags": ["merger", "contract"]}
{"id": 41941775, "time": "2024-11-13 09:52:22", "headline": "Oppenheimer Maintains Outperform on Viad, Raises Price Target to $54", "summary": "", "symbols": ["VVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941775/oppenheimer-maintains-outperform-on-viad-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 41941776, "time": "2024-11-13 09:52:42", "headline": "Spirit Airlines Shares Resumed Trade", "summary": "", "symbols": ["SAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41941776/spirit-airlines-shares-resumed-trade", "tags": []}
{"id": 41941786, "time": "2024-11-13 09:53:03", "headline": "BTC Digital Shares Resume Trade", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41941786/btc-digital-shares-resume-trade", "tags": []}
{"id": 41941799, "time": "2024-11-13 09:53:20", "headline": "These Analysts Boost Their Forecasts On Alight Following Strong Sales", "summary": " ", "symbols": ["ALIT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41941799/these-analysts-boost-their-forecasts-on-alight-following-strong-sales", "tags": []}
{"id": 41938466, "time": "2024-11-13 08:31:23", "headline": "Major indexes are higher following in-line Oct. CPI figures.", "summary": "", "symbols": ["DIA", "IWM", "QQQ", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41938466/major-indexes-are-higher-following-in-line-oct-cpi-figures", "tags": []}
{"id": 41941806, "time": "2024-11-13 09:53:38", "headline": "RBC Capital Maintains Outperform on EverCommerce, Raises Price Target to $14", "summary": "", "symbols": ["EVCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41941806/rbc-capital-maintains-outperform-on-evercommerce-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 41942019, "time": "2024-11-13 09:59:23", "headline": "'Planet Fitness Loses 11th Hour Bid To Acquire Bankrupt Blink' - CNBC", "summary": "", "symbols": ["PLNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41942019/planet-fitness-loses-11th-hour-bid-to-acquire-bankrupt-blink-cnbc", "tags": ["merger"]}
{"id": 41942121, "time": "2024-11-13 10:00:32", "headline": "JP Morgan Maintains Overweight on AbbVie, Lowers Price Target to $200", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942121/jp-morgan-maintains-overweight-on-abbvie-lowers-price-target-to-200", "tags": ["analyst_other", "price_target_down"]}
{"id": 41942123, "time": "2024-11-13 10:00:37", "headline": "Test0.0339524583461549: Bitcoin Up More Than 5% In 24 hours", "summary": "Bitcoin&#39;s (CRYPTO: BTC) price has increased 5.24% over the past 24 hours to $91,723.00. Over the past week, BTC has experienced an uptick of over 20.0%, moving from $74,354.33 to its current price.  As it stands right now, the coin&#39;s all-time high is $91,938.00. ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cryptocurrency/24/11/41942123/test0-0339524583461549-bitcoin-up-more-than-5-in-24-hours", "tags": []}
{"id": 41942124, "time": "2024-11-13 10:00:38", "headline": "Industry Comparison: Evaluating NVIDIA Against Competitors In Semiconductors &amp; Semiconductor Equipment Industry", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41942124/industry-comparison-evaluating-nvidia-against-competitors-in-semiconductors-amp-semiconductor-equip", "tags": []}
{"id": 41942125, "time": "2024-11-13 10:00:44", "headline": "Eli Lilly Unusual Options Activity For November 13", "summary": " ", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41942125/eli-lilly-unusual-options-activity-for-november-13", "tags": []}
{"id": 41942126, "time": "2024-11-13 10:00:44", "headline": "Watching Longeveron; Zacks Small-Cap Research Sets $9.50 Price Valuation", "summary": "", "symbols": ["LGVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942126/watching-longeveron-zacks-small-cap-research-sets-9-50-price-valuation", "tags": []}
{"id": 41942127, "time": "2024-11-13 10:00:47", "headline": "Investigating Microsoft's Standing In Software Industry Compared To Competitors", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41942127/investigating-microsofts-standing-in-software-industry-compared-to-competitors", "tags": []}
{"id": 41942134, "time": "2024-11-13 10:00:50", "headline": "Alibaba Gr Hldgs Unusual Options Activity For November 13", "summary": " ", "symbols": ["BABA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41942134/alibaba-gr-hldgs-unusual-options-activity-for-november-13", "tags": []}
{"id": 41942136, "time": "2024-11-13 10:00:55", "headline": "Taiwan Semiconductor's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["TSM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41942136/taiwan-semiconductors-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 41942137, "time": "2024-11-13 10:00:56", "headline": "Insights Into Apple's Performance Versus Peers In Technology Hardware, Storage &amp; Peripherals Sector", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41942137/insights-into-apples-performance-versus-peers-in-technology-hardware-storage-amp-peripherals-sector", "tags": []}
{"id": 41942158, "time": "2024-11-13 10:01:02", "headline": "Pagaya Techs Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)", "summary": " ", "symbols": ["PGY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41942158/pagaya-techs-stock-a-deep-dive-into-analyst-perspectives-7-ratings", "tags": []}
{"id": 41942177, "time": "2024-11-13 10:01:05", "headline": "Assessing Meta Platforms's Performance Against Competitors In Interactive Media &amp; Services Industry", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41942177/assessing-meta-platformss-performance-against-competitors-in-interactive-media-amp-services-industr", "tags": []}
{"id": 41942245, "time": "2024-11-13 10:01:12", "headline": "Decoding 5 Analyst Evaluations For Genius Sports", "summary": " ", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41942245/decoding-5-analyst-evaluations-for-genius-sports", "tags": []}
{"id": 41942246, "time": "2024-11-13 10:01:15", "headline": "Evaluating Amazon.com Against Peers In Broadline Retail Industry", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41942246/evaluating-amazon-com-against-peers-in-broadline-retail-industry", "tags": []}
{"id": 41942253, "time": "2024-11-13 10:01:22", "headline": "Assessing Topgolf Callaway Brands: Insights From 7 Financial Analysts", "summary": " ", "symbols": ["MODG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41942253/assessing-topgolf-callaway-brands-insights-from-7-financial-analysts", "tags": []}
{"id": 41942255, "time": "2024-11-13 10:01:30", "headline": "Demystifying Astrana Health: Insights From 3 Analyst Reviews", "summary": " ", "symbols": ["ASTH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41942255/demystifying-astrana-health-insights-from-3-analyst-reviews", "tags": []}
{"id": 41942261, "time": "2024-11-13 10:01:37", "headline": "A Closer Look at 7 Analyst Recommendations For Bioceres Crop Solutions", "summary": " ", "symbols": ["BIOX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41942261/a-closer-look-at-7-analyst-recommendations-for-bioceres-crop-solutions", "tags": []}
{"id": 41942275, "time": "2024-11-13 10:01:49", "headline": "A Peek at Ocular Therapeutix's Future Earnings", "summary": " ", "symbols": ["OCUL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942275/a-peek-at-ocular-therapeutixs-future-earnings", "tags": ["earnings"]}
{"id": 41942278, "time": "2024-11-13 10:01:56", "headline": "Insights Ahead: Telesat's Quarterly Earnings", "summary": " ", "symbols": ["TSAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942278/insights-ahead-telesats-quarterly-earnings", "tags": ["earnings"]}
{"id": 41942279, "time": "2024-11-13 10:02:00", "headline": "US Stocks Mixed; Inflation Rate Increases In October", "summary": " ", "symbols": ["BTCT", "GCTK", "KXIN", "MVST", "PET", "SYRS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41942279/us-stocks-mixed-inflation-rate-increases-in-october", "tags": []}
{"id": 41942285, "time": "2024-11-13 10:02:03", "headline": "Exploring bluebird bio's Earnings Expectations", "summary": " ", "symbols": ["BLUE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942285/exploring-bluebird-bios-earnings-expectations", "tags": ["earnings"]}
{"id": 41942290, "time": "2024-11-13 10:02:05", "headline": "Lionsgate And Kingdom Story Company Announced Today That The Companies Have Agreed To Renew Their 3-Year First-Look Deal, Extending The Studios' Total Collaboration To 10 Years", "summary": "", "symbols": ["LION"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942290/lionsgate-and-kingdom-story-company-announced-today-that-the-companies-have-agreed-to-renew-their-3", "tags": ["contract"]}
{"id": 41942293, "time": "2024-11-13 10:02:13", "headline": "RBC Capital Maintains Sector Perform on Honeywell Intl, Raises Price Target to $253", "summary": "", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942293/rbc-capital-maintains-sector-perform-on-honeywell-intl-raises-price-target-to-253", "tags": ["analyst_other", "price_target_up"]}
{"id": 41942294, "time": "2024-11-13 10:02:13", "headline": "Insights Ahead: Aqua Metals's Quarterly Earnings", "summary": " ", "symbols": ["AQMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942294/insights-ahead-aqua-metalss-quarterly-earnings", "tags": ["earnings"]}
{"id": 41942300, "time": "2024-11-13 10:02:22", "headline": "Earnings Preview: Cineverse", "summary": " ", "symbols": ["CNVS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942300/earnings-preview-cineverse", "tags": ["earnings"]}
{"id": 41942306, "time": "2024-11-13 10:02:34", "headline": "Peeling Back The Layers: Exploring Pentair Through Analyst Insights", "summary": " ", "symbols": ["PNR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41942306/peeling-back-the-layers-exploring-pentair-through-analyst-insights", "tags": []}
{"id": 41942309, "time": "2024-11-13 10:02:40", "headline": "What's Next: BioXcel Therapeutics's Earnings Preview", "summary": " ", "symbols": ["BTAI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942309/whats-next-bioxcel-therapeuticss-earnings-preview", "tags": ["earnings"]}
{"id": 41942322, "time": "2024-11-13 10:02:56", "headline": "JP Morgan Maintains Neutral on MercadoLibre, Lowers Price Target to $2150", "summary": "", "symbols": ["MELI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942322/jp-morgan-maintains-neutral-on-mercadolibre-lowers-price-target-to-2150", "tags": ["analyst_other", "price_target_down"]}
{"id": 41942328, "time": "2024-11-13 10:03:05", "headline": "Examining the Future: Despegar.com's Earnings Outlook", "summary": " ", "symbols": ["DESP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942328/examining-the-future-despegar-coms-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41942336, "time": "2024-11-13 10:03:13", "headline": "Jet.AI Shares Resume Trade Then Again Halt On Circuit Breaker To The Upside, Stock Now Up 56%", "summary": "", "symbols": ["JTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41942336/jet-ai-shares-resume-trade-then-again-halt-on-circuit-breaker-to-the-upside-stock-now-up-56", "tags": ["halt"]}
{"id": 41942353, "time": "2024-11-13 10:03:32", "headline": "Intuitive Machines's Earnings Outlook", "summary": " ", "symbols": ["LUNR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942353/intuitive-machiness-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41942366, "time": "2024-11-13 10:03:54", "headline": "A Peek at D-Wave Quantum's Future Earnings", "summary": " ", "symbols": ["QBTS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942366/a-peek-at-d-wave-quantums-future-earnings", "tags": ["earnings"]}
{"id": 41942372, "time": "2024-11-13 10:04:02", "headline": "Earnings Preview For Surf Air Mobility Inc. Common Stock", "summary": " ", "symbols": ["SRFM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942372/earnings-preview-for-surf-air-mobility-inc-common-stock", "tags": ["earnings"]}
{"id": 41942379, "time": "2024-11-13 10:04:12", "headline": "Earnings Preview For Aspira Womens Health", "summary": " ", "symbols": ["AWH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942379/earnings-preview-for-aspira-womens-health", "tags": ["earnings"]}
{"id": 41942388, "time": "2024-11-13 10:04:23", "headline": "A Look Ahead: Workhorse Gr's Earnings Forecast", "summary": " ", "symbols": ["WKHS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41942388/a-look-ahead-workhorse-grs-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41942420, "time": "2024-11-13 10:04:56", "headline": "JP Morgan Maintains Overweight on Spotify Technology, Raises Price Target to $530", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942420/jp-morgan-maintains-overweight-on-spotify-technology-raises-price-target-to-530", "tags": ["analyst_other", "price_target_up"]}
{"id": 41942480, "time": "2024-11-13 10:05:20", "headline": "Rio Tinto Has Approved Construction Of A New 25-Megawatt Solar Plant At Its Kennecott Copper Operation In Utah, Bringing The Mine's Total Solar Capacity To 30MW", "summary": "", "symbols": ["RIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942480/rio-tinto-has-approved-construction-of-a-new-25-megawatt-solar-plant-at-its-kennecott-copper-operati", "tags": []}
{"id": 41942514, "time": "2024-11-13 10:06:26", "headline": "RBC Capital Maintains Outperform on Lineage, Lowers Price Target to $81", "summary": "", "symbols": ["LINE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942514/rbc-capital-maintains-outperform-on-lineage-lowers-price-target-to-81", "tags": ["analyst_other", "price_target_down"]}
{"id": 41942527, "time": "2024-11-13 10:06:57", "headline": "JP Morgan Maintains Overweight on Maplebear, Raises Price Target to $52", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942527/jp-morgan-maintains-overweight-on-maplebear-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 41942558, "time": "2024-11-13 10:07:53", "headline": "Jet.AI Shares Resume Trade", "summary": "", "symbols": ["JTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41942558/jet-ai-shares-resume-trade", "tags": []}
{"id": 41942577, "time": "2024-11-13 10:08:40", "headline": "Jet.AI Shares Halted On Circuit Breaker To The Downside, Stock Now Up 27.3%", "summary": "", "symbols": ["JTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41942577/jet-ai-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-27-3", "tags": ["halt"]}
{"id": 41942581, "time": "2024-11-13 10:08:55", "headline": "JP Morgan Maintains Neutral on Cava Group, Raises Price Target to $110", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942581/jp-morgan-maintains-neutral-on-cava-group-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 41942612, "time": "2024-11-13 10:09:41", "headline": "Coinbase Launches COIN50 Index To Track Top 50 Digital Assets, Includes Bitcoin, Ethereum, Dogecoin, Solana", "summary": "Coinbase Inc. (NASDAQ:COIN) has introduced the Coinbase 50 Index (COIN50), a new benchmark tracking the performance of the top 50 digital assets listed ", "symbols": ["BTCUSD", "COIN", "DOGEUSD", "ETHUSD", "SOLUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41942612/coinbase-launches-coin50-index-to-track-top-50-digital-assets-includes-bitcoin-ethereum-dogecoin-solana", "tags": []}
{"id": 41942615, "time": "2024-11-13 10:09:44", "headline": "RBC Capital Maintains Sector Perform on Rocket Companies, Lowers Price Target to $18", "summary": "", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942615/rbc-capital-maintains-sector-perform-on-rocket-companies-lowers-price-target-to-18", "tags": ["analyst_other", "price_target_down"]}
{"id": 41941444, "time": "2024-11-13 09:43:09", "headline": "Genius Group shares are trading higher after the company announced it adopted a Bitcoin treasury reserve strategy.", "summary": "", "symbols": ["GNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41941444/genius-group-shares-are-trading-higher-after-the-company-announced-it-adopted-a-bitcoin-treasury-res", "tags": ["why_moving"]}
{"id": 41938713, "time": "2024-11-13 08:39:46", "headline": "BioRestorative Therapies shares are trading higher after the company reported better-than-expected Q3 revenue results. Additionally, the company reported preliminary Phase 2 BRTX-100 clinical data showing a material decrease in pain and increased function.", "summary": "", "symbols": ["BRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41938713/biorestorative-therapies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q", "tags": ["earnings", "why_moving", "fda"]}
{"id": 41938229, "time": "2024-11-13 08:25:59", "headline": "Aileron Therapeutics shares are trading higher after the company announced topline data from cohort 2 of its Phase 1b clinical trial of LTI-03 in IPF.", "summary": "", "symbols": ["ALRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41938229/aileron-therapeutics-shares-are-trading-higher-after-the-company-announced-topline-data-from-cohort", "tags": ["why_moving", "fda"]}
{"id": 41938095, "time": "2024-11-13 08:23:43", "headline": "Giftify shares are trading higher. The company reported Q3 financial results.", "summary": "", "symbols": ["GIFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41938095/giftify-shares-are-trading-higher-the-company-reported-q3-financial-results", "tags": ["why_moving"]}
{"id": 41942346, "time": "2024-11-13 10:03:16", "headline": "Markets Breathe Sigh Of Relief After In-Line Inflation Data: Stocks Rebound As Small Caps, Bonds Soar", "summary": "October inflation data meets expectations with a slight uptick in annual rate, core inflation steady at 3.3%. Fed may cut rates in Dec. Market reacts positively.", "symbols": ["ALB", "CHTR", "FICO", "GEV", "GLD", "IWM", "QQQ", "SPY", "SWKS", "TECH", "TLT"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41942346/markets-breath-sigh-of-relief-after-in-line-inflation-data-stocks-rebound-as-small-caps-bonds-soar", "tags": []}
{"id": 41942726, "time": "2024-11-13 10:11:55", "headline": "JP Morgan Maintains Overweight on Natera, Raises Price Target to $160", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942726/jp-morgan-maintains-overweight-on-natera-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 41937493, "time": "2024-11-13 08:08:06", "headline": "Tharimmune shares are trading higher after the company announced a European patent covering its biodegradable polymeric nanoparticles designed for carrying therapeutic and targeting agents.", "summary": "", "symbols": ["THAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41937493/tharimmune-shares-are-trading-higher-after-the-company-announced-a-european-patent-covering-its-biod", "tags": ["why_moving"]}
{"id": 41942749, "time": "2024-11-13 10:12:46", "headline": "RBC Capital Maintains Outperform on Shopify, Raises Price Target to $130", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942749/rbc-capital-maintains-outperform-on-shopify-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 41942778, "time": "2024-11-13 10:13:29", "headline": "Stifel Maintains Buy on 908 Devices, Lowers Price Target to $6", "summary": "", "symbols": ["MASS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942778/stifel-maintains-buy-on-908-devices-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 41942839, "time": "2024-11-13 10:15:23", "headline": "Barclays Maintains Equal-Weight on EverCommerce, Raises Price Target to $12", "summary": "", "symbols": ["EVCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41942839/barclays-maintains-equal-weight-on-evercommerce-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41942907, "time": "2024-11-13 10:15:39", "headline": "ARM Holdings Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["ARM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41942907/arm-holdings-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 41942954, "time": "2024-11-13 10:15:45", "headline": "Spotify Technology Unusual Options Activity", "summary": " ", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41942954/spotify-technology-unusual-options-activity", "tags": []}
{"id": 41943002, "time": "2024-11-13 10:15:50", "headline": "Snowflake Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41943002/snowflake-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 41943033, "time": "2024-11-13 10:16:19", "headline": "Barclays Maintains Overweight on Gauzy, Lowers Price Target to $15", "summary": "", "symbols": ["GAUZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943033/barclays-maintains-overweight-on-gauzy-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 41943037, "time": "2024-11-13 10:16:31", "headline": "Keybanc Maintains Overweight on Alight, Raises Price Target to $11", "summary": "", "symbols": ["ALIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943037/keybanc-maintains-overweight-on-alight-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943049, "time": "2024-11-13 10:16:49", "headline": "Cloudflare's Golden Cross, AI Innovation Signal Next Growth Phase", "summary": "Cloudflare&#39;s Golden Cross signals potential long-term strength, supported by Q3 earnings growth and AI innovation. However, high P/E ratio and volatile revenue may pose challenges.", "symbols": ["NET"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/24/11/41943049/net-golden-cross-ta", "tags": ["earnings"]}
{"id": 41943173, "time": "2024-11-13 10:17:44", "headline": "Barclays Maintains Equal-Weight on Shoals Technologies Gr, Lowers Price Target to $5", "summary": "", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943173/barclays-maintains-equal-weight-on-shoals-technologies-gr-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41943177, "time": "2024-11-13 10:17:50", "headline": "Department Of Justice Seeks To Seize $16 Million In Crypto Assets Tied To FTX Bribery Case", "summary": "The U.S. Department of Justice (DOJ) has filed a civil forfeiture complaint to seize approximately $16 million in cryptocurrency held in a Binance account.", "symbols": ["ADAUSD", "ICPUSD", "SOLUSD", "USDTUSD", "XRPUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41943177/department-of-justice-seeks-to-seize-16-million-in-crypto-assets-tied-to-ftx-bribery-case", "tags": []}
{"id": 41943183, "time": "2024-11-13 10:17:58", "headline": "Stifel Maintains Hold on Treehouse Foods, Lowers Price Target to $32", "summary": "", "symbols": ["THS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943183/stifel-maintains-hold-on-treehouse-foods-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 41943226, "time": "2024-11-13 10:19:38", "headline": "Keybanc Maintains Overweight on Dayforce, Raises Price Target to $92", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943226/keybanc-maintains-overweight-on-dayforce-raises-price-target-to-92", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943229, "time": "2024-11-13 10:19:41", "headline": "Stifel Maintains Buy on Alto Neuroscience, Lowers Price Target to $10", "summary": "", "symbols": ["ANRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943229/stifel-maintains-buy-on-alto-neuroscience-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 41943234, "time": "2024-11-13 10:19:50", "headline": "Barclays Maintains Equal-Weight on Treehouse Foods, Lowers Price Target to $32", "summary": "", "symbols": ["THS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943234/barclays-maintains-equal-weight-on-treehouse-foods-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 41943233, "time": "2024-11-13 10:19:50", "headline": "Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday", "summary": " ", "symbols": ["ALB", "AMPS", "CAVA", "DAVE", "FNA", "HNST", "JBLU", "JHX", "JTAI", "NTRA", "ORGO", "PAY", "RIVN", "RKLB", "SPOT", "TSEM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41943233/paymentus-posts-better-than-expected-earnings-joins-dave-honest-company-natera-cava-group-and-other-big-stocks-moving-higher-on-wednesday", "tags": ["earnings", "why_moving"]}
{"id": 41943268, "time": "2024-11-13 10:21:00", "headline": "Stifel Maintains Buy on Cava Group, Raises Price Target to $175", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943268/stifel-maintains-buy-on-cava-group-raises-price-target-to-175", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943294, "time": "2024-11-13 10:21:37", "headline": "Barclays Maintains Equal-Weight on Dayforce, Raises Price Target to $80", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943294/barclays-maintains-equal-weight-on-dayforce-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943319, "time": "2024-11-13 10:22:32", "headline": "Stifel Maintains Buy on Rocket Lab USA, Raises Price Target to $22", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943319/stifel-maintains-buy-on-rocket-lab-usa-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943352, "time": "2024-11-13 10:23:04", "headline": "Barclays Maintains Overweight on First Solar, Lowers Price Target to $275", "summary": "", "symbols": ["FSLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943352/barclays-maintains-overweight-on-first-solar-lowers-price-target-to-275", "tags": ["analyst_other", "price_target_down"]}
{"id": 41943387, "time": "2024-11-13 10:24:06", "headline": "Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $209", "summary": "", "symbols": ["ICUI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943387/keybanc-maintains-overweight-on-icu-medical-raises-price-target-to-209", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943401, "time": "2024-11-13 10:24:48", "headline": "Barclays Maintains Overweight on Flutter Entertainment, Raises Price Target to $301", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943401/barclays-maintains-overweight-on-flutter-entertainment-raises-price-target-to-301", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943696, "time": "2024-11-13 10:28:22", "headline": "Barclays Maintains Overweight on Grab Holdings, Raises Price Target to $5.5", "summary": "", "symbols": ["GRAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943696/barclays-maintains-overweight-on-grab-holdings-raises-price-target-to-5-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943725, "time": "2024-11-13 10:28:52", "headline": "Microvast Shares Halted On Circuit Breaker To The Upside, Stock Now Up 481.1%", "summary": "", "symbols": ["MVST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41943725/microvast-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-481-1", "tags": ["halt"]}
{"id": 41943753, "time": "2024-11-13 10:29:37", "headline": "Barclays Maintains Overweight on Honeywell Intl, Raises Price Target to $252", "summary": "", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943753/barclays-maintains-overweight-on-honeywell-intl-raises-price-target-to-252", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943756, "time": "2024-11-13 10:29:39", "headline": "Cisco Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["CSCO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41943756/cisco-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-2", "tags": ["earnings"]}
{"id": 41943757, "time": "2024-11-13 10:29:40", "headline": "Bp's Chief Economist Says By 2035 The World Will Need 80M-100M Barrels/Day Of Oil In A Net Zero Environment; Non-OPEC Supply Growth Will Exceed Demand Growth Over The Next Several Years", "summary": "", "symbols": ["BP", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41943757/bps-chief-economist-says-by-2035-the-world-will-need-80m-100m-barrelsday-of-oil-i", "tags": []}
{"id": 41943785, "time": "2024-11-13 10:30:17", "headline": "Keybanc Maintains Overweight on Shopify, Raises Price Target to $130", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943785/keybanc-maintains-overweight-on-shopify-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943804, "time": "2024-11-13 10:30:38", "headline": "Citigroup Partners With Bank Of Shanghai To Simplify Payments For Travelers In China: Details", "summary": "Citigroup announced a partnership with Bank of Shanghai to launch a seamless payment solution for international travelers in China.", "symbols": ["C", "FPAG", "FTXO"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/equities/24/11/41943804/citigroup-partners-with-bank-of-shanghai-to-simplify-payments-for-travelers-in-china-details", "tags": ["contract"]}
{"id": 41943899, "time": "2024-11-13 10:32:23", "headline": "Check Out What Whales Are Doing With DAL", "summary": " ", "symbols": ["DAL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41943899/check-out-what-whales-are-doing-with-dal", "tags": []}
{"id": 41943902, "time": "2024-11-13 10:32:23", "headline": "Keybanc Maintains Overweight on Spotify Technology, Raises Price Target to $520", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41943902/keybanc-maintains-overweight-on-spotify-technology-raises-price-target-to-520", "tags": ["analyst_other", "price_target_up"]}
{"id": 41943908, "time": "2024-11-13 10:32:28", "headline": "Check Out What Whales Are Doing With GOOGL", "summary": " ", "symbols": ["GOOGL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41943908/check-out-what-whales-are-doing-with-googl", "tags": []}
{"id": 41943915, "time": "2024-11-13 10:32:34", "headline": "Datadog's Options: A Look at What the Big Money is Thinking", "summary": " ", "symbols": ["DDOG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41943915/datadogs-options-a-look-at-what-the-big-money-is-thinking", "tags": []}
{"id": 41943925, "time": "2024-11-13 10:32:48", "headline": "Microvast Shares Resume Trade", "summary": "", "symbols": ["MVST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41943925/microvast-shares-resume-trade", "tags": []}
{"id": 41943966, "time": "2024-11-13 10:33:26", "headline": "Stratasys CEO Touts Turnaround: Strong Market Gains, Cost Cuts Drive Q3 Beat, Guidance Raised", "summary": "Stratasys stock surged after the company reported fiscal third-quarter 2024 revenue of $140.01 million, down 13.6% year-on-year.", "symbols": ["SSYS"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/24/11/41943966/stratasys-ceo-touts-turnaround-strong-market-gains-cost-cuts-drive-q3-beat-guidance-raised", "tags": ["earnings", "guidance", "management"]}
{"id": 41943973, "time": "2024-11-13 10:33:40", "headline": "Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth", "summary": "Atai Life Sciences reports Q3 results, highlighting FDA clearance for DMT film, upcoming MDMA trials, and a strong cash position.", "symbols": ["ATAI"], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/news/earnings/24/11/41943973/atai-q3-report-strong-cash-position-clinical-pipeline-growth", "tags": ["earnings", "fda"]}
{"id": 41944063, "time": "2024-11-13 10:35:37", "headline": "Barclays Maintains Overweight on IAC, Lowers Price Target to $66", "summary": "", "symbols": ["IAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944063/barclays-maintains-overweight-on-iac-lowers-price-target-to-66", "tags": ["analyst_other", "price_target_down"]}
{"id": 41944096, "time": "2024-11-13 10:36:52", "headline": "Keybanc Maintains Overweight on Westinghouse Air Brake, Raises Price Target to $220", "summary": "", "symbols": ["WAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944096/keybanc-maintains-overweight-on-westinghouse-air-brake-raises-price-target-to-220", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944164, "time": "2024-11-13 10:38:13", "headline": "Barclays Maintains Overweight on Maplebear, Raises Price Target to $56", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944164/barclays-maintains-overweight-on-maplebear-raises-price-target-to-56", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944168, "time": "2024-11-13 10:38:20", "headline": "CORRECTION: Griffon Q4 Adj EPS $1.47 Beats $1.18 Estimate, Sales $659.67M Beat $641.24M Estimate", "summary": "", "symbols": ["GFF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41944168/correction-griffon-q4-adj-eps-1-47-beats-1-18-estimate-sales-659-67m-beat-641-24m-estimate", "tags": ["earnings"]}
{"id": 41944180, "time": "2024-11-13 10:39:13", "headline": "Barclays Maintains Overweight on On Holding, Raises Price Target to $63", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944180/barclays-maintains-overweight-on-on-holding-raises-price-target-to-63", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944206, "time": "2024-11-13 10:40:19", "headline": "Stephens & Co. Initiates Coverage On Atlanticus Holdings with Overweight Rating, Announces Price Target of $54", "summary": "", "symbols": ["ATLC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944206/stephens-co-initiates-coverage-on-atlanticus-holdings-with-overweight-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 41944207, "time": "2024-11-13 10:40:20", "headline": "Spire Global Soars On Heels Of $241 Million Sale Of Maritime Business, Plans Debt Payoff", "summary": "Spire plans to use the sale proceeds to fully pay off its outstanding debt and invest in growth opportunities.", "symbols": ["SPIR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/asset-sales/24/11/41944207/spire-global-soars-on-heels-of-241-million-sale-of-maritime-business-plans-debt-payoff", "tags": []}
{"id": 41944218, "time": "2024-11-13 10:40:38", "headline": "BMO Capital Maintains Market Perform on Westlake, Lowers Price Target to $165", "summary": "", "symbols": ["WLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944218/bmo-capital-maintains-market-perform-on-westlake-lowers-price-target-to-165", "tags": ["analyst_other", "price_target_down"]}
{"id": 41944236, "time": "2024-11-13 10:40:53", "headline": "Griffon Sees FY25 Revenue To Be Consistent With 2024 At $2.6B Vs $2.66B Est.; Adjusted EBITDA In A Range Of $575M-$600M", "summary": "", "symbols": ["GFF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944236/griffon-sees-fy25-revenue-to-be-consistent-with-2024-at-2-6b-vs-2-66b-est-adjusted-ebitda-in-a-range", "tags": ["earnings"]}
{"id": 41944281, "time": "2024-11-13 10:43:04", "headline": "Bl\u00fcm Holdings Q3 Revenue Grows 182% YoY, Subsidiary Unrivaled Brands Files For Bankruptcy", "summary": " ", "symbols": ["BLMH"], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/news/earnings/24/11/41944281/blum-holdings-q3-revenue-grows-182-yoy-subsidiary-unrivaled-brands-files-for-bankruptcy", "tags": ["earnings"]}
{"id": 41944285, "time": "2024-11-13 10:43:21", "headline": "Barclays Maintains Underweight on Rocket Companies, Lowers Price Target to $13", "summary": "", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944285/barclays-maintains-underweight-on-rocket-companies-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 41944287, "time": "2024-11-13 10:43:25", "headline": "Stephens & Co. Initiates Coverage On Enova International with Overweight Rating, Announces Price Target of $108", "summary": "", "symbols": ["ENVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944287/stephens-co-initiates-coverage-on-enova-international-with-overweight-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 41942999, "time": "2024-11-13 10:44:09", "headline": "Griffon Surges Ahead: Strong Q4 Earnings Beat, Dividend Hike, Buyback & More (UPDATED)", "summary": "Griffon reported better-than-expected fourth-quarter earnings, with revenue growth of 3% year-over-year to $659.67 million, beating the consensus. Griffon&#39;s board approved an additional $400 million share buyback and raised the quarterly dividend by 20%.", "symbols": ["GFF"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/news/buybacks/24/11/41942999/griffon-surges-ahead-strong-q4-earnings-beat-dividend-hike-buyback-more", "tags": ["earnings", "buyback", "dividend"]}
{"id": 41944301, "time": "2024-11-13 10:44:16", "headline": "BMO Capital Maintains Market Perform on Tyson Foods, Raises Price Target to $62", "summary": "", "symbols": ["TSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944301/bmo-capital-maintains-market-perform-on-tyson-foods-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944305, "time": "2024-11-13 10:44:36", "headline": "Barclays Maintains Equal-Weight on Shopify, Raises Price Target to $93", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944305/barclays-maintains-equal-weight-on-shopify-raises-price-target-to-93", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944319, "time": "2024-11-13 10:45:16", "headline": "How Is The Market Feeling About Expedia Group?", "summary": " ", "symbols": ["EXPE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41944319/how-is-the-market-feeling-about-expedia-group", "tags": []}
{"id": 41944321, "time": "2024-11-13 10:45:21", "headline": "How Is The Market Feeling About ONEOK?", "summary": " ", "symbols": ["OKE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41944321/how-is-the-market-feeling-about-oneok", "tags": []}
{"id": 41944324, "time": "2024-11-13 10:45:26", "headline": "(KXIN) - Analyzing Kaixin Hldgs's Short Interest", "summary": " ", "symbols": ["KXIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41944324/kxin-analyzing-kaixin-hldgss-short-interest", "tags": []}
{"id": 41944346, "time": "2024-11-13 10:46:09", "headline": "Stephens & Co. Initiates Coverage On FirstCash Hldgs with Overweight Rating, Announces Price Target of $137", "summary": "", "symbols": ["FCFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944346/stephens-co-initiates-coverage-on-firstcash-hldgs-with-overweight-rating-announces-price-target-of-1", "tags": ["analyst_init"]}
{"id": 41944420, "time": "2024-11-13 10:47:11", "headline": "Barclays Maintains Underweight on Skyworks Solutions, Lowers Price Target to $80", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944420/barclays-maintains-underweight-on-skyworks-solutions-lowers-price-target-to-80", "tags": ["analyst_other", "price_target_down"]}
{"id": 41944424, "time": "2024-11-13 10:47:25", "headline": "Fusion Fuel Receives Staff Determination Notice From Nasdaq, Submits Appeal Request For Hearing Before A Nasdaq Hearings Panel", "summary": "", "symbols": ["HTOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944424/fusion-fuel-receives-staff-determination-notice-from-nasdaq-submits-appeal-request-for-hearing-befor", "tags": []}
{"id": 41944453, "time": "2024-11-13 10:48:02", "headline": "BMO Capital Maintains Market Perform on Telos, Raises Price Target to $4.5", "summary": "", "symbols": ["TLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944453/bmo-capital-maintains-market-perform-on-telos-raises-price-target-to-4-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944477, "time": "2024-11-13 10:49:09", "headline": "BMO Capital Maintains Outperform on Schrodinger, Raises Price Target to $28", "summary": "", "symbols": ["SDGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944477/bmo-capital-maintains-outperform-on-schrodinger-raises-price-target-to-28", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944479, "time": "2024-11-13 10:49:14", "headline": "Kyndryl, Dell, Nvidia Join Forces To Launch AI Private Cloud For Japanese Enterprises", "summary": "Kyndryl Holdings shares are trading higher after the company launched a dedicated AI private cloud in Japan.", "symbols": ["CSD", "DELL", "KD", "NVDA", "SMCO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/mid-cap/24/11/41944479/kyndryl-dell-nvidia-join-forces-to-launch-ai-private-cloud-for-japanese-enterprises", "tags": ["why_moving"]}
{"id": 41944486, "time": "2024-11-13 10:49:27", "headline": "Barclays Maintains Overweight on Spotify Technology, Raises Price Target to $475", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944486/barclays-maintains-overweight-on-spotify-technology-raises-price-target-to-475", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944519, "time": "2024-11-13 10:50:33", "headline": "Stephens & Co. Initiates Coverage On PROG Holdings with Overweight Rating, Announces Price Target of $60", "summary": "", "symbols": ["PRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944519/stephens-co-initiates-coverage-on-prog-holdings-with-overweight-rating-announces-price-target-of-60", "tags": ["analyst_init"]}
{"id": 41944527, "time": "2024-11-13 10:50:43", "headline": "BMO Capital Maintains Outperform on Axalta Coating Sys, Raises Price Target to $48", "summary": "", "symbols": ["AXTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944527/bmo-capital-maintains-outperform-on-axalta-coating-sys-raises-price-target-to-48", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944529, "time": "2024-11-13 10:51:19", "headline": "What's Going On With Bank Of America (BAC) Shares", "summary": "Bank of America shares have climbed 10% over the past week following Donald Trump&#39;s re-election. The move is fueled by investor optimism around anticipated pro-business policies.", "symbols": ["BAC"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41944529/whats-going-on-with-bank-of-america-bac-shares", "tags": ["why_moving"]}
{"id": 41944536, "time": "2024-11-13 10:51:38", "headline": "Barclays Maintains Equal-Weight on Zeta Global Holdings, Raises Price Target to $32", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944536/barclays-maintains-equal-weight-on-zeta-global-holdings-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944563, "time": "2024-11-13 10:52:28", "headline": "B of A Securities Maintains Buy on Progyny, Lowers Price Target to $21", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944563/b-of-a-securities-maintains-buy-on-progyny-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 41944626, "time": "2024-11-13 10:53:22", "headline": "Reported November 12, 2024: \"AMD Confirms Laying Off 4% Of Its Employees To Align Resources With 'Largest Growth Opportunities'\" - WCCFtech", "summary": "", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944626/reported-november-12-2024-amd-confirms-laying-off-4-of-its-employees-to-align-resources-with-largest", "tags": []}
{"id": 41944635, "time": "2024-11-13 10:53:40", "headline": "Inflation On Track, But Fed May 'Go Slowly' On Interest Rate Cuts, Experts Say", "summary": "October CPI rises to 2.6%, in line with predictions. Experts weigh in on Fed&#39;s decision for Dec rate cut, with concerns over strong economy and softening labor market.", "symbols": [], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/econ-s/24/11/41944635/inflation-on-track-but-fed-may-go-slowly-on-interest-rate-cuts-experts-say", "tags": []}
{"id": 41944678, "time": "2024-11-13 10:54:28", "headline": "Barclays Maintains Underweight on Heartland Express, Raises Price Target to $11", "summary": "", "symbols": ["HTLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944678/barclays-maintains-underweight-on-heartland-express-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944757, "time": "2024-11-13 10:55:18", "headline": "Barclays Maintains Overweight on Knight-Swift, Raises Price Target to $68", "summary": "", "symbols": ["KNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944757/barclays-maintains-overweight-on-knight-swift-raises-price-target-to-68", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944788, "time": "2024-11-13 10:56:14", "headline": "NeoVolta $250M Loan Application Part One Approved By The U.S. Department Of Energy Title 17 Loan Program; Has Been Approved To Proceed With Phase Two Technical Due Diligence", "summary": "", "symbols": ["NEOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944788/neovolta-250m-loan-application-part-one-approved-by-the-u-s-department-of-energy-title-17-loan-progr", "tags": []}
{"id": 41944789, "time": "2024-11-13 10:56:17", "headline": "Barclays Maintains Equal-Weight on Old Dominion Freight Line, Raises Price Target to $220", "summary": "", "symbols": ["ODFL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944789/barclays-maintains-equal-weight-on-old-dominion-freight-line-raises-price-target-to-220", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944819, "time": "2024-11-13 10:57:27", "headline": "Microvast Stock Is Soaring Wednesday: Here's Why", "summary": "Microvast Holdings Inc (NASDAQ:MVST) shares are soaring Wednesday morning on the heels of the company&#39;s unaudited third-quarter financial results. Here&#39;s what you need to know.", "symbols": ["MVST"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41944819/microvast-stock-is-soaring-wednesday-heres-why", "tags": []}
{"id": 41944829, "time": "2024-11-13 10:57:49", "headline": "Barclays Maintains Overweight on Saia, Raises Price Target to $620", "summary": "", "symbols": ["SAIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944829/barclays-maintains-overweight-on-saia-raises-price-target-to-620", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944851, "time": "2024-11-13 10:58:05", "headline": "Stephens & Co. Initiates Coverage On Upbound Group with Overweight Rating, Announces Price Target of $38", "summary": "", "symbols": ["UPBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944851/stephens-co-initiates-coverage-on-upbound-group-with-overweight-rating-announces-price-target-of-38", "tags": ["analyst_init"]}
{"id": 41944879, "time": "2024-11-13 10:58:32", "headline": "B of A Securities Maintains Buy on Viking Holdings, Raises Price Target to $51", "summary": "", "symbols": ["VIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944879/b-of-a-securities-maintains-buy-on-viking-holdings-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944891, "time": "2024-11-13 10:59:45", "headline": "B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $120", "summary": "", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944891/b-of-a-securities-maintains-buy-on-healthequity-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944911, "time": "2024-11-13 11:00:05", "headline": "Stephens & Co. Initiates Coverage On America's Car-Mart with Equal-Weight Rating, Announces Price Target of $50", "summary": "", "symbols": ["CRMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944911/stephens-co-initiates-coverage-on-americas-car-mart-with-equal-weight-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 41944939, "time": "2024-11-13 11:00:16", "headline": "Looking Into Palantir Technologies's Recent Short Interest", "summary": " ", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41944939/looking-into-palantir-technologiess-recent-short-interest", "tags": []}
{"id": 41944940, "time": "2024-11-13 11:00:22", "headline": "(ROOT) - Analyzing Root's Short Interest", "summary": " ", "symbols": ["ROOT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41944940/root-analyzing-roots-short-interest", "tags": []}
{"id": 41944942, "time": "2024-11-13 11:00:25", "headline": "Expert Ratings For Prothena Corp", "summary": " ", "symbols": ["PRTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41944942/expert-ratings-for-prothena-corp", "tags": []}
{"id": 41944943, "time": "2024-11-13 11:00:27", "headline": "How Is The Market Feeling About Shift4 Payments?", "summary": " ", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41944943/how-is-the-market-feeling-about-shift4-payments", "tags": []}
{"id": 41944950, "time": "2024-11-13 11:00:34", "headline": "Decoding 5 Analyst Evaluations For PROG Holdings", "summary": " ", "symbols": ["PRG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41944950/decoding-5-analyst-evaluations-for-prog-holdings", "tags": []}
{"id": 41944952, "time": "2024-11-13 11:00:39", "headline": "Barclays Maintains Equal-Weight on Werner Enterprises, Raises Price Target to $40", "summary": "", "symbols": ["WERN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41944952/barclays-maintains-equal-weight-on-werner-enterprises-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41944979, "time": "2024-11-13 11:00:44", "headline": "Expert Ratings For Mosaic", "summary": " ", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41944979/expert-ratings-for-mosaic", "tags": []}
{"id": 41944984, "time": "2024-11-13 11:00:50", "headline": "Breaking Down ICU Medical: 4 Analysts Share Their Views", "summary": " ", "symbols": ["ICUI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41944984/breaking-down-icu-medical-4-analysts-share-their-views", "tags": []}
{"id": 41944990, "time": "2024-11-13 11:00:58", "headline": "In-Depth Examination Of 11 Analyst Recommendations For Viridian Therapeutics", "summary": " ", "symbols": ["VRDN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41944990/in-depth-examination-of-11-analyst-recommendations-for-viridian-therapeutics", "tags": []}
{"id": 41944994, "time": "2024-11-13 11:01:06", "headline": "Analyst Scoreboard: 4 Ratings For IAC", "summary": " ", "symbols": ["IAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41944994/analyst-scoreboard-4-ratings-for-iac", "tags": []}
{"id": 41945000, "time": "2024-11-13 11:01:17", "headline": "Earnings Outlook For Pioneer Power Solutions", "summary": " ", "symbols": ["PPSI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945000/earnings-outlook-for-pioneer-power-solutions", "tags": ["earnings", "guidance"]}
{"id": 41945006, "time": "2024-11-13 11:01:25", "headline": "What's Next: Ryvyl's Earnings Preview", "summary": " ", "symbols": ["RVYL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945006/whats-next-ryvyls-earnings-preview", "tags": ["earnings"]}
{"id": 41945014, "time": "2024-11-13 11:01:33", "headline": "Examining the Future: Natural Gas Services Gr's Earnings Outlook", "summary": " ", "symbols": ["NGS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945014/examining-the-future-natural-gas-services-grs-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41945028, "time": "2024-11-13 11:01:40", "headline": "Los Angeles Department Of Building And Safety Selects Clariti And Unisys For New Permitting System And Implementation", "summary": "", "symbols": ["UIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945028/los-angeles-department-of-building-and-safety-selects-clariti-and-unisys-for-new-permitting-system-a", "tags": []}
{"id": 41945029, "time": "2024-11-13 11:01:45", "headline": "A Peek at Plus Therapeutics's Future Earnings", "summary": " ", "symbols": ["PSTV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945029/a-peek-at-plus-therapeuticss-future-earnings", "tags": ["earnings"]}
{"id": 41945030, "time": "2024-11-13 11:01:46", "headline": "B of A Securities Maintains Buy on Eaton Corp, Raises Price Target to $410", "summary": "", "symbols": ["ETN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945030/b-of-a-securities-maintains-buy-on-eaton-corp-raises-price-target-to-410", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945033, "time": "2024-11-13 11:01:52", "headline": "Stephens & Co. Initiates Coverage On EZCORP with Equal-Weight Rating, Announces Price Target of $13", "summary": "", "symbols": ["EZPW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945033/stephens-co-initiates-coverage-on-ezcorp-with-equal-weight-rating-announces-price-target-of-13", "tags": ["analyst_init"]}
{"id": 41945043, "time": "2024-11-13 11:01:58", "headline": "Insights Ahead: T2 Biosystems's Quarterly Earnings", "summary": " ", "symbols": ["TTOO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945043/insights-ahead-t2-biosystemss-quarterly-earnings", "tags": ["earnings"]}
{"id": 41945071, "time": "2024-11-13 11:02:12", "headline": "An Overview of Data Storage's Earnings", "summary": " ", "symbols": ["DTST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945071/an-overview-of-data-storages-earnings", "tags": ["earnings"]}
{"id": 41945072, "time": "2024-11-13 11:02:19", "headline": "Earnings Outlook For Eastside Distilling", "summary": " ", "symbols": ["EAST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945072/earnings-outlook-for-eastside-distilling", "tags": ["earnings", "guidance"]}
{"id": 41945075, "time": "2024-11-13 11:02:26", "headline": "IonQ Stock Is Trading Higher Today: What's Going On?", "summary": "IonQ Inc (NYSE:IONQ) shares are trading higher. The company on Wednesday announced the issuance of five new U.S. patents.", "symbols": ["IONQ"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41945075/ionq-stock-is-trading-higher-today-whats-going-on", "tags": ["why_moving"]}
{"id": 41945076, "time": "2024-11-13 11:02:27", "headline": "Earnings Outlook For Invivyd", "summary": " ", "symbols": ["IVVD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945076/earnings-outlook-for-invivyd", "tags": ["earnings", "guidance"]}
{"id": 41945079, "time": "2024-11-13 11:02:34", "headline": "Movano's Earnings: A Preview", "summary": " ", "symbols": ["MOVE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945079/movanos-earnings-a-preview", "tags": ["earnings"]}
{"id": 41945085, "time": "2024-11-13 11:02:44", "headline": "A Preview Of Inovio Pharmaceuticals's Earnings", "summary": " ", "symbols": ["INO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945085/a-preview-of-inovio-pharmaceuticalss-earnings", "tags": ["earnings"]}
{"id": 41945087, "time": "2024-11-13 11:02:50", "headline": "A Peek at IM Cannabis's Future Earnings", "summary": " ", "symbols": ["IMCC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945087/a-peek-at-im-cannabiss-future-earnings", "tags": ["earnings"]}
{"id": 41945092, "time": "2024-11-13 11:02:58", "headline": "Uncovering Potential: PDS Biotechnology's Earnings Preview", "summary": " ", "symbols": ["PDSB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41945092/uncovering-potential-pds-biotechnologys-earnings-preview", "tags": ["earnings"]}
{"id": 41945111, "time": "2024-11-13 11:03:18", "headline": "Pepe Listed On Robinhood, Coinbase, Reaches New All-Time High On 44% Gain\u2014Traders Speculate About 'Dogecoin Like Run'", "summary": "Backed by a listing on Robinhood (NASDAQ:CRYPTO) Crypto, Pepe (CRYPTO: PEPE) has reached a new all-time high, up 44% on the day.", "symbols": ["ADAUSD", "COIN", "CRYPTO", "PEPEUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41945111/pepe-listed-on-robinhood-coinbase-reaches-new-all-time-high-on-44-gain-traders-speculate-about-dogecoin-like-run", "tags": []}
{"id": 41945114, "time": "2024-11-13 11:03:26", "headline": "Barclays Maintains Overweight on XPO, Raises Price Target to $170", "summary": "", "symbols": ["XPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945114/barclays-maintains-overweight-on-xpo-raises-price-target-to-170", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945146, "time": "2024-11-13 11:04:04", "headline": "Dow Jones Announces The Launch Of Factiva Smart Summary, A GenAI Content Licensing Agreements With Thousands Of Sources Worldwide", "summary": "", "symbols": ["NWS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945146/dow-jones-announces-the-launch-of-factiva-smart-summary-a-genai-content-licensing-agreements-with-th", "tags": []}
{"id": 41945158, "time": "2024-11-13 11:04:45", "headline": "Barclays Maintains Underweight on C.H. Robinson Worldwide, Raises Price Target to $95", "summary": "", "symbols": ["CHRW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945158/barclays-maintains-underweight-on-c-h-robinson-worldwide-raises-price-target-to-95", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945225, "time": "2024-11-13 11:06:09", "headline": "Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease", "summary": "After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.", "symbols": ["AZN", "GSK", "REGN", "SNY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41945225/regeneron-sanofis-dupixent-approval-signals-major-treatment-breakthrough-for-smokers-lung-disease", "tags": []}
{"id": 41945227, "time": "2024-11-13 11:06:11", "headline": "TD Cowen Reiterates Buy on Energy Vault Holdings, Maintains $2.5 Price Target", "summary": "", "symbols": ["NRGV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945227/td-cowen-reiterates-buy-on-energy-vault-holdings-maintains-2-5-price-target", "tags": ["analyst_other"]}
{"id": 41945248, "time": "2024-11-13 11:06:43", "headline": "Stephens & Co. Initiates Coverage On Katapult Holdings with Equal-Weight Rating, Announces Price Target of $9", "summary": "", "symbols": ["KPLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945248/stephens-co-initiates-coverage-on-katapult-holdings-with-equal-weight-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 41945250, "time": "2024-11-13 11:06:44", "headline": "Barclays Maintains Overweight on CSX, Raises Price Target to $41", "summary": "", "symbols": ["CSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945250/barclays-maintains-overweight-on-csx-raises-price-target-to-41", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945288, "time": "2024-11-13 11:07:40", "headline": "B of A Securities Maintains Buy on Carnival, Raises Price Target to $28", "summary": "", "symbols": ["CCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945288/b-of-a-securities-maintains-buy-on-carnival-raises-price-target-to-28", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945329, "time": "2024-11-13 11:08:42", "headline": "Barclays Maintains Overweight on FedEx, Raises Price Target to $365", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945329/barclays-maintains-overweight-on-fedex-raises-price-target-to-365", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945336, "time": "2024-11-13 11:08:50", "headline": "B of A Securities Maintains Neutral on Royal Caribbean Gr, Raises Price Target to $240", "summary": "", "symbols": ["RCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945336/b-of-a-securities-maintains-neutral-on-royal-caribbean-gr-raises-price-target-to-240", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945380, "time": "2024-11-13 11:09:54", "headline": "McDonald's Franchisee Arcos Dorados Beats On Q3 Earnings, Systemwide Comparable Sales Jump", "summary": "Arcos Dorados Q3 earnings beat expectations, but stock falls despite strong sales growth.", "symbols": ["ARCO"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/news/earnings/24/11/41945380/mcdonalds-franchisee-arcos-dorados-beats-on-q3-earnings-systemwide-comparable-sales-jump", "tags": ["earnings"]}
{"id": 41945387, "time": "2024-11-13 11:10:01", "headline": "B of A Securities Maintains Neutral on Norwegian Cruise Line, Raises Price Target to $29", "summary": "", "symbols": ["NCLH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945387/b-of-a-securities-maintains-neutral-on-norwegian-cruise-line-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945402, "time": "2024-11-13 11:10:24", "headline": "Barclays Maintains Equal-Weight on GXO Logistics, Raises Price Target to $60", "summary": "", "symbols": ["GXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945402/barclays-maintains-equal-weight-on-gxo-logistics-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945411, "time": "2024-11-13 11:11:16", "headline": "B of A Securities Maintains Buy on Salesforce, Raises Price Target to $390", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945411/b-of-a-securities-maintains-buy-on-salesforce-raises-price-target-to-390", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945418, "time": "2024-11-13 11:11:47", "headline": "Netflix Stock Hit A New All-Time High: What's Going On?", "summary": "Netflix shares are trading higher by roughly 9% in November. The stock has gained amid overall market strength after Donald Trump&#39;s re-election.", "symbols": ["NFLX"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41945418/netflix-stock-hit-a-new-all-time-high-whats-going-on", "tags": ["why_moving"]}
{"id": 41945436, "time": "2024-11-13 11:12:19", "headline": "Barclays Maintains Equal-Weight on Hub Group, Raises Price Target to $52", "summary": "", "symbols": ["HUBG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945436/barclays-maintains-equal-weight-on-hub-group-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945444, "time": "2024-11-13 11:12:35", "headline": "Stephens & Co. Downgrades Advanced Drainage Systems to Equal-Weight, Announces $135 Price Target", "summary": "", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945444/stephens-co-downgrades-advanced-drainage-systems-to-equal-weight-announces-135-price-target", "tags": ["analyst_down"]}
{"id": 41945558, "time": "2024-11-13 11:14:23", "headline": "Barclays Maintains Equal-Weight on JB Hunt Transport Servs, Raises Price Target to $195", "summary": "", "symbols": ["JBHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945558/barclays-maintains-equal-weight-on-jb-hunt-transport-servs-raises-price-target-to-195", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945610, "time": "2024-11-13 11:15:15", "headline": "(IRM) - Analyzing Iron Mountain's Short Interest", "summary": " ", "symbols": ["IRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41945610/irm-analyzing-iron-mountains-short-interest", "tags": []}
{"id": 41945612, "time": "2024-11-13 11:15:19", "headline": "Barclays Maintains Overweight on Norfolk Southern, Raises Price Target to $305", "summary": "", "symbols": ["NSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945612/barclays-maintains-overweight-on-norfolk-southern-raises-price-target-to-305", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945614, "time": "2024-11-13 11:15:20", "headline": "(NFLX) - Analyzing Netflix's Short Interest", "summary": " ", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41945614/nflx-analyzing-netflixs-short-interest", "tags": []}
{"id": 41945616, "time": "2024-11-13 11:15:25", "headline": "How Is The Market Feeling About Marsh & McLennan?", "summary": " ", "symbols": ["MMC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41945616/how-is-the-market-feeling-about-marsh-mclennan", "tags": []}
{"id": 41945626, "time": "2024-11-13 11:15:40", "headline": "What's Going On With Bitcoin Mining Stocks MARA Holdings, Riot Platforms And CleanSpark?", "summary": "Bitcoin\u00a0(CRYPTO:\u00a0BTC) mining stocks\u00a0MARA Holdings\u00a0Inc\u00a0(NASDAQ:MARA),\u00a0Riot Platforms\u00a0Inc\u00a0(NASDAQ:RIOT)\u00a0and CleanSpark\u00a0Inc\u00a0(NASDAQ:CLSK) are trading lower Wednesday morning despite a surge in the price of bitcoin. Here&#39;s a look at what&#39;s going on.", "symbols": ["BTCUSD", "CLSK", "MARA", "RIOT"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41945626/whats-going-on-with-bitcoin-mining-stocks-mara-holdings-riot-platforms-and-cleanspark", "tags": ["why_moving"]}
{"id": 41945632, "time": "2024-11-13 11:15:45", "headline": "Craig-Hallum Maintains Buy on TechTarget, Raises Price Target to $40", "summary": "", "symbols": ["TTGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945632/craig-hallum-maintains-buy-on-techtarget-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945659, "time": "2024-11-13 11:17:02", "headline": "Dogecoin To 69 Cents Or $1? Benzinga Readers Predict How High It Could Fly By End Of 2024", "summary": "Meme cryptocurrency Dogecoin (CRYPTO: DOGE) has soared in value since the 2024 presidential election and the establishment of the Department of Government Efficiency, or", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41945659/dogecoin-to-69-cents-or-1-benzinga-readers-predict-how-high-it-could-fly-by-end-of-2024", "tags": []}
{"id": 41945690, "time": "2024-11-13 11:17:08", "headline": "Craig-Hallum Maintains Buy on Viant Technology, Raises Price Target to $18", "summary": "", "symbols": ["DSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945690/craig-hallum-maintains-buy-on-viant-technology-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945722, "time": "2024-11-13 11:18:09", "headline": "Craig-Hallum Maintains Buy on Airgain, Raises Price Target to $12", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945722/craig-hallum-maintains-buy-on-airgain-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945732, "time": "2024-11-13 11:18:55", "headline": "LIVE: Watch Donald Trump Makes His Return To Washington In Meeting With Joe Biden", "summary": "", "symbols": ["DJT", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41945732/live-watch-donald-trump-makes-his-return-to-washington-in-meeting-with-joe-biden", "tags": []}
{"id": 41945740, "time": "2024-11-13 11:19:05", "headline": "Stephens & Co. Maintains Overweight on Occidental Petroleum, Raises Price Target to $71", "summary": "", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945740/stephens-co-maintains-overweight-on-occidental-petroleum-raises-price-target-to-71", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945741, "time": "2024-11-13 11:19:06", "headline": "Craig-Hallum Maintains Buy on Integral Ad Science, Lowers Price Target to $16", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945741/craig-hallum-maintains-buy-on-integral-ad-science-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 41945480, "time": "2024-11-13 11:13:34", "headline": "Spotify Technology Rallies After Earnings: 'Ample Capacity For Capital Returns'", "summary": "Spotify earnings were &#34;very strong,&#34; with gross margin, operating income and free cash flows &#34;well above our forecast.&#34;", "symbols": ["SPOT"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/news/earnings/earnings-beats/24/11/41945480/spotify-technology-rallies-after-earnings-ample-capacity-for-capital-returns", "tags": ["earnings", "guidance"]}
{"id": 41945751, "time": "2024-11-13 11:19:27", "headline": "Barclays Maintains Overweight on Union Pacific, Raises Price Target to $285", "summary": "", "symbols": ["UNP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945751/barclays-maintains-overweight-on-union-pacific-raises-price-target-to-285", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945917, "time": "2024-11-13 11:22:03", "headline": "Barclays Maintains Equal-Weight on Cava Group, Raises Price Target to $142", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945917/barclays-maintains-equal-weight-on-cava-group-raises-price-target-to-142", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945934, "time": "2024-11-13 11:23:31", "headline": "Stephens & Co. Maintains Equal-Weight on Tyson Foods, Raises Price Target to $60", "summary": "", "symbols": ["TSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945934/stephens-co-maintains-equal-weight-on-tyson-foods-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 41945945, "time": "2024-11-13 11:24:28", "headline": "Barclays Downgrades SoundHound AI to Neutral, Maintains Price Target to $7", "summary": "", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41945945/barclays-downgrades-soundhound-ai-to-neutral-maintains-price-target-to-7", "tags": ["analyst_down", "analyst_other"]}
{"id": 41946048, "time": "2024-11-13 11:26:25", "headline": "Maxim Group Maintains Buy on Theriva Biologics, Lowers Price Target to $6", "summary": "", "symbols": ["TOVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946048/maxim-group-maintains-buy-on-theriva-biologics-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946052, "time": "2024-11-13 11:27:29", "headline": "Craig-Hallum Maintains Hold on Chegg, Lowers Price Target to $1.5", "summary": "", "symbols": ["CHGG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946052/craig-hallum-maintains-hold-on-chegg-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946086, "time": "2024-11-13 11:28:24", "headline": "Maxim Group Maintains Buy on Palisade Bio, Lowers Price Target to $8", "summary": "", "symbols": ["PALI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946086/maxim-group-maintains-buy-on-palisade-bio-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946088, "time": "2024-11-13 11:28:38", "headline": "Craig-Hallum Maintains Buy on Natera, Raises Price Target to $157", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946088/craig-hallum-maintains-buy-on-natera-raises-price-target-to-157", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946098, "time": "2024-11-13 11:29:46", "headline": "Craig-Hallum Maintains Buy on Flutter Entertainment, Raises Price Target to $350", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946098/craig-hallum-maintains-buy-on-flutter-entertainment-raises-price-target-to-350", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946134, "time": "2024-11-13 11:30:40", "headline": "Craig-Hallum Maintains Buy on BioLife Solns, Raises Price Target to $32", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946134/craig-hallum-maintains-buy-on-biolife-solns-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946236, "time": "2024-11-13 11:31:20", "headline": "Smart Money Is Betting Big In AMZN Options", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41946236/smart-money-is-betting-big-in-amzn-options", "tags": []}
{"id": 41946237, "time": "2024-11-13 11:31:25", "headline": "Booking Holdings's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["BKNG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41946237/booking-holdingss-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 41946251, "time": "2024-11-13 11:31:44", "headline": "Craig-Hallum Maintains Hold on SoundThinking, Lowers Price Target to $16", "summary": "", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946251/craig-hallum-maintains-hold-on-soundthinking-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946271, "time": "2024-11-13 11:32:27", "headline": "JPMorgan (JPM) Stock Is Up 9% In November: What's Going On?", "summary": "JPMorgan Chase has seen its stock rise some 9% in November. The stock has gained following Donald Trump&#39;s election win, with investors optimistic about the potential impact of pro-business policies.", "symbols": ["DIA", "JPM", "SPY"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41946271/jpmorgan-jpm-stock-is-up-9-in-november-whats-going-on", "tags": ["why_moving"]}
{"id": 41946311, "time": "2024-11-13 11:33:58", "headline": "Boeing Forecasts 67% Growth In Global Air Cargo Fleet By 2043, Driven By Asia Demand", "summary": "Boeing expects 4% annual increase in air cargo traffic through 2043, with Asia driving demand. Deliveries lower in Oct after strike resolved.", "symbols": ["BA", "GCAD", "MISL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/24/11/41946311/boeing-forecasts-67-growth-in-global-air-cargo-fleet-by-2043-driven-by-asia-demand", "tags": []}
{"id": 41946380, "time": "2024-11-13 11:36:45", "headline": "Evercore ISI Group Maintains Outperform on PubMatic, Raises Price Target to $22", "summary": "", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946380/evercore-isi-group-maintains-outperform-on-pubmatic-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946383, "time": "2024-11-13 11:37:09", "headline": "What's Going On With Exxon Mobil (XOM) Stock?", "summary": "Exxon Mobil shares have remained flat over the past week since Donald Trump&#39;s presidential election win. Investor may be cautious about how Trump&#39;s energy policies may impact the oil and gas giant.", "symbols": ["XLE", "XOM"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41946383/whats-going-on-with-exxon-mobil-xom-stock-3", "tags": ["why_moving"]}
{"id": 41946386, "time": "2024-11-13 11:37:31", "headline": "HC Wainwright & Co. Reiterates Buy on Xenon Pharmaceuticals, Maintains $53 Price Target", "summary": "", "symbols": ["XENE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946386/hc-wainwright-co-reiterates-buy-on-xenon-pharmaceuticals-maintains-53-price-target", "tags": ["analyst_other"]}
{"id": 41946406, "time": "2024-11-13 11:37:49", "headline": "Evercore ISI Group Maintains Outperform on Home Depot, Raises Price Target to $430", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946406/evercore-isi-group-maintains-outperform-on-home-depot-raises-price-target-to-430", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946435, "time": "2024-11-13 11:39:02", "headline": "Evercore ISI Group Maintains Outperform on Plug Power, Lowers Price Target to $4", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946435/evercore-isi-group-maintains-outperform-on-plug-power-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946440, "time": "2024-11-13 11:39:10", "headline": "Needham Maintains Buy on Viant Technology, Raises Price Target to $18", "summary": "", "symbols": ["DSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946440/needham-maintains-buy-on-viant-technology-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946451, "time": "2024-11-13 11:40:49", "headline": "Needham Maintains Buy on Genius Sports, Raises Price Target to $12", "summary": "", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946451/needham-maintains-buy-on-genius-sports-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946456, "time": "2024-11-13 11:40:51", "headline": "Goldman Sachs Maintains Buy on Shopify, Raises Price Target to $135", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946456/goldman-sachs-maintains-buy-on-shopify-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946520, "time": "2024-11-13 11:42:41", "headline": "What's Going On With Spirit Airlines Stock Wednesday?", "summary": "Spirit Airlines stock is moving lower on Wednesday after the company filed a Form 12b-25 with the Securities and Exchange Commission.", "symbols": ["SAVE", "ULCC"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41946520/whats-going-on-with-spirit-airlines-stock-wednesday-2", "tags": ["why_moving"]}
{"id": 41946559, "time": "2024-11-13 11:44:29", "headline": "Galaxy Payroll Group Shares Halted On Circuit Breaker To The Upside, Stock Now Down -51.2%", "summary": "", "symbols": ["GLXG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41946559/galaxy-payroll-group-shares-halted-on-circuit-breaker-to-the-upside-stock-now-down-51-2", "tags": ["halt"]}
{"id": 41946565, "time": "2024-11-13 11:45:00", "headline": "Morgan Stanley Maintains Equal-Weight on Choice Hotels Intl, Raises Price Target to $141", "summary": "", "symbols": ["CHH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946565/morgan-stanley-maintains-equal-weight-on-choice-hotels-intl-raises-price-target-to-141", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946569, "time": "2024-11-13 11:45:12", "headline": "HC Wainwright & Co. Maintains Buy on Belite Bio, Raises Price Target to $100", "summary": "", "symbols": ["BLTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946569/hc-wainwright-co-maintains-buy-on-belite-bio-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946571, "time": "2024-11-13 11:45:16", "headline": "P/E Ratio Insights for Huntington Bancshares", "summary": " ", "symbols": ["HBAN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41946571/pe-ratio-insights-for-huntington-bancshares", "tags": []}
{"id": 41946618, "time": "2024-11-13 11:46:55", "headline": "HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $115 Price Target", "summary": "", "symbols": ["KRRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946618/hc-wainwright-co-reiterates-buy-on-korro-bio-maintains-115-price-target", "tags": ["analyst_other"]}
{"id": 41946620, "time": "2024-11-13 11:47:04", "headline": "Walmart Stock Hits A New All-Time High: What's Going On?", "summary": "Walmart shares hit a new all-time high of $85.54 Wednesday morning. Investors assess the mixed impacts of Donald Trump&#39;s policy agenda could have on the retail giant.", "symbols": ["WMT"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41946620/walmart-stock-hits-a-new-all-time-high-whats-going-on", "tags": ["why_moving"]}
{"id": 41946690, "time": "2024-11-13 11:48:32", "headline": "HC Wainwright & Co. Reiterates Buy on Neumora Therapeutics, Maintains $30 Price Target", "summary": "", "symbols": ["NMRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946690/hc-wainwright-co-reiterates-buy-on-neumora-therapeutics-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 41946701, "time": "2024-11-13 11:49:19", "headline": "Piper Sandler Maintains Neutral on Skyworks Solutions, Lowers Price Target to $85", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946701/piper-sandler-maintains-neutral-on-skyworks-solutions-lowers-price-target-to-85", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946716, "time": "2024-11-13 11:50:06", "headline": "Trading Halt: Halt status updated at 11:50:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["IZTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41946716/trading-halt-halt-status-updated-at-11-50-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 41946717, "time": "2024-11-13 11:50:08", "headline": "What's Going On With CAVA Stock Wednesday?", "summary": "CAVA shares are moving higher on Wednesday after the company reported better-than-expected 2024 third-quarter earnings after the bell on Tuesday.", "symbols": ["CAVA"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41946717/whats-going-on-with-cava-stock-wednesday", "tags": ["earnings", "why_moving"]}
{"id": 41946718, "time": "2024-11-13 11:50:18", "headline": "Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["AUTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946718/needham-reiterates-buy-on-autolus-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41946735, "time": "2024-11-13 11:50:31", "headline": "Piper Sandler Maintains Overweight on Tempest Therapeutics, Lowers Price Target to $5", "summary": "", "symbols": ["TPST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946735/piper-sandler-maintains-overweight-on-tempest-therapeutics-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946780, "time": "2024-11-13 11:52:33", "headline": "What's Going On With XPeng Stock Wednesday?", "summary": "XPeng stock is down amid broader market concerns, while its flying car subsidiary secures 2,008 pre-orders for its modular Land Aircraft Carrier.", "symbols": ["HAIL", "XPEV"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41946780/whats-going-on-with-xpeng-stock-wednesday", "tags": ["why_moving"]}
{"id": 41946782, "time": "2024-11-13 11:52:34", "headline": "WestPark Capital Reiterates Buy on Glimpse Group, Maintains $2.65 Price Target", "summary": "", "symbols": ["VRAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946782/westpark-capital-reiterates-buy-on-glimpse-group-maintains-2-65-price-target", "tags": ["analyst_other"]}
{"id": 41946815, "time": "2024-11-13 11:53:39", "headline": "Piper Sandler Maintains Neutral on Spotify Technology, Raises Price Target to $450", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946815/piper-sandler-maintains-neutral-on-spotify-technology-raises-price-target-to-450", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946842, "time": "2024-11-13 11:54:53", "headline": "Piper Sandler Maintains Overweight on Integral Ad Science, Lowers Price Target to $16", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946842/piper-sandler-maintains-overweight-on-integral-ad-science-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946896, "time": "2024-11-13 11:55:35", "headline": "Home Depot Hammers Down Strong Q3 Sales, Builds For Long-Term Success", "summary": "Home Depot has strong Q3 earnings and revenue, with analyst notes from Goldman Sachs, J.P. Morgan and BofA Securities showing continued bullishness.", "symbols": ["HD"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/news/earnings/earnings-beats/24/11/41946896/home-depot-hammers-down-strong-q3-sales-builds-for-long-term-success", "tags": ["earnings"]}
{"id": 41946907, "time": "2024-11-13 11:55:51", "headline": "Piper Sandler Maintains Overweight on Maplebear, Raises Price Target to $58", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946907/piper-sandler-maintains-overweight-on-maplebear-raises-price-target-to-58", "tags": ["analyst_other", "price_target_up"]}
{"id": 41946916, "time": "2024-11-13 11:56:32", "headline": "WestPark Capital Reiterates Buy on WM Tech, Maintains $2.61 Price Target", "summary": "", "symbols": ["MAPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946916/westpark-capital-reiterates-buy-on-wm-tech-maintains-2-61-price-target", "tags": ["analyst_other"]}
{"id": 41946931, "time": "2024-11-13 11:57:01", "headline": "Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $10.5", "summary": "", "symbols": ["RBOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946931/piper-sandler-maintains-neutral-on-vicarious-surgical-lowers-price-target-to-10-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946955, "time": "2024-11-13 11:58:06", "headline": "Piper Sandler Maintains Overweight on Interparfums, Lowers Price Target to $155", "summary": "", "symbols": ["IPAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946955/piper-sandler-maintains-overweight-on-interparfums-lowers-price-target-to-155", "tags": ["analyst_other", "price_target_down"]}
{"id": 41946970, "time": "2024-11-13 11:58:20", "headline": "Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Sets $17.75 Price Valuation On Stock", "summary": "", "symbols": ["MIRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946970/watching-mira-pharmaceuticals-zacks-small-cap-research-sets-17-75-price-valuation-on-stock", "tags": []}
{"id": 41946990, "time": "2024-11-13 11:59:17", "headline": "Piper Sandler Maintains Overweight on OptiNose, Lowers Price Target to $1", "summary": "", "symbols": ["OPTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41946990/piper-sandler-maintains-overweight-on-optinose-lowers-price-target-to-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947015, "time": "2024-11-13 11:59:57", "headline": "JMP Securities Maintains Market Outperform on Maplebear, Raises Price Target to $51", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947015/jmp-securities-maintains-market-outperform-on-maplebear-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947078, "time": "2024-11-13 12:00:37", "headline": "Piper Sandler Maintains Underweight on Tyson Foods, Raises Price Target to $58", "summary": "", "symbols": ["TSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947078/piper-sandler-maintains-underweight-on-tyson-foods-raises-price-target-to-58", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947098, "time": "2024-11-13 12:01:07", "headline": "Looking Into Intuit's Recent Short Interest", "summary": " ", "symbols": ["INTU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41947098/looking-into-intuits-recent-short-interest", "tags": []}
{"id": 41947100, "time": "2024-11-13 12:01:12", "headline": "The Latest Analyst Ratings For Enova International", "summary": " ", "symbols": ["ENVA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41947100/the-latest-analyst-ratings-for-enova-international", "tags": []}
{"id": 41947101, "time": "2024-11-13 12:01:12", "headline": "Peering Into Booking Holdings's Recent Short Interest", "summary": " ", "symbols": ["BKNG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41947101/peering-into-booking-holdingss-recent-short-interest", "tags": []}
{"id": 41947104, "time": "2024-11-13 12:01:18", "headline": "Looking Into ASGN's Recent Short Interest", "summary": " ", "symbols": ["ASGN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41947104/looking-into-asgns-recent-short-interest", "tags": []}
{"id": 41947108, "time": "2024-11-13 12:01:25", "headline": "What 16 Analyst Ratings Have To Say About Maplebear", "summary": " ", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41947108/what-16-analyst-ratings-have-to-say-about-maplebear", "tags": []}
{"id": 41947114, "time": "2024-11-13 12:01:34", "headline": "Coinbase Acquires Utopia Labs Team To Accelerate Onchain Payments Development In Coinbase Wallet, Enhancing Crypto Payment Capabilities", "summary": "", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41947114/coinbase-acquires-utopia-labs-team-to-accelerate-onchain-payments-development-in-coinbase-", "tags": ["merger"]}
{"id": 41947115, "time": "2024-11-13 12:01:36", "headline": "Where BankUnited Stands With Analysts", "summary": " ", "symbols": ["BKU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41947115/where-bankunited-stands-with-analysts", "tags": []}
{"id": 41947129, "time": "2024-11-13 12:01:50", "headline": "Beyond The Numbers: 4 Analysts Discuss Viant Technology Stock", "summary": " ", "symbols": ["DSP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41947129/beyond-the-numbers-4-analysts-discuss-viant-technology-stock", "tags": []}
{"id": 41947135, "time": "2024-11-13 12:01:59", "headline": "Demystifying StoneCo: Insights From 4 Analyst Reviews", "summary": " ", "symbols": ["STNE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41947135/demystifying-stoneco-insights-from-4-analyst-reviews", "tags": []}
{"id": 41947163, "time": "2024-11-13 12:02:21", "headline": "In-Depth Examination Of 20 Analyst Recommendations For FedEx", "summary": " ", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41947163/in-depth-examination-of-20-analyst-recommendations-for-fedex", "tags": []}
{"id": 41947171, "time": "2024-11-13 12:02:28", "headline": "Truist Securities Maintains Hold on EastGroup Props, Lowers Price Target to $186", "summary": "", "symbols": ["EGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947171/truist-securities-maintains-hold-on-eastgroup-props-lowers-price-target-to-186", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947179, "time": "2024-11-13 12:02:39", "headline": "What's Next: iPower's Earnings Preview", "summary": " ", "symbols": ["IPW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947179/whats-next-ipowers-earnings-preview", "tags": ["earnings"]}
{"id": 41947181, "time": "2024-11-13 12:02:49", "headline": "Earnings Outlook For Protalix BioTherapeutics", "summary": " ", "symbols": ["PLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947181/earnings-outlook-for-protalix-biotherapeutics", "tags": ["earnings", "guidance"]}
{"id": 41947183, "time": "2024-11-13 12:03:03", "headline": "Examining the Future: Sachem Cap's Earnings Outlook", "summary": " ", "symbols": ["SACH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947183/examining-the-future-sachem-caps-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41947194, "time": "2024-11-13 12:03:11", "headline": "GDEV Earnings Preview", "summary": " ", "symbols": ["GDEV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947194/gdev-earnings-preview", "tags": ["earnings"]}
{"id": 41947198, "time": "2024-11-13 12:03:20", "headline": "Insights into Dare Bioscience's Upcoming Earnings", "summary": " ", "symbols": ["DARE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947198/insights-into-dare-biosciences-upcoming-earnings", "tags": ["earnings"]}
{"id": 41947200, "time": "2024-11-13 12:03:31", "headline": "Truist Securities Maintains Buy on IAC, Lowers Price Target to $80", "summary": "", "symbols": ["IAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947200/truist-securities-maintains-buy-on-iac-lowers-price-target-to-80", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947201, "time": "2024-11-13 12:03:33", "headline": "Lineage Cell Therapeutics's Earnings Outlook", "summary": " ", "symbols": ["LCTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947201/lineage-cell-therapeuticss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41947203, "time": "2024-11-13 12:03:42", "headline": "Examining the Future: Curis's Earnings Outlook", "summary": " ", "symbols": ["CRIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947203/examining-the-future-curiss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41947215, "time": "2024-11-13 12:03:50", "headline": "TMC Metals Earnings Preview", "summary": " ", "symbols": ["TMC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947215/tmc-metals-earnings-preview", "tags": ["earnings"]}
{"id": 41947219, "time": "2024-11-13 12:03:57", "headline": "JMP Securities Maintains Market Outperform on SoundThinking, Lowers Price Target to $19", "summary": "", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947219/jmp-securities-maintains-market-outperform-on-soundthinking-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947220, "time": "2024-11-13 12:04:00", "headline": "Earnings Preview: BIO-key Intl", "summary": " ", "symbols": ["BKYI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947220/earnings-preview-bio-key-intl", "tags": ["earnings"]}
{"id": 41947227, "time": "2024-11-13 12:04:10", "headline": "Earnings Preview For VolitionRX", "summary": " ", "symbols": ["VNRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947227/earnings-preview-for-volitionrx", "tags": ["earnings"]}
{"id": 41947229, "time": "2024-11-13 12:04:17", "headline": "What's Going On With Royal Caribbean Cruises (RCL) Stock?", "summary": "Royal Caribbean Cruises shares hit a new all-time high of $238.10 Wednesday morning. The stock has now gained some 16% in November following Donald Trump&#39;s presidential election win.", "symbols": ["RCL"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41947229/whats-going-on-with-royal-caribbean-cruises-rcl-stock", "tags": ["why_moving"]}
{"id": 41947231, "time": "2024-11-13 12:04:19", "headline": "Earnings Preview For Vislink Technologies", "summary": " ", "symbols": ["VISL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947231/earnings-preview-for-vislink-technologies", "tags": ["earnings"]}
{"id": 41947238, "time": "2024-11-13 12:04:33", "headline": "Spero Therapeutics's Earnings Outlook", "summary": " ", "symbols": ["SPRO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41947238/spero-therapeuticss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41947240, "time": "2024-11-13 12:04:40", "headline": "Truist Securities Maintains Hold on Shopify, Raises Price Target to $110", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947240/truist-securities-maintains-hold-on-shopify-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947250, "time": "2024-11-13 12:04:44", "headline": "EIA Forecasts U.S. Oil Production To Average 13.44M BPD In November, Rising To 13.52M BPD In December; Natural Gas Output At 113.7 BCF/Day In November, Projected At 113.8 BCF/Day In December; 2024 U.S. Oil Output Expected At 13.23M BPD And NatGas At 103.3 BCF/Day; Global Oil Demand To Reach 103.1M BPD In 2024; WTI And Brent Prices Forecasted At $77/BBL And $80.95/BBL Respectively", "summary": "", "symbols": ["SPY", "UNG", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/macro-notification/24/11/41947250/eia-forecasts-u-s-oil-production-to-average-13-44m-bpd-in-november-rising-to-13-52m-bp", "tags": []}
{"id": 41947266, "time": "2024-11-13 12:05:13", "headline": "BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function", "summary": "BioRestorative Therapies shares promising Phase 2 trial results for BRTX-100, showing significant pain reduction and functional improvement in cLDD patients.", "symbols": ["BRTX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41947266/biorestorative-therapies-lower-back-candidate-shows-decrease-in-pain-increased-function", "tags": ["fda"]}
{"id": 41947276, "time": "2024-11-13 12:05:35", "headline": "JMP Securities Maintains Market Outperform on Shopify, Raises Price Target to $120", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947276/jmp-securities-maintains-market-outperform-on-shopify-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947286, "time": "2024-11-13 12:05:51", "headline": "Republican U.S. Senator John Thune Elected Majority Leader In Secret Ballot", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41947286/republican-u-s-senator-john-thune-elected-majority-leader-in-secret-ballot", "tags": []}
{"id": 41947299, "time": "2024-11-13 12:06:09", "headline": "Truist Securities Maintains Buy on Home Depot, Raises Price Target to $465", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947299/truist-securities-maintains-buy-on-home-depot-raises-price-target-to-465", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947312, "time": "2024-11-13 12:06:35", "headline": "Pure Storage Announces Strategic Investment And Technology Partnership With CoreWeave To Accelerate Large-Scale AI Cloud Services Innovation; No Financial Terms Disclosed", "summary": "", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947312/pure-storage-announces-strategic-investment-and-technology-partnership-with-coreweave-to-accelerate", "tags": ["contract"]}
{"id": 41947319, "time": "2024-11-13 12:06:41", "headline": "Benzinga Market Summary: CPI Falls In Line With Estimates, Chip Stocks Pull Back, Gold Continues Lower As US Dollar Rises", "summary": "", "symbols": ["GLD", "SMH", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41947319/benzinga-market-summary-cpi-falls-in-line-with-estimates-chip-stocks-pull-back-go", "tags": []}
{"id": 41947340, "time": "2024-11-13 12:07:20", "headline": "JMP Securities Maintains Market Outperform on Flutter Entertainment, Raises Price Target to $299", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947340/jmp-securities-maintains-market-outperform-on-flutter-entertainment-raises-price-target-to-299", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947401, "time": "2024-11-13 12:07:58", "headline": "Truist Securities Maintains Buy on Integral Ad Science, Lowers Price Target to $16", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947401/truist-securities-maintains-buy-on-integral-ad-science-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947427, "time": "2024-11-13 12:08:56", "headline": "JMP Securities Maintains Market Outperform on EverCommerce, Raises Price Target to $15", "summary": "", "symbols": ["EVCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947427/jmp-securities-maintains-market-outperform-on-evercommerce-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947441, "time": "2024-11-13 12:09:32", "headline": "Truist Securities Maintains Buy on On Holding, Raises Price Target to $61", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947441/truist-securities-maintains-buy-on-on-holding-raises-price-target-to-61", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947462, "time": "2024-11-13 12:10:28", "headline": "Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $18", "summary": "", "symbols": ["SIBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947462/truist-securities-maintains-buy-on-si-bone-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947465, "time": "2024-11-13 12:10:34", "headline": "JMP Securities Maintains Market Outperform on Viant Technology, Raises Price Target to $17", "summary": "", "symbols": ["DSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947465/jmp-securities-maintains-market-outperform-on-viant-technology-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947486, "time": "2024-11-13 12:11:23", "headline": "Live On CNBC, Jim Lebenthal Announces Trimmed Microsoft Position", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947486/live-on-cnbc-jim-lebenthal-announces-trimmed-microsoft-position", "tags": []}
{"id": 41947492, "time": "2024-11-13 12:11:52", "headline": "Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default", "summary": "Syros Pharmaceuticals&#39; Phase 3 trial of tamibarotene in higher-risk myelodysplastic syndrome did not meet primary endpoints, impacting future trial plans.", "symbols": ["BMY", "SYRS"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41947492/syros-pharmaceuticals-stock-sinks-as-pivotal-blood-cancer-trial-flunks-triggers-loan-default", "tags": ["fda"]}
{"id": 41947500, "time": "2024-11-13 12:12:10", "headline": "JMP Securities Maintains Market Outperform on Atlanticus Holdings, Raises Price Target to $54", "summary": "", "symbols": ["ATLC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947500/jmp-securities-maintains-market-outperform-on-atlanticus-holdings-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947512, "time": "2024-11-13 12:12:50", "headline": "Wells Fargo Maintains Overweight on Stifel Financial, Raises Price Target to $130", "summary": "", "symbols": ["SF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947512/wells-fargo-maintains-overweight-on-stifel-financial-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947582, "time": "2024-11-13 12:13:33", "headline": "Truist Securities Maintains Buy on Topgolf Callaway Brands, Lowers Price Target to $14", "summary": "", "symbols": ["MODG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947582/truist-securities-maintains-buy-on-topgolf-callaway-brands-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947585, "time": "2024-11-13 12:13:47", "headline": "JMP Securities Maintains Market Outperform on Angi, Lowers Price Target to $3", "summary": "", "symbols": ["ANGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947585/jmp-securities-maintains-market-outperform-on-angi-lowers-price-target-to-3", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947592, "time": "2024-11-13 12:14:28", "headline": "Truist Securities Maintains Hold on Treehouse Foods, Lowers Price Target to $30", "summary": "", "symbols": ["THS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947592/truist-securities-maintains-hold-on-treehouse-foods-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947594, "time": "2024-11-13 12:14:50", "headline": "Live On CNBC, Joe Terranova Announces Bought Twilio", "summary": "", "symbols": ["TWLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947594/live-on-cnbc-joe-terranova-announces-bought-twilio", "tags": []}
{"id": 41947610, "time": "2024-11-13 12:15:36", "headline": "What the Options Market Tells Us About Rocket Lab USA", "summary": " ", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41947610/what-the-options-market-tells-us-about-rocket-lab-usa", "tags": []}
{"id": 41947613, "time": "2024-11-13 12:15:46", "headline": "ServiceNow Unusual Options Activity", "summary": " ", "symbols": ["NOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41947613/servicenow-unusual-options-activity", "tags": []}
{"id": 41947622, "time": "2024-11-13 12:16:06", "headline": "Truist Securities Maintains Hold on Triumph Group, Raises Price Target to $18", "summary": "", "symbols": ["TGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947622/truist-securities-maintains-hold-on-triumph-group-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947723, "time": "2024-11-13 12:17:18", "headline": "Hovde Group Downgrades Renasant to Market Perform", "summary": "", "symbols": ["RNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947723/hovde-group-downgrades-renasant-to-market-perform", "tags": ["analyst_down"]}
{"id": 41947724, "time": "2024-11-13 12:17:28", "headline": "Invizyne Technologies Shares Open For Trade At $11.10/Share; IPO Priced At $8/Share On 1.875M Shares", "summary": "", "symbols": ["IZTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947724/invizyne-technologies-shares-open-for-trade-at-11-10share-ipo-priced-at-8share-on-1-875m-shares", "tags": []}
{"id": 41947738, "time": "2024-11-13 12:18:14", "headline": "Invizyne Technologies Shares Halted On Circuit Breaker To The Downside", "summary": "", "symbols": ["IZTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41947738/invizyne-technologies-shares-halted-on-circuit-breaker-to-the-downside", "tags": ["halt"]}
{"id": 41947788, "time": "2024-11-13 12:18:44", "headline": "B. Riley Securities Maintains Buy on Dave, Raises Price Target to $103", "summary": "", "symbols": ["DAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947788/b-riley-securities-maintains-buy-on-dave-raises-price-target-to-103", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947801, "time": "2024-11-13 12:19:19", "headline": "Hovde Group Downgrades Orrstown Finl Servs to Market Perform", "summary": "", "symbols": ["ORRF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947801/hovde-group-downgrades-orrstown-finl-servs-to-market-perform", "tags": ["analyst_down"]}
{"id": 41947802, "time": "2024-11-13 12:19:20", "headline": "Wells Fargo Maintains Overweight on NeuroPace, Lowers Price Target to $13", "summary": "", "symbols": ["NPCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947802/wells-fargo-maintains-overweight-on-neuropace-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947805, "time": "2024-11-13 12:19:37", "headline": "B. Riley Securities Maintains Buy on DHI Group, Lowers Price Target to $3.5", "summary": "", "symbols": ["DHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947805/b-riley-securities-maintains-buy-on-dhi-group-lowers-price-target-to-3-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947809, "time": "2024-11-13 12:20:35", "headline": "B. Riley Securities Maintains Buy on Shift4 Payments, Raises Price Target to $110", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947809/b-riley-securities-maintains-buy-on-shift4-payments-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947812, "time": "2024-11-13 12:21:02", "headline": "Hovde Group Downgrades SouthState to Market Perform", "summary": "", "symbols": ["SSB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947812/hovde-group-downgrades-southstate-to-market-perform", "tags": ["analyst_down"]}
{"id": 41947817, "time": "2024-11-13 12:21:16", "headline": "B. Riley Securities Maintains Neutral on L.B. Foster, Raises Price Target to $25", "summary": "", "symbols": ["FSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947817/b-riley-securities-maintains-neutral-on-l-b-foster-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947841, "time": "2024-11-13 12:22:09", "headline": "B. Riley Securities Maintains Buy on Gauzy, Lowers Price Target to $14", "summary": "", "symbols": ["GAUZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947841/b-riley-securities-maintains-buy-on-gauzy-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947846, "time": "2024-11-13 12:22:32", "headline": "Wells Fargo Maintains Overweight on Shopify, Raises Price Target to $120", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947846/wells-fargo-maintains-overweight-on-shopify-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947861, "time": "2024-11-13 12:23:03", "headline": "B. Riley Securities Maintains Buy on Genius Sports, Raises Price Target to $12", "summary": "", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947861/b-riley-securities-maintains-buy-on-genius-sports-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947906, "time": "2024-11-13 12:24:00", "headline": "Wells Fargo Maintains Overweight on Spotify Technology, Raises Price Target to $520", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947906/wells-fargo-maintains-overweight-on-spotify-technology-raises-price-target-to-520", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947907, "time": "2024-11-13 12:24:00", "headline": "B. Riley Securities Maintains Buy on Hallador Energy, Raises Price Target to $13", "summary": "", "symbols": ["HNRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947907/b-riley-securities-maintains-buy-on-hallador-energy-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 41947917, "time": "2024-11-13 12:24:49", "headline": "Cyclacel Pharmaceuticals Announces Exercise Of Warrants For $2.1M, Has Entered Into A Definitive Agreement For The Exercise Of Certain Existing Warrants To Purchase An Aggregate Of 4,968,945 Shares Of Its Common Stock Having An Original Exercise Price Of $1.36 Per Share, Originally Issued In May 2024, At A Reduced Exercise Price Of $0.415 Per Share", "summary": "", "symbols": ["CYCC", "CYCCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947917/cyclacel-pharmaceuticals-announces-exercise-of-warrants-for-2-1m-has-entered-into-a-definitive-agree", "tags": ["contract"]}
{"id": 41947918, "time": "2024-11-13 12:24:52", "headline": "B. Riley Securities Maintains Buy on RumbleON, Lowers Price Target to $7", "summary": "", "symbols": ["RMBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41947918/b-riley-securities-maintains-buy-on-rumbleon-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947919, "time": "2024-11-13 12:24:52", "headline": "High Tide Closes Final Tranche Of $15M Debt, Plans Retail Growth", "summary": "High Tide Inc. closes final tranche of $15M debt facility, enhancing financial strength for retail expansion and debt repayment.", "symbols": ["HITI"], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/news/financing/24/11/41947919/high-tide-closes-final-tranche-of-15m-debt-plans-retail-growth", "tags": []}
{"id": 41948015, "time": "2024-11-13 12:25:39", "headline": "Live On CNBC, Joe Terranova Announces Sold Amgen", "summary": "", "symbols": ["AMGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948015/live-on-cnbc-joe-terranova-announces-sold-amgen", "tags": []}
{"id": 41948018, "time": "2024-11-13 12:25:45", "headline": "Wells Fargo Maintains Underweight on FuelCell Energy, Lowers Price Target to $5", "summary": "", "symbols": ["FCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948018/wells-fargo-maintains-underweight-on-fuelcell-energy-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948021, "time": "2024-11-13 12:25:54", "headline": "Benchmark Maintains Buy on Spotify Technology, Raises Price Target to $520", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948021/benchmark-maintains-buy-on-spotify-technology-raises-price-target-to-520", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948023, "time": "2024-11-13 12:25:59", "headline": "B. Riley Securities Maintains Buy on FiscalNote Holdings, Lowers Price Target to $1.75", "summary": "", "symbols": ["NOTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948023/b-riley-securities-maintains-buy-on-fiscalnote-holdings-lowers-price-target-to-1-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948024, "time": "2024-11-13 12:26:08", "headline": "Live On CNBC, Jim Lebenthal Announces Bought More Lockheed Martin", "summary": "", "symbols": ["LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948024/live-on-cnbc-jim-lebenthal-announces-bought-more-lockheed-martin", "tags": []}
{"id": 41948028, "time": "2024-11-13 12:26:24", "headline": "Mastercard Lowers Financial Forecast, Signals Slower EPS, Revenue Growth Ahead", "summary": "Mastercard projects slower net revenue growth through 2027 due to lower consumer spending, with estimates for EPS growth also decreasing.", "symbols": ["BAC", "C", "JPM", "MA", "V", "WFC"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41948028/mastercard-lowers-financial-forecast-signals-slower-eps-revenue-growth-ahead", "tags": ["earnings", "guidance"]}
{"id": 41948041, "time": "2024-11-13 12:27:12", "headline": "B. Riley Securities Maintains Buy on Rigetti Computing, Raises Price Target to $3.5", "summary": "", "symbols": ["RGTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948041/b-riley-securities-maintains-buy-on-rigetti-computing-raises-price-target-to-3-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948048, "time": "2024-11-13 12:27:39", "headline": "EHang Expands eVTOL Infrastructure: New UAM Hub Powers Up Future of Autonomous Flights", "summary": "EHang Holdings Limited has launched a UAM Hub in Hefei, China, to support the operation of their EH216-S drones. ", "symbols": ["EH", "HAIL", "KOMP"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/small-cap/24/11/41948048/ehang-expands-evtol-infrastructure-new-uam-hub-powers-up-future-of-autonomous-flights", "tags": []}
{"id": 41948051, "time": "2024-11-13 12:27:50", "headline": "'Roblox Data Breach Exposes Millions Of User Accounts' - Daily Dark Web", "summary": "", "symbols": ["RBLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948051/roblox-data-breach-exposes-millions-of-user-accounts-daily-dark-web", "tags": []}
{"id": 41948052, "time": "2024-11-13 12:27:53", "headline": "Benchmark Maintains Buy on Sea, Raises Price Target to $130", "summary": "", "symbols": ["SE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948052/benchmark-maintains-buy-on-sea-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948084, "time": "2024-11-13 12:28:37", "headline": "B. Riley Securities Maintains Buy on Honest Co, Raises Price Target to $7", "summary": "", "symbols": ["HNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948084/b-riley-securities-maintains-buy-on-honest-co-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948127, "time": "2024-11-13 12:29:40", "headline": "Wells Fargo Maintains Equal-Weight on Rocket Lab USA, Raises Price Target to $13.5", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948127/wells-fargo-maintains-equal-weight-on-rocket-lab-usa-raises-price-target-to-13-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41935143, "time": "2024-11-13 07:11:58", "headline": "CyberArk Software shares are trading higher after the company reported better-than-expected Q3 financial results and raised FY24 outlook.", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41935143/cyberark-software-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-finan", "tags": ["guidance", "why_moving"]}
{"id": 41948162, "time": "2024-11-13 12:30:15", "headline": "Benchmark Maintains Buy on Flutter Entertainment, Raises Price Target to $275", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948162/benchmark-maintains-buy-on-flutter-entertainment-raises-price-target-to-275", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948163, "time": "2024-11-13 12:30:16", "headline": "How Is The Market Feeling About NOV?", "summary": " ", "symbols": ["NOV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41948163/how-is-the-market-feeling-about-nov", "tags": []}
{"id": 41948173, "time": "2024-11-13 12:30:21", "headline": "Looking Into Skechers USA's Recent Short Interest", "summary": " ", "symbols": ["SKX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41948173/looking-into-skechers-usas-recent-short-interest", "tags": []}
{"id": 41948175, "time": "2024-11-13 12:30:27", "headline": "How Is The Market Feeling About Evercore?", "summary": " ", "symbols": ["EVR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41948175/how-is-the-market-feeling-about-evercore", "tags": []}
{"id": 41948277, "time": "2024-11-13 12:31:19", "headline": "'Meta to Launch Ads on Threads in Early 2025' -The Information", "summary": "", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948277/meta-to-launch-ads-on-threads-in-early-2025-the-information", "tags": []}
{"id": 41948286, "time": "2024-11-13 12:32:00", "headline": "Wells Fargo Maintains Equal-Weight on Paymentus Holdings, Raises Price Target to $27", "summary": "", "symbols": ["PAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948286/wells-fargo-maintains-equal-weight-on-paymentus-holdings-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948297, "time": "2024-11-13 12:32:28", "headline": "MARA Holdings Faces Mixed Analyst Sentiment: Revenue Miss And Conservative Forecasts Amid Bitcoin Rally", "summary": "MARA shares down as Q3 earnings miss estimates with lower revenue and adjusted loss, analysts maintain mixed views and price targets.", "symbols": ["CRPT", "IBLC", "MARA"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/11/41948297/bitcoin-miner-mara-analysts-weigh-in-on-lower-sales-outlook-and-bitcoin-surge", "tags": ["earnings"]}
{"id": 41948314, "time": "2024-11-13 12:32:55", "headline": "Benchmark Maintains Buy on IAC, Lowers Price Target to $105", "summary": "", "symbols": ["IAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948314/benchmark-maintains-buy-on-iac-lowers-price-target-to-105", "tags": ["analyst_other", "price_target_down"]}
{"id": 41947016, "time": "2024-11-13 11:59:52", "headline": "What's Going On With Rivian Shares Wednesday?", "summary": "Rivian stock is moving higher on Wednesday after the company announced a joint venture launch with Volkswagen valued at up to $5.8 billion.", "symbols": ["RIVN"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41947016/whats-going-on-with-rivian-shares-wednesday", "tags": ["why_moving"]}
{"id": 41948347, "time": "2024-11-13 12:34:35", "headline": "Wells Fargo Maintains Equal-Weight on Honeywell Intl, Raises Price Target to $254", "summary": "", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948347/wells-fargo-maintains-equal-weight-on-honeywell-intl-raises-price-target-to-254", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948386, "time": "2024-11-13 12:34:52", "headline": "Benchmark Maintains Buy on Genius Sports, Raises Price Target to $11", "summary": "", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948386/benchmark-maintains-buy-on-genius-sports-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948387, "time": "2024-11-13 12:35:12", "headline": "10 Information Technology Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AMD", "CLSK", "CORZ", "CRWD", "MARA", "MSTR", "MU", "NVDA", "PLTR", "SMCI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41948387/10-information-technology-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 41948391, "time": "2024-11-13 12:35:18", "headline": "10 Health Care Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["ALT", "AMGN", "BMY", "BSX", "CVS", "HIMS", "INCY", "MRK", "PTGX", "VKTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41948391/10-health-care-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 41948392, "time": "2024-11-13 12:35:23", "headline": "10 Consumer Discretionary Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["ABNB", "AMZN", "BABA", "HD", "PDD", "PVH", "RIVN", "SBUX", "TSLA", "URBN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41948392/10-consumer-discretionary-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 41948395, "time": "2024-11-13 12:35:49", "headline": "'Biden And Chinese President Xi Jinping To Meet In Peru This Weekend' - CBS News", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41948395/biden-and-chinese-president-xi-jinping-to-meet-in-peru-this-weekend-cbs-news", "tags": []}
{"id": 41948398, "time": "2024-11-13 12:35:58", "headline": "Wells Fargo Maintains Overweight on Flutter Entertainment, Raises Price Target to $300", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948398/wells-fargo-maintains-overweight-on-flutter-entertainment-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948414, "time": "2024-11-13 12:36:34", "headline": "Benchmark Maintains Buy on Angi, Lowers Price Target to $6", "summary": "", "symbols": ["ANGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948414/benchmark-maintains-buy-on-angi-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948428, "time": "2024-11-13 12:37:22", "headline": "Wells Fargo Maintains Overweight on Shift4 Payments, Raises Price Target to $110", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948428/wells-fargo-maintains-overweight-on-shift4-payments-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948430, "time": "2024-11-13 12:37:35", "headline": "What's Going On With US Listed Chinese Stocks Alibaba, JD, Nio, Li XPeng On Wednesday?", "summary": "Chinese stocks fall after Trump&#39;s election victory and concerns over geopolitical tensions. Alibaba and JD.com report strong Singles&#39; Day sales.", "symbols": ["AAPL", "BABA", "JD", "NKE", "PDD", "XIACF", "XIACY", "XPEV"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/government/regulations/24/11/41948430/whats-going-on-with-us-listed-chinese-stocks-alibaba-jd-nio-li-xpeng-on-wednesday", "tags": ["why_moving"]}
{"id": 41948440, "time": "2024-11-13 12:38:04", "headline": "'Following OpenAI, Google Changes Tack to Overcome Slowdown In AI Improvement' - The Information", "summary": "", "symbols": ["GOOG", "GOOGL", "MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948440/following-openai-google-changes-tack-to-overcome-slowdown-in-ai-improvement-the-information", "tags": []}
{"id": 41948483, "time": "2024-11-13 12:40:16", "headline": "'Give Me A Break, New York Times,' Says Actor Jim Belushi As He Defends Cannabis, Criticizes Big Pharma, Food Industry", "summary": "Jim Belushi critiques Big Pharma, food industry, and media bias while defending cannabis at Benzinga event.", "symbols": [], "source": "benzinga", "author": "Javier Hasse", "url": "https://www.benzinga.com/markets/cannabis/24/11/41948483/give-me-a-break-new-york-times-says-actor-jim-belushi-as-he-defends-cannabis-criticizes-big-pharma-food-industry", "tags": []}
{"id": 41948486, "time": "2024-11-13 12:40:43", "headline": "Biden Pledges 'Smooth' Transition To Trump In White House Meeting", "summary": "Biden and Trump met in Oval Office, pledging a smooth transition of power. Trump shaping agenda, considering energy czar Burgum as frontrunner.", "symbols": ["CVX", "LCID", "RIVN", "XOM"], "source": "benzinga", "author": "Michael Cohen", "url": "https://www.benzinga.com/news/24/11/41948486/biden-pledges-smooth-transition-to-trump-in-white-house-meeting", "tags": []}
{"id": 41948534, "time": "2024-11-13 12:42:43", "headline": "Watching Radware; Hearing Traders Circulate Stock Picked By Zacks Newsletter", "summary": "", "symbols": ["RDWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948534/watching-radware-hearing-traders-circulate-stock-picked-by-zacks-newsletter", "tags": []}
{"id": 41948549, "time": "2024-11-13 12:43:23", "headline": "Xbox Handheld 'A Few Years Out,' Says Microsoft Gaming CEO; Hints At Cross-Platform Games, New Acquisitions", "summary": "Microsoft&#39;s Phil Spencer confirms an Xbox handheld console is on the way, but gamers will need to be patient as the company develops it.", "symbols": ["MSFT", "NTDOY", "SONY"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/11/41948549/xbox-handheld-a-few-years-out-says-microsoft-gaming-ceo-hints-at-cross-platform-games-new-acquisitions", "tags": ["management"]}
{"id": 41948560, "time": "2024-11-13 12:44:05", "headline": "Maxim Group Maintains Buy on Indaptus Therapeutics, Lowers Price Target to $5", "summary": "", "symbols": ["INDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948560/maxim-group-maintains-buy-on-indaptus-therapeutics-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948566, "time": "2024-11-13 12:44:45", "headline": "Citigroup Maintains Neutral on Cava Group, Raises Price Target to $163", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948566/citigroup-maintains-neutral-on-cava-group-raises-price-target-to-163", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948567, "time": "2024-11-13 12:44:51", "headline": "TD Cowen Maintains Buy on IHS Holding, Raises Price Target to $15", "summary": "", "symbols": ["IHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948567/td-cowen-maintains-buy-on-ihs-holding-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948586, "time": "2024-11-13 12:45:20", "headline": "Dow Jumps Over 150 Points; CyberArk Posts Upbeat Earnings", "summary": " ", "symbols": ["BTCT", "CYBR", "GCTK", "KXIN", "MVST", "PET", "SYRS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41948586/dow-jumps-over-150-points-cyberark-posts-upbeat-earnings", "tags": ["earnings"]}
{"id": 41948588, "time": "2024-11-13 12:45:24", "headline": "What the Options Market Tells Us About GE Aero", "summary": " ", "symbols": ["GE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41948588/what-the-options-market-tells-us-about-ge-aero", "tags": []}
{"id": 41948589, "time": "2024-11-13 12:45:26", "headline": "Maxim Group Maintains Buy on NeoVolta, Raises Price Target to $7.5", "summary": "", "symbols": ["NEOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948589/maxim-group-maintains-buy-on-neovolta-raises-price-target-to-7-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948590, "time": "2024-11-13 12:45:30", "headline": "Smart Money Is Betting Big In ABBV Options", "summary": " ", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41948590/smart-money-is-betting-big-in-abbv-options", "tags": []}
{"id": 41948591, "time": "2024-11-13 12:45:35", "headline": "Behind the Scenes of Celsius Holdings's Latest Options Trends", "summary": " ", "symbols": ["CELH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41948591/behind-the-scenes-of-celsius-holdingss-latest-options-trends", "tags": []}
{"id": 41948614, "time": "2024-11-13 12:46:37", "headline": "What's Going On With Occidental Petroleum Shares Wednesday?", "summary": "Occidental Petroleum reported 2024 third-quarter earnings after the market closed on Tuesday.", "symbols": ["OXY"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41948614/whats-going-on-with-occidental-petroleum-shares-wednesday", "tags": ["earnings", "why_moving"]}
{"id": 41948718, "time": "2024-11-13 12:48:19", "headline": "Citigroup Maintains Buy on NVIDIA, Raises Price Target to $170", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948718/citigroup-maintains-buy-on-nvidia-raises-price-target-to-170", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948727, "time": "2024-11-13 12:49:49", "headline": "Macquarie Maintains Outperform on Surgery Partners, Lowers Price Target to $34", "summary": "", "symbols": ["SGRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948727/macquarie-maintains-outperform-on-surgery-partners-lowers-price-target-to-34", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948758, "time": "2024-11-13 12:50:16", "headline": "Citigroup Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $68", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948758/citigroup-maintains-buy-on-mirum-pharmaceuticals-raises-price-target-to-68", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948798, "time": "2024-11-13 12:51:22", "headline": "California's Diablo Canyon Nuclear Plant To Implement AI System From Atomic Canyon, Powered By Nvidia, To Meet New Licensing Challenges And Streamline Document Management And Maintenance", "summary": "", "symbols": ["NVDA", "PCG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948798/californias-diablo-canyon-nuclear-plant-to-implement-ai-system-from-atomic-canyon-powered-by-nvidia", "tags": []}
{"id": 41948800, "time": "2024-11-13 12:51:27", "headline": "TD Cowen Maintains Buy on IAC, Lowers Price Target to $77", "summary": "", "symbols": ["IAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948800/td-cowen-maintains-buy-on-iac-lowers-price-target-to-77", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948802, "time": "2024-11-13 12:51:40", "headline": "Citigroup Maintains Sell on Agilon Health, Lowers Price Target to $1.75", "summary": "", "symbols": ["AGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948802/citigroup-maintains-sell-on-agilon-health-lowers-price-target-to-1-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948808, "time": "2024-11-13 12:52:09", "headline": "'Newly Elected Republican Senate Majority Leader Opposes Marijuana Legalization, Rescheduling And Industry Banking Access' - Marijuana Moment", "summary": "", "symbols": ["ACB", "AKAN", "CGC", "CRON", "GRWG", "IGC", "IMCC", "LFLY", "MAPS", "MJ", "MSOS", "SNDL", "SPY", "TLRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41948808/newly-elected-republican-senate-majority-leader-opposes-marijuana-legalization-re", "tags": []}
{"id": 41948823, "time": "2024-11-13 12:52:47", "headline": "TD Cowen Maintains Buy on EchoStar, Lowers Price Target to $30", "summary": "", "symbols": ["SATS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948823/td-cowen-maintains-buy-on-echostar-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948824, "time": "2024-11-13 12:52:50", "headline": "Macquarie Maintains Outperform on Genius Sports, Raises Price Target to $12", "summary": "", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948824/macquarie-maintains-outperform-on-genius-sports-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948834, "time": "2024-11-13 12:53:11", "headline": "Citigroup Maintains Buy on Evolent Health, Lowers Price Target to $21", "summary": "", "symbols": ["EVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948834/citigroup-maintains-buy-on-evolent-health-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948860, "time": "2024-11-13 12:54:09", "headline": "Citigroup Maintains Buy on GoodRx Holdings, Lowers Price Target to $7", "summary": "", "symbols": ["GDRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948860/citigroup-maintains-buy-on-goodrx-holdings-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948863, "time": "2024-11-13 12:54:20", "headline": "TD Cowen Maintains Hold on Sea, Raises Price Target to $100", "summary": "", "symbols": ["SE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948863/td-cowen-maintains-hold-on-sea-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948866, "time": "2024-11-13 12:55:02", "headline": "Citigroup Maintains Buy on Health Catalyst, Raises Price Target to $10.5", "summary": "", "symbols": ["HCAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948866/citigroup-maintains-buy-on-health-catalyst-raises-price-target-to-10-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948871, "time": "2024-11-13 12:55:11", "headline": "Macquarie Maintains Neutral on Sphere Entertainment, Lowers Price Target to $45", "summary": "", "symbols": ["SPHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948871/macquarie-maintains-neutral-on-sphere-entertainment-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 41948874, "time": "2024-11-13 12:55:17", "headline": "'Amazon Shuts Down Secret Project To Develop Fertility Tracker' - CNBC", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948874/amazon-shuts-down-secret-project-to-develop-fertility-tracker-cnbc", "tags": []}
{"id": 41948971, "time": "2024-11-13 12:56:14", "headline": "TD Cowen Maintains Buy on Endava, Raises Price Target to $36", "summary": "", "symbols": ["DAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948971/td-cowen-maintains-buy-on-endava-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948974, "time": "2024-11-13 12:56:29", "headline": "Citigroup Maintains Buy on McKesson, Raises Price Target to $713", "summary": "", "symbols": ["MCK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41948974/citigroup-maintains-buy-on-mckesson-raises-price-target-to-713", "tags": ["analyst_other", "price_target_up"]}
{"id": 41948981, "time": "2024-11-13 12:57:07", "headline": "BYD To Enter South Korea's Passenger Car Market In 2025, Challenging Tesla Model 3 And Hyundai IONIQ 6: Report", "summary": "BYD reportedly plans to launch passenger cars in South Korea by 2025, competing with Tesla Model 3 and Hyundai IONIQ 6 in the growing EV market.", "symbols": ["BYDDF", "BYDDY"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/equities/24/11/41948981/byd-to-enter-south-koreas-passenger-car-market-in-2025-challenging-tesla-model-3-and-hyundai-ioniq-6-report", "tags": []}
{"id": 41949002, "time": "2024-11-13 12:58:17", "headline": "Watching NeuroBo Pharmaceuticals; Zacks Small-Cap Research Gives Stock $22 Price Valuation", "summary": "", "symbols": ["NRBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949002/watching-neurobo-pharmaceuticals-zacks-small-cap-research-gives-stock-22-price-valuation", "tags": []}
{"id": 41949027, "time": "2024-11-13 12:58:25", "headline": "B of A Securities Maintains Buy on Spotify Technology, Raises Price Target to $515", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949027/b-of-a-securities-maintains-buy-on-spotify-technology-raises-price-target-to-515", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949051, "time": "2024-11-13 12:58:59", "headline": "What's Going On With Amazon Stock Wednesday?", "summary": "Amazon.com Inc (NASDAQ:AMZN) shares are trading higher. The company on Tuesday launched an online storefront designed to compete with Temu.", "symbols": ["AMZN"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/global/24/11/41949051/whats-going-on-with-amazon-stock-wednesday-2", "tags": ["why_moving"]}
{"id": 41949058, "time": "2024-11-13 12:59:21", "headline": "Reported Earlier, \"Chips Giant TSMC Sued Over 'Anti-American' Discrimination\" - Forbes", "summary": "", "symbols": ["TSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949058/reported-earlier-chips-giant-tsmc-sued-over-anti-american-discrimination-forbes", "tags": []}
{"id": 41949068, "time": "2024-11-13 12:59:37", "headline": "Bitcoin Could Reach $1 Million By 2037, Economist Says: 'Buy Of A Lifetime' Opportunity", "summary": "A massive, &#34;everything bubble&#34; will burst in 2025, resulting in a crash and possibly a depression. ", "symbols": ["BTCUSD", "SPY"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity", "tags": []}
{"id": 41949074, "time": "2024-11-13 12:59:50", "headline": "TD Cowen Maintains Hold on Quanterix, Raises Price Target to $16", "summary": "", "symbols": ["QTRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949074/td-cowen-maintains-hold-on-quanterix-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949076, "time": "2024-11-13 12:59:52", "headline": "Exact Sciences CEO Kevin Conroy Buys 19,500 Shares At $51.35 Each, Investing $1M; Now Holds 1.07M Direct Shares, With Total Holdings Reaching 1.41M Shares Plus 683K Options And Restricted Stock Units", "summary": "", "symbols": ["EXAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949076/exact-sciences-ceo-kevin-conroy-buys-19-500-shares-at-51-35-each-investing-1m-now-holds-1-07m-direct", "tags": ["insider", "management"]}
{"id": 41949075, "time": "2024-11-13 12:59:52", "headline": "Leerink Partners Maintains Outperform on Lexeo Therapeutics, Lowers Price Target to $19", "summary": "", "symbols": ["LXEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949075/leerink-partners-maintains-outperform-on-lexeo-therapeutics-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 41949115, "time": "2024-11-13 13:00:52", "headline": "CNBC Halftime Report Final Trades: Amazon, CrowdStrike, iShares U.S. Industrials ETF", "summary": "", "symbols": ["AMZN", "CRWD", "IYJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949115/cnbc-halftime-report-final-trades-amazon-crowdstrike-ishares-u-s-industrials-etf", "tags": []}
{"id": 41949136, "time": "2024-11-13 13:01:43", "headline": "Stocks Edge Higher, Dollar Hits 1-Year Peak, Bitcoin Soars To $93,000: What's Driving Markets Wednesday?", "summary": "Wall Street rebounds on inflation report, with consumer discretionary and real estate sectors leading. Senator John Thune elected majority leader. U.S. dollar hits 1-year high.", "symbols": ["ALB", "AMD", "CYBR", "DIA", "FLUT", "IWM", "LOAR", "NTRA", "OXY", "QQQ", "RIVN", "SPOT", "SPY", "UUP", "XLB", "XLP", "XLU", "XLY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/news/econ-s/24/11/41949136/stocks-edge-higher-dollar-hits-1-year-peak-bitcoin-soars-to-93000-whats-driving-markets-wednesday", "tags": []}
{"id": 41949140, "time": "2024-11-13 13:02:02", "headline": "Citigroup Maintains Buy on NICE, Raises Price Target to $334", "summary": "", "symbols": ["NICE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949140/citigroup-maintains-buy-on-nice-raises-price-target-to-334", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949141, "time": "2024-11-13 13:02:02", "headline": "Exact Sciences Unveils Data Showing Multi-Cancer Early Detection At AACR Special Conference On Liquid Biopsy; New Evidence Shows Multi-Biomarker Class Approach Improved Cancer Detection, Including In Earlier Stages When Treatment May Be More Effective; Modeling Data Estimate Adding MCED Testing To Standard-Of-Care Screening Could Reduce Cancer Mortality By 17%", "summary": "", "symbols": ["EXAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41949141/exact-sciences-unveils-data-showing-multi-cancer-early-detection-at-aacr-special-conference-on-li", "tags": []}
{"id": 41949143, "time": "2024-11-13 13:02:08", "headline": "Beyond The Numbers: 4 Analysts Discuss Treehouse Foods Stock", "summary": " ", "symbols": ["THS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41949143/beyond-the-numbers-4-analysts-discuss-treehouse-foods-stock", "tags": []}
{"id": 41949151, "time": "2024-11-13 13:02:14", "headline": "TD Cowen Maintains Buy on BeiGene, Raises Price Target to $260", "summary": "", "symbols": ["BGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949151/td-cowen-maintains-buy-on-beigene-raises-price-target-to-260", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949159, "time": "2024-11-13 13:02:20", "headline": "In-Depth Examination Of 5 Analyst Recommendations For GXO Logistics", "summary": " ", "symbols": ["GXO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41949159/in-depth-examination-of-5-analyst-recommendations-for-gxo-logistics", "tags": []}
{"id": 41949163, "time": "2024-11-13 13:02:25", "headline": "Leerink Partners Downgrades 908 Devices to Market Perform, Lowers Price Target to $4", "summary": "", "symbols": ["MASS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949163/leerink-partners-downgrades-908-devices-to-market-perform-lowers-price-target-to-4", "tags": ["analyst_down", "price_target_down"]}
{"id": 41949164, "time": "2024-11-13 13:02:26", "headline": "Smart Money Is Betting Big In CSCO Options", "summary": " ", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41949164/smart-money-is-betting-big-in-csco-options", "tags": []}
{"id": 41949165, "time": "2024-11-13 13:02:27", "headline": "Analyst Expectations For BKV's Future", "summary": " ", "symbols": ["BKV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41949165/analyst-expectations-for-bkvs-future", "tags": []}
{"id": 41949168, "time": "2024-11-13 13:02:38", "headline": "Breaking Down Integral Ad Science: 4 Analysts Share Their Views", "summary": " ", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41949168/breaking-down-integral-ad-science-4-analysts-share-their-views", "tags": []}
{"id": 41949170, "time": "2024-11-13 13:02:38", "headline": "St. Louis Fed's Musalem: U.S. Central Bank May Be On The 'Last Mile' To Price Stability, Inflation Expected To Converge To 2% Target Over The Medium Term; Recent Information 'Suggests' That The Risk Of Inflation Moving Higher Has Risen, While Risks To The Job Market Remain Unchanged Or Have Fallen; Monetary Policy 'Well Positioned,' Fed Can 'Judiciously And Patiently' Judge Incoming Data To Decide On Further Rate Cuts; Monetary Policy To Remain 'Appropriately Restrictive' While Inflation Remains Above 2%", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949170/st-louis-feds-musalem-u-s-central-bank-may-be-on-the-last-mile-to-price-stability-inflation-expected", "tags": []}
{"id": 41949177, "time": "2024-11-13 13:02:50", "headline": "The Latest Analyst Ratings For Health Catalyst", "summary": " ", "symbols": ["HCAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41949177/the-latest-analyst-ratings-for-health-catalyst", "tags": []}
{"id": 41949182, "time": "2024-11-13 13:02:58", "headline": "Cracking The Code: Understanding Analyst Reviews For Shoals Technologies Gr", "summary": " ", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41949182/cracking-the-code-understanding-analyst-reviews-for-shoals-technologies-gr", "tags": []}
{"id": 41949184, "time": "2024-11-13 13:03:11", "headline": "Elon Musk-Endorsed Peanut The Squirrel Surges 270% To $1.5 Billion Valuation: 'Only More Wild Moves Ahead,' Says Millionaire Trader", "summary": "Peanut The Squirrel (CRYPTO: PNUT) has surged in both price and valuation, rewarding traders with substantial profits as it continues to attract attention.", "symbols": ["DOGEUSD", "FLOKIUSD", "SHIBUSD", "SOLUSD", "WIFUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41949184/elon-musk-endorsed-peanut-the-squirrel-surges-270-to-15-billion-valuation-only-more-wild-moves-ahead-says-millionaire-trader", "tags": []}
{"id": 41949191, "time": "2024-11-13 13:03:18", "headline": "Booz Allen Ventures Invests In Starfish Space To Enhance Satellite Servicing Technology;  Investment Aims To Strengthen The Resilience And Sustainability Of Space Infrastructure Through Innovative Offerings For Both Government And Commercial Mission Sets; No Financial Terms Disclosed", "summary": "", "symbols": ["BAH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949191/booz-allen-ventures-invests-in-starfish-space-to-enhance-satellite-servicing-technology-investment-a", "tags": []}
{"id": 41949195, "time": "2024-11-13 13:03:23", "headline": "Citigroup Maintains Buy on Tanger, Raises Price Target to $41", "summary": "", "symbols": ["SKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949195/citigroup-maintains-buy-on-tanger-raises-price-target-to-41", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949198, "time": "2024-11-13 13:03:27", "headline": "Uncovering Potential: LiqTech Intl's Earnings Preview", "summary": " ", "symbols": ["LIQT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949198/uncovering-potential-liqtech-intls-earnings-preview", "tags": ["earnings"]}
{"id": 41949200, "time": "2024-11-13 13:03:29", "headline": "Fed's Musalem Says Further Rates Easing Appropriate If Inflation Continues To Fall; Musalem: Labor Market Remains In The Range Of Full Employment; Strong Economy On Track For A 'Solid' Fourth Quarter; Growth Is Broad-based And Driven By Consumption, Income Growth, Productivity, Supportive Financial Conditions, And Wealth Effects; Recent High Productivity Could 'Prove Durably Structural,' But That Remains Uncertain", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949200/feds-musalem-says-further-rates-easing-appropriate-if-inflation-continues-to-fall-musalem-labor-mark", "tags": []}
{"id": 41949203, "time": "2024-11-13 13:03:35", "headline": "Skyworks Solutions Faces Headwinds: Analysts Slash Price Forecasts Amid Weak Guidance And Inventory Challenges", "summary": "Skyworks Solutions reported Q4 results, beat EPS estimate, revenue in line with forecast. Several analyst cut price target. ", "symbols": ["FTXL", "SNSR", "SWKS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41949203/skyworks-solutions-faces-headwinds-analysts-slash-price-forecasts-amid-weak-guidance-and-inventory-challenges", "tags": ["earnings", "guidance"]}
{"id": 41949205, "time": "2024-11-13 13:03:41", "headline": "Biora Therapeutics's Earnings Outlook", "summary": " ", "symbols": ["BIOR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949205/biora-therapeuticss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41949215, "time": "2024-11-13 13:03:49", "headline": "Exploring American Res's Earnings Expectations", "summary": " ", "symbols": ["AREC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949215/exploring-american-ress-earnings-expectations", "tags": ["earnings"]}
{"id": 41949220, "time": "2024-11-13 13:03:57", "headline": "A Look Ahead: Palatin Techs's Earnings Forecast", "summary": " ", "symbols": ["PTN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949220/a-look-ahead-palatin-techss-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41949228, "time": "2024-11-13 13:03:58", "headline": "Morgan Stanley Maintains Equal-Weight on Zoom Video Comms, Raises Price Target to $86", "summary": "", "symbols": ["ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949228/morgan-stanley-maintains-equal-weight-on-zoom-video-comms-raises-price-target-to-86", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949230, "time": "2024-11-13 13:04:02", "headline": "Fed's Musalem Says Business Sector 'Generally Healthy,' Though Smallest Businesses And Those In Consumer Discretionary Market Seeing Slower Earnings Growth; Says He Is Attuned To The Risks Of Rising Layoffs, Though 'Disorderly' Deterioration Of Labor Market Unlikely Given Health Of Businesses; Core Consumer Price Index And Core Personal Consumption Expenditures Price Index Remain Elevated", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949230/feds-musalem-says-business-sector-generally-healthy-though-smallest-businesses-and-those-in-consumer", "tags": ["earnings"]}
{"id": 41949232, "time": "2024-11-13 13:04:09", "headline": "Exploring Lifeway Foods's Earnings Expectations", "summary": " ", "symbols": ["LWAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949232/exploring-lifeway-foodss-earnings-expectations", "tags": ["earnings"]}
{"id": 41949243, "time": "2024-11-13 13:04:22", "headline": "Examining the Future: MiNK Therapeutics's Earnings Outlook", "summary": " ", "symbols": ["INKT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949243/examining-the-future-mink-therapeuticss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41949244, "time": "2024-11-13 13:04:24", "headline": "TD Cowen Maintains Buy on BioLife Solns, Raises Price Target to $31", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949244/td-cowen-maintains-buy-on-biolife-solns-raises-price-target-to-31", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949246, "time": "2024-11-13 13:04:30", "headline": "A Look at Iterum Therapeutics's Upcoming Earnings Report", "summary": " ", "symbols": ["ITRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949246/a-look-at-iterum-therapeuticss-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 41949248, "time": "2024-11-13 13:04:40", "headline": "What to Expect from Dolphin Entertainment's Earnings", "summary": " ", "symbols": ["DLPN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949248/what-to-expect-from-dolphin-entertainments-earnings", "tags": ["earnings"]}
{"id": 41949258, "time": "2024-11-13 13:04:48", "headline": "A Glimpse of SuperCom's Earnings Potential", "summary": " ", "symbols": ["SPCB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949258/a-glimpse-of-supercoms-earnings-potential", "tags": ["earnings"]}
{"id": 41949259, "time": "2024-11-13 13:04:49", "headline": "Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis", "summary": "Aileron Therapeutics&#39; Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to enhance lung function in IPF patients.", "symbols": ["ALRN"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41949259/aileron-therapeutics-investigational-drug-shows-encouraging-action-in-lung-fibrosis", "tags": ["fda"]}
{"id": 41949262, "time": "2024-11-13 13:04:55", "headline": "Reed's Earnings Preview", "summary": " ", "symbols": ["REED"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949262/reeds-earnings-preview", "tags": ["earnings"]}
{"id": 41949271, "time": "2024-11-13 13:05:13", "headline": "Earnings Preview: Motorsport Games", "summary": " ", "symbols": ["MSGM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949271/earnings-preview-motorsport-games", "tags": ["earnings"]}
{"id": 41949285, "time": "2024-11-13 13:05:25", "headline": "A Preview Of Local Bounti's Earnings", "summary": " ", "symbols": ["LOCL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41949285/a-preview-of-local-bountis-earnings", "tags": ["earnings"]}
{"id": 41949305, "time": "2024-11-13 13:06:13", "headline": "TD Cowen Maintains Buy on Biohaven, Raises Price Target to $75", "summary": "", "symbols": ["BHVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949305/td-cowen-maintains-buy-on-biohaven-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949325, "time": "2024-11-13 13:06:37", "headline": "Citigroup Maintains Sell on Skyworks Solutions, Lowers Price Target to $72", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949325/citigroup-maintains-sell-on-skyworks-solutions-lowers-price-target-to-72", "tags": ["analyst_other", "price_target_down"]}
{"id": 41949330, "time": "2024-11-13 13:06:41", "headline": "Amkor Technology Increases Quarterly Dividend From $0.07875 To $0.08269 Per Share", "summary": "", "symbols": ["AMKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949330/amkor-technology-increases-quarterly-dividend-from-0-07875-to-0-08269-per-share", "tags": ["dividend"]}
{"id": 41949363, "time": "2024-11-13 13:07:48", "headline": "TD Cowen Maintains Buy on Shoals Technologies Gr, Raises Price Target to $11", "summary": "", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949363/td-cowen-maintains-buy-on-shoals-technologies-gr-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949384, "time": "2024-11-13 13:08:27", "headline": "BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition", "summary": "BioNTech acquires Biotheus for $800 million plus milestone payments, securing global rights to BNT327/PM8002 and expanding its oncology and R&amp;D presence in China.", "symbols": ["BNTX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41949384/biontech-boosts-oncology-strategy-with-800-million-china-based-biotheus-acquisition", "tags": ["merger"]}
{"id": 41949433, "time": "2024-11-13 13:09:36", "headline": "TD Cowen Maintains Sell on Spirit Airlines, Lowers Price Target to $1", "summary": "", "symbols": ["SAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949433/td-cowen-maintains-sell-on-spirit-airlines-lowers-price-target-to-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 41949436, "time": "2024-11-13 13:09:47", "headline": "Cannabist, COAST Team Up To Launch Premium Edibles In Two States", "summary": "Cannabist partners with COAST Cannabis to launch artisan chocolates and gummies in Maryland and New Jersey, expanding edibles market reach.", "symbols": ["CBSTF"], "source": "benzinga", "author": "Patricio Liddle", "url": "https://www.benzinga.com/24/11/41949436/cannabist-coast-team-up-to-launch-premium-edibles-in-two-states", "tags": ["contract"]}
{"id": 41949508, "time": "2024-11-13 13:11:13", "headline": "Citigroup Maintains Neutral on Brown-Forman, Lowers Price Target to $43", "summary": "", "symbols": ["BF", "BF/B"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949508/citigroup-maintains-neutral-on-brown-forman-lowers-price-target-to-43", "tags": ["analyst_other", "price_target_down"]}
{"id": 41949509, "time": "2024-11-13 13:11:17", "headline": "TD Cowen Maintains Hold on Triumph Group, Raises Price Target to $20", "summary": "", "symbols": ["TGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949509/td-cowen-maintains-hold-on-triumph-group-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949651, "time": "2024-11-13 13:14:03", "headline": "TD Cowen Maintains Buy on On Holding, Raises Price Target to $60", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949651/td-cowen-maintains-buy-on-on-holding-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949654, "time": "2024-11-13 13:14:18", "headline": "UBS Upgrades Carrier Global to Buy, Announces $94 Price Target", "summary": "", "symbols": ["CARR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949654/ubs-upgrades-carrier-global-to-buy-announces-94-price-target", "tags": ["analyst_up"]}
{"id": 41949659, "time": "2024-11-13 13:14:37", "headline": "Stock Of The Day: Could Troubled Spirit Airlines Stock Recover?", "summary": "Shares of Spirit Airlines (SAVE) had a short interest of 35%. This is an extremely high amount and may result in the stock moving higher.", "symbols": ["SAVE"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/general/travel/24/11/41949659/stock-of-the-day-could-troubled-spirit-airlines-stock-recover", "tags": []}
{"id": 41949695, "time": "2024-11-13 13:15:48", "headline": "'Southwest Air Sees Boeing Strike Cutting Into 2025 Deliveries' - Bloomberg News", "summary": "", "symbols": ["BA", "LUV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949695/southwest-air-sees-boeing-strike-cutting-into-2025-deliveries-bloomberg-news", "tags": []}
{"id": 41949697, "time": "2024-11-13 13:15:49", "headline": "Bird Flu Puts Teen In Critical Condition As Canada Reports First Human Case: What You Need To Know", "summary": "Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies&#39; respective COVID-19 vaccines.", "symbols": ["MRNA", "PFE"], "source": "benzinga", "author": "Anthony Noto", "url": "https://www.benzinga.com/general/health-care/24/11/41949697/bird-flu-puts-teen-in-critical-condition-as-canada-reports-first-human-case-what-you-need-to-know", "tags": []}
{"id": 41949711, "time": "2024-11-13 13:16:16", "headline": "TD Cowen Maintains Hold on Spotify Technology, Raises Price Target to $416", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949711/td-cowen-maintains-hold-on-spotify-technology-raises-price-target-to-416", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949760, "time": "2024-11-13 13:17:16", "headline": "Amkor Technology Approves The Payment Of An ~$100M Special Cash Dividend, Or $0.40546 Per Share, On The Company's Common Stock", "summary": "", "symbols": ["AMKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949760/amkor-technology-approves-the-payment-of-an-100m-special-cash-dividend-or-0-40546-per-share-on-the-c", "tags": ["dividend"]}
{"id": 41949858, "time": "2024-11-13 13:18:08", "headline": "TD Cowen Maintains Buy on Natera, Raises Price Target to $175", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949858/td-cowen-maintains-buy-on-natera-raises-price-target-to-175", "tags": ["analyst_other", "price_target_up"]}
{"id": 41949859, "time": "2024-11-13 13:18:16", "headline": "UBS Downgrades Rockwell Automation to Neutral, Announces $313 Price Target", "summary": "", "symbols": ["ROK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949859/ubs-downgrades-rockwell-automation-to-neutral-announces-313-price-target", "tags": ["analyst_down"]}
{"id": 41949909, "time": "2024-11-13 13:20:25", "headline": "UBS Upgrades 3M to Buy, Raises Price Target to $184", "summary": "", "symbols": ["MMM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41949909/ubs-upgrades-3m-to-buy-raises-price-target-to-184", "tags": ["analyst_up", "price_target_up"]}
{"id": 41950001, "time": "2024-11-13 13:23:50", "headline": "UBS Initiates Coverage On Fortive with Neutral Rating, Announces Price Target of $84", "summary": "", "symbols": ["FTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950001/ubs-initiates-coverage-on-fortive-with-neutral-rating-announces-price-target-of-84", "tags": ["analyst_init"]}
{"id": 41950023, "time": "2024-11-13 13:24:52", "headline": "US Stock Market's Equity Risk Premium Disappears: Should You Sell Now?", "summary": "&#34;We are now just 10 basis points away from the Equity Risk Premium shifting negative,&#34; David Rosenberg says.", "symbols": ["SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41950023/us-stock-markets-equity-risk-premium-disappears-should-you-sell-now", "tags": []}
{"id": 41950069, "time": "2024-11-13 13:26:09", "headline": "UBS Initiates Coverage On Dover with Neutral Rating, Announces Price Target of $217", "summary": "", "symbols": ["DOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950069/ubs-initiates-coverage-on-dover-with-neutral-rating-announces-price-target-of-217", "tags": ["analyst_init"]}
{"id": 41950100, "time": "2024-11-13 13:27:45", "headline": "Wolfe Research Upgrades Phillips Edison to Outperform", "summary": "", "symbols": ["PECO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950100/wolfe-research-upgrades-phillips-edison-to-outperform", "tags": ["analyst_up"]}
{"id": 41950108, "time": "2024-11-13 13:27:51", "headline": "Amgen Executive Says Co Continues To Be \"Laser Focused\" On A Phase Three Development Program For Its Obesity Drug Maritide; Says Co Has Not Seen Any Association Between Administration Of Maritide And Bone Mineral Density Changes Or Safety Signals For Bone; Believe That A Research Note Had Suggested \"An Inappropriate Inference\" Of Maritide Data Given Its Limitations", "summary": "", "symbols": ["AMGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41950108/amgen-executive-says-co-continues-to-be-laser-focused-on-a-phase-three-development-program-for-it", "tags": []}
{"id": 41950142, "time": "2024-11-13 13:28:20", "headline": "UBS Initiates Coverage On Vertiv Hldgs with Buy Rating, Announces Price Target of $155", "summary": "", "symbols": ["VRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950142/ubs-initiates-coverage-on-vertiv-hldgs-with-buy-rating-announces-price-target-of-155", "tags": ["analyst_init"]}
{"id": 41950175, "time": "2024-11-13 13:30:10", "headline": "Shopify's Q3 Earnings Beat Drives Analyst Upgrades, Market Confidence", "summary": "Shopify&#39;s shares rose after the company reported upbeat Q3 earnings. JPMorgan and Goldman Sachs raise price targets.", "symbols": ["SHOP"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/news/earnings/earnings-beats/24/11/41950175/shopifys-q3-earnings-beat-drives-analyst-upgrades-market-confidence", "tags": ["analyst_up", "earnings"]}
{"id": 41950241, "time": "2024-11-13 13:30:35", "headline": "Looking At e.l.f. Beauty's Recent Unusual Options Activity", "summary": " ", "symbols": ["ELF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41950241/looking-at-e-l-f-beautys-recent-unusual-options-activity", "tags": []}
{"id": 41950243, "time": "2024-11-13 13:30:40", "headline": "What the Options Market Tells Us About JD.com", "summary": " ", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41950243/what-the-options-market-tells-us-about-jd-com", "tags": []}
{"id": 41950244, "time": "2024-11-13 13:30:45", "headline": "Decoding Energy Transfer's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["ET"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41950244/decoding-energy-transfers-options-activity-whats-the-big-picture", "tags": []}
{"id": 41950245, "time": "2024-11-13 13:30:52", "headline": "UBS Initiates Coverage On Parker Hannifin with Buy Rating, Announces Price Target of $842", "summary": "", "symbols": ["PH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950245/ubs-initiates-coverage-on-parker-hannifin-with-buy-rating-announces-price-target-of-842", "tags": ["analyst_init"]}
{"id": 41950254, "time": "2024-11-13 13:31:18", "headline": "Pure Storage Positioned For AI-Driven Growth: Analyst Sees 12% Revenue Surge Ahead", "summary": "Oppenheimer analyst initiates coverage on Pure Storage with Outperform rating and $70 price target, citing potential growth in demand for unstructured data and the company&#39;s strong position in the data storage market.", "symbols": ["IDAT", "PSTG", "SKYY"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41950254/pure-storage-positioned-for-ai-driven-growth-analyst-sees-12-revenue-surge-ahead", "tags": ["analyst_init", "earnings"]}
{"id": 41950264, "time": "2024-11-13 13:31:43", "headline": "Fed's Schmid Says 'Remains To Be Seen' How Much More Fed Will Cut Rates, And Where They May Settle; Fed Rate Cuts To Date 'acknowledgement' Of Growing Confidence Inflation On Path To 2% Goal; Hope Productivity Growth Can Outrun Effects Of Slowing Population Growth, Rising Fiscal Deficits; Won't Let Enthusiasm Over Rising Productivity Get Ahead Of Data Or Commitment To Reaching Fed's Goals", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41950264/feds-schmid-says-remains-to-be-seen-how-much-more-fed-will-cut-rates-and-where-th", "tags": []}
{"id": 41950329, "time": "2024-11-13 13:33:26", "headline": "Ascendiant Capital Maintains Buy on Quantum Computing, Raises Price Target to $8.5", "summary": "", "symbols": ["QUBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950329/ascendiant-capital-maintains-buy-on-quantum-computing-raises-price-target-to-8-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41950350, "time": "2024-11-13 13:34:14", "headline": "Watching Zeta Global Holdings; Culper Research Issues Report On Co Titled \"Zeta Global Holdings Corp (ZETA): Shams, Scams, and Spam\"", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950350/watching-zeta-global-holdings-culper-research-issues-report-on-co-titled-zeta-global-holdings-corp-z", "tags": []}
{"id": 41950361, "time": "2024-11-13 13:34:34", "headline": "Fed's Musalem Says Monetary Policy Is Restrictive, But Financial Conditions Overall Are Supportive Of Economic Activity", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41950361/feds-musalem-says-monetary-policy-is-restrictive-but-financial-conditions-overall", "tags": []}
{"id": 41950363, "time": "2024-11-13 13:34:52", "headline": "HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $30 Price Target", "summary": "", "symbols": ["OLMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950363/hc-wainwright-co-reiterates-buy-on-olema-pharmaceuticals-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 41950364, "time": "2024-11-13 13:34:55", "headline": "UBS Assumes Trane Technologies at Buy, Raises Price Target to $500", "summary": "", "symbols": ["TT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950364/ubs-assumes-trane-technologies-at-buy-raises-price-target-to-500", "tags": ["price_target_up"]}
{"id": 41950390, "time": "2024-11-13 13:37:39", "headline": "HC Wainwright & Co. Maintains Buy on Atossa Therapeutics, Raises Price Target to $7", "summary": "", "symbols": ["ATOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950390/hc-wainwright-co-maintains-buy-on-atossa-therapeutics-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 41950398, "time": "2024-11-13 13:37:47", "headline": "UBS Assumes Ingersoll Rand at Buy, Raises Price Target to $124", "summary": "", "symbols": ["IR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950398/ubs-assumes-ingersoll-rand-at-buy-raises-price-target-to-124", "tags": ["price_target_up"]}
{"id": 41950413, "time": "2024-11-13 13:38:26", "headline": "WATCH LIVE: Senator John Thune Speaks To Reporters After Being Elected Majority Leader", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41950413/watch-live-senator-john-thune-speaks-to-reporters-after-being-elected-majority-le", "tags": []}
{"id": 41950428, "time": "2024-11-13 13:38:59", "headline": "Natera Analysts Increase Their Forecasts Following Upbeat Results", "summary": " ", "symbols": ["NTRA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41950428/natera-analysts-increase-their-forecasts-following-upbeat-results", "tags": []}
{"id": 41950430, "time": "2024-11-13 13:39:15", "headline": "HC Wainwright & Co. Reiterates Buy on Absci, Maintains $7 Price Target", "summary": "", "symbols": ["ABSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950430/hc-wainwright-co-reiterates-buy-on-absci-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41950440, "time": "2024-11-13 13:40:01", "headline": "What's Going On With Jet.AI Shares Today?", "summary": "Jet.AI Inc. (NASDAQ: JTAI) shares are trading higher Wednesday\u00a0after the company&#39;s board approved a $2 million share repurchase program through 2025 and announced the withdrawal of its S-1 registration. Here&#39;s what you need to know.", "symbols": ["JTAI"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41950440/whats-going-on-with-jet-ai-shares-today", "tags": ["why_moving", "buyback"]}
{"id": 41950456, "time": "2024-11-13 13:40:24", "headline": "UBS Assumes Honeywell Intl at Buy, Raises Price Target to $298", "summary": "", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950456/ubs-assumes-honeywell-intl-at-buy-raises-price-target-to-298", "tags": ["price_target_up"]}
{"id": 41947920, "time": "2024-11-13 12:24:51", "headline": "A Dogecoin Strategic Reserve? One Company Is Working On It", "summary": "Spirit Blockchain Capital appears to be positioning itself as a significant player in the Dogecoin (CRYPTO: DOGE) ecosystem, with CEO Lewis Bateman likening the company&#39;s strategy to ", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41947920/a-dogecoin-strategic-reserve-one-company-is-working-on-it", "tags": ["management"]}
{"id": 41950494, "time": "2024-11-13 13:43:07", "headline": "Fed's Musalem Says Monetary Policy Is Restrictive, But Financial Conditions Overall Are Supportive Of Economic Activity; Hard To Derive Much Signal From Most Recent Jobs Report; Low Number Clouded By Storm And Other Impacts; Monetary Policy Decisions Are Already Complicated; Adding Political Considerations Would Make Them Even Harder", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950494/feds-musalem-says-monetary-policy-is-restrictive-but-financial-conditions-overall-are-supportive-of", "tags": []}
{"id": 41950499, "time": "2024-11-13 13:43:21", "headline": "UBS Assumes Eaton Corp at Buy, Raises Price Target to $431", "summary": "", "symbols": ["ETN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950499/ubs-assumes-eaton-corp-at-buy-raises-price-target-to-431", "tags": ["price_target_up"]}
{"id": 41950519, "time": "2024-11-13 13:44:19", "headline": "Occidental Expects 2025 Low Carbon Ventures Capital Budget To Be Around $450M; Occidental Expects Chemicals Capital Budget To Be ~$900M In 2025; DAC Grant Could Potentially Increase By $150M; Occidental Targets Debt Reduction In 2025 Despite Where Oil Prices Will Be", "summary": "", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950519/occidental-expects-2025-low-carbon-ventures-capital-budget-to-be-around-450m-occidental-expects-chem", "tags": []}
{"id": 41950531, "time": "2024-11-13 13:44:31", "headline": "UBS Maintains Buy on On Holding, Raises Price Target to $63", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950531/ubs-maintains-buy-on-on-holding-raises-price-target-to-63", "tags": ["analyst_other", "price_target_up"]}
{"id": 41950537, "time": "2024-11-13 13:44:57", "headline": "'Musk's X Names Mahmoud Reza Banki CFO; Former Tubi Finance Chief Joins X Amid Financial Challenges At The Social Media Company' - WSJ", "summary": "", "symbols": ["META", "PINS", "SNAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950537/musks-x-names-mahmoud-reza-banki-cfo-former-tubi-finance-chief-joins-x-amid-financial-challenges-at", "tags": ["management"]}
{"id": 41950541, "time": "2024-11-13 13:45:12", "headline": "What's Going On With Hims & Hers Health Stock On Wednesday?", "summary": "Hims &amp; Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing rising demand and pharmacy shortages.", "symbols": ["HIMS", "NVO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/24/11/41950541/whats-going-on-with-hims-hers-health-stock-on-wednesday", "tags": ["why_moving"]}
{"id": 41950542, "time": "2024-11-13 13:45:16", "headline": "A Look Into Northern Trust Inc's Price Over Earnings", "summary": " ", "symbols": ["NTRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41950542/a-look-into-northern-trust-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 41949918, "time": "2024-11-13 13:21:42", "headline": "Landmark Case Paves Way For Cannabis Distribution To Martha's Vineyard And Nantucket Islands", "summary": "The Green Lady Dispensary becomes Nantucket&#39;s first to receive legal cannabis shipment, enhancing local access and signaling industry progress.", "symbols": [], "source": "benzinga", "author": "Javier Hasse", "url": "https://www.benzinga.com/news/retail-sales/24/11/41949918/landmark-case-paves-way-for-cannabis-distribution-to-marthas-vineyard-and-nantucket-islands", "tags": []}
{"id": 41950567, "time": "2024-11-13 13:46:38", "headline": "UBS Assumes Emerson Electric at Neutral, Raises Price Target to $135", "summary": "", "symbols": ["EMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950567/ubs-assumes-emerson-electric-at-neutral-raises-price-target-to-135", "tags": ["price_target_up"]}
{"id": 41950576, "time": "2024-11-13 13:47:03", "headline": "Bank Of America CEO Brian Moynihan Says We See A Strong Pipeline In M&A; IPO Pipelines Are Full And Ready To Go", "summary": "", "symbols": ["BAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41950576/bank-of-america-ceo-brian-moynihan-says-we-see-a-strong-pipeline-in-m-a-ipo-pipelines-are-full-and-r", "tags": ["management"]}
{"id": 41950604, "time": "2024-11-13 13:47:30", "headline": "HC Wainwright & Co. Maintains Buy on Crinetics Pharmaceuticals, Raises Price Target to $81", "summary": "", "symbols": ["CRNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950604/hc-wainwright-co-maintains-buy-on-crinetics-pharmaceuticals-raises-price-target-to-81", "tags": ["analyst_other", "price_target_up"]}
{"id": 41950611, "time": "2024-11-13 13:48:27", "headline": "'Shell Aims to Sell Majority Stake in Carbon Offsets Business' -Bloomberg", "summary": "", "symbols": ["SHEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950611/shell-aims-to-sell-majority-stake-in-carbon-offsets-business-bloomberg", "tags": []}
{"id": 41950629, "time": "2024-11-13 13:49:21", "headline": "Needham Maintains Buy on Flutter Entertainment, Raises Price Target to $300", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950629/needham-maintains-buy-on-flutter-entertainment-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 41950662, "time": "2024-11-13 13:50:57", "headline": "UBS Assumes Johnson Controls Intl at Neutral, Raises Price Target to $90", "summary": "", "symbols": ["JCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950662/ubs-assumes-johnson-controls-intl-at-neutral-raises-price-target-to-90", "tags": ["price_target_up"]}
{"id": 41950672, "time": "2024-11-13 13:51:17", "headline": "HC Wainwright & Co. Maintains Neutral on Terns Pharma, Raises Price Target to $7.5", "summary": "", "symbols": ["TERN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950672/hc-wainwright-co-maintains-neutral-on-terns-pharma-raises-price-target-to-7-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41950701, "time": "2024-11-13 13:52:46", "headline": "Needham Reiterates Hold on First Advantage", "summary": "", "symbols": ["FA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950701/needham-reiterates-hold-on-first-advantage", "tags": ["analyst_other"]}
{"id": 41950713, "time": "2024-11-13 13:53:36", "headline": "UBS Assumes W.W. Grainger at Neutral, Raises Price Target to $1280", "summary": "", "symbols": ["GWW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950713/ubs-assumes-w-w-grainger-at-neutral-raises-price-target-to-1280", "tags": ["price_target_up"]}
{"id": 41950726, "time": "2024-11-13 13:54:10", "headline": "Occidental Says Trump Election Is Positive For Carbon Capture Project", "summary": "", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950726/occidental-says-trump-election-is-positive-for-carbon-capture-project", "tags": []}
{"id": 41950733, "time": "2024-11-13 13:54:38", "headline": "HC Wainwright & Co. Reiterates Buy on Myomo, Maintains $7.5 Price Target", "summary": "", "symbols": ["MYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950733/hc-wainwright-co-reiterates-buy-on-myomo-maintains-7-5-price-target", "tags": ["analyst_other"]}
{"id": 41950755, "time": "2024-11-13 13:55:08", "headline": "Lockheed Martin And Anduril Join Forces To Successfully Detect And Track Drone Threats In Middle East", "summary": "", "symbols": ["LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950755/lockheed-martin-and-anduril-join-forces-to-successfully-detect-and-track-drone-threats-in-middle-eas", "tags": []}
{"id": 41950758, "time": "2024-11-13 13:55:19", "headline": "UBS Assumes Otis Worldwide at Neutral, Raises Price Target to $113", "summary": "", "symbols": ["OTIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950758/ubs-assumes-otis-worldwide-at-neutral-raises-price-target-to-113", "tags": ["price_target_up"]}
{"id": 41950798, "time": "2024-11-13 13:56:06", "headline": "Bitcoin Hits $93,000: Experts Predict Over $100,000 Until Year-End", "summary": "Bitcoin (CRYPTO: BTC) surged to a high of $93,434 on Wednesday, up 4.5% on the day during the U.S. trading session.\n\n\n\nEthereum (CRYPTO: ETH) is trading flat at $3,278, but is up 23% over the past week.", "symbols": ["BTCUSD", "COIN", "DOGEUSD", "ETHUSD", "IBIT", "PEPEUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41950798/bitcoin-hits-93000-experts-predict-over-100000-until-year-end", "tags": []}
{"id": 41950802, "time": "2024-11-13 13:56:32", "headline": "HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $66 Price Target", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950802/hc-wainwright-co-reiterates-buy-on-mirum-pharmaceuticals-maintains-66-price-target", "tags": ["analyst_other"]}
{"id": 41950815, "time": "2024-11-13 13:57:08", "headline": "Commvault's Growth To Outpace Legacy Competitors Like Dell And IBM, Analyst Says", "summary": "Oppenheimer analyst initiates coverage on Commvault with an Outperform rating, forecasting strong growth driven by cloud and SaaS offerings.", "symbols": ["CVLT", "DELL", "IBM"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41950815/commvaults-growth-to-outpace-legacy-competitors-like-dell-and-ibm-analyst-says", "tags": ["analyst_init"]}
{"id": 41950826, "time": "2024-11-13 13:57:44", "headline": "Trump's Appointment Of Kristi Noem To Homeland Security Chief Raises Questions About Fed Cannabis Policy", "summary": "Donald Trump selected South Dakota Governor Kristi Noem to serve as his secretary for the Department of Homeland Security. Noem will oversee Trump&#39;s border policies, including the key campaign pledge of &#34;mass deportations.&#34; Over the years she signed into law a myriad of bills aimed at polishing up the state&#39;s medical cannabis program. ", "symbols": [], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/24/11/41950826/kristi-noems-appointment-as-homeland-security-secretary-raises-questions-about-federal-cannabis-policy", "tags": []}
{"id": 41950852, "time": "2024-11-13 13:58:39", "headline": "What's Going On With Spotify Shares Wednesday?", "summary": "Spotify Technology S.A. (NYSE:SPOT) shares are moving higher on Wednesday after the company reported better-than-expected third-quarter earnings after the market closed on Tuesday.", "symbols": ["SPOT"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/news/earnings/24/11/41950852/whats-going-on-with-spotify-shares-wednesday", "tags": ["earnings", "why_moving"]}
{"id": 41950853, "time": "2024-11-13 13:58:46", "headline": "HC Wainwright & Co. Maintains Buy on Disc Medicine, Raises Price Target to $118", "summary": "", "symbols": ["IRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950853/hc-wainwright-co-maintains-buy-on-disc-medicine-raises-price-target-to-118", "tags": ["analyst_other", "price_target_up"]}
{"id": 41950871, "time": "2024-11-13 13:59:20", "headline": "Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density", "summary": "Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone density at the highest dose.", "symbols": ["AMGN", "LLY", "NVO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41950871/amgen-defends-its-investigational-monthly-weight-loss-injection-after-analyst-cites-maritides-impact-on-bone-density", "tags": []}
{"id": 41950895, "time": "2024-11-13 14:00:15", "headline": "Analyst Expectations For Peraso's Future", "summary": " ", "symbols": ["PRSO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41950895/analyst-expectations-for-perasos-future", "tags": []}
{"id": 41950906, "time": "2024-11-13 14:00:21", "headline": "In-Depth Examination Of 15 Analyst Recommendations For Honeywell Intl", "summary": " ", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41950906/in-depth-examination-of-15-analyst-recommendations-for-honeywell-intl", "tags": []}
{"id": 41950913, "time": "2024-11-13 14:00:31", "headline": "Navigating 5 Analyst Ratings For Westinghouse Air Brake", "summary": " ", "symbols": ["WAB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41950913/navigating-5-analyst-ratings-for-westinghouse-air-brake", "tags": []}
{"id": 41950914, "time": "2024-11-13 14:00:32", "headline": "Mastercard Unusual Options Activity For November 13", "summary": " ", "symbols": ["MA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41950914/mastercard-unusual-options-activity-for-november-13", "tags": []}
{"id": 41950915, "time": "2024-11-13 14:00:35", "headline": "HC Wainwright & Co. Reiterates Buy on Roivant Sciences, Maintains $18 Price Target", "summary": "", "symbols": ["ROIV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950915/hc-wainwright-co-reiterates-buy-on-roivant-sciences-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 41950917, "time": "2024-11-13 14:00:39", "headline": "Demystifying Paymentus Holdings: Insights From 4 Analyst Reviews", "summary": " ", "symbols": ["PAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41950917/demystifying-paymentus-holdings-insights-from-4-analyst-reviews", "tags": []}
{"id": 41950934, "time": "2024-11-13 14:00:57", "headline": "Breaking Down Fastenal: 8 Analysts Share Their Views", "summary": " ", "symbols": ["FAST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41950934/breaking-down-fastenal-8-analysts-share-their-views", "tags": []}
{"id": 41950940, "time": "2024-11-13 14:01:08", "headline": "Expert Ratings For Upbound Group", "summary": " ", "symbols": ["UPBD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41950940/expert-ratings-for-upbound-group", "tags": []}
{"id": 41950966, "time": "2024-11-13 14:02:05", "headline": "S&P 500 Tops 6,000; Rumble Shares Slide After Q3 Results", "summary": " ", "symbols": ["BTCT", "GCTK", "KXIN", "MVST", "PET", "RUM", "SYRS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41950966/s-rumble-shares-slide-after-q3-results", "tags": ["earnings"]}
{"id": 41950969, "time": "2024-11-13 14:02:10", "headline": "Needham Reiterates Buy on TechTarget, Maintains $40 Price Target", "summary": "", "symbols": ["TTGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41950969/needham-reiterates-buy-on-techtarget-maintains-40-price-target", "tags": ["analyst_other"]}
{"id": 41950975, "time": "2024-11-13 14:02:30", "headline": "A Look Ahead: TriSalus Life Sciences's Earnings Forecast", "summary": " ", "symbols": ["TLSI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41950975/a-look-ahead-trisalus-life-sciencess-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41950979, "time": "2024-11-13 14:02:40", "headline": "Exploring Glimpse Group's Earnings Expectations", "summary": " ", "symbols": ["VRAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41950979/exploring-glimpse-groups-earnings-expectations", "tags": ["earnings"]}
{"id": 41950990, "time": "2024-11-13 14:03:05", "headline": "Preview: Air Industries's Earnings", "summary": " ", "symbols": ["AIRI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41950990/preview-air-industriess-earnings", "tags": ["earnings"]}
{"id": 41951000, "time": "2024-11-13 14:03:12", "headline": "Earnings Preview: Bakkt Hldgs", "summary": " ", "symbols": ["BKKT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41951000/earnings-preview-bakkt-hldgs", "tags": ["earnings"]}
{"id": 41951069, "time": "2024-11-13 14:05:33", "headline": "Dogecoin's Flat Inflation Is 'A Feature, Not A Bug,' Says Elon Musk", "summary": "Elon Musk on Wednesday reaffirmed his support for Dogecoin&#39;s (CRYPTO: DOGE) inflation model, labeling its flat inflation rate as a &#34;feature, not a bug.&#34; ", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41951069/dogecoins-flat-inflation-is-a-feature-not-a-bug-says-elon-musk", "tags": []}
{"id": 41951107, "time": "2024-11-13 14:06:09", "headline": "Cava Group Posts Q3 Beat: 'Notable Tangible Sales Drivers,' Analysts Say, Raise Forecasts", "summary": "Shares of CAVA Group rise Wednesday after reporting upbeat earnings. Analysts note same store sales growth, while raising price targets.", "symbols": ["CAVA"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/general/restaurants/24/11/41951107/cava-group-posts-q3-beat-notable-tangible-sales-drivers-analysts-say-raise-forecasts", "tags": ["earnings"]}
{"id": 41951274, "time": "2024-11-13 14:12:55", "headline": "Nutanix Catalysts Include HCI Growth, VMware Market Share Shift, And AI Demand: Analyst", "summary": "Oppenheimer analyst initiates coverage on Nutanix Inc with Outperform rating and $80 price target, citing rising demand for HCI and market share opportunities from weakening VMware.", "symbols": ["AVGO", "NTNX", "NVDA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/11/41951274/nutanix-catalysts-include-hci-growth-vmware-market-share-shift-and-ai-demand-analyst", "tags": ["analyst_init"]}
{"id": 41951342, "time": "2024-11-13 14:16:11", "headline": "Spotlight on NVIDIA: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41951342/spotlight-on-nvidia-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 41951343, "time": "2024-11-13 14:16:16", "headline": "A Closer Look at T-Mobile US's Options Market Dynamics", "summary": " ", "symbols": ["TMUS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41951343/a-closer-look-at-t-mobile-uss-options-market-dynamics", "tags": []}
{"id": 41951400, "time": "2024-11-13 14:16:59", "headline": "Activist Nelson Peltz Says Disney Will Get A 'Respectable Ceo' With Former Morgan Stanley CEO James Gorman Spearheading Search To Find Successor For Bob Iger", "summary": "", "symbols": ["DIS", "MS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41951400/activist-nelson-peltz-says-disney-will-get-a-respectable-ceo-with-former-morgan-stanley-ceo-james-go", "tags": ["management"]}
{"id": 41950681, "time": "2024-11-13 13:51:51", "headline": "Trump Once Said John Thune's 'Political Career Over': Now He'll Work With Senate Majority Leader On GOP Agenda", "summary": "John Thune will be the next Senate Majority Leader. Thune beat out Donald Trump ally Rick Scott in the vote and previously clashed with the president-elect.", "symbols": ["SPY"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/politics/24/11/41950681/trump-once-said-political-career-over-about-john-thune-now-senate-majority-leader-working-with-him-to-pass-gop-agenda", "tags": []}
{"id": 41951409, "time": "2024-11-13 14:17:33", "headline": "Traveling The World With Legal Cannabis: Fascinating Case Of Lawyer Who Carries Marijuana In His Luggage", "summary": "Lawyer Piero Liebman challenges international norms by traveling with medical cannabis, focusing on need for global regs &amp; patients rights.", "symbols": [], "source": "benzinga", "author": "Javier Hasse", "url": "https://www.benzinga.com/general/travel/24/11/41951409/traveling-the-world-with-legal-cannabis-fascinating-case-of-lawyer-who-carries-marijuana-in-his-luggage", "tags": []}
{"id": 41951575, "time": "2024-11-13 14:22:13", "headline": "Taiwan Semi Boosts Advanced Chipmaking with Record EUV Expansion, Grabs 56% Global Share", "summary": "Taiwan Semi expands EUV use, increasing global share to 56% by 2023. Stock drops from China export ban. Surges 85% YTD. TSM stock down 1.89% at $188.21.", "symbols": ["ASML", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/emerging-markets/24/11/41951575/taiwan-semi-boosts-advanced-chipmaking-with-record-euv-expansion-grabs-56-global-share", "tags": []}
{"id": 41951578, "time": "2024-11-13 14:22:22", "headline": "Trump Taps Cannabis Supporters Elon Musk, Vivek Ramaswamy To Slash Government Spending", "summary": "Donald Trump appoints Elon Musk and Vivek Ramaswamy to head the new Department of Government Efficiency (DOGE) to cut government costs and bureaucracy.", "symbols": [], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/markets/cannabis/24/11/41951578/trump-taps-cannabis-supporters-elon-musk-vivek-ramaswamy-to-slash-government-spending", "tags": ["management"]}
{"id": 41951750, "time": "2024-11-13 14:29:57", "headline": "OpenAI Nears Launch Of AI Agents To Automate Tasks", "summary": "", "symbols": ["CRM", "MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41951750/openai-nears-launch-of-ai-agents-to-automate-tasks", "tags": []}
{"id": 41951774, "time": "2024-11-13 14:30:38", "headline": "Looking At Intuitive Machines's Recent Unusual Options Activity", "summary": " ", "symbols": ["LUNR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41951774/looking-at-intuitive-machiness-recent-unusual-options-activity", "tags": []}
{"id": 41951777, "time": "2024-11-13 14:30:42", "headline": "SoFi Techs Unusual Options Activity For November 13", "summary": " ", "symbols": ["SOFI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41951777/sofi-techs-unusual-options-activity-for-november-13", "tags": []}
{"id": 41951779, "time": "2024-11-13 14:30:48", "headline": "Palo Alto Networks Unusual Options Activity For November 13", "summary": " ", "symbols": ["PANW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41951779/palo-alto-networks-unusual-options-activity-for-november-13", "tags": []}
{"id": 41951740, "time": "2024-11-13 14:29:16", "headline": "AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?", "summary": "AI and psychedelic medicine are merging, with research showing AI&#39;s role in drug discovery, trials, and personalized mental health care.", "symbols": ["ATAI", "CMPS", "DELCF", "MNMD"], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/markets/cannabis/24/11/41951740/ai-and-psychedelics-a-marriage-made-in-heaven-for-mental-health-care", "tags": []}
{"id": 41951888, "time": "2024-11-13 14:36:43", "headline": "'OpenAI Discusses AI Data Center That Could Cost $100 Billion With U.S. Government' - The Information", "summary": "", "symbols": ["MSFT", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41951888/openai-discusses-ai-data-center-that-could-cost-100-billion-with-u-s-government-the-information", "tags": []}
{"id": 41951917, "time": "2024-11-13 14:39:00", "headline": "Fed's Musalem Says Data Since Previous Central Bank Policy Meeting Suggest Economy May Be Materially Stronger Than Expected; Inflation Data Also Stronger, But Has Not Yet Changed View That Policy Is On A Path To Neutral; There Is Likely Space For A Gradual Easing Of Policy Towards Neutral Rate; Stronger Data Likely Behind Rise In Treasury Bonds' Term Premia; Too Soon To Understand Contours Of Incoming Trump Administration's Policies", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41951917/feds-musalem-says-data-since-previous-central-bank-policy-meeting-suggest-economy-may-be-materially", "tags": []}
{"id": 41951924, "time": "2024-11-13 14:39:25", "headline": "Fed's Musalem Says In Rising Bond Yields There Is Also Some Sense Of Higher Inflation Risk, And Some Sense Fed May Not Cut Rates As Much; Most Recent CPI Numbers Were 'As Expected,' But He Would Have Preferred To See Some Continued Decline On A Three-Month Basis", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41951924/feds-musalem-says-in-rising-bond-yields-there-is-also-some-sense-of-higher-inflation-risk-and-some-s", "tags": []}
{"id": 41951937, "time": "2024-11-13 14:41:18", "headline": "Solana Rallies 13% In 7 Days: 'Bullish As Long As $200 Holds,' Says Veteran Trader", "summary": "Solana (CRYPTO: SOL) is gaining traction as a strong contender for the next major altcoin rally, with one crypto trader marking a critical level to watch.", "symbols": ["SOLUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41951937/solana-rallies-13-in-7-days-bullish-as-long-as-200-holds-says-veteran-trader", "tags": []}
{"id": 41951961, "time": "2024-11-13 14:42:36", "headline": "Bitcoin To $100K? Benzinga Readers Predict If BTC Can Hit New Milestone Before End Of 2024", "summary": "Leading cryptocurrency Bitcoin (CRYPTO: BTC) has soared in price since the 2024 presidential election and is ne", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41951961/bitcoin-to-100k-benzinga-readers-predict-if-btc-can-hit-new-milestone-before-end-of-2024", "tags": []}
{"id": 41952020, "time": "2024-11-13 14:45:39", "headline": "76% Of Children Plan To Ask For Video Games This Christmas, Survey Shows", "summary": "A new survey from the ESA shows that 76% of U.S. kids are asking for video games or consoles this Christmas.", "symbols": [], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/11/41952020/76-of-children-plan-to-ask-for-video-games-this-christmas-survey-shows", "tags": []}
{"id": 41952023, "time": "2024-11-13 14:45:53", "headline": "Looking Into Aurora Innovation's Recent Short Interest", "summary": " ", "symbols": ["AUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41952023/looking-into-aurora-innovations-recent-short-interest", "tags": []}
{"id": 41952030, "time": "2024-11-13 14:45:58", "headline": "Looking Into Cleveland-Cliffs's Recent Short Interest", "summary": " ", "symbols": ["CLF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41952030/looking-into-cleveland-cliffss-recent-short-interest", "tags": []}
{"id": 41952032, "time": "2024-11-13 14:46:04", "headline": "(A) - Analyzing Agilent Technologies's Short Interest", "summary": " ", "symbols": ["A"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41952032/a-analyzing-agilent-technologiess-short-interest", "tags": []}
{"id": 41952040, "time": "2024-11-13 14:46:21", "headline": "AMC Entertainment Shares Are On The Rise Today: What's Going On?", "summary": "AMC Entertainment Holdings, Inc. (NYSE: AMC) shares are trading higher Wednesday. The company disclosed a debt retirement move in a SEC filing late Tuesday. Here&#39;s what you need to know.", "symbols": ["AMC", "CHWY", "GME"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41952040/amc-entertainment-shares-are-on-the-rise-today-whats-going-on", "tags": ["why_moving"]}
{"id": 41952244, "time": "2024-11-13 14:56:01", "headline": "Michael Novogratz: Bitcoin Reserve Could Push Price To $500,000, But Likelihood Is Low", "summary": "Galaxy Digital CEO Michael Novogratz on Wednesday discussed the prospect of Bitcoin (CRYPTO: BTC) reaching unprecedented price levels if adopted as a reserve asset by nations, although he acknowledged the ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41952244/michael-novogratz-bitcoin-reserve-could-push-price-to-500000-but-likelihood-is-low", "tags": ["management"]}
{"id": 41952327, "time": "2024-11-13 15:00:17", "headline": "A Closer Look at 12 Analyst Recommendations For Vertiv Hldgs", "summary": " ", "symbols": ["VRT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41952327/a-closer-look-at-12-analyst-recommendations-for-vertiv-hldgs", "tags": []}
{"id": 41952345, "time": "2024-11-13 15:00:32", "headline": "Expert Outlook: Carrier Global Through The Eyes Of 18 Analysts", "summary": " ", "symbols": ["CARR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41952345/expert-outlook-carrier-global-through-the-eyes-of-18-analysts", "tags": ["guidance"]}
{"id": 41952346, "time": "2024-11-13 15:00:36", "headline": "Check Out What Whales Are Doing With AVGO", "summary": " ", "symbols": ["AVGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41952346/check-out-what-whales-are-doing-with-avgo", "tags": []}
{"id": 41952349, "time": "2024-11-13 15:00:48", "headline": "Cracking The Code: Understanding Analyst Reviews For Zoom Video Comms", "summary": " ", "symbols": ["ZM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41952349/cracking-the-code-understanding-analyst-reviews-for-zoom-video-comms", "tags": []}
{"id": 41952352, "time": "2024-11-13 15:00:57", "headline": "7 Analysts Have This To Say About Dover", "summary": " ", "symbols": ["DOV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41952352/7-analysts-have-this-to-say-about-dover", "tags": []}
{"id": 41952358, "time": "2024-11-13 15:01:06", "headline": "Decoding 15 Analyst Evaluations For Fortive", "summary": " ", "symbols": ["FTV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41952358/decoding-15-analyst-evaluations-for-fortive", "tags": []}
{"id": 41952360, "time": "2024-11-13 15:01:07", "headline": "Trump Says He Will Nominate Senator Marco Rubio For Secretary Of State", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41952360/trump-says-he-will-nominate-senator-marco-rubio-for-secretary-of-state", "tags": []}
{"id": 41952366, "time": "2024-11-13 15:01:15", "headline": "3M Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)", "summary": " ", "symbols": ["MMM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41952366/3m-stock-a-deep-dive-into-analyst-perspectives-10-ratings", "tags": []}
{"id": 41952390, "time": "2024-11-13 15:01:46", "headline": "Digital Brands Group Reports 34% Boost In Digital Revenue And 7% Rise In Average Order Volume Following Marketing Partnership With VaynerCommerce, Plans To Expand Into Email And SMS Campaigns", "summary": "", "symbols": ["DBGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41952390/digital-brands-group-reports-34-boost-in-digital-revenue-and-7-rise-in-average-order-volume-followin", "tags": ["earnings", "contract"]}
{"id": 41952433, "time": "2024-11-13 15:03:49", "headline": "HBO Reveals Release Window For The Last Of Us Season 2", "summary": "HBO reveals the release window for The Last of Us Season 2. Here&#39;s everything we know so far about the upcoming season&#39;s plot and characters.", "symbols": ["WBD"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/entertainment/24/11/41952433/hbo-reveals-release-window-for-the-last-of-us-season-2", "tags": []}
{"id": 41952445, "time": "2024-11-13 15:04:21", "headline": "Diamond Sports Group Partners With Prime Video For Multi-Year Deal, Offering Direct-To-Consumer Access To FanDuel Sports Network's 16 Regional Sports Networks Across 31 States; Local Fans Can Subscribe To Live Games And Programming Through Prime Video", "summary": "", "symbols": ["AMZN", "SBGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41952445/diamond-sports-group-partners-with-prime-video-for-multi-year-deal-offering-direct-to-consumer-acces", "tags": ["offering", "contract"]}
{"id": 41952579, "time": "2024-11-13 15:10:48", "headline": "Trump Picks Former Democratic Congresswoman Tulsi Gabbard To Serve As Director Of National Intelligence", "summary": "", "symbols": ["DJT", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41952579/trump-picks-former-democratic-congresswoman-tulsi-gabbard-to-serve-as-director-of-national-intellige", "tags": []}
{"id": 41952657, "time": "2024-11-13 15:15:49", "headline": "BioSig Technologies Regains Nasdaq Compliance For Minimum Bid Price Rule", "summary": "", "symbols": ["BSGM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41952657/biosig-technologies-regains-nasdaq-compliance-for-minimum-bid-price-rule", "tags": []}
{"id": 41952720, "time": "2024-11-13 15:20:22", "headline": "CDC Reports 104 Cases Of E. Coli O157:H7 Across 14 U.S. States As Of November 13", "summary": "", "symbols": ["MCD", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41952720/cdc-reports-104-cases-of-e-coli-o157-h7-across-14-u-s-states-as-of-november-13", "tags": []}
{"id": 41952818, "time": "2024-11-13 15:24:05", "headline": "CDC Says FDA Finds Non-Outbreak Strain Of Shiga Toxin-Producing E. Coli In Recalled Onions; No Human Illnesses Linked To This Strain", "summary": "", "symbols": ["MCD", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41952818/cdc-says-fda-finds-non-outbreak-strain-of-shiga-toxin-producing-e-coli-in-recalled-onions-no-human-i", "tags": ["fda"]}
{"id": 41952823, "time": "2024-11-13 15:24:32", "headline": "Republicans Set To Hold Slim House Majority: What It Means For Energy, Financial, Defense Sectors", "summary": "Trump&#39;s win secures Republican control of the House and Senate, allowing for swift implementation of policy changes, potentially reshaping economic and energy sectors.", "symbols": ["BAC", "CVX", "ITA", "JPM", "LMT", "RTX", "XLE", "XLF", "XOM"], "source": "benzinga", "author": "Michael Cohen", "url": "https://www.benzinga.com/etfs/sector-etfs/24/11/41952823/republicans-set-to-hold-slim-house-majority-what-it-means-for-energy-financial-defense-sectors", "tags": []}
{"id": 41952918, "time": "2024-11-13 15:27:05", "headline": "Trump Picks Matt Gaetz To Serve As Attorney General", "summary": "", "symbols": ["DJT", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41952918/trump-picks-matt-gaetz-to-serve-as-attorney-general", "tags": []}
{"id": 41952962, "time": "2024-11-13 15:29:47", "headline": "Trump's Surprise Defense Secretary Pick Pete Hegseth Jolts Wall Street", "summary": "Trump picks Fox News host Pete Hegseth as Defense Secretary despite lack of government experience.", "symbols": ["FOX", "FOXA", "GD", "ITA", "LMT", "RTX"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/news/24/11/41952962/trumps-surprise-defense-secretary-pick-pete-hegseth-jolts-wall-street", "tags": []}
{"id": 41952975, "time": "2024-11-13 15:30:32", "headline": "Intuitive Machines, AST SpaceMobile Shares Are Surging: What's Going On?", "summary": "Shares of Intuitive Machines Inc. (NASDAQ: LUNR) and AST SpaceMobile inc. (NASDAQ: ASTS) are trading higher Wednesday, boosted by Rocket Lab Inc.&#39;s (NASDAQ: RKLB) strong earnings and recent contract wins. Both Intuitive Machines and AST SpaceMobile are set to report earnings on Thursday. Here&#39;s what you need to know.", "symbols": ["ASTS", "LUNR", "RKLB"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/news/earnings/24/11/41952975/intuitive-machines-ast-spacemobile-shares-are-surging-whats-going-on", "tags": ["earnings", "why_moving", "contract"]}
{"id": 41953167, "time": "2024-11-13 15:37:53", "headline": "SolarEdge Chairman Avery More Buys 156,000 Shares At Average Price Of $13.65, Increasing Beneficial Ownership To 244,478 Shares", "summary": "", "symbols": ["SEDG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41953167/solaredge-chairman-avery-more-buys-156-000-shares-at-average-price-of-13-65-increasing-beneficial-ow", "tags": ["insider"]}
{"id": 41953220, "time": "2024-11-13 15:41:19", "headline": "Dollar Powers To 4-Month Highs Against Yen: Trump Tariff Expectations Spark Carry Trade Frenzy", "summary": "Investors piled back into yen-dollar carry trades. The speculation is that the incoming Trump administration will aggressively hike tariffs on imports.", "symbols": ["UUP"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41953220/dollar-powers-to-4-month-highs-against-yen-trump-tariff-expectations-spark-carry-trade-frenzy", "tags": []}
{"id": 41953419, "time": "2024-11-13 15:54:08", "headline": "Quantum Computing Shares Are Up By More Than 70%: Here's What You Need To Know", "summary": "Quantum Computing shares are trading higher today. Th company announced its first secured order for thin film lithium niobate (TFLN) photonic chip technology, marking a milestone for its foundry services.", "symbols": ["QUBT"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41953419/quantum-computing-shares-are-up-by-more-than-70-heres-what-you-need-to-know", "tags": ["why_moving"]}
{"id": 41953427, "time": "2024-11-13 15:54:33", "headline": "Palantir Technologies Unusual Options Activity", "summary": " ", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41953427/palantir-technologies-unusual-options-activity", "tags": []}
{"id": 41953495, "time": "2024-11-13 15:57:11", "headline": "Pfizer Exec Says The Impact Of IRA On Co Is \"Something We Can Likely Manage\"", "summary": "", "symbols": ["PFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41953495/pfizer-exec-says-the-impact-of-ira-on-co-is-something-we-can-likely-manage", "tags": []}
{"id": 41953523, "time": "2024-11-13 15:58:54", "headline": "ParaZero Technologies Has Received A Notice Of Allowance For A Patent Titled \"AERIAL VEHICLE BASED DAMAGE AVOIDANCE SYSTEM INCLUDING SAFETY APPARATUS FOR MITIGATING DAMAGE TO NEARBY BYSTANDERS OR VEHICLES\".", "summary": "", "symbols": ["PRZO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41953523/parazero-technologies-has-received-a-notice-of-allowance-for-a-patent-titled-aerial-vehicle-based", "tags": []}
{"id": 41953543, "time": "2024-11-13 16:00:03", "headline": "Worksport Q3 EPS $(0.14) Misses $(0.13) Estimate, Sales $3.12M Beat $2.40M Estimate", "summary": "", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41953543/worksport-q3-eps-0-14-misses-0-13-estimate-sales-3-12m-beat-2-40m-estimate", "tags": ["earnings"]}
{"id": 41953562, "time": "2024-11-13 16:00:07", "headline": "Worksport Says 'For 2025, Worksport Projects Its Existing Product Lines To Generate $20M In Revenue, With New Product Launches, Including Its AL4 Cover And COR And SOLIS Systems, Contributing Up To An Additional $18.5M Depending On Timing And Circumstances, These Projections Lead To A Robust Revenue Outlook Ranging From $25M-$34.5M In 2025, A Pivotal Year Anticipated To Drive Worksport Towards Cash Flow Positivity.'", "summary": "", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41953562/worksport-says-for-2025-worksport-projects-its-existing-product-lines-to-generate-20m-in-revenue-wit", "tags": ["earnings", "guidance"]}
{"id": 41953565, "time": "2024-11-13 16:00:10", "headline": "Worksport Says It Expects To Exceed Its Previously Issued Revenue Guidance Of $6M-$8M By Year-End 2024", "summary": "", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41953565/worksport-says-it-expects-to-exceed-its-previously-issued-revenue-guidance-of-6m-8m-by-year-end-2024", "tags": ["earnings", "guidance"]}
{"id": 41953568, "time": "2024-11-13 16:00:14", "headline": "Trading Halt: Halted at 4:00:10 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41953568/trading-halt-halted-at-4-00-10-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41953585, "time": "2024-11-13 16:00:53", "headline": "Breaking Down Mirum Pharmaceuticals: 5 Analysts Share Their Views", "summary": " ", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41953585/breaking-down-mirum-pharmaceuticals-5-analysts-share-their-views", "tags": []}
{"id": 41953629, "time": "2024-11-13 16:01:01", "headline": "Analyst Expectations For SoundHound AI's Future", "summary": " ", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41953629/analyst-expectations-for-soundhound-ais-future", "tags": []}
{"id": 41953658, "time": "2024-11-13 16:01:17", "headline": "7 Analysts Have This To Say About NICE", "summary": " ", "symbols": ["NICE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41953658/7-analysts-have-this-to-say-about-nice", "tags": []}
{"id": 41953659, "time": "2024-11-13 16:01:22", "headline": "Acelyrin Q3 2024 GAAP EPS $(0.49) Beats $(0.75) Estimate", "summary": "", "symbols": ["SLRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953659/acelyrin-q3-2024-gaap-eps-0-49-beats-0-75-estimate", "tags": ["earnings"]}
{"id": 41953667, "time": "2024-11-13 16:01:28", "headline": "EXCLUSIVE: Worksport's Q3 Revenue Soars 581% As New Product Lines Boost Growth, Raises 2025 Outlook", "summary": "Worksport Ltd (NASDAQ: WKSP) reported strong Q3 2024 revenue growth of 581% and expects to exceed revenue guidance for 2025. New product launches and government sales are driving expansion.", "symbols": ["WKSP"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/24/11/41953667/exclusive-worksports-q3-revenue-soars-581-as-new-product-lines-boost-growth-raises-2025-outlook", "tags": ["earnings", "guidance"]}
{"id": 41953668, "time": "2024-11-13 16:01:28", "headline": "The Analyst Landscape: 5 Takes On Roivant Sciences", "summary": " ", "symbols": ["ROIV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41953668/the-analyst-landscape-5-takes-on-roivant-sciences", "tags": []}
{"id": 41953677, "time": "2024-11-13 16:01:35", "headline": "Key Takeaways From Americold Realty Trust Analyst Ratings", "summary": " ", "symbols": ["COLD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41953677/key-takeaways-from-americold-realty-trust-analyst-ratings", "tags": []}
{"id": 41953700, "time": "2024-11-13 16:01:55", "headline": "In-Depth Examination Of 8 Analyst Recommendations For HealthEquity", "summary": " ", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41953700/in-depth-examination-of-8-analyst-recommendations-for-healthequity", "tags": []}
{"id": 41953703, "time": "2024-11-13 16:01:58", "headline": "AN2 Therapeutics Q3 EPS $(0.43) Beats $(0.54) Estimate", "summary": "", "symbols": ["ANTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953703/an2-therapeutics-q3-eps-0-43-beats-0-54-estimate", "tags": ["earnings"]}
{"id": 41953734, "time": "2024-11-13 16:02:32", "headline": "AN2 Therapeutics Provides Important EBO-301 Update And Highlights Progress Across Boron Chemistry Pipeline; Achieved 50% Reduction In Expenditures Through Strategic Realignment Of Operations", "summary": "", "symbols": ["ANTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41953734/an2-therapeutics-provides-important-ebo-301-update-and-highlights-progress-across-boron-chemistry", "tags": []}
{"id": 41953745, "time": "2024-11-13 16:02:45", "headline": "Tetra Tech Q4 2024 GAAP EPS $0.35 Misses $0.37 Estimate, Sales $1.370B Beat $1.135B Estimate", "summary": "", "symbols": ["TTEK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953745/tetra-tech-q4-2024-gaap-eps-0-35-misses-0-37-estimate-sales-1-370b-beat-1-135b-estimate", "tags": ["earnings"]}
{"id": 41953746, "time": "2024-11-13 16:02:46", "headline": "scPharmaceuticals Q3 Sales $10.03M Miss $10.80M Estimate", "summary": "", "symbols": ["SCPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953746/scpharmaceuticals-q3-sales-10-03m-miss-10-80m-estimate", "tags": []}
{"id": 41953748, "time": "2024-11-13 16:02:48", "headline": "icad Q3 2024 Adj. EPS $(0.07) Beats $(0.08) Estimate, Sales $4.217M Miss $4.521M Estimate", "summary": "", "symbols": ["ICAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953748/icad-q3-2024-adj-eps-0-07-beats-0-08-estimate-sales-4-217m-miss-4-521m-estimate", "tags": ["earnings"]}
{"id": 41953750, "time": "2024-11-13 16:02:50", "headline": "Capricor Therapeutics Q3 2024 GAAP EPS $(0.38) Misses $(0.36) Estimate, Sales $2.30M Miss $3.57M Estimate", "summary": "", "symbols": ["CAPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953750/capricor-therapeutics-q3-2024-gaap-eps-0-38-misses-0-36-estimate-sales-2-30m-miss-3-57m-estimate", "tags": ["earnings"]}
{"id": 41953751, "time": "2024-11-13 16:02:51", "headline": "Durect Q3 2024 GAAP EPS $(0.14) Beats $(0.17) Estimate, Sales $1.927M Miss $1.975M Estimate", "summary": "", "symbols": ["DRRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953751/durect-q3-2024-gaap-eps-0-14-beats-0-17-estimate-sales-1-927m-miss-1-975m-estimate", "tags": ["earnings"]}
{"id": 41953754, "time": "2024-11-13 16:03:00", "headline": "Tetra Tech FY 2024 GAAP EPS $1.23 Misses $1.25 Estimate, Sales $5.200B Beat $4.311B Estimate", "summary": "", "symbols": ["TTEK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953754/tetra-tech-fy-2024-gaap-eps-1-23-misses-1-25-estimate-sales-5-200b-beat-4-311b-estimate", "tags": ["earnings"]}
{"id": 41953782, "time": "2024-11-13 16:03:26", "headline": "Ibotta Q3 2024 Adj EPS $0.94 May Not Compare To $0.35 Estimate, Sales $98.60M Beat $94.05M Estimate", "summary": "", "symbols": ["IBTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953782/ibotta-q3-2024-adj-eps-0-94-may-not-compare-to-0-35-estimate-sales-98-60m-beat-94-05m-estimate", "tags": ["earnings"]}
{"id": 41953803, "time": "2024-11-13 16:03:46", "headline": "Omeros Q3 2024 GAAP EPS $(0.56) Beats $(0.70) Estimate", "summary": "", "symbols": ["OMER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953803/omeros-q3-2024-gaap-eps-0-56-beats-0-70-estimate", "tags": ["earnings"]}
{"id": 41953805, "time": "2024-11-13 16:03:53", "headline": "Worksport Q3 2024 GAAP EPS $(0.14) Misses $(0.13) Estimate, Sales $3.122M Beat $2.400M Estimate", "summary": "", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953805/worksport-q3-2024-gaap-eps-0-14-misses-0-13-estimate-sales-3-122m-beat-2-400m-estimate", "tags": ["earnings"]}
{"id": 41953817, "time": "2024-11-13 16:04:08", "headline": "Structure Therapeutics Doses First Patients In Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist GSBR-1290 In Obesity", "summary": "", "symbols": ["GPCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41953817/structure-therapeutics-doses-first-patients-in-phase-2b-access-clinical-study-evaluating-oral-sma", "tags": ["fda"]}
{"id": 41953818, "time": "2024-11-13 16:04:08", "headline": "Nu Holdings Q3 Adj EPS $0.1132 Beats $0.11 Estimate", "summary": "", "symbols": ["NU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953818/nu-holdings-q3-adj-eps-0-1132-beats-0-11-estimate", "tags": ["earnings"]}
{"id": 41953836, "time": "2024-11-13 16:04:40", "headline": "Nu Holdings Q3 Sales $2.94B Beat $2.85B Estimate", "summary": "", "symbols": ["NU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953836/nu-holdings-q3-sales-2-94b-beat-2-85b-estimate", "tags": []}
{"id": 41953839, "time": "2024-11-13 16:04:46", "headline": "CVD Equipment Receives $3.5M Follow On Chemical Vapor Infiltration System Order", "summary": "", "symbols": ["CVV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41953839/cvd-equipment-receives-3-5m-follow-on-chemical-vapor-infiltration-system-order", "tags": []}
{"id": 41953841, "time": "2024-11-13 16:04:49", "headline": "Ibotta Sees Q4 2024 Revenue $100M-$106M Vs $110.29M Estimate; Sees Adj. EBITDA $30M-$34M", "summary": "", "symbols": ["IBTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41953841/ibotta-sees-q4-2024-revenue-100m-106m-vs-110-29m-estimate-sees-adj-ebitda-30m-34m", "tags": ["earnings"]}
{"id": 41953845, "time": "2024-11-13 16:04:56", "headline": "Forian Q3 EPS $(0.01) Beats $(0.03) Estimate, Sales $4.69M Miss $4.81M Estimate", "summary": "", "symbols": ["FORA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953845/forian-q3-eps-0-01-beats-0-03-estimate-sales-4-69m-miss-4-81m-estimate", "tags": ["earnings"]}
{"id": 41953960, "time": "2024-11-13 16:05:34", "headline": "Safe Bulkers Q3 Adj $0.16 Misses $0.17 Estimate, Sales $75.90M Beat $74.77M Estimate", "summary": "", "symbols": ["SB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953960/safe-bulkers-q3-adj-0-16-misses-0-17-estimate-sales-75-90m-beat-74-77m-estimate", "tags": []}
{"id": 41953965, "time": "2024-11-13 16:05:38", "headline": "12 Information Technology Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["BTCS", "BTCT", "CCTG", "CXAI", "DSP", "FOXO", "INSG", "MAPS", "NA", "RSKD", "SGN", "SOUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41953965/12-information-technology-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41953973, "time": "2024-11-13 16:05:44", "headline": "12 Industrials Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["AIRT", "ALTG", "BTM", "CETY", "MVST", "NMHI", "RKLB", "SAVE", "SIDU", "SLND", "VINO", "ZONE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41953973/12-industrials-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41953977, "time": "2024-11-13 16:05:45", "headline": "Cisco Systems Q1 2025 Adj. EPS $0.91 Beats $0.87 Estimate, Sales $13.841B Beat $13.771B Estimate", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953977/cisco-systems-q1-2025-adj-eps-0-91-beats-0-87-estimate-sales-13-841b-beat-13-771b-estimate", "tags": ["earnings"]}
{"id": 41953979, "time": "2024-11-13 16:05:50", "headline": "12 Health Care Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["CERO", "CLDI", "ENSC", "GCTK", "GOVX", "KAPA", "LXEO", "MRSN", "NTRA", "PBM", "SYRS", "VRPX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41953979/12-health-care-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41953985, "time": "2024-11-13 16:05:55", "headline": "12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["ADD", "CAVA", "CHGG", "FFIE", "GNS", "GRPN", "KXIN", "LNW", "PET", "RIVN", "VRM", "ZK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41953985/12-consumer-discretionary-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41953989, "time": "2024-11-13 16:05:57", "headline": "Tarsus Pharmaceuticals Q3 2024 GAAP EPS $(0.61) Beats $(0.92) Estimate, Sales $48.12M Beat $43.44M Estimate", "summary": "", "symbols": ["TARS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953989/tarsus-pharmaceuticals-q3-2024-gaap-eps-0-61-beats-0-92-estimate-sales-48-12m-beat-43-44m-estimate", "tags": ["earnings"]}
{"id": 41953993, "time": "2024-11-13 16:05:58", "headline": "Lulus Fashion Lounge Q3 2024 GAAP EPS $(0.16) Misses $(0.03) Estimate, Sales $80.515M Beat $76.277M Estimate", "summary": "", "symbols": ["LVLU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41953993/lulus-fashion-lounge-q3-2024-gaap-eps-0-16-misses-0-03-estimate-sales-80-515m-beat-76-277m-estimate", "tags": ["earnings"]}
{"id": 41954038, "time": "2024-11-13 16:06:25", "headline": "Kulicke & Soffa Indus Q4 Adj $0.35, Inline, Sales $181.32M Beat $180.01M Estimate", "summary": "", "symbols": ["KLIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954038/kulicke-soffa-indus-q4-adj-0-35-inline-sales-181-32m-beat-180-01m-estimate", "tags": []}
{"id": 41954062, "time": "2024-11-13 16:06:40", "headline": "Cisco Sees Q2 FY25 Revenue $13.75B-$13.95B, Non-GAAP EPS $0.89-$0.91; Sees FY25 Revenue $55.3B-$56.3B, Non-GAAP EPS $3.60-$3.66", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954062/cisco-sees-q2-fy25-revenue-13-75b-13-95b-non-gaap-eps-0-89-0-91-sees-fy25-revenue-55-3b-56-3b-non-ga", "tags": ["earnings"]}
{"id": 41954081, "time": "2024-11-13 16:06:59", "headline": "NextNav Q3 2024 GAAP EPS $(0.11) Beats $(0.15) Estimate, Sales $1.607M Beat $1.105M Estimate", "summary": "", "symbols": ["NN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954081/nextnav-q3-2024-gaap-eps-0-11-beats-0-15-estimate-sales-1-607m-beat-1-105m-estimate", "tags": ["earnings"]}
{"id": 41954113, "time": "2024-11-13 16:07:20", "headline": "Anterix Q2 2025 GAAP EPS $(0.69) Misses $(0.52) Estimate, Sales $1.551M Miss $1.747M Estimate", "summary": "", "symbols": ["ATEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954113/anterix-q2-2025-gaap-eps-0-69-misses-0-52-estimate-sales-1-551m-miss-1-747m-estimate", "tags": ["earnings"]}
{"id": 41954125, "time": "2024-11-13 16:07:33", "headline": "Digi Intl Q4 2024 Adj EPS $0.52 Beats $0.50 Estimate, Sales $105.00M Beat $104.08M Estimate", "summary": "", "symbols": ["DGII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954125/digi-intl-q4-2024-adj-eps-0-52-beats-0-50-estimate-sales-105-00m-beat-104-08m-estimate", "tags": ["earnings"]}
{"id": 41954128, "time": "2024-11-13 16:07:34", "headline": "Smith Micro Software Q3 2024 Adj. EPS $(0.30) Beats $(0.31) Estimate, Sales $4.648M Miss $4.774M Estimate", "summary": "", "symbols": ["SMSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954128/smith-micro-software-q3-2024-adj-eps-0-30-beats-0-31-estimate-sales-4-648m-miss-4-774m-estimate", "tags": ["earnings"]}
{"id": 41954130, "time": "2024-11-13 16:07:36", "headline": "Owlet Q3 2024 Adj. EPS $0.03 Beats $(0.24) Estimate, Sales $22.100M Miss $22.460M Estimate", "summary": "", "symbols": ["OWLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954130/owlet-q3-2024-adj-eps-0-03-beats-0-24-estimate-sales-22-100m-miss-22-460m-estimate", "tags": ["earnings"]}
{"id": 41954156, "time": "2024-11-13 16:07:58", "headline": "Kulicke & Soffa Raises Quarterly Dividend From $0.20 To $0.205; Announces New $300M Share Repurchase Program", "summary": "", "symbols": ["KLIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954156/kulicke-soffa-raises-quarterly-dividend-from-0-20-to-0-205-announces-new-300m-share-repurchase-progr", "tags": ["buyback", "dividend"]}
{"id": 41954167, "time": "2024-11-13 16:08:10", "headline": "OptimizeRx Sees FY2024 Sales $88.000M-92.000M vs $100.69M Est", "summary": "", "symbols": ["OPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954167/optimizerx-sees-fy2024-sales-88-000m-92-000m-vs-100-69m-est", "tags": []}
{"id": 41954216, "time": "2024-11-13 16:08:49", "headline": "Talphera Q3 2024 GAAP EPS $(0.13) Beats $(0.20) Estimate", "summary": "", "symbols": ["TLPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954216/talphera-q3-2024-gaap-eps-0-13-beats-0-20-estimate", "tags": ["earnings"]}
{"id": 41954217, "time": "2024-11-13 16:08:50", "headline": "DMC Global Says Michael Kuta Will Retire As President, CEO And As A Member Of The Board, Effective November 29;  James O'Leary To Serve As Interim President & CEO", "summary": "", "symbols": ["BOOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954217/dmc-global-says-michael-kuta-will-retire-as-president-ceo-and-as-a-member-of-the-board-effective-nov", "tags": ["management"]}
{"id": 41954220, "time": "2024-11-13 16:08:53", "headline": "DiaMedica Therapeutics Doses First Patient In Phase 2 Trial Of DM199 In Treatment Of Preeclampsia", "summary": "", "symbols": ["DMAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41954220/diamedica-therapeutics-doses-first-patient-in-phase-2-trial-of-dm199-in-treatment-of-preeclampsia", "tags": ["fda"]}
{"id": 41954257, "time": "2024-11-13 16:09:21", "headline": "Kulicke & Soffa Has Received An Order From A Leading Foundry Customer For Multiple APTURA Fluxless TCB Systems To Support The Broadening Global Adoption Of Advanced Packaging Capacity For Leading-Edge Semiconductor Production; During Fiscal Year 2025, K&S Anticipates Its TCB Business Will Grow By 40-50% Sequentially", "summary": "", "symbols": ["KLIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954257/kulicke-soffa-has-received-an-order-from-a-leading-foundry-customer-for-multiple-aptura-fluxless-tcb", "tags": []}
{"id": 41954297, "time": "2024-11-13 16:09:44", "headline": "Kulicke & Soffa And ROHM Semiconductor Develop New CuFirst Hybrid Bonding Process", "summary": "", "symbols": ["KLIC", "TYO:6963"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954297/kulicke-soffa-and-rohm-semiconductor-develop-new-cufirst-hybrid-bonding-process", "tags": []}
{"id": 41954312, "time": "2024-11-13 16:10:02", "headline": "Digi International Sees Q1 2025 Revenue $102M-$106M Vs $105.98M Estimate; Sees Adj. EBITDA $24M-$25.5M", "summary": "", "symbols": ["DGII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954312/digi-international-sees-q1-2025-revenue-102m-106m-vs-105-98m-estimate-sees-adj-ebitda-24m-25-5m", "tags": ["earnings"]}
{"id": 41954320, "time": "2024-11-13 16:10:05", "headline": "OptimizeRx Q3 2024 Adj. EPS $0.12 Beats $0.06 Estimate, Sales $21.309M Miss $24.997M Estimate", "summary": "", "symbols": ["OPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954320/optimizerx-q3-2024-adj-eps-0-12-beats-0-06-estimate-sales-21-309m-miss-24-997m-estimate", "tags": ["earnings"]}
{"id": 41954328, "time": "2024-11-13 16:10:11", "headline": "Immuneering Q3 2024 GAAP EPS $(0.49) Beats $(0.56) Estimate", "summary": "", "symbols": ["IMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954328/immuneering-q3-2024-gaap-eps-0-49-beats-0-56-estimate", "tags": ["earnings"]}
{"id": 41954337, "time": "2024-11-13 16:10:16", "headline": "Spruce Power Holding Q3 2024 GAAP EPS $(2.88), Sales $21.400M Miss $22.822M Estimate", "summary": "", "symbols": ["SPRU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954337/spruce-power-holding-q3-2024-gaap-eps-2-88-sales-21-400m-miss-22-822m-estimate", "tags": ["earnings"]}
{"id": 41954359, "time": "2024-11-13 16:10:47", "headline": "CVD Equipment Q3 EPS $0.03 Up From $(0.11) YoY, Sales $8.19M Up From $6.23M YoY", "summary": "", "symbols": ["CVV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954359/cvd-equipment-q3-eps-0-03-up-from-0-11-yoy-sales-8-19m-up-from-6-23m-yoy", "tags": ["earnings"]}
{"id": 41954361, "time": "2024-11-13 16:10:54", "headline": "Digi International Sees Q1 2025 Adj. EPS $0.46-$0.50 Vs $0.50 Estimate", "summary": "", "symbols": ["DGII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954361/digi-international-sees-q1-2025-adj-eps-0-46-0-50-vs-0-50-estimate", "tags": ["earnings"]}
{"id": 41954385, "time": "2024-11-13 16:11:15", "headline": "Kulicke and Soffa Industries Sees Q1 Adj. EPS $0.28 +/- 10% Vs $0.33 Est.; Revenue $165M, +/- $10M Vs $179.47M Est.", "summary": "", "symbols": ["KLIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954385/kulicke-and-soffa-industries-sees-q1-adj-eps-0-28-10-vs-0-33-est-revenue-165m-10m-vs-179-47m-est", "tags": ["earnings"]}
{"id": 41954431, "time": "2024-11-13 16:11:53", "headline": "Strata Skin Sciences Q3 2024 GAAP EPS $(0.53) Beats $(0.57) Estimate, Sales $8.797M Beat $8.536M Estimate", "summary": "", "symbols": ["SSKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954431/strata-skin-sciences-q3-2024-gaap-eps-0-53-beats-0-57-estimate-sales-8-797m-beat-8-536m-estimate", "tags": ["earnings"]}
{"id": 41954436, "time": "2024-11-13 16:12:01", "headline": "BrightView Hldgs Q4 Adj $0.30 Misses $0.31 Estimate, Sales $728.70M Beat $723.19M Estimate", "summary": "", "symbols": ["BV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954436/brightview-hldgs-q4-adj-0-30-misses-0-31-estimate-sales-728-70m-beat-723-19m-estimate", "tags": []}
{"id": 41954441, "time": "2024-11-13 16:12:05", "headline": "Synaptics Intends To Offer $400M Of Convertible Senior Notes Due 2031 In Private Offering", "summary": "", "symbols": ["SYNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954441/synaptics-intends-to-offer-400m-of-convertible-senior-notes-due-2031-in-private-offering", "tags": ["offering"]}
{"id": 41954452, "time": "2024-11-13 16:12:17", "headline": "Sonos Q4 2024 GAAP EPS $(0.44) Misses $(0.38) Estimate, Sales $255.400M Beat $249.496M Estimate", "summary": "", "symbols": ["SONO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954452/sonos-q4-2024-gaap-eps-0-44-misses-0-38-estimate-sales-255-400m-beat-249-496m-estimate", "tags": ["earnings"]}
{"id": 41954464, "time": "2024-11-13 16:12:32", "headline": "BlueLinx Holdings Announces Distribution Partnership With Oldcastle To Expand  Its Products In the Outdoor Railing Category", "summary": "", "symbols": ["BXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/24/11/41954464/bluelinx-holdings-announces-distribution-partnership-with-oldcastle-to-expand-its-products-in-the-ou", "tags": ["contract"]}
{"id": 41954472, "time": "2024-11-13 16:12:39", "headline": "Sonos FY 2024 GAAP EPS $(0.31) Misses $(0.27) Estimate, Sales $1.518B Beat $1.513B Estimate", "summary": "", "symbols": ["SONO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954472/sonos-fy-2024-gaap-eps-0-31-misses-0-27-estimate-sales-1-518b-beat-1-513b-estimate", "tags": ["earnings"]}
{"id": 41954489, "time": "2024-11-13 16:13:07", "headline": "Zai Lab Announces $200M Proposed Public Offering Of American Depositary Shares", "summary": "", "symbols": ["ZLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954489/zai-lab-announces-200m-proposed-public-offering-of-american-depositary-shares", "tags": ["offering"]}
{"id": 41954492, "time": "2024-11-13 16:13:11", "headline": "BrightView Sees FY25 Revenue $2.75B-$2.84B Vs $2.8B Est.", "summary": "", "symbols": ["BV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954492/brightview-sees-fy25-revenue-2-75b-2-84b-vs-2-8b-est", "tags": ["earnings"]}
{"id": 41954512, "time": "2024-11-13 16:13:17", "headline": "Blue Owl Technology Finance Corp Announced A Definitive Merger Agreement With Blue Owl Technology Finance Corp II", "summary": "", "symbols": ["OWL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954512/blue-owl-technology-finance-corp-announced-a-definitive-merger-agreement-with-blue-owl-technology-fi", "tags": ["merger", "contract"]}
{"id": 41954519, "time": "2024-11-13 16:13:23", "headline": "'Meta to Face Trial Over Whatsapp, Instagram Acquisitions' - The Information", "summary": "", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954519/meta-to-face-trial-over-whatsapp-instagram-acquisitions-the-information", "tags": ["fda"]}
{"id": 41954524, "time": "2024-11-13 16:13:30", "headline": "Oxbridge Re Holdings Q3 EPS $(0.09) Up From $(1.24) YoY, Sales $205.00K Up From $(6.38M) YoY", "summary": "", "symbols": ["OXBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954524/oxbridge-re-holdings-q3-eps-0-09-up-from-1-24-yoy-sales-205-00k-up-from-6-38m-yoy", "tags": ["earnings"]}
{"id": 41954531, "time": "2024-11-13 16:13:39", "headline": "Aytu BioPharma Q1 2025 GAAP EPS $(0.20) Beats $(0.34) Estimate, Sales $16.574M Beat $13.768M Estimate", "summary": "", "symbols": ["AYTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954531/aytu-biopharma-q1-2025-gaap-eps-0-20-beats-0-34-estimate-sales-16-574m-beat-13-768m-estimate", "tags": ["earnings"]}
{"id": 41954583, "time": "2024-11-13 16:14:32", "headline": "AEON Biopharma Q3 2024 GAAP EPS $(0.16), Inline", "summary": "", "symbols": ["AEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954583/aeon-biopharma-q3-2024-gaap-eps-0-16-inline", "tags": ["earnings"]}
{"id": 41954655, "time": "2024-11-13 16:15:01", "headline": "Tenon Medical Q3 2024 GAAP EPS $(3.63) Beats $(4.24) Estimate, Sales $887.000K Miss $1.190M Estimate", "summary": "", "symbols": ["TNON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954655/tenon-medical-q3-2024-gaap-eps-3-63-beats-4-24-estimate-sales-887-000k-miss-1-190m-estimate", "tags": ["earnings"]}
{"id": 41954694, "time": "2024-11-13 16:15:16", "headline": "Boxlight Q3 2024 Adj EPS $(0.34) Misses $(0.16) Estimate, Sales $36.30M Miss $41.06M Estimate", "summary": "", "symbols": ["BOXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954694/boxlight-q3-2024-adj-eps-0-34-misses-0-16-estimate-sales-36-30m-miss-41-06m-estimate", "tags": ["earnings"]}
{"id": 41954699, "time": "2024-11-13 16:15:39", "headline": "Conifer Holdings Q3 Adj $(0.60) Down From $(0.35) YoY, Sales $14.60M Down From $23.98M YoY", "summary": "", "symbols": ["CNFR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954699/conifer-holdings-q3-adj-0-60-down-from-0-35-yoy-sales-14-60m-down-from-23-98m-yoy", "tags": []}
{"id": 41954700, "time": "2024-11-13 16:15:40", "headline": "Enliven Therapeutics Q3 2024 GAAP EPS $(0.48) Beats $(0.49) Estimate", "summary": "", "symbols": ["ELVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954700/enliven-therapeutics-q3-2024-gaap-eps-0-48-beats-0-49-estimate", "tags": ["earnings"]}
{"id": 41954718, "time": "2024-11-13 16:16:05", "headline": "electroCore Q3 2024 GAAP EPS $(0.31) Beats $(0.34) Estimate, Sales $6.554M Beat $6.493M Estimate", "summary": "", "symbols": ["ECOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954718/electrocore-q3-2024-gaap-eps-0-31-beats-0-34-estimate-sales-6-554m-beat-6-493m-estimate", "tags": ["earnings"]}
{"id": 41954719, "time": "2024-11-13 16:16:05", "headline": "Stryve Foods Q3 2024 Adj. EPS $(0.89) Beats $(1.01) Estimate, Sales $5.701M Miss $6.261M Estimate", "summary": "", "symbols": ["SNAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954719/stryve-foods-q3-2024-adj-eps-0-89-beats-1-01-estimate-sales-5-701m-miss-6-261m-estimate", "tags": ["earnings"]}
{"id": 41954723, "time": "2024-11-13 16:16:08", "headline": "Beazer Homes USA Q4 2024 GAAP EPS $1.69 Beats $1.35 Estimate, Sales $806.16M Beat $774.56M Estimate", "summary": "", "symbols": ["BZH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954723/beazer-homes-usa-q4-2024-gaap-eps-1-69-beats-1-35-estimate-sales-806-16m-beat-774-56m-estimate", "tags": ["earnings"]}
{"id": 41954731, "time": "2024-11-13 16:16:25", "headline": "Vaxart Q3 EPS $(0.06) Beats $(0.10) Estimate, Sales $4.93M Beat $850.00K Estimate", "summary": "", "symbols": ["VXRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954731/vaxart-q3-eps-0-06-beats-0-10-estimate-sales-4-93m-beat-850-00k-estimate", "tags": ["earnings"]}
{"id": 41954740, "time": "2024-11-13 16:16:38", "headline": "J&J Snack Foods Q4 2024 Adj EPS $1.60 Misses $1.84 Estimate, Sales $426.76M Miss $429.75M Estimate", "summary": "", "symbols": ["JJSF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954740/j-j-snack-foods-q4-2024-adj-eps-1-60-misses-1-84-estimate-sales-426-76m-miss-429-75m-estimate", "tags": ["earnings"]}
{"id": 41954762, "time": "2024-11-13 16:16:52", "headline": "Owlet Raises FY2024 Sales Guidance from $72.50M-77.50M to $74.00M-77.50M", "summary": "", "symbols": ["OWLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954762/owlet-raises-fy2024-sales-guidance-from-72-50m-77-50m-to-74-00m-77-50m", "tags": ["guidance"]}
{"id": 41954771, "time": "2024-11-13 16:16:59", "headline": "Equillium Q3 EPS $0.00Beats $(0.26) Estimate, Sales $12.16M Miss $15.40M Estimate", "summary": "", "symbols": ["EQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954771/equillium-q3-eps-0-00beats-0-26-estimate-sales-12-16m-miss-15-40m-estimate", "tags": ["earnings"]}
{"id": 41954793, "time": "2024-11-13 16:17:24", "headline": "Canoo Q3 2024 Adj EPS $(0.54) Beats $(0.77) Estimate, Sales $891.00K Miss $2.11M Estimate", "summary": "", "symbols": ["GOEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954793/canoo-q3-2024-adj-eps-0-54-beats-0-77-estimate-sales-891-00k-miss-2-11m-estimate", "tags": ["earnings"]}
{"id": 41954845, "time": "2024-11-13 16:17:37", "headline": "Alvotech Q3 Sales $103.000M Beat $89.000M Estimate", "summary": "", "symbols": ["ALVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954845/alvotech-q3-sales-103-000m-beat-89-000m-estimate", "tags": []}
{"id": 41954875, "time": "2024-11-13 16:17:55", "headline": "DLocal Q3 2024 GAAP EPS $0.09 Misses $0.11 Estimate, Sales $185.774M Beat $181.463M Estimate", "summary": "", "symbols": ["DLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954875/dlocal-q3-2024-gaap-eps-0-09-misses-0-11-estimate-sales-185-774m-beat-181-463m-estimate", "tags": ["earnings"]}
{"id": 41954882, "time": "2024-11-13 16:18:07", "headline": "Quantum Sees Q3 Adj EPS $(0.80)-(0.70); Sees Sales $70.000M-$74.000M vs $81.05M Est", "summary": "", "symbols": ["QMCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954882/quantum-sees-q3-adj-eps-0-80-0-70-sees-sales-70-000m-74-000m-vs-81-05m-est", "tags": ["earnings"]}
{"id": 41954890, "time": "2024-11-13 16:18:20", "headline": "DLocal Says Guidance Remains Unchanged In Light Of Q3 Results", "summary": "", "symbols": ["DLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954890/dlocal-says-guidance-remains-unchanged-in-light-of-q3-results", "tags": ["earnings", "guidance"]}
{"id": 41954893, "time": "2024-11-13 16:18:23", "headline": "Snail Q3 2024 GAAP EPS $0.01 Misses $0.07 Estimate, Sales $22.530M Miss $25.000M Estimate", "summary": "", "symbols": ["SNAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954893/snail-q3-2024-gaap-eps-0-01-misses-0-07-estimate-sales-22-530m-miss-25-000m-estimate", "tags": ["earnings"]}
{"id": 41954894, "time": "2024-11-13 16:18:24", "headline": "KORU Medical Systems Raises FY2024 Sales Guidance from $32.00M-32.50M to $32.75M-33.25M", "summary": "", "symbols": ["KRMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954894/koru-medical-systems-raises-fy2024-sales-guidance-from-32-00m-32-50m-to-32-75m-33-25m", "tags": ["guidance"]}
{"id": 41954898, "time": "2024-11-13 16:18:26", "headline": "Jones Soda Q3 EPS $(0.02) Down From $(0.01) YoY, Sales $4.21M Down From $4.50M YoY", "summary": "", "symbols": ["JSDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954898/jones-soda-q3-eps-0-02-down-from-0-01-yoy-sales-4-21m-down-from-4-50m-yoy", "tags": ["earnings"]}
{"id": 41954905, "time": "2024-11-13 16:18:31", "headline": "Espey Manufacturing & Electronics Q1 2025 Net Sales $10.44M Vs $8.56M YoY; EPS $0.61 Vs $0.44 YoY", "summary": "", "symbols": ["ESP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954905/espey-manufacturing-electronics-q1-2025-net-sales-10-44m-vs-8-56m-yoy-eps-0-61-vs-0-44-yoy", "tags": ["earnings"]}
{"id": 41954930, "time": "2024-11-13 16:18:58", "headline": "Canoo Expects Q4 Cash Outflow Of $30M - $40M, Adjusted EBITDA Of $(30)M - $(35)M", "summary": "", "symbols": ["GOEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41954930/canoo-expects-q4-cash-outflow-of-30m-40m-adjusted-ebitda-of-30-m-35-m", "tags": []}
{"id": 41954957, "time": "2024-11-13 16:19:30", "headline": "Structure Therapeutics Q3 EPS $(0.20), Inline", "summary": "", "symbols": ["GPCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41954957/structure-therapeutics-q3-eps-0-20-inline", "tags": ["earnings"]}
{"id": 41955014, "time": "2024-11-13 16:20:01", "headline": "4D Molecular Therapeutics Q3 2024 GAAP EPS $(0.79) Misses $(0.72) Estimate", "summary": "", "symbols": ["FDMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955014/4d-molecular-therapeutics-q3-2024-gaap-eps-0-79-misses-0-72-estimate", "tags": ["earnings"]}
{"id": 41955082, "time": "2024-11-13 16:20:19", "headline": "Intellinetics Q3 2024 GAAP EPS $(0.09) Misses $0.01 Estimate, Sales $4.590M Miss $4.685M Estimate", "summary": "", "symbols": ["INLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955082/intellinetics-q3-2024-gaap-eps-0-09-misses-0-01-estimate-sales-4-590m-miss-4-685m-estimate", "tags": ["earnings"]}
{"id": 41955142, "time": "2024-11-13 16:20:57", "headline": "Gladstone Cap FY 2024 EPS $4.34 vs $2.29 YoY; Total Investment Income $96.621M, Up 11.8% YoY", "summary": "", "symbols": ["GLAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955142/gladstone-cap-fy-2024-eps-4-34-vs-2-29-yoy-total-investment-income-96-621m-up-11-8-yoy", "tags": ["earnings"]}
{"id": 41955144, "time": "2024-11-13 16:21:01", "headline": "Montana Technologies Q3 EPS $0.61 Up From $(0.12) YoY", "summary": "", "symbols": ["AIRJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955144/montana-technologies-q3-eps-0-61-up-from-0-12-yoy", "tags": ["earnings"]}
{"id": 41955157, "time": "2024-11-13 16:21:37", "headline": "Ontrak Q3 Adj $(1.38) Beats $(1.56) Estimate, Sales $2.57M Miss $2.60M Estimate", "summary": "", "symbols": ["OTRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955157/ontrak-q3-adj-1-38-beats-1-56-estimate-sales-2-57m-miss-2-60m-estimate", "tags": []}
{"id": 41955158, "time": "2024-11-13 16:21:41", "headline": "DiaMedica Therapeutics Q3 2024 GAAP EPS $(0.15), Inline", "summary": "", "symbols": ["DMAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955158/diamedica-therapeutics-q3-2024-gaap-eps-0-15-inline", "tags": ["earnings"]}
{"id": 41955159, "time": "2024-11-13 16:21:42", "headline": "Beazer Homes Expects Further Expansion Of Its Community Count To Lead To Growth In Revenue And Double-Digit Return On Capital Employed For FY25", "summary": "", "symbols": ["BZH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955159/beazer-homes-expects-further-expansion-of-its-community-count-to-lead-to-growth-in-revenue-and-doubl", "tags": ["earnings"]}
{"id": 41955160, "time": "2024-11-13 16:21:44", "headline": "Taysha Gene Therapies Q3 2024 GAAP EPS $(0.10) Misses $(0.09) Estimate, Sales $1.788M Beat $1.648M Estimate", "summary": "", "symbols": ["TSHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955160/taysha-gene-therapies-q3-2024-gaap-eps-0-10-misses-0-09-estimate-sales-1-788m-beat-1-648m-estimate", "tags": ["earnings"]}
{"id": 41955161, "time": "2024-11-13 16:21:45", "headline": "Intellicheck Q3 2024 GAAP EPS $(0.04) Misses $(0.01) Estimate, Sales $4.709M Miss $4.783M Estimate", "summary": "", "symbols": ["IDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955161/intellicheck-q3-2024-gaap-eps-0-04-misses-0-01-estimate-sales-4-709m-miss-4-783m-estimate", "tags": ["earnings"]}
{"id": 41955180, "time": "2024-11-13 16:22:08", "headline": "Immunome Q3 EPS $(0.78) Misses $(0.56) Estimate, Sales $2.91M Beat $2.13M Estimate", "summary": "", "symbols": ["IMNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955180/immunome-q3-eps-0-78-misses-0-56-estimate-sales-2-91m-beat-2-13m-estimate", "tags": ["earnings"]}
{"id": 41955183, "time": "2024-11-13 16:22:10", "headline": "Helmerich & Payne Q4 2024 Adj EPS $0.76 Misses $0.81 Estimate, Sales $694.00M Miss $695.24M Estimate", "summary": "", "symbols": ["HP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955183/helmerich-payne-q4-2024-adj-eps-0-76-misses-0-81-estimate-sales-694-00m-miss-695-24m-estimate", "tags": ["earnings"]}
{"id": 41955184, "time": "2024-11-13 16:22:13", "headline": "M-Tron Industries Raises FY2024 Sales Guidance from $43.00M-45.00M to $46.00M-48.00M.", "summary": "", "symbols": ["MPTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955184/m-tron-industries-raises-fy2024-sales-guidance-from-43-00m-45-00m-to-46-00m-48-00m", "tags": ["guidance"]}
{"id": 41955207, "time": "2024-11-13 16:22:58", "headline": "Itron And PG&E Collaborate To Enable Real-Time Control Of Electric Vehicle Charging With Grid Edge Intelligence", "summary": "", "symbols": ["ITRI", "PCG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955207/itron-and-pg-e-collaborate-to-enable-real-time-control-of-electric-vehicle-charging-with-grid-edge-i", "tags": []}
{"id": 41955211, "time": "2024-11-13 16:23:00", "headline": "The Oncology Institute Q3 2024 GAAP EPS $(0.18) Misses $(0.07) Estimate, Sales $99.901M Miss $107.542M Estimate", "summary": "", "symbols": ["TOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955211/the-oncology-institute-q3-2024-gaap-eps-0-18-misses-0-07-estimate-sales-99-901m-miss-107-542m-estim", "tags": ["earnings"]}
{"id": 41955229, "time": "2024-11-13 16:23:31", "headline": "Cisco Systems Sees Q2 Adj EPS $0.89-0.91 vs $0.87 Est; Sees Sales $13.750B-13.950B vs $13.77B Est", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955229/cisco-systems-sees-q2-adj-eps-0-89-0-91-vs-0-87-est-sees-sales-13-750b-13-950b-vs-13-77b-est", "tags": ["earnings"]}
{"id": 41955231, "time": "2024-11-13 16:23:46", "headline": "Cisco Systems Raises FY2025 Adj EPS Guidance from $3.52-3.58 to $3.60-3.66 vs $3.58 Est; Raises FY2025 Sales Guidance from $55.00B-56.20B to $55.30B-56.30B vs $55.89B Est", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955231/cisco-systems-raises-fy2025-adj-eps-guidance-from-3-52-3-58-to-3-60-3-66-vs-3-58-est-raises-fy2025-s", "tags": ["earnings", "guidance"]}
{"id": 41955241, "time": "2024-11-13 16:24:13", "headline": "Spruce Power Holding Revises FY24 Operating EBITDA Guidance From $68M-$86M To $57M-$62M; Revises Adj. Free Cash Flow From $0-$5M To $(12M)-$(7M).", "summary": "", "symbols": ["SPRU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955241/spruce-power-holding-revises-fy24-operating-ebitda-guidance-from-68m-86m-to-57m-62m-revises-adj-free", "tags": ["guidance"]}
{"id": 41955242, "time": "2024-11-13 16:24:18", "headline": "Quince Therapeutics Q3 EPS $(0.13) Up From $(0.15) YoY", "summary": "", "symbols": ["QNCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955242/quince-therapeutics-q3-eps-0-13-up-from-0-15-yoy", "tags": ["earnings"]}
{"id": 41955259, "time": "2024-11-13 16:24:48", "headline": "Metagenomi Q3 2024 GAAP EPS $(0.51) Beats $(0.78) Estimate, Sales $11.50M Beat $6.79M Estimate", "summary": "", "symbols": ["MGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955259/metagenomi-q3-2024-gaap-eps-0-51-beats-0-78-estimate-sales-11-50m-beat-6-79m-estimate", "tags": ["earnings"]}
{"id": 41955291, "time": "2024-11-13 16:25:02", "headline": "Warren Buffett-Backed Bank Nu Holdings Posts Q3 Results: EPS In Line, Revenues Beat Estimates", "summary": "Nu Holdings reported its third-quarter results after Wednesday&#39;s closing bell. Here&#39;s a look at the details from the report.", "symbols": ["NU"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/11/41955291/warren-buffett-backed-bank-nu-holdings-posts-q3-results-eps-in-line-revenues-beat-estimates", "tags": ["earnings"]}
{"id": 41955312, "time": "2024-11-13 16:25:21", "headline": "Afya Limited Q3 2024 Adj. EPS $0.32, Revenue $151.639M", "summary": "", "symbols": ["AFYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955312/afya-limited-q3-2024-adj-eps-0-32-revenue-151-639m", "tags": ["earnings"]}
{"id": 41955321, "time": "2024-11-13 16:25:29", "headline": "Elicio Therapeutics Files For Offering Of Up To 3.4M Shares By Selling Stockholder", "summary": "", "symbols": ["ELTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955321/elicio-therapeutics-files-for-offering-of-up-to-3-4m-shares-by-selling-stockholder", "tags": ["offering"]}
{"id": 41955492, "time": "2024-11-13 16:26:12", "headline": "Elicio Therapeutics Q3 2024 GAAP EPS $(1.39) Misses $(0.73) Estimate", "summary": "", "symbols": ["ELTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955492/elicio-therapeutics-q3-2024-gaap-eps-1-39-misses-0-73-estimate", "tags": ["earnings"]}
{"id": 41955498, "time": "2024-11-13 16:26:25", "headline": "Kronos Bio Q3 2024 GAAP EPS $(0.23) Beats $(0.26) Estimate, Sales $2.37M Beat $2.10M Estimate", "summary": "", "symbols": ["KRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955498/kronos-bio-q3-2024-gaap-eps-0-23-beats-0-26-estimate-sales-2-37m-beat-2-10m-estimate", "tags": ["earnings"]}
{"id": 41955499, "time": "2024-11-13 16:26:29", "headline": "Roadzen Q2 EPS $(0.32) Beats $(0.35) Estimate, Sales $11.87M Miss $12.64M Estimate", "summary": "", "symbols": ["RDZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955499/roadzen-q2-eps-0-32-beats-0-35-estimate-sales-11-87m-miss-12-64m-estimate", "tags": ["earnings"]}
{"id": 41955511, "time": "2024-11-13 16:26:44", "headline": "KORU Medical Systems Q3 Adj $(0.01) Beats $(0.04) Estimate, Sales $8.18M Beat $7.68M Estimate", "summary": "", "symbols": ["KRMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955511/koru-medical-systems-q3-adj-0-01-beats-0-04-estimate-sales-8-18m-beat-7-68m-estimate", "tags": []}
{"id": 41955521, "time": "2024-11-13 16:27:11", "headline": "Hillenbrand Q4 2024 Adj EPS $1.01 Beats $0.92 Estimate, Sales $837.60M Beat $792.98M Estimate", "summary": "", "symbols": ["HI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955521/hillenbrand-q4-2024-adj-eps-1-01-beats-0-92-estimate-sales-837-60m-beat-792-98m-estimate", "tags": ["earnings"]}
{"id": 41955524, "time": "2024-11-13 16:27:21", "headline": "Quantum Q2 EPS $(1.82) Misses $(1.10) Estimate, Sales $70.47M Miss $72.70M Estimate", "summary": "", "symbols": ["QMCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955524/quantum-q2-eps-1-82-misses-1-10-estimate-sales-70-47m-miss-72-70m-estimate", "tags": ["earnings"]}
{"id": 41955527, "time": "2024-11-13 16:27:31", "headline": "Ontrak Sees Q4 Sales $2.900M-3.200M vs $2.60M Est", "summary": "", "symbols": ["OTRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955527/ontrak-sees-q4-sales-2-900m-3-200m-vs-2-60m-est", "tags": []}
{"id": 41955577, "time": "2024-11-13 16:29:00", "headline": "Greenlight's Einhorn Says Inflation Likely To Be 3.5%-4.5% Next Year", "summary": "", "symbols": [], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/hedge-funds/24/11/41955577/greenlights-einhorn-says-inflation-likely-to-be-3-5-4-5-next-year", "tags": []}
{"id": 41955607, "time": "2024-11-13 16:29:16", "headline": "Curbline Properties Q3 Sales $29.76M Up From $24.23M YoY", "summary": "", "symbols": ["CURB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955607/curbline-properties-q3-sales-29-76m-up-from-24-23m-yoy", "tags": []}
{"id": 41955613, "time": "2024-11-13 16:29:36", "headline": "Hillenbrand Sees FY25 Adj. EPS $2.80-$3.15 Vs $3.22 Est.; Revenue $2.825B-$3.090B Vs $3.138B Est.", "summary": "", "symbols": ["HI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955613/hillenbrand-sees-fy25-adj-eps-2-80-3-15-vs-3-22-est-revenue-2-825b-3-090b-vs-3-138b-est", "tags": ["earnings"]}
{"id": 41955614, "time": "2024-11-13 16:29:37", "headline": "Cisco Q1 Earnings: Revenue Beat, EPS Beat, 'Strong Start' To Year, Customers Investing In AI And More", "summary": "Cisco reported first-quarter revenue of $13.84 billion, beating the\u00a0consensus estimate\u00a0of $13.77 billion.", "symbols": ["CSCO"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41955614/cisco-q1-earnings-revenue-beat-eps-beat-strong-start-to-year-customers-investing-in-ai-and-more", "tags": ["earnings"]}
{"id": 41955615, "time": "2024-11-13 16:29:44", "headline": "Hillenbrand Sees Q1 Adj. EPS $0.52-$0.57; Revenue $685M-$705M", "summary": "", "symbols": ["HI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955615/hillenbrand-sees-q1-adj-eps-0-52-0-57-revenue-685m-705m", "tags": ["earnings"]}
{"id": 41955636, "time": "2024-11-13 16:30:04", "headline": "Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41955636/trading-halt-halt-status-updated-at-4-30-00-pm-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41955639, "time": "2024-11-13 16:30:05", "headline": "ESS Tech Q3 EPS $(1.90) Misses $(1.26) Estimate, Sales $359.00K Miss $5.63M Estimate", "summary": "", "symbols": ["GWH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955639/ess-tech-q3-eps-1-90-misses-1-26-estimate-sales-359-00k-miss-5-63m-estimate", "tags": ["earnings"]}
{"id": 41955677, "time": "2024-11-13 16:30:20", "headline": "Curbline Properties Announces Acquisition And Leasing Update; Company Has Closed Over $100M Of Acquisitions In Q4 To Date", "summary": "", "symbols": ["CURB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41955677/curbline-properties-announces-acquisition-and-leasing-update-company-has-closed-over-100m-of-acquisi", "tags": []}
{"id": 41955688, "time": "2024-11-13 16:30:34", "headline": "Gryphon Digital Mining Q3 2024 GAAP EPS $(0.15), Sales $3.689M Miss $3.900M Estimate", "summary": "", "symbols": ["GRYP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955688/gryphon-digital-mining-q3-2024-gaap-eps-0-15-sales-3-689m-miss-3-900m-estimate", "tags": ["earnings"]}
{"id": 41955707, "time": "2024-11-13 16:30:53", "headline": "Xos Lowers FY2024 Sales Guidance from $66.70M-100.40M to $54.10M-67.60M", "summary": "", "symbols": ["XOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955707/xos-lowers-fy2024-sales-guidance-from-66-70m-100-40m-to-54-10m-67-60m", "tags": ["guidance"]}
{"id": 41955716, "time": "2024-11-13 16:30:55", "headline": "SELLAS Life Sciences Gr Q3 2024 GAAP EPS $(0.10) Beats $(0.13) Estimate", "summary": "", "symbols": ["SLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955716/sellas-life-sciences-gr-q3-2024-gaap-eps-0-10-beats-0-13-estimate", "tags": ["earnings"]}
{"id": 41955769, "time": "2024-11-13 16:31:15", "headline": "3D Prelim Revenue $112.9M Vs $115.735M Est.", "summary": "", "symbols": ["DDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955769/3d-prelim-revenue-112-9m-vs-115-735m-est", "tags": ["earnings"]}
{"id": 41955790, "time": "2024-11-13 16:31:41", "headline": "Armata Pharmaceuticals Q3 EPS $(0.15) Beats $(0.28) Estimate, Sales $2.97M Beat $900.00K Estimate", "summary": "", "symbols": ["ARMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955790/armata-pharmaceuticals-q3-eps-0-15-beats-0-28-estimate-sales-2-97m-beat-900-00k-estimate", "tags": ["earnings"]}
{"id": 41955911, "time": "2024-11-13 16:33:20", "headline": "Electro-Sensors Q3 EPS $0.07 Up From $0.00 YoY; Revenue $2.512B Up From $2.057B YoY", "summary": "", "symbols": ["ELSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955911/electro-sensors-q3-eps-0-07-up-from-0-00-yoy-revenue-2-512b-up-from-2-057b-yoy", "tags": ["earnings"]}
{"id": 41955914, "time": "2024-11-13 16:33:26", "headline": "Adaptimmune Therapeutics Q3 2024 GAAP EPS $(0.07) Beats $(0.13) Estimate, Sales $40.901M Beat $11.172M Estimate", "summary": "", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955914/adaptimmune-therapeutics-q3-2024-gaap-eps-0-07-beats-0-13-estimate-sales-40-901m-beat-11-172m-estim", "tags": ["earnings"]}
{"id": 41955915, "time": "2024-11-13 16:33:26", "headline": "KULR Tech Gr Q3 EPS $(0.01) Beats $(0.02) Estimate, Sales $3.19M Beat $2.41M Estimate", "summary": "", "symbols": ["KULR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955915/kulr-tech-gr-q3-eps-0-01-beats-0-02-estimate-sales-3-19m-beat-2-41m-estimate", "tags": ["earnings"]}
{"id": 41955923, "time": "2024-11-13 16:33:37", "headline": "BioCardia Q3 2024 GAAP EPS $(0.61) Beats $(1.19) Estimate", "summary": "", "symbols": ["BCDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955923/biocardia-q3-2024-gaap-eps-0-61-beats-1-19-estimate", "tags": ["earnings"]}
{"id": 41955925, "time": "2024-11-13 16:33:37", "headline": "Anebulo Pharmaceuticals Q1 EPS $(0.08) Up From $(0.10) YoY", "summary": "", "symbols": ["ANEB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955925/anebulo-pharmaceuticals-q1-eps-0-08-up-from-0-10-yoy", "tags": ["earnings"]}
{"id": 41955931, "time": "2024-11-13 16:33:41", "headline": "Adecoagro Q3 2024 Adj EPS $0.28 Misses $0.69 Estimate, Sales $456.70M Miss $464.66M Estimate", "summary": "", "symbols": ["AGRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955931/adecoagro-q3-2024-adj-eps-0-28-misses-0-69-estimate-sales-456-70m-miss-464-66m-estimate", "tags": ["earnings"]}
{"id": 41955977, "time": "2024-11-13 16:34:46", "headline": "Trump Ignites Investor Optimism For Growth, Small Caps, US Dollar: Bank Of America Survey", "summary": "Investors bullish on US economy and stock market, but fear rising inflation after Trump&#39;s win. High-growth, high-inflation bets on US stocks, small caps, and high-yield bonds. Survey shows shift in sentiment and expectations. Stronger dollar predicted to lead currency gains.", "symbols": ["IWM"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41955977/trump-ignites-investor-optimism-for-growth-small-caps-us-dollar-bank-of-america-survey", "tags": []}
{"id": 41955982, "time": "2024-11-13 16:34:50", "headline": "Alumis Q3 EPS $(1.73) Beats $(4.50) Estimate", "summary": "", "symbols": ["ALMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41955982/alumis-q3-eps-1-73-beats-4-50-estimate", "tags": ["earnings"]}
{"id": 41956011, "time": "2024-11-13 16:35:21", "headline": "Docler Holding S.\u00e0 r.l Reported Stake Of 16.6% In PLBY In 13D Filing", "summary": "", "symbols": ["PLBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956011/docler-holding-s-r-l-reported-stake-of-16-6-in-plby-in-13d-filing", "tags": []}
{"id": 41956014, "time": "2024-11-13 16:35:24", "headline": "WidePoint Q3 2024 GAAP EPS $(0.04) Beats $(0.07) Estimate, Sales $34.620M Beat $30.405M Estimate", "summary": "", "symbols": ["WYY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956014/widepoint-q3-2024-gaap-eps-0-04-beats-0-07-estimate-sales-34-620m-beat-30-405m-estimate", "tags": ["earnings"]}
{"id": 41955612, "time": "2024-11-13 16:29:26", "headline": "Big Buffett Bet: Leveraged ETF To Offer Extra Exposure To Legendary Investor", "summary": "A new leveraged ETF for Berkshire Hathaway stock could be launched soon.", "symbols": ["BRK", "TSLL"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/etfs/specialty-etfs/24/11/41955612/big-bet-on-buffett-leveraged-etf-coming-to-give-investors-extra-exposure-to-legendary-investor", "tags": []}
{"id": 41956018, "time": "2024-11-13 16:35:27", "headline": "Intensity Therapeutics Q3 EPS $(0.25) Beats $(0.30) Estimate", "summary": "", "symbols": ["INTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956018/intensity-therapeutics-q3-eps-0-25-beats-0-30-estimate", "tags": ["earnings"]}
{"id": 41956057, "time": "2024-11-13 16:36:08", "headline": "Harrow Q3 2024 GAAP EPS $(0.05), Inline, Sales $49.30M Miss $52.81M Estimate", "summary": "", "symbols": ["HROW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956057/harrow-q3-2024-gaap-eps-0-05-inline-sales-49-30m-miss-52-81m-estimate", "tags": ["earnings"]}
{"id": 41956101, "time": "2024-11-13 16:36:36", "headline": "Canoo Q3 Earnings: Revenue Miss, EPS Beat, Continued Operations Consolidation And More", "summary": "Canoo reports third-quarter financial results after the market close on Wednesday. Here&#39;s a rundown of the EV maker&#39;s report.", "symbols": ["GOEV"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41956101/canoo-q3-earnings-revenue-miss-eps-beat-continued-operations-consolidation-and-more", "tags": ["earnings"]}
{"id": 41956102, "time": "2024-11-13 16:36:37", "headline": "Cisco Exec Said Deals With US Federal Customers Are Simply Delayed Not Lost -Conf Call", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956102/cisco-exec-said-deals-with-us-federal-customers-are-simply-delayed-not-lost-conf-call", "tags": []}
{"id": 41956107, "time": "2024-11-13 16:36:40", "headline": "Drilling Tools Intl Q3 2024 GAAP EPS $0.03 Misses $0.06 Estimate, Sales $40.093M Miss $42.025M Estimate", "summary": "", "symbols": ["DTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956107/drilling-tools-intl-q3-2024-gaap-eps-0-03-misses-0-06-estimate-sales-40-093m-miss-42-025m-estimate", "tags": ["earnings"]}
{"id": 41956109, "time": "2024-11-13 16:36:48", "headline": "Pharvaris Q3 EPS $(0.85) Misses $(0.67) Estimate", "summary": "", "symbols": ["PHVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956109/pharvaris-q3-eps-0-85-misses-0-67-estimate", "tags": ["earnings"]}
{"id": 41956134, "time": "2024-11-13 16:37:32", "headline": "Astria Therapeutics Q3 EPS $(0.42) Misses $(0.41) Estimate", "summary": "", "symbols": ["ATXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956134/astria-therapeutics-q3-eps-0-42-misses-0-41-estimate", "tags": ["earnings"]}
{"id": 41956152, "time": "2024-11-13 16:37:59", "headline": "DTI Sees FY24 Revenue $145M-$155M, Adj. Net Income $7.7M-$9.8M, Adj. EBITDA $38M-$43M, Adj. Free Cash Flow $18M-$21M", "summary": "", "symbols": ["DTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956152/dti-sees-fy24-revenue-145m-155m-adj-net-income-7-7m-9-8m-adj-ebitda-38m-43m-adj-free-cash-flow-18m-2", "tags": ["earnings"]}
{"id": 41956166, "time": "2024-11-13 16:38:17", "headline": "Markel Group Approves New Share Repurchase Program With Immediate Effect Authorizing Repurchase Up To $2B Of Outstanding Common Stock", "summary": "", "symbols": ["MKL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956166/markel-group-approves-new-share-repurchase-program-with-immediate-effect-authorizing-repurchase-up-t", "tags": ["buyback"]}
{"id": 41956167, "time": "2024-11-13 16:38:31", "headline": "StandardAero Q3 2024 GAAP EPS $0.06 Beats $0.05 Estimate, Sales $1.245B Beat $1.226B Estimate", "summary": "", "symbols": ["SARO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956167/standardaero-q3-2024-gaap-eps-0-06-beats-0-05-estimate-sales-1-245b-beat-1-226b-estimate", "tags": ["earnings"]}
{"id": 41956186, "time": "2024-11-13 16:39:05", "headline": "Sonim Technologies Q3 2024 GAAP EPS $(0.52) Beats $(0.66) Estimate, Sales $15M Beat $14.781M Estimate", "summary": "", "symbols": ["SONM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956186/sonim-technologies-q3-2024-gaap-eps-0-52-beats-0-66-estimate-sales-15m-beat-14-781m-estimate", "tags": ["earnings"]}
{"id": 41956187, "time": "2024-11-13 16:39:07", "headline": "Kyverna Therapeutics Q3 EPS $(0.80), Inline", "summary": "", "symbols": ["KYTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956187/kyverna-therapeutics-q3-eps-0-80-inline", "tags": ["earnings"]}
{"id": 41956213, "time": "2024-11-13 16:40:19", "headline": "Sonos Reports Mixed Q4, FY24 Results: EPS Miss, Revenues Beat", "summary": "Sonos reports its fourth-quarter and fiscal year results after Wednesday&#39;s closing bell. Here&#39;s a look at the details from the report.", "symbols": ["SONO"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/11/41956213/sonos-reports-mixed-q4-fy24-results-eps-miss-revenues-beat", "tags": ["earnings"]}
{"id": 41956214, "time": "2024-11-13 16:40:22", "headline": "Dermata Therapeutics Q3 EPS $(2.04) Beats $(2.64) Estimate", "summary": "", "symbols": ["DRMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956214/dermata-therapeutics-q3-eps-2-04-beats-2-64-estimate", "tags": ["earnings"]}
{"id": 41956257, "time": "2024-11-13 16:41:18", "headline": "ImmuCell Q3 GAAP EPS $(0.09) Up From $(0.12) YoY, Sales $6.01M Up From $5.40M YoY", "summary": "", "symbols": ["ICCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956257/immucell-q3-gaap-eps-0-09-up-from-0-12-yoy-sales-6-01m-up-from-5-40m-yoy", "tags": ["earnings"]}
{"id": 41956299, "time": "2024-11-13 16:42:02", "headline": "BT Brands Q3 EPS $(0.04), Sales $4.35M Up From $4.01M YoY", "summary": "", "symbols": ["BTBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956299/bt-brands-q3-eps-0-04-sales-4-35m-up-from-4-01m-yoy", "tags": ["earnings"]}
{"id": 41956310, "time": "2024-11-13 16:42:27", "headline": "Lulus Fashion Lounge Sees Q4 Sales $67.500M-70.000M vs $76.28M Est", "summary": "", "symbols": ["LVLU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956310/lulus-fashion-lounge-sees-q4-sales-67-500m-70-000m-vs-76-28m-est", "tags": []}
{"id": 41956313, "time": "2024-11-13 16:42:33", "headline": "NexGel Q3 EPS $(0.11) Misses $(0.10) Estimate, Sales $2.94M Beat $2.85M Estimate", "summary": "", "symbols": ["NXGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956313/nexgel-q3-eps-0-11-misses-0-10-estimate-sales-2-94m-beat-2-85m-estimate", "tags": ["earnings"]}
{"id": 41956322, "time": "2024-11-13 16:42:51", "headline": "Lulus Fashion Lounge Lowers FY2024 Sales Guidance from $350.00M-360.00M to $317.50M-320.00M", "summary": "", "symbols": ["LVLU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956322/lulus-fashion-lounge-lowers-fy2024-sales-guidance-from-350-00m-360-00m-to-317-50m-320-00m", "tags": ["guidance"]}
{"id": 41956372, "time": "2024-11-13 16:44:14", "headline": "Gladstone Cap Q4 EPS $0.50 Misses $0.53 Estimate", "summary": "", "symbols": ["GLAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956372/gladstone-cap-q4-eps-0-50-misses-0-53-estimate", "tags": ["earnings"]}
{"id": 41956389, "time": "2024-11-13 16:44:52", "headline": "Cisco Exec Said Co's New AI Server Is Expected To Begin Shipping Next Month -Conf Call", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956389/cisco-exec-said-cos-new-ai-server-is-expected-to-begin-shipping-next-month-conf-call", "tags": []}
{"id": 41956400, "time": "2024-11-13 16:45:33", "headline": "Oruka Therapeutics Q3 2024 GAAP EPS $(1.46) Misses $(0.40) Estimate", "summary": "", "symbols": ["ORKA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956400/oruka-therapeutics-q3-2024-gaap-eps-1-46-misses-0-40-estimate", "tags": ["earnings"]}
{"id": 41956421, "time": "2024-11-13 16:46:32", "headline": "Worksport Affirms FY2024 Sales Guidance from $6.00M-8.00M to $6.00M-8.00M", "summary": "", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956421/worksport-affirms-fy2024-sales-guidance-from-6-00m-8-00m-to-6-00m-8-00m", "tags": ["guidance"]}
{"id": 41956424, "time": "2024-11-13 16:46:39", "headline": "API Weekly Crude Stock: 777K Barrel Draw vs 1.000M Barrel Build Est.", "summary": "", "symbols": ["USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41956424/api-weekly-crude-stock-777k-barrel-draw-vs-1-000m-barrel-build-est", "tags": []}
{"id": 41956590, "time": "2024-11-13 16:48:32", "headline": "M-Tron Industries Q3 GAAP EPS $0.81 Beats $0.54 Estimate, Sales $13.21M Beat $12.20M Estimate", "summary": "", "symbols": ["MPTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956590/m-tron-industries-q3-gaap-eps-0-81-beats-0-54-estimate-sales-13-21m-beat-12-20m-estimate", "tags": ["earnings"]}
{"id": 41956432, "time": "2024-11-13 16:46:52", "headline": "Worksport Sees FY2025 Sales $25.000M-$34.500M vs $28.80M Est", "summary": "", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956432/worksport-sees-fy2025-sales-25-000m-34-500m-vs-28-80m-est", "tags": []}
{"id": 41956594, "time": "2024-11-13 16:48:51", "headline": "Matt Gaetz Is Trump's Attorney General Pick: Would-Be Top Cop Is Under House Ethics Investigation", "summary": "Matt Gaetz has been named the attorney general nominee by Donald Trump. The selection comes while Gaetz is being investigated by Congress.", "symbols": ["MSOS"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/legal/24/11/41956594/matt-gaetz-is-trumps-attorney-general-pick-would-be-top-cop-is-under-house-ethics-investigation", "tags": ["legal"]}
{"id": 41956604, "time": "2024-11-13 16:49:14", "headline": "Ventas Announces Underwritten Offering Of 10.6M Shares of Common Stock", "summary": "", "symbols": ["VTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956604/ventas-announces-underwritten-offering-of-10-6m-shares-of-common-stock", "tags": ["offering"]}
{"id": 41956638, "time": "2024-11-13 16:50:10", "headline": "Sutro Biopharma Q3 EPS $(0.59) Beats $(0.73) Estimate, Sales $8.52M Miss $15.25M Estimate", "summary": "", "symbols": ["STRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956638/sutro-biopharma-q3-eps-0-59-beats-0-73-estimate-sales-8-52m-miss-15-25m-estimate", "tags": ["earnings"]}
{"id": 41956702, "time": "2024-11-13 16:51:47", "headline": "Natural Alternatives Intl Q1 EPS $(0.33) Down From $(0.12) YoY, Sales $33.15M Down From $33.97M YoY", "summary": "", "symbols": ["NAII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956702/natural-alternatives-intl-q1-eps-0-33-down-from-0-12-yoy-sales-33-15m-down-from-33-97m-yoy", "tags": ["earnings"]}
{"id": 41955969, "time": "2024-11-13 16:34:26", "headline": "Calidi Biotherapeutics Intends To Offer To Sell Shares Of Its Common Stock And/Or Pre-funded Warrants In Lieu Thereof In An Public Offering; No Size Or Amount Disclosed", "summary": "", "symbols": ["CLDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41955969/calidi-biotherapeutics-intends-to-offer-to-sell-shares-of-its-common-stock-andor-pre-funded-warrants", "tags": ["offering"]}
{"id": 41956707, "time": "2024-11-13 16:52:25", "headline": "Cannabis 'Gifting' Shops Sue Washington DC Authorities  Over Closures", "summary": "D.C. cannabis gifting shops sue city officials over aggressive enforcement actions, arguing violations of constitutional rights...", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/government/regulations/24/11/41956707/cannabis-gifting-shops-sue-washington-dc-authorities-over-closures", "tags": []}
{"id": 41953395, "time": "2024-11-13 15:52:47", "headline": "Disney Q4 Earnings Preview: Disney+ Profitability, Deadpool Box Office Success Top Items To Watch", "summary": "Disney has returned to its box office success in 2024 with several hit films like &#34;Inside Out 2&#34; and &#34;Deadpool &amp; Wolverine.&#34;", "symbols": ["DIS"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/entertainment/24/11/41953395/disney-q4-earnings-preview-disney-profitability-deadpool-box-office-success-top-items-to-watch", "tags": ["earnings"]}
{"id": 41956762, "time": "2024-11-13 16:53:24", "headline": "Aethlon Medical Q2 2025 GAAP EPS $(0.20), Inline", "summary": "", "symbols": ["AEMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956762/aethlon-medical-q2-2025-gaap-eps-0-20-inline", "tags": ["earnings"]}
{"id": 41956763, "time": "2024-11-13 16:53:30", "headline": "LGL Group Q3 EPS $0.01 Down From $0.02 YoY, Sales $1.18M Up From $978.00K YoY", "summary": "", "symbols": ["LGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956763/lgl-group-q3-eps-0-01-down-from-0-02-yoy-sales-1-18m-up-from-978-00k-yoy", "tags": ["earnings"]}
{"id": 41952923, "time": "2024-11-13 15:27:25", "headline": "Bitcoin Crosses $90,000, Ethereum, Dogecoin Move Higher As Coinbase Lists Pepe, Dogwifhat", "summary": "Cryptocurrency markets are trading higher as meme coins Pepe and Dogwifhat were listed for trading on Coinbase (NASDAQ:COIN).", "symbols": ["BTCUSD", "COIN", "DOGEUSD", "ETHUSD", "PEPEUSD", "SHIBUSD", "SOLUSD", "WIFUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41952923/bitcoin-crosses-90000-ethereum-dogecoin-move-upwards-as-pepe-dogwifhat-get-listed-on-coinbase", "tags": []}
{"id": 41956768, "time": "2024-11-13 16:54:05", "headline": "New Concept Energy Q3 EPS $(0.01) Down From $0.01 YoY, Sales $37.00K Up From $35.00K YoY", "summary": "", "symbols": ["GBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956768/new-concept-energy-q3-eps-0-01-down-from-0-01-yoy-sales-37-00k-up-from-35-00k-yoy", "tags": ["earnings"]}
{"id": 41956959, "time": "2024-11-13 16:58:43", "headline": "RGC Resources Q4 2024 GAAP EPS $0.01 Down From $0.10 YoY, Sales $13.10M Beat $13.00M Estimate", "summary": "", "symbols": ["RGCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41956959/rgc-resources-q4-2024-gaap-eps-0-01-down-from-0-10-yoy-sales-13-10m-beat-13-00m-estimate", "tags": ["earnings"]}
{"id": 41957108, "time": "2024-11-13 17:02:27", "headline": "Dada Nexus Q3 Sales RMB2.43B Beat RMB2.37B Estimate", "summary": "", "symbols": ["DADA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957108/dada-nexus-q3-sales-rmb2-43b-beat-rmb2-37b-estimate", "tags": []}
{"id": 41957168, "time": "2024-11-13 17:04:12", "headline": "Stardust Power Q3 2024 GAAP EPS $(0.22) Down From $(0.02) YoY", "summary": "", "symbols": ["SDST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957168/stardust-power-q3-2024-gaap-eps-0-22-down-from-0-02-yoy", "tags": ["earnings"]}
{"id": 41957205, "time": "2024-11-13 17:05:15", "headline": "Cosan Q3 Net Profit R$293M Down From R$679M YoY", "summary": "", "symbols": ["CSAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957205/cosan-q3-net-profit-r-293m-down-from-r-679m-yoy", "tags": []}
{"id": 41957250, "time": "2024-11-13 17:06:51", "headline": "Kayne Anderson BDC Q3 2024 GAAP EPS $0.53 Beats $0.47 Estimate, Sales $57.82M Beat $48.04M Estimate", "summary": "", "symbols": ["KBDC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957250/kayne-anderson-bdc-q3-2024-gaap-eps-0-53-beats-0-47-estimate-sales-57-82m-beat-48-04m-estimate", "tags": ["earnings"]}
{"id": 41957259, "time": "2024-11-13 17:07:10", "headline": "SBC Medical Q3 2024 GAAP EPS $0.03 Down From $0.09 YoY, Total Revenues $53.08M Up From $47.28M YoY", "summary": "", "symbols": ["SBC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957259/sbc-medical-q3-2024-gaap-eps-0-03-down-from-0-09-yoy-total-revenues-53-08m-up-from-47-28m-yoy", "tags": ["earnings"]}
{"id": 41957295, "time": "2024-11-13 17:08:54", "headline": "SeaStar Medical Holding Q3 2024 GAAP EPS $(1.10) Beats $(1.13) Estimate, Sales $68.00K Miss $75.00K Estimate", "summary": "", "symbols": ["ICU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957295/seastar-medical-holding-q3-2024-gaap-eps-1-10-beats-1-13-estimate-sales-68-00k-miss-75-00k-estimate", "tags": ["earnings"]}
{"id": 41957303, "time": "2024-11-13 17:09:21", "headline": "Jones Trading Upgrades BrightSpire Capital to Buy, Announces $7.25 Price Target", "summary": "", "symbols": ["BRSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957303/jones-trading-upgrades-brightspire-capital-to-buy-announces-7-25-price-target", "tags": ["analyst_up"]}
{"id": 41957320, "time": "2024-11-13 17:10:16", "headline": "Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY", "summary": "", "symbols": ["SHPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957320/shuttle-pharmaceuticals-q3-eps-1-59-down-from-0-91-yoy", "tags": ["earnings"]}
{"id": 41957357, "time": "2024-11-13 17:11:35", "headline": "Bluejay Diagnostics Announces 1-For-50 Reverse Stock Split, Will Open For Trading On The Nasdaq Capital Market On A Post-Split Basis On November 18, 2024", "summary": "", "symbols": ["BJDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957357/bluejay-diagnostics-announces-1-for-50-reverse-stock-split-will-open-for-trading-on-the-nasdaq-capit", "tags": []}
{"id": 41957360, "time": "2024-11-13 17:11:39", "headline": "Eli Lilly Reports Detailed Results From Phase 3 SURMOUNT-1 Three-year Study; Says Tirzepatide In Adults With Pre-diabetes And Obesity Or Overweight Resulted In Sustained Weight Loss And Nearly 99% Remained Diabetes-Free At 176 Weeks", "summary": "", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957360/eli-lilly-reports-detailed-results-from-phase-3-surmount-1-three-year-study-says-tirzepatide-in-adul", "tags": ["fda"]}
{"id": 41957363, "time": "2024-11-13 17:11:55", "headline": "Chardan Capital Maintains Buy on Cargo Therapeutics, Maintains $28 Price Target", "summary": "", "symbols": ["CRGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957363/chardan-capital-maintains-buy-on-cargo-therapeutics-maintains-28-price-target", "tags": ["analyst_other"]}
{"id": 41957377, "time": "2024-11-13 17:12:52", "headline": "EZCORP Q4 2024 Adj EPS $0.26 Misses $0.27 Estimate, Sales $294.55M Beat $288.49M Estimate", "summary": "", "symbols": ["EZPW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957377/ezcorp-q4-2024-adj-eps-0-26-misses-0-27-estimate-sales-294-55m-beat-288-49m-estimate", "tags": ["earnings"]}
{"id": 41957435, "time": "2024-11-13 17:14:22", "headline": "Macquarie Maintains Underperform on AMC Enter Hldgs, Maintains $4 Price Target", "summary": "", "symbols": ["AMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957435/macquarie-maintains-underperform-on-amc-enter-hldgs-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 41957454, "time": "2024-11-13 17:15:11", "headline": "Cheetah Net Supply Chain Q3 2024 GAAP EPS $(1.06) Misses $(0.32) Estimate, Sales $61K Miss $900.00K Estimate", "summary": "", "symbols": ["CTNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957454/cheetah-net-supply-chain-q3-2024-gaap-eps-1-06-misses-0-32-estimate-sales-61k-miss-900-00k-estimate", "tags": ["earnings"]}
{"id": 41957518, "time": "2024-11-13 17:17:35", "headline": "Barrington Research Maintains Outperform on American Public Education, Raises Price Target to $24", "summary": "", "symbols": ["APEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957518/barrington-research-maintains-outperform-on-american-public-education-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 41957559, "time": "2024-11-13 17:17:48", "headline": "Heritage Commerce Says Vice President And CFO Lawrence McGovern Is Expected To Depart Company In February 2025; Thomas Sa To Assume Duties Of CFO On Interim Basis Beginning November 18", "summary": "", "symbols": ["HTBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957559/heritage-commerce-says-vice-president-and-cfo-lawrence-mcgovern-is-expected-to-depart-company-in-feb", "tags": ["management"]}
{"id": 41957615, "time": "2024-11-13 17:18:11", "headline": "Biofrontera Q3 EPS $(0.98) Misses $(0.83) Estimate, Sales $9.01M Miss $10.01M Estimate", "summary": "", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957615/biofrontera-q3-eps-0-98-misses-0-83-estimate-sales-9-01m-miss-10-01m-estimate", "tags": ["earnings"]}
{"id": 41957657, "time": "2024-11-13 17:19:45", "headline": "Chardan Capital Maintains Buy on Lexeo Therapeutics, Raises Price Target to $25", "summary": "", "symbols": ["LXEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957657/chardan-capital-maintains-buy-on-lexeo-therapeutics-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41957663, "time": "2024-11-13 17:19:52", "headline": "Faraday Future Enters Comprehensive Strategic Licensing Agreement With Grow Fandor; Receives Initial $250,000 Annual License Fee", "summary": "", "symbols": ["FFIE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957663/faraday-future-enters-comprehensive-strategic-licensing-agreement-with-grow-fandor-receives-initial", "tags": ["contract"]}
{"id": 41957706, "time": "2024-11-13 17:21:32", "headline": "Pure Cycle Q4 EPS $0.27 Up From $0.05 YoY, Sales $12.56M Up From $3.40M YoY", "summary": "", "symbols": ["PCYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957706/pure-cycle-q4-eps-0-27-up-from-0-05-yoy-sales-12-56m-up-from-3-40m-yoy", "tags": ["earnings"]}
{"id": 41957707, "time": "2024-11-13 17:21:34", "headline": "Macquarie Maintains Neutral on Getty Images Holdings, Raises Price Target to $3.75", "summary": "", "symbols": ["GETY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957707/macquarie-maintains-neutral-on-getty-images-holdings-raises-price-target-to-3-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41957727, "time": "2024-11-13 17:22:54", "headline": "L Catterton Agrees To Sell 2.35M ODDITY Class A Ordinary Shares Back To ODDITY For Total Cash Consideration Of $100M At Purchase Price Of $42.501 Per Share", "summary": "", "symbols": ["ODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957727/l-catterton-agrees-to-sell-2-35m-oddity-class-a-ordinary-shares-back-to-oddity-for-total-cash-consid", "tags": []}
{"id": 41957800, "time": "2024-11-13 17:25:11", "headline": "Dada Nexus Q3 Adj EPS $(0.03) Beats $(0.11) Estimate, Sales $367.06M Beat $329.44M Estimate", "summary": "", "symbols": ["DADA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41957800/dada-nexus-q3-adj-eps-0-03-beats-0-11-estimate-sales-367-06m-beat-329-44m-estimate", "tags": ["earnings"]}
{"id": 41957888, "time": "2024-11-13 17:26:51", "headline": "D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target", "summary": "", "symbols": ["CLNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957888/d-boral-capital-maintains-buy-on-clene-maintains-23-price-target", "tags": ["analyst_other"]}
{"id": 41957955, "time": "2024-11-13 17:29:50", "headline": "BWS Financial Maintains Buy on Shenandoah, Maintains $26 Price Target", "summary": "", "symbols": ["SHEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41957955/bws-financial-maintains-buy-on-shenandoah-maintains-26-price-target", "tags": ["analyst_other"]}
{"id": 41958050, "time": "2024-11-13 17:30:56", "headline": "Icahn Enterprises Prices Offering Of $500M Of 10.000% Senior Secured Notes Due 2029 In Private Placement", "summary": "", "symbols": ["IEP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958050/icahn-enterprises-prices-offering-of-500m-of-10-000-senior-secured-notes-due-2029-in-private-placeme", "tags": ["offering"]}
{"id": 41958058, "time": "2024-11-13 17:31:27", "headline": "BWS Financial Maintains Buy on A10 Networks, Raises Price Target to $24", "summary": "", "symbols": ["ATEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958058/bws-financial-maintains-buy-on-a10-networks-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 41958070, "time": "2024-11-13 17:33:16", "headline": "Trex Updates On Its Program To Expand Exclusivity With Existing Partners To Include Its Railing Products", "summary": "", "symbols": ["TREX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958070/trex-updates-on-its-program-to-expand-exclusivity-with-existing-partners-to-include-its-railing-prod", "tags": []}
{"id": 41958075, "time": "2024-11-13 17:33:44", "headline": "Macquarie Maintains Outperform on Spotify Technology, Raises Price Target to $500", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958075/macquarie-maintains-outperform-on-spotify-technology-raises-price-target-to-500", "tags": ["analyst_other", "price_target_up"]}
{"id": 41958095, "time": "2024-11-13 17:35:24", "headline": "Google's 'Holiday 100' Trending Gift List Features Sony, e.l.f. Beauty, Nike", "summary": "Google has released its Holiday 100 annual list of curated gift ideas based on Google search trends data and Google&#39;s Shopping graph dataset of 45 billion product listings.", "symbols": ["EL", "ELF", "GOOG", "GOOGL", "MAT", "NKE", "SONY"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/large-cap/24/11/41958095/googles-holiday-100-trending-gift-list-features-sony-e-l-f-beauty-nike", "tags": []}
{"id": 41958122, "time": "2024-11-13 17:35:49", "headline": "BWS Financial Maintains Buy on Eventbrite, Maintains $7 Price Target", "summary": "", "symbols": ["EB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958122/bws-financial-maintains-buy-on-eventbrite-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41958159, "time": "2024-11-13 17:39:02", "headline": "Barrington Research Maintains Outperform on Crawford, Raises Price Target to $13", "summary": "", "symbols": ["CRD", "CRD/A", "TSX:CRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958159/barrington-research-maintains-outperform-on-crawford-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 41958199, "time": "2024-11-13 17:40:40", "headline": "Barrington Research Maintains Outperform on VerifyMe, Maintains $1.5 Price Target", "summary": "", "symbols": ["VRME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958199/barrington-research-maintains-outperform-on-verifyme-maintains-1-5-price-target", "tags": ["analyst_other"]}
{"id": 41958250, "time": "2024-11-13 17:41:52", "headline": "Barrington Research Maintains Outperform on DHI Group, Maintains $7 Price Target", "summary": "", "symbols": ["DHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958250/barrington-research-maintains-outperform-on-dhi-group-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41958257, "time": "2024-11-13 17:43:01", "headline": "Barrington Research Maintains Outperform on Marcus, Maintains $24 Price Target", "summary": "", "symbols": ["MCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958257/barrington-research-maintains-outperform-on-marcus-maintains-24-price-target", "tags": ["analyst_other"]}
{"id": 41958266, "time": "2024-11-13 17:44:11", "headline": "Barrington Research Maintains Outperform on Alithya Group, Maintains C$3.5 Price Target", "summary": "", "symbols": ["TSX:ALYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958266/barrington-research-maintains-outperform-on-alithya-group-maintains-c-3-5-price-target", "tags": ["analyst_other"]}
{"id": 41958322, "time": "2024-11-13 17:47:11", "headline": "Barrington Research Maintains Outperform on Perdoceo Education, Raises Price Target to $32", "summary": "", "symbols": ["PRDO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958322/barrington-research-maintains-outperform-on-perdoceo-education-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 41958408, "time": "2024-11-13 17:49:58", "headline": "Barrington Research Maintains Outperform on Outfront Media, Maintains $21 Price Target", "summary": "", "symbols": ["OUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958408/barrington-research-maintains-outperform-on-outfront-media-maintains-21-price-target", "tags": ["analyst_other"]}
{"id": 41958471, "time": "2024-11-13 17:53:50", "headline": "D. Boral Capital Maintains Buy on US Energy, Maintains $2 Price Target", "summary": "", "symbols": ["USEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958471/d-boral-capital-maintains-buy-on-us-energy-maintains-2-price-target", "tags": ["analyst_other"]}
{"id": 41958582, "time": "2024-11-13 17:59:06", "headline": "D. Boral Capital Maintains Buy on Hoth Therapeutics, Maintains $5 Price Target", "summary": "", "symbols": ["HOTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958582/d-boral-capital-maintains-buy-on-hoth-therapeutics-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 41958625, "time": "2024-11-13 18:01:11", "headline": "Inspire Veterinary Q3 EPS $(0.38), Sales $4.05M Down From $4.12M YoY", "summary": "", "symbols": ["IVP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41958625/inspire-veterinary-q3-eps-0-38-sales-4-05m-down-from-4-12m-yoy", "tags": ["earnings"]}
{"id": 41958626, "time": "2024-11-13 18:01:28", "headline": "Tesla Short Sellers Down $8 Billion Since 2024 Election \u2014 And There Could Be More Pain Ahead", "summary": "Tesla short sellers are down big since the 2024 election with the stock soaring after Donald Trump won.", "symbols": ["TSLA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/trading-ideas/24/11/41958626/tesla-short-sellers-down-8-billion-since-2024-election-and-there-could-be-more-pain-ahead", "tags": []}
{"id": 41958637, "time": "2024-11-13 18:02:08", "headline": "D. Boral Capital Maintains Buy on FibroBiologics, Maintains $16 Price Target", "summary": "", "symbols": ["FBLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958637/d-boral-capital-maintains-buy-on-fibrobiologics-maintains-16-price-target", "tags": ["analyst_other"]}
{"id": 41958641, "time": "2024-11-13 18:02:31", "headline": "Apple Inveils Final Cut Pro 11, With Intelligent New Features", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958641/apple-inveils-final-cut-pro-11-with-intelligent-new-features", "tags": []}
{"id": 41958674, "time": "2024-11-13 18:04:54", "headline": "D. Boral Capital Maintains Buy on Marinus Pharma, Maintains $3 Price Target", "summary": "", "symbols": ["MRNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958674/d-boral-capital-maintains-buy-on-marinus-pharma-maintains-3-price-target", "tags": ["analyst_other"]}
{"id": 41958710, "time": "2024-11-13 18:07:50", "headline": "D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $15 Price Target", "summary": "", "symbols": ["RVPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958710/d-boral-capital-maintains-buy-on-reviva-pharmaceuticals-maintains-15-price-target", "tags": ["analyst_other"]}
{"id": 41958764, "time": "2024-11-13 18:12:18", "headline": "D. Boral Capital Maintains Buy on Geovax Labs, Maintains $18 Price Target", "summary": "", "symbols": ["GOVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958764/d-boral-capital-maintains-buy-on-geovax-labs-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 41958774, "time": "2024-11-13 18:14:23", "headline": "Telsey Advisory Group Maintains Market Perform on FIGS, Maintains $7 Price Target", "summary": "", "symbols": ["FIGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958774/telsey-advisory-group-maintains-market-perform-on-figs-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41958777, "time": "2024-11-13 18:15:06", "headline": "Driven By Facts: Cannabis Public Health Data Sets The Standard In Maryland", "summary": "Maryland&#39;s Cannabis Public Health Data Dashboard tracks youth use decline, increased emergency visits, and booming market sales post-legalization.", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/government/regulations/24/11/41958777/driven-by-facts-cannabis-public-health-data-sets-the-standard-in-maryland", "tags": []}
{"id": 41958795, "time": "2024-11-13 18:15:40", "headline": "Telsey Advisory Group Maintains Outperform on TJX Companies, Maintains $134 Price Target", "summary": "", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958795/telsey-advisory-group-maintains-outperform-on-tjx-companies-maintains-134-price-target", "tags": ["analyst_other"]}
{"id": 41958807, "time": "2024-11-13 18:17:46", "headline": "Telsey Advisory Group Maintains Outperform on On Holding, Raises Price Target to $62", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958807/telsey-advisory-group-maintains-outperform-on-on-holding-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 41958896, "time": "2024-11-13 18:19:30", "headline": "Telsey Advisory Group Maintains Outperform on Target, Maintains $195 Price Target", "summary": "", "symbols": ["TGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958896/telsey-advisory-group-maintains-outperform-on-target-maintains-195-price-target", "tags": ["analyst_other"]}
{"id": 41958902, "time": "2024-11-13 18:20:10", "headline": "Hemp Co. Wins $8.4M Grant From US Energy Dept. To Develop Carbon-Negative Building Materials", "summary": "Hempitecture wins $8.4M grant to expand carbon-negative building materials production in Tennessee, supporting U.S. clean energy goals.", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/markets/cannabis/24/11/41958902/hemp-co-wins-8-4m-grant-from-us-energy-dept-to-develop-carbon-negative-building-materials", "tags": []}
{"id": 41958912, "time": "2024-11-13 18:21:06", "headline": "Telsey Advisory Group Maintains Outperform on Walmart, Maintains $92 Price Target", "summary": "", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958912/telsey-advisory-group-maintains-outperform-on-walmart-maintains-92-price-target", "tags": ["analyst_other"]}
{"id": 41958939, "time": "2024-11-13 18:24:58", "headline": "Telsey Advisory Group Maintains Outperform on Grove Collaborative Hldgs, Maintains $2 Price Target", "summary": "", "symbols": ["GROV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41958939/telsey-advisory-group-maintains-outperform-on-grove-collaborative-hldgs-maintains-2-price-target", "tags": ["analyst_other"]}
{"id": 41959013, "time": "2024-11-13 18:26:37", "headline": "Telsey Advisory Group Maintains Market Perform on Steven Madden, Maintains $50 Price Target", "summary": "", "symbols": ["SHOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959013/telsey-advisory-group-maintains-market-perform-on-steven-madden-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 41959023, "time": "2024-11-13 18:28:06", "headline": "Telsey Advisory Group Maintains Market Perform on Honest Co, Raises Price Target to $6", "summary": "", "symbols": ["HNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959023/telsey-advisory-group-maintains-market-perform-on-honest-co-raises-price-target-to-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 41959076, "time": "2024-11-13 18:30:15", "headline": "Chardan Capital Maintains Buy on Avidity Biosciences, Maintains $65 Price Target", "summary": "", "symbols": ["RNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959076/chardan-capital-maintains-buy-on-avidity-biosciences-maintains-65-price-target", "tags": ["analyst_other"]}
{"id": 41959099, "time": "2024-11-13 18:33:48", "headline": "Chardan Capital Maintains Buy on Dyne Therapeutics, Maintains $50 Price Target", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959099/chardan-capital-maintains-buy-on-dyne-therapeutics-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 41959165, "time": "2024-11-13 18:41:56", "headline": "Chardan Capital Maintains Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target", "summary": "", "symbols": ["OBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959165/chardan-capital-maintains-buy-on-orchestra-biomed-hldgs-maintains-20-price-target", "tags": ["analyst_other"]}
{"id": 41959173, "time": "2024-11-13 18:43:53", "headline": "Jefferies Maintains Buy on DHT Holdings, Maintains $14 Price Target", "summary": "", "symbols": ["DHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959173/jefferies-maintains-buy-on-dht-holdings-maintains-14-price-target", "tags": ["analyst_other"]}
{"id": 41959178, "time": "2024-11-13 18:45:44", "headline": "Chardan Capital Maintains Buy on Prime Medicine, Lowers Price Target to $15", "summary": "", "symbols": ["PRME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959178/chardan-capital-maintains-buy-on-prime-medicine-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 41959196, "time": "2024-11-13 18:47:07", "headline": "Chardan Capital Maintains Buy on Femasys, Lowers Price Target to $8", "summary": "", "symbols": ["FEMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959196/chardan-capital-maintains-buy-on-femasys-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41959233, "time": "2024-11-13 18:48:17", "headline": "YouGov Poll Reveals What Women Want With Weed: Relax, Mindfulness And Great Deals", "summary": "The data sheds light on key trends shaping female consumer behavior, offering brands and marketers a valuable look into this market segment.", "symbols": [], "source": "benzinga", "author": "Nicol\u00e1s Jose Rodriguez", "url": "https://www.benzinga.com/general/health-care/24/11/41959233/yougov-poll-reveals-what-women-want-with-weed-relax-mindfulness-and-great-deals", "tags": ["offering"]}
{"id": 41959248, "time": "2024-11-13 18:48:50", "headline": "Telsey Advisory Group Maintains Outperform on Home Depot, Maintains $455 Price Target", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959248/telsey-advisory-group-maintains-outperform-on-home-depot-maintains-455-price-target", "tags": ["analyst_other"]}
{"id": 41959266, "time": "2024-11-13 18:51:43", "headline": "Barrington Research Maintains Outperform on Cars.com, Maintains $25 Price Target", "summary": "", "symbols": ["CARS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959266/barrington-research-maintains-outperform-on-cars-com-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 41959276, "time": "2024-11-13 18:54:09", "headline": "DA Davidson Maintains Buy on e.l.f. Beauty, Maintains $170 Price Target", "summary": "", "symbols": ["ELF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959276/da-davidson-maintains-buy-on-e-l-f-beauty-maintains-170-price-target", "tags": ["analyst_other"]}
{"id": 41959333, "time": "2024-11-13 18:56:32", "headline": "Chardan Capital Maintains Buy on Seres Therapeutics, Maintains $1.25 Price Target", "summary": "", "symbols": ["MCRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41959333/chardan-capital-maintains-buy-on-seres-therapeutics-maintains-1-25-price-target", "tags": ["analyst_other"]}
{"id": 41959476, "time": "2024-11-13 19:10:49", "headline": "FBI Raids Polymarket CEO Over Crypto Betting Platform's US Activities \u2014 He Fires Back: 'In The Face Of Adversity, We Build'", "summary": "FBI raids Polymarket CEO&#39;s residence for allowing US users to bet on elections, raising concerns of political targeting. Investigation ongoing.", "symbols": [], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41959476/fbi-raids-polymarket-ceo-over-crypto-betting-platforms-us-activities-he-fires-back-in-the-face-of-adversity-we-build", "tags": ["legal", "management"]}
{"id": 41959650, "time": "2024-11-13 19:23:15", "headline": "The Oncology Bet Is Already Paying Off For Pfizer", "summary": "With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew\u00a014% on an operational basis\u00a0due to approved cancer products from Seagen it acquired last December.", "symbols": ["MRNA", "MYNZ", "PFE", "TMO"], "source": "benzinga", "author": "Upwallstreet", "url": "https://www.benzinga.com/markets/penny-stocks/24/11/41959650/the-oncology-bet-is-already-paying-off-for-pfizer", "tags": ["earnings", "merger"]}
{"id": 41959036, "time": "2024-11-13 18:28:30", "headline": "Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General", "summary": "Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.", "symbols": ["CRLBF", "CURLF", "GTBIF", "MSOS", "TCNNF"], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/news/legal/24/11/41959036/trump-nominates-another-cannabis-supporter-to-cabinet-rep-matt-gaetz-for-attorney-general", "tags": []}
{"id": 41959718, "time": "2024-11-13 19:27:58", "headline": "Georgian Election Plunges Nation Into EU-Russian Deadlock", "summary": " ", "symbols": [], "source": "benzinga", "author": "European Capital Insights", "url": "https://www.benzinga.com/general/market-summary/24/11/41959718/georgian-election-plunges-nation-into-eu-russian-deadlock", "tags": []}
{"id": 41959787, "time": "2024-11-13 19:31:45", "headline": "Tradepulse Power Inflow Alert: Spotify Technology S.A. Climbs Over 5% After Tradepulse Alert", "summary": " ", "symbols": ["SPOT"], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/general/entertainment/24/11/41959787/tradepulse-power-inflow-alert-spotify-technology-s-a-climbs-over-5-after-tradepulse-alert", "tags": []}
{"id": 41959825, "time": "2024-11-13 19:36:35", "headline": "Buying In Stocks On Inflation Data, Musk And Ramaswamy Doge", "summary": "\n\n\n\nTo gain an edge, this is what you need to know today.", "symbols": ["AAPL", "AMZN", "BTCUSD", "F", "GLD", "GOOG", "META", "MSFT", "NVDA", "QQQ", "SLV", "SPY", "TLT", "TSLA", "USO"], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/general/market-summary/24/11/41959825/buying-in-stocks-on-inflation-data-musk-and-ramaswamy-doge", "tags": []}
{"id": 41959835, "time": "2024-11-13 19:37:41", "headline": "Trump Nominates Marco Rubio As Secretary of State, Calls Florida Senator A 'Powerful Voice For Freedom'", "summary": "Trump nominated Sen. Marco Rubio as Secretary of State, praising his leadership and anti-China stance, which aligns with Trump&#39;s proposed tariffs; Rubio expressed honor at the appointment.", "symbols": [], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/24/11/41959835/trump-nominates-marco-rubio-as-secretary-of-state-calls-florida-senator-a-powerful-voice-for-freedom", "tags": []}
{"id": 41959843, "time": "2024-11-13 19:38:11", "headline": "Trump Trade Update", "summary": " ", "symbols": ["BTBT", "HOOD", "TSLA"], "source": "benzinga", "author": "David Pinsen", "url": "https://www.benzinga.com/trading-ideas/24/11/41959843/trump-trade-update", "tags": []}
{"id": 41959976, "time": "2024-11-13 19:50:03", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["AKAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41959976/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41959977, "time": "2024-11-13 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["INM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41959977/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41960322, "time": "2024-11-13 20:23:26", "headline": "Palantir Co-Founder Peter Thiel On How Elon Musk Conquered Both Automobiles And Space\u2014And Why He'd 'Never Bet' Against The Tesla CEO", "summary": "Peter Thiel highlighted Elon Musk&#39;s success in transforming the auto and aerospace industries through Tesla and SpaceX by targeting weak competition and leveraging complex coordination of existing technologies.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/24/11/41960322/palantir-co-founder-peter-thiel-on-how-elon-musk-conquered-both-automobiles-and-space-and-why-hed-never-bet-against-the-tesla-ceo", "tags": ["management"]}
{"id": 41960463, "time": "2024-11-13 20:35:30", "headline": "Last Supermoon Of 2024: Tips To Take That Perfect Shot With Just Your Phone", "summary": "The final supermoon of 2024 appears on Thursday, with smartphone photography tips such as using a tripod, RAW mode, and apps for capturing its brighter, larger view.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/11/41960463/dont-miss-2024s-final-supermoon-heres-how-to-capture-stunning-photos-with-just-your-smartphone", "tags": []}
{"id": 41960485, "time": "2024-11-13 20:39:18", "headline": "Nvidia's Crypto Past Returns To Haunt As Supreme Court Signals Green Light For Lawsuit", "summary": "The U.S. Supreme Court has signaled its inclination to uphold a class-action lawsuit against Nvidia Corp for allegedly providing misleading information to investors about its reliance on cryptocurrency mining.", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/news/legal/24/11/41960485/nvidias-crypto-past-returns-to-haunt-as-supreme-court-signals-green-light-for-lawsuit", "tags": ["legal"]}
{"id": 41960639, "time": "2024-11-13 20:55:48", "headline": "Bitcoin Flirts With $100K, Dogecoin Edges Higher, Ethereum Dips As CPI Numbers Fuel Rate Cut Hopes: Analyst Says BTC Could See Over 180% Upside Due To This Bullish Pattern", "summary": "Bitcoin continued to make records as supportive inflation numbers raised the market&#39;s expectations of further interest rate cuts by the Federal Reserve.", "symbols": ["BTC", "BTCUSD", "DOGEUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41960639/bitcoin-flirts-with-100k-dogecoin-edges-higher-ethereum-dips-as-cpi-numbers-fuel-rate-cut-hopes-analyst-says-btc-could-see-over-180-upside-due-to-this-bullish-pattern", "tags": []}
{"id": 41960833, "time": "2024-11-13 21:18:11", "headline": "Cathie Wood Cashes Out On Rocket Lab's 28% Surge in $9M Share Sale But Expands Bet On Flying Cars", "summary": "Ark Invest made significant trades on Wednesday, selling Rocket Lab shares and purchasing Amazon, Archer Aviation, Joby Aviation shares on Wednesday Nov 13, 2024.", "symbols": ["ACHR", "AMD", "AMZN", "ARKQ", "ARKX", "JOBY", "RKLB"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/11/41960833/cathie-wood-cashes-out-on-rocket-labs-28-surge-in-9m-share-sale-but-expands-bet-on-flying-cars", "tags": []}
{"id": 41961022, "time": "2024-11-13 21:42:49", "headline": "Palantir, Amazon, Cisco, Intuitive Machines, And Tesla: Why These 5 Stocks Are On Investors' Radars Today", "summary": "On Wednesday, major U.S. indices showed mixed results: the Dow Jones Industrial Average edged up 0.1% to close at 43,958.19.", "symbols": ["AMZN", "CSCO", "LUNR", "PLTR", "TSLA"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/11/41961022/palantir-amazon-cisco-intuitive-machines-and-tesla-why-these-5-stocks-are-on-investors-radars-today", "tags": []}
{"id": 41961033, "time": "2024-11-13 21:45:37", "headline": "Gene Munster Says Elon Musk's DOGE Efficiency Plans Should Not Be Underestimated, But Warns 'It'll Likely Take Many Years' To Achieve $2 Trillion In Government Spending Cuts", "summary": "Deepwater Asset Management\u2019s managing partner Gene Munster has supported Tesla Inc. (NASDAQ:TSLA) and SpaceX CEO Elon Musk\u2019s ", "symbols": ["DOGEUSD", "TSLA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/news/24/11/41961033/gene-munster-says-elon-musks-doge-efficiency-plans-should-not-be-underestimated-but-warns-itll-likely-take-many-years-to-achieve-2-trillion-in-government-spending", "tags": ["management"]}
{"id": 41961054, "time": "2024-11-13 21:47:46", "headline": "SoftBank Is In Profit Once Again Thanks To Indian IPOs: What's Next For Masayoshi Son?", "summary": "SoftBank Group has made a significant financial turnaround, reporting a profit of $7.8 billion in its latest quarter, largely attributed to successful Indian IPOs and improved tech valuations.", "symbols": ["SFTBF", "SFTBY"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/11/41961054/softbank-returns-to-profit-driven-by-indian-ipos-whats-next-for-masayoshi-son", "tags": []}
{"id": 41961161, "time": "2024-11-13 22:02:04", "headline": "Ted Cruz Says Running DOGE Won't Be A Cake Walk, Offers Reading Advice To Elon Musk", "summary": "Senator Ted Cruz (R-Texas) anticipated the newly established Department of Government Efficiency (DOGE) department to yield \u201cgood results\u201d but warned that Elon Musk and Vivek Ramaswamy would have their work cut out.", "symbols": ["BTCUSD", "DOGEUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/24/11/41961161/musk-ramaswamy-headed-doge-department-will-be-an-incredibly-challenging-endeavor-says-ted-cruzshares-this-piece-of-advice", "tags": []}
{"id": 41961230, "time": "2024-11-13 22:23:50", "headline": "AMD Plans To Cut 4% Of Workforce Amid Strategic Shift Toward AI Chip Development To Rival Jensen Huang-Led Nvidia's Dominance: Report", "summary": "AMD is laying off about 1,000 employees, or 4% of its workforce, as part of a strategy shift to focus on competing with Nvidia in the high-demand AI data center chip market.", "symbols": ["AMD", "INTC", "MSFT", "NVDA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/11/41961230/amd-plans-to-cut-4-of-workforce-amid-strategic-shift-toward-ai-chip-development-to-rival-jensen-huang-led-nvidias-dominance-report", "tags": []}
{"id": 41961309, "time": "2024-11-13 22:43:10", "headline": "Rocket Lab CEO Touts SpaceX Rival Status, Trump Impact On Space As Stock Surges Almost 30%", "summary": "Rocket Lab USA Inc&#39;s stock surged nearly 30% in trading on Wednesday following strong third-quarter results, with CEO Peter Beck highlighting the company&#39;s expanding presence across multiple space sectors during an interview.", "symbols": ["RKLB"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/general/space/24/11/41961309/rocket-lab-ceo-touts-spacex-rival-status-trump-impact-on-space-as-stock-surges-almost-30", "tags": ["management"]}
{"id": 41961419, "time": "2024-11-13 23:08:40", "headline": "Bitcoin Proxy MicroStrategy Added More To Its Market Cap In Last 2 Months Than What Ford Is Worth Currently", "summary": "Bitcoin&#39;s (CRYPTO: BTC) bullish turn since early September has reflected well on MicroStrategy Inc. (NASDAQ:MSTR), with the proxy firm increasing its valuation by $50 billion in the last two months.", "symbols": ["BTCUSD", "CTSH", "F", "MSTR"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41961419/bitcoin-proxy-microstrategy-added-more-to-its-market-cap-in-last-2-months-than-what-ford-is-worth-currently", "tags": []}
{"id": 41961878, "time": "2024-11-13 23:48:47", "headline": "Mark Zuckerberg Teams Up With T-Pain For A Jaw-Dropping 'Get Low' Cover \u2014 Prepare For The Z-Pain Experience You Didn't Know You Needed", "summary": "Meta CEO Mark Zuckerberg teamed up with rapper T-Pain to release a slowed-down acoustic cover of Lil Jon&#39;s &#34;Get Low,&#34; sharing it on Instagram to celebrate a personal memory.", "symbols": ["META"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/general/entertainment/24/11/41961878/mark-zuckerberg-teams-up-with-t-pain-for-a-jaw-dropping-get-low-cover-prepare-for-the-z-pain-experience-you-didnt-know-you-needed", "tags": ["management"]}
{"id": 41932057, "time": "2024-11-13 04:11:22", "headline": "Chipotle's New CEO Scott Boatwright Will Make Millions, But It Will Still Be Half Of Ex-CEO Brian Niccol's Pay", "summary": "Chipotle Mexican Grill, Inc. announced Monday that Scott Boatwright, who served as interim CEO since August, will permanently lead the fast-casual restaurant chain with a compensation package valued less than half of his predecessor&#39;s pay.", "symbols": ["CMG"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/markets/equities/24/11/41932057/chipotles-new-ceo-scott-boatwright-will-make-millions-but-it-will-still-be-half-of-ex-ceo-brian-niccols-pay", "tags": ["management"]}
{"id": 41956632, "time": "2024-11-13 16:49:56", "headline": "Aytu Biopharma Said On November 11 Terminated CFO Mark K Oki; Named Ryan Selhorn As New CFO", "summary": "", "symbols": ["AYTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41956632/aytu-biopharma-said-on-november-11-terminated-cfdo-mark-k-oki-named-ryan-selhorn-as-new-cfo", "tags": ["management"]}
